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Reversible protein phosphorylation is a key regulatory mechanism for controlling 
various cellular processes that determine cell fate. Phosphorylation status is controlled 
by kinases and phosphatases, which phosphorylate and dephosphorylate specific residues 
in target proteins respectively. Protein Phosphatase 1 (PP1) is a major serine/threonine 
phosphatase that is highly conserved in eukaryotes. Its catalytic subunit (PP1c) 
associates with numerous subunits that target and regulate its activity to specific 
subcellular localisations and substrates to define its role in various processes. PP1 
Nuclear Targeting Subunit (PNUTS) is one of the most abundant regulatory subunits of 
PP1 in the nucleus. The aim of this work was to characterise a Drosophila orthologue of 
PNUTS and identify interacting proteins to further understand the role of PNUTS-PP1 in 
nuclear processes using various genetic and biochemical approaches. Mutational analysis 
revealed dPNUTS is essential for cell growth and survival as mutant animals die as 1st 
instar larvae and mutant cells are eliminated from developing tissues. PNUTS-PP1 co-
localise on Drosophila polytene chromosomes, with many sites also marked by RNA 
Polymerase II (RNAPII). Biochemical analysis revealed Serine 5 of the C-terminal 
domain of RNAPII (CTD-Ser5) is a possible substrate of PP1-dPNUTS. Various 
RNAPII-dependent genes are misregulated in dPNUTS mutant animals, including genes 
involved in metabolic processes, most likely as a consequence of deregulated CTD-Ser5 
phosphorylation. Another possible mechanism could be through regulation of histone 
modifications that determine gene expression patterns since clonal analysis revealed 
various histone marks are upregulated in dPNUTS and PP1 mutant cells. Methodologies 
to screen for regulatory enzymes affecting histone phosphorylation were also assessed. 
 
To further understand the role of dPNUTS in cell growth and development, a yeast two-
hybrid approach together with biochemical analysis was used to identify dPNUTS 
! 2 
interacting proteins. The top hit was dTOX4, the Drosophila homologue of 
LCP1/TOX4, which binds to PNUTS in humans. Mutational analysis revealed dTOX4 is 
essential for fertility in female and male adult flies. Homozygous mutant females 
displayed defects in nurse cell chromosome dispersal and abnormal dorsal-ventral 
patterning in the oocyte. Homozygous mutant males failed to complete spermatogenesis 
and exhibited a range of abnormal phenotypes in the testes, including defective 
cytokinesis, small nuclei, decondensed chromatin and Stellate crystal formation. Novel 
dPNUTS-interactors were also identified, which could offer further mechanistic insight 
into dPNUTS-PP1 function.  
! 3 
1. Introduction 
A major mechanism employed by cells to regulate intracellular signalling pathways 
that determine cell fate is reversible protein phosphorylation. Phosphorylation is a 
post-translational modification that acts to regulate protein activity by either 
activating or deactivating the target and can also affect protein localisation, stability 
and the ability to interact with other proteins. Phosphorylation state is finely balanced 
through the action of kinases and phosphatases, which phosphorylate and 
dephosphorylate proteins respectively. Protein kinases are responsible for catalysing 
the transfer of a phosphate group (PO32-) from adenosine triphosphate (ATP) to a 
specific residue in a protein target and protein phosphatases antagonise this reaction 
by removing the phosphate group (Figure 1.1). The importance of phosphorylation in 
the cell is highlighted by the fact that approximately one third of cellular proteins are 
regulated by phosphorylation and protein kinases are one of the largest families of 
proteins in eukaryotes with 518 members in humans, contributing 2% of the genome 
(Cohen, 2002b; Ubersax and Ferrell, 2007; Sacco et al., 2012).  
 
Protein phosphatases comprise approximately 200 members in humans and have 
been largely under-studied and under-appreciated in comparison to kinases because 
they were thought to have a non-specific role in regulating phosphorylation from in 
vitro studies (Sacco et al., 2012; Virshup and Shenolikar, 2009). However in vivo 
studies have revealed phosphatases are essential for maintaining appropriate levels of 
protein phosphorylation and play a key role in rapidly controlling various cellular 
activities in response to internal and external stimuli (Sacco et al., 2012; Virshup and 










 Figure 1.1. Reversible protein phosphorylation by kinases and phosphatases. 
Protein kinases transfer a phosphate group from ATP to the hydroxyl group of amino 
acids. Protein phosphatases catalyse the removal of the phosphate group. 
 
1.1. Discovery of protein phosphorylation 
Edmond Fischer and Edwin Krebs first uncovered the concept of phosphorylation in 
the 1950’s during studies on glycogen metabolism. They described how the 
conversion of inactive glycogen phosphorylase ‘b’ to active phosphorylase ‘a’ 
required ATP and was a result of the transfer of a phosphate group onto ‘a’ by 
phosphorylase kinase (Fischer and Krebs, 1955). Work on glycogen phosphorylase 
and its two forms had originated in the 1930’s when Carl and Gerty Cori described 
the requirement of adenylic acid (AMP) for phosphorylase ‘b’ activity, but not 
phosphorylase ‘a’, however, they did not know how the two forms were different 
(Fischer, 2010). The work done by Edmond Fischer and his colleagues revealed 















It was not realised at the time, how fundamental their finding was and since then 
phosphorylation has been shown to regulate not just glycogen metabolism but a large 
number of diverse cellular processes that determine cell fate including cell growth 
and proliferation, the cell cycle, apoptosis as well as numerous signal transduction 
pathways (reviewed in Bononi et al., 2011). This has led to protein phosphorylation 
being referred to as a major ‘molecular switch’ to control such physiological 
processes in response to various cues (Bononi et al., 2011). 
 
1.2. Classification of protein phosphatases 
In eukaryotes, the amino acids serine (ser), threonine (thr) and tyrosine (tyr) are 
predominantly targeted by phosphorylation, each accounting for 86.4, 11.8 and 1.8% 
of phosphorylated residues in humans respectively (Shi, 2009; Olsen et al., 2006). 
These form the basis of classification as phosphatases are grouped into families 
according to their substrate specificity. There are four major protein phosphatase 
families: 1) phosphoprotein phosphatases (PPPs); 2) metal-dependent protein 
phosphatases (PPMs); 3) aspartate based phosphatases (FCPs); and, 4) protein 
tyrosine phosphatases (PTPs) (Shi, 2009). The PPP, PPM and FCP families 
dephosphorylate serine and threonine residues and include the well-studied PPP, 
Protein Phosphatase 1 (PP1), the main subject of this work (Shi, 2009). The PTP 
family targets tyrosine for dephosphorylation and is divided into various classes, one 
being the dual-specificity protein phosphatases (DSPs), which dephosphorylate both 




1.3. Protein Serine/Threonine phosphatases (PSTPs) 
PSTPs are classified into the three distinct families based upon their biochemical 
properties and amino acid sequence homology (McConnell and Wadzinski, 2009). 
PPPs make up the largest family and are further classified into the following 
subfamilies: PP1, PP2A, PP2B (calcineurin), PP4, PP5, PP6 and PP7 (Shi, 2009; 
Bollen and Beullens, 2002).  The PPM family is derived from phosphatases that 
depend on magnesium/manganese (Mg2+/Mn2+) ions and comprises PP2C, PP2C 
‘like’ phosphatases and pyruvate dehydrogenase phosphatase (McConnell and 
Wadzinski, 2009). The FCP family is the smallest and most recently identified 
family and includes FCP1 and SCP1, which dephosphorylate Ser5 on the C-terminal 
domain of the largest RNA polymerase II (RNAPII) subunit (Yeo et al., 2003). 
 
1.3.1. The PPP family 
PP1 and PP2A have been extensively studied and are the two most abundant 
serine/threonine phosphatases, accounting for 90% of phosphatase activity in 
eukaryotes (Aggen et al., 2000; Virshup and Shenolikar, 2009; Moorhead et al., 
2007). Initial characterisation depended on their sensitivity to two inhibitors termed 
Inhibitor-1 (I-1) and Inhibitor-2 (I-2) and their ability to dephosphorylate either the $ 
or the % subunit of phosphorylase kinase (Cohen, 1989). Type 1, now known as PP1, 
targeted the % subunit and was sensitive to both inhibitors whereas Type 2, now 
known as PP2, targeted the $ subunit and was insensitive to both inhibitors (Cohen, 
1989). Type 2 phosphatases were further characterised into the three distinct 
enzymes we know today by their dependence on divalent cations, with PP2A not 
requiring them at all and PP2B and PP2C (a PPM, see 1.3.7) requiring calcium 
(Ca2+) and magnesium (Mg2+) respectively, for activity (Cohen, 1989).   
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All members of the PPP family have a structurally similar catalytic subunit, which 
consists of a %-sheet between two $-helices and therefore display a similar 
mechanism of action, which was used to identify the newer members of the family 
(Shi, 2009). Their activity is distinguished by the proteins they interact with and this 
is determined by their exposed loops, which specify the shape and charge of the 
surface of the protein and their affinity for different ligands (Bollen et al., 2010; 
Heroes et al., 2013). There are less than 40 serine/threonine phosphatases in the 
human genome, which counteract approximately 300 serine/threonine kinases and a 
similarly high ratio is seen in Drosophila (Cohen, 2002b). This has led to the 
questions: how is such versatility achieved with such a small number of catalytic 
subunits and how can they regulate the phosphorylation status of so many proteins 
individually? (Bollen et al., 2010). We now know this is possible due to the 
association of PPP catalytic subunits with numerous regulatory subunits that form 
distinct holoenzymes. These target PPPs to particular tissues and subcellular 
localisations and determine their substrate specificity and phosphatase activity by 
enhancing or suppressing their catalytic activity towards particular substrates 
(Virshup and Shenolikar, 2009).  
 
1.3.2. PP1c 
Protein Phosphatase 1 (PP1) is a major protein serine/threonine phosphatase that is 
highly conserved in all eukaryotes (Shi, 2009; Ceulemans, 2004). Its catalytic 
subunit (PP1c) is responsible for dephosphorylating and regulating thousands of 
independent protein targets in vivo, which is possible due to its broad specificity 
(Cohen, 2002b). In mammals, three PP1 catalytic subunit (PP1c) genes exist, namely 
PP1$, PP1%/& and PP1', from which two splice variants (PP1'1 and PP1'2) are 
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generated; all are ubiquitously expressed apart from PP1'2, which is enriched in the 
testes (Ceulemans, 2004). Drosophila encodes four PP1c genes, which are named 
according to their cytological locations: PP1!87B, PP1!96A, PP1!13C, which are 
related to mammalian PP1$/PP1', and PP1"9C, which is related to PP1%/& (Bennett 
and Alphey, 2007; Cohen, 2002b; Dombrádi et al., 1993). The level of conservation 
between each PP1c isoform is very high (>85%) and their enzymatic activities are 
very similar, which has made it difficult to study their specificity using biochemical 
analysis (Bennett and Alphey, 2007; Kirchner et al., 2008). For this reason, a lot of 
work has been done to identify PP1c regulatory subunits that target PP1 to different 
subcellular localisations and regulate its activity towards specific substrates involved 
in a diverse array of cellular and developmental processes including the cell cycle, 
transcription, apoptosis, RNA processing and intracellular signalling (Cohen, 2002b; 
Trinkle-Mulcahy et al., 2003; Jerebtsova et al., 2011).  
 
Various strategies have been used to identify PP1-interacting proteins (PIPs) 
including classical biochemical approaches, yeast two-hybrid screens, in silico 
methods, affinity chromatography and antibody arrays (Bollen et al., 2010). To date, 
PP1 is known to interact with approximately 200 proteins in humans, creating 
numerous stable PP1 holoenzymes that target separate and distinct substrates (Heroes 
et al., 2013).  With so many regulatory subunits already discovered, it is clear how 
PP1 can be involved in many independent processes and it highlights the importance 
of PP1 and phosphorylation in the cell. It also raises the question, how can so many 
unrelated and structurally distinct proteins interact with PP1. This has been partly 
answered through the discovery of a short canonical sequence K/R/H/N/S-(x)-V/I/L-
x-F/W/Y (where x is any amino acid) generally referred to as the RVxF motif in PIPs 
! 9 
(Zhao and Lee, 1997). This motif is present in approximately 70% of PIPs and 
interacts with a hydrophobic channel in PP1c that is distant from the catalytic site of 
the enzyme, therefore binding of RVxF proteins does not have a major effect on the 
activity of the phosphatase (Egloff et al., 1997; Bollen, 2001; Bollen et al., 2010). 
Instead, it is believed the motif functions as an anchor for PP1 to allow other contacts 
to be made with various regulatory subunits that determine its activity and substrate 
specificity (Bollen, 2001). Other PP1 docking motifs exist in PIPs, including the 
SILK-motif, which contains the consensus sequence G/SILR/K and the MyPhoNE 
(Myosin Phosphatase N-terminal Element) motif which interacts with the consensus 
sequence RxxQVI/LK/RxY/W (where x is any amino acid) (Hendrickx et al., 2009). 
 
1.3.3. Drosophila PP1c 
PP1!87B is the major PP1c isoform in Drosophila, accounting for approximately 
80% of the total PP1 activity in Drosophila larvae (Dombrádi et al., 1990). 
Mutational and inhibitory analysis of PP1!87B in Drosophila has revealed it is 
essential for survival as mutants die as larvae and is necessary for proper 
chromosome segregation, condensation and spindle organisation during mitosis 
(Axton et al., 1990; Wang et al., 2008). Certain homozygous mutant alleles of 
PP1!87B also suppress position-effect variegation (PEV), a phenomenon whereby 
genes become silenced upon translocation to a heterochromatic region by 
chromosomal rearrangements (reviewed in Schotta et al., 2003). PP1"9C and 
PP1!96A each contribute approximately 10% of the total PP1 activity (Bennett and 
Alphey, 2007). PP1"9C corresponds to the flapwing (flw) gene, with weak mutant 
alleles exhibiting crumpled or blistered wings and defects in the indirect flight 
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muscles, which render them flightless and stronger mutant alleles displaying semi 
lethality and degeneration of the indirect flight muscles (Raghavan et al., 2000).  
 
Mutational analysis of PP1!96A revealed it is not an essential gene and unlike 
PP1!87B, it does not suppress PEV (Kirchner et al., 2007). It genetically interacts 
with PP1"9C as PP1!96A mutants enhance a weak PP1"9C mutant allele and has a 
role in regulating non-muscle myosin (Kirchner et al., 2007). Complementation 
analysis revealed that a certain level of redundancy exists between the different PP1 
isoforms. PP1!96A and PP1"9C are redundant with PP1!87B, as the lethal 
phenotype of PP1!87B transheterozygous mutants can be rescued by overexpressing 
PP1!96A and PP1"9C, suggesting lethality is a consequence of a reduction in total 
PP1 activity (Kirchner et al., 2007). However, ectopic PP1"9C cannot rescue 
PP1!87B, PP1!96A double mutants and a PP1"9C mutant cannot be rescued by 
overexpression of PP1!87B or PP1!96A, suggesting non-overlapping functions do 
exist between the different isoforms (Kirchner et al., 2007). PP1!13C is the most 
recently identified member of the PP1 family and exhibits low levels of expression 
and is not essential for viability (Dombrádi et al., 1993; Clyne et al., 1999; Bennett et 
al., 2006).  
 
1.3.4. PP1c regulatory subunits 
Given PP1 is the main phosphatase in eukaryotes, a lot of work has been done to 
identify PP1 regulatory subunits to understand its role and regulation in various 
cellular processes. Some PIPs serve to regulate PP1 activity towards different 
substrates and are sometimes themselves targets of PP1 dephosphorylation. Other 
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PIPs act more to target PP1 and other interacting proteins to various substrates but 
have no role in regulating PP1 activity and others serve as both regulatory and 
targeting subunits. Many of the regulatory subunits that do not serve to target PP1 are 
inhibitor proteins, some of which are only present in particular tissues and 
subcellular localisations. Inhibitor proteins that interact with PP1 in humans include 
I-1 (PPP1R1A)/DARPP-32 (dopamine and cAMP-regulated phosphoprotein Mr 
32000), which is mainly present in the brain but also the kidney (Hemmings et al., 
1984; Cohen, 2002b) and I-2 (PPP1R2), which also interacts with PP1 in Drosophila 
and is widely distributed (Bennett et al., 2006; Wang et al., 2008).  
 
The concept that PP1 associates with targeting/regulatory subunits came from studies 
on glycogen metabolism (Strålfors et al., 1985). These revealed PP1 has an important 
role in the metabolic response to insulin signals and at least four regulatory subunits 
associate with PP1 that target it to glycogen; GM (R3, PPP1R3A), GL (R4, 
PPP1R3B), R5 (PTG, PPP1R3C) and R6 (PPP1R3D) (Cohen, 2002b). These 
subunits have distinct spatial expression patterns and act as molecular scaffolds for 
PP1 and its metabolic substrates. Substrates that are targeted and regulated by PP1 in 
glycogen metabolism include glycogen phosphorylase, which becomes deactivated 
upon dephosphorylation by PP1 as well as glycogen synthase and phosphorylase 
kinase (Dent et al., 1990; Newgard et al., 2000). Other regulatory subunits have been 
identified that implicate PP1 in smooth muscle relaxation by associating with M110 
(Myosin phosphatase targeting subunit) to dephosphorylate the myosin P-light chains 
at Ser19 (Cohen, 2002b) and apoptosis by interacting with and dephosphorylating 
Bcl-2 proteins that control the permeability of the outer mitochondrial membrane 
(Garcia et al., 2003; Cohen, 2002b). 
! 12 
1.3.5. Nuclear PP1c targeting/regulatory subunits 
The role of PP1 in glycogen metabolism and myosin targeting has been well studied 
but such roles only represent cytosolic forms of PP1. PPPs, including PP1, are 
known to be enriched in the nucleus with PPPs in general showing a 2-10 fold higher 
concentration compared to the cytoplasm, yet they don’t have a canonical nuclear 
localisation signal (Bollen and Beullens, 2002). They are targeted to the nucleus via 
association with regulatory subunits that specify their role in various nuclear 
processes including transcription, mRNA processing, mitosis and chromosome 
decondensation (Landsverk et al., 2005). Major regulatory/targeting subunits 
identified to date include Nuclear Inhibitor of PP1 (NIPP1) (Van Eynde et al., 1995) 
and the PP1 Nuclear Targeting Subunit (PNUTS, p99) (Allen et al., 1998), both of 
which are conserved and bind to PP1 in Drosophila (Bennett et al., 2006). The 
PNUTS-PP1 holoenzyme is the main focus of this thesis and a discussion of its 
structure and function can be found in Chapter 3. NIPP1 is an RNA binding protein 
(Jagiello et al., 1997) and a nuclear inhibitor of PP1c (Van Eynde et al., 1995). It is 
distributed in the nucleus as nuclear speckles, where it largely co-localises with 
factors involved in pre-mRNA splicing including small nuclear ribonucleic proteins 
(snRNPs) and targets PP1 to dephosphorylate and activate proteins required for the 
first catalytic step of splicing (Trinkle-Mulcahy et al., 1999). 
 
As previously mentioned, some regulatory subunits of PP1 do not target it to a 
specific location but to specific substrates and in some cases the interacting protein is 
the substrate itself. The well known tumour suppressor Retinoblastoma (Rb) is an 
example of this and is a major regulator of the eukaryotic cell cycle and cell 
proliferation, implicating PP1 as an important phosphatase in regulating cell growth 
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and development (Berndt and Ludlow, 2004; van den Heuvel and Dyson, 2008). Rb 
activity is controlled by its phosphorylation status at several serine/threonine 
residues, which are targeted by PP1. Rb becomes activated upon dephosphorylation, 
allowing it to repress expression of cell cycle genes by sequestering the E2F1-3 
transcription factors that control gene expression of cell cycle related genes such as 
cyclin E and cyclin A (Kolupaeva and Janssens, 2012). However, recent evidence 
suggests other PP1 regulatory subunits may be responsible for targeting PP1 to Rb 
and regulating its phosphorylation status in response to various cues such as 
oxidative stress and hypoxia, including the myosin targeting subunit M110 and 
PNUTS (Udho et al., 2002)  (see Kolupaeva and Janssens, 2012, for a review). 
Finally the Trithorax group (TrxG) of epigenetic regulators have been shown to bind 
PP1c on polytene chromsomes in Drosophila (Rudenko et al., 2003). TrxG proteins 
are required for the normal expression of genes including homeotic genes and PP1 is 
believed to regulate Trx dependent transcriptional control but whether it is a 
substrate of PP1 itself remains to be determined (Rudenko et al., 2003). 
 
1.3.6. Regulatory subunits of other PPP’s 
Like PP1, PP2A is known to be involved in a diverse array of physiological 
processes including mitosis, signal transduction, transcription and translation, 
metabolism, cell proliferation, DNA replication and apoptosis (Rivers, 1996; 
Seshacharyulu et al., 2013). PP2A is a heterotrimeric holoenzyme consisting of a 
structural A subunit, a variable regulatory B subunit that determines substrate 
specificity, localisation and phosphatase activity and a catalytic C subunit, which can 
be regulated by post-translational modifications to control association with various 
B-type subunits (Sents et al., 2013). In humans, there are at least four families of B 
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subunits, namely PR55 (B), PR61 (B’), PR72 (B”) and PR93/PR110 (B’”) each 
encoded by several genes that have tissue and subcellular specific expression patterns 
(Janssens and Goris, 2001; Janssens et al., 2008; Lambrecht et al., 2013). For 
example PR55 is encoded by four genes; PR55!, PR55", PR55# and PR55$ with 
PR55$ showing a wide-spread tissue distribution and PR55% being enriched in the 
brain (Janssens and Goris, 2001). These B-type regulatory subunits target the PP2A 
holoenzyme to different substrates such as Rb, which is targeted by PR70/B” (a 
member of the PR72 family) and mitogen-activated protein kinase (MAPK), which is 
targeted by PR61/B’ (Kolupaeva and Janssens, 2012; Janssens et al., 2008). PP2A 
holoenzymes are also critical regulators of the Bcl-2 and PI3K-Akt signalling 
pathways (Garcia et al., 2003). 
 
1.3.7. The PPM Family 
Protein phosphatases belonging to the PPM family are present in both eukaryotes and 
prokaryotes and were not only characterised by their requirement for exogenous 
bivalent metal ions but also their insensitivity to inhibitors of the PPP family, 
including the broad-spectrum inhibitor okadaic acid (Barford, 2010; Lammers and 
Lavi, 2007). The defining member is PP2C, which shares no sequence similarity with 
members of the PPP family but comparison of the crystal structures revealed PP2C 
has a similar tertiary structure and catalytic domain architecture, which is formed by 
two anti-parallel %-sheets flanked by two antiparallel $-helices (Barford, 2010). So 
far, at least 16 PP2C genes have been identified in humans with several of them 
shown to be involved in cell growth and cell cycle progression by regulating cyclin-
dependent kinase (CDK) activity (Cheng et al., 2000) and cellular stress pathways 
such as the MAPK stress activated signalling pathway (Hanada et al., 1998) (for a 
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review see Lammers and Lavi, 2007). Unlike PPPs they do not associate with 
regulatory subunits for controlling activity and instead are likely to be regulated by 
spatially specific expression, post-translational modifications and degradation 
(Lammers and Lavi, 2007) 
 
1.3.8. The FCP Family 
FCP1 is the major member of the FCP family and is highly conserved throughout 
eukaryotes. It is an essential gene required for the recycling of hyperphosphorylated 
RNA polymerase II (RNAPII) and directly targets the C-terminal domain (CTD) of 
RNAPII for dephosphorylation (Kamenski et al., 2004; Yeo et al., 2003). SCP1 is 
the newest member of the family and also targets the CTD of RNAPII for 
dephosphorylation at Serine 5, with a preference for RNAPII that has been 
phosphorylated by TFIIH (Yeo et al., 2003).  
 
1.4. Protein Tyrosine Phosphatases (PTPs) 
PTP’s are only present in eukaryotes and were originally thought to have a 
housekeeping role in signal transduction pathways (Tonks and Neel, 2001). Instead, 
it is now known they are a large superfamily of related proteins and are involved in 
numerous signalling pathways that regulate gene transcription, mRNA processing, 
cell growth and differentiation (Alonso et al., 2004; Tonks and Neel, 2001). They are 
defined by the catalytic sequence motif H-C-X-X-G-X-X-R in their active site and 
can be subdivided into classical PTPs (those that target only tyrosine) and dual 
specificity phosphatases (DSPs) that target tyrosine and serine/threonine (Tonks and 
Neel, 2001). Classical PTPs can be subdivided into transmembrane receptor-like 
(includes CD45 and PTP$/%/'/µ/() and non-transmembrane (includes PTP1B and 
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SHP1/2) (Tonks and Neel, 2001). DSPs are also subdivided into VHR-like and 
Cdc25 and also include the well-known tumour suppressor PTEN, which can 
dephosphorylate both proteins and lipids. DSPs are able to dephosphorylate tyrosine 
and serine/threonine due to the formation of a shallow catalytic site. This allows the 
shorter side chains of serine and threonine to reach the cysteine residue that sits in 
the active site whereas classical PTPs have a deep active site which only allows the 
longer side chain of tyrosine to reach the cysteine residue (Böhmer et al., 2012).  
 
1.5. RNA polymerase II phosphorylation 
Studies on PP1 have often focused on its role in transcriptional regulation and in 
2002, Washington et al., described the carboxy-terminal domain (CTD) of RNA 
polymerase II (RNAPII) as a target of PP1 (Washington et al., 2002). RNAPII is one 
of three eukaryotic, highly conserved nuclear DNA-dependent RNA polymerases 
and is responsible for the synthesis of various classes of RNA including all mRNA 
and many noncoding RNAs (Hahn, 2004; Hsin and Manley, 2012). The CTD of its 
largest subunit, Rbp1 (possesses the enzyme’s catalytic activity), is well 
characterised and comprises a consensus heptapeptide repeat, Y1S2P3T4S5P6S7, which 
is subject to phosphorylation on its five hydroxylated amino acids (Tyr-1, Ser-2, Thr-
4, Ser-5 and Ser-7 but principally Ser-2 and Ser-5) (Phatnani and Greenleaf, 2006). 
The number of heptapeptide repeats varies between species from 26 in yeast to 45 in 
Drosophila and 52 in mammals (Hirose and Manley, 2000; Egloff and Murphy, 
2008).  Regulation of CTD phosphorylation by various CTD kinases and 
phosphatases (see Hsin and Manley, 2012 for review) is essential throughout the 
different stages of transcription and for coordinating events required for RNA 
synthesis and processing for maturation of the transcript (Hsin and Manley, 2012). It 
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is required for the recruitment of various histone modifiers, chromatin modifying 
complexes to influence transcription and various enzymes and complexes that are 
necessary for processing mRNA to mature RNA for export from the nucleus (Hsin 
and Manley, 2012). Phosphorylation at different residues alters the structure of 
RNAPII and its ability to interact with the various different factors (Rosado-Lugo 
and Hampsey, 2014; Egloff and Murphy, 2008; Hintermair et al., 2012).   
 
Before transcription initiation, the CTD is unphosphorylated (designated RNAPIIA) 
when it is recruited to the promoter and forms part of the preinitiation complex but 
upon initiation the CTD becomes hyperphosphorylated (designated RNAPIIO) and a 
pattern of phosphorylation begins, marking the different stages of transcription (Hsin 
and Manley, 2012). Ser-5 phosphorylation occurs concomitantly with transcription 
initiation and peaks around the transcription start site (TSS) (Hsin and Manley, 
2012). It is essential for coupling transcription to the first mRNA processing event, 
5’ capping, by associating with the capping enzyme (guanylytransferases) (Schroeder 
et al., 2000; Komarnitsky et al., 2000). As the nascent RNA emerges from RNAPII 
shortly after initiation, when it reaches 20-30 nucleotides in length, the capping 
enzyme adds a methylguanosine cap to the 5’ end to stabilise and regulate the 
nascent mRNA (Egloff and Murphy, 2008; Schroeder et al., 2000).   
 
As RNAPII clears the promoter and enters the elongation phase, dynamic changes in 
phosphorylation occur as Ser-5 becomes gradually dephosphorylated and Ser-2 
becomes phosphorylated until the end of genes (as RNAPII nears termination) when 
both are dephosphorylated and RNAPII is recycled for another round of transcription 
(Hsin and Manley, 2012; Buratowski, 2009). It is thought phosphorylation of Ser-2 is 
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required for RNAPII to enter the elongation phase (Egloff and Murphy, 2008). There 
is much evidence to suggest elongating RNAPII is responsible for coupling 
transcription to splicing, the next stage of RNA processing. Most mRNAs contain 
introns, which are removed by a large macromolecular complex termed the 
splicesome during splicing to produce functional RNAs. Various splicing factors 
have been shown to associate with phosphorylated RNAPII and specifically the 
elongating form including mammalian CA150 and U2AF65, to activate and enhance 
splicing and thus couple this RNA processing event to transcription (David et al., 
2011; Hsin and Manley, 2012; Hirose and Manley, 2000; Egloff and Murphy, 2008).     
 
The final stage of RNA processing, polyadenylation is also coupled to transcription 
through the CTD phosphorylated at Ser-2. Polyadenylation is a two-step process 
marked by the polyadenylation signal at the 3’end of protein coding genes, where 
ChIP analysis suggests most of the Ser-5 phosphorylation has been lost (Egloff and 
Murphy, 2008; Komarnitsky et al., 2000). The first stage is endonucleolytic cleavage 
followed by Poly(A) tail synthesis by a very complex set of proteins, to stabilise the 
RNA for export from the nucleus and to aid translation (Shi et al., 2009; Hsin and 
Manley, 2012). Several 3’ end processing factors are known to interact with the CTD 
including the polyadenylation cleavage factor (Pcf)11, which directly binds to CTD 
repeats phosphorylated at Ser-2 (Egloff and Murphy, 2008; Meinhart and Cramer, 
2004; Hsin and Manley, 2012). Both the Poly(A) signal in RNA and Ser-2 
phosphorylation are thought to contribute to the recruitment and assembly of the 
polyadenylation complex (for review see Hsin and Manley, 2012). There is also 
evidence to suggest the interaction between the CTD and polyadenylation factors 
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contribute to transcription termination, for example Pcf11 has been linked to 
termination (Buratowski, 2009). 
 
Other residues of the heptapeptide repeat are also phosphorylated but their exact 
roles are poorly understood. Ser-7 has been shown to somewhat overlap with Ser-5 
phosphorylation at the start of transcribed genes but has also been shown to peak at 
the 3’ end of genes (Egloff and Murphy, 2008; Egloff et al., 2012). It has been 
demonstrated to be required for the recruitment of the integrator complex, which is 
involved in 3’ end processing of snRNA genes (Egloff et al., 2012). Thr-4 
phosphorylation overlaps with Ser-2 phosphorylation towards the 3’ end of 
transcribed genes and it appears to be dependent on Ser-2 phosphorylation (Hsin and 
Manley, 2012; Hintermair et al., 2012; Egloff and Murphy, 2008; Svejstrup, 2012).  
This phospho site has been implicated in transcription elongation and may therefore 
be essential for linking transcription to splicing (Hintermair et al., 2012). No clear 
function has been linked to Try-1 phosphorylation. 
 
1.6. Protein phosphorylation and disease 
Aberrant phosphorylation has been linked to many pathological conditions including 
cancer, Alzheimer’s, diabetes and autoimmune disease (He et al., 2014; Stebbing et 
al., 2014; Ma et al., 2013). As kinases and phosphatases are the enzymes that control 
the phosphorylation state of proteins, they have been the targets of therapeutic 
compounds to treat these diseases using inhibitors. Together they make up 26% of 
the druggable genome, which is predicted based on what makes a good drug (e.g. 
degree of potency) and what makes a good drug target (e.g. the number of ligand 
binding domains, implicated in human disease) (Hopkins and Groom, 2002; Pandey 
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and Nichols, 2011). As kinases contribute the larger portion of that percentage, with 
22%, they have been the main focus for the development of therapeutic compounds 
to treat diseases characterised by abnormal phosphorylation patterns (Hopkins and 
Groom, 2002). Their popularity as drug targets is demonstrated by the fact that 
approximately 30% of drug discovery programs in the pharmaceutical industry are 
targeting kinases (Cohen, 2002a). One of the better-known examples of the 
successful use of a kinase inhibitor to treat disease is Rapamycin. This inhibits the 
protein kinase mammalian Target of Rapamycin (mTOR), which is involved in cell 
growth, proliferation and survival through the PI3K signalling pathway and T-cell 
proliferation (Cohen, 2002a; Ballou and Lin, 2008). It has successfully been used for 
the treatment of cancer and as an immunosuppressant for patients undergoing organ 
transplants (Ballou and Lin, 2008). Another famous example is Imatinib (otherwise 
known as Gleevec), a tyrosine kinase inhibitor, to treat chronic myeloid leukemia as 
well as other malignancies that involve expression of a tyrosine kinase (Dulucq and 
Krajinovic, 2010).  
 
It is only in recent years that efforts have been made to study the clinical potential of 
phosphatases and discover therapeutic compounds that target them, but their 
successful use in treatment is made difficult by their broad specificity (Figueiredo et 
al., 2014). Most phosphatases are involved in numerous signalling pathways and 
cellular processes and manipulation of their activity could be detrimental without a 
deep understanding of how they achieve selectivity in these processes (Figueiredo et 
al., 2014). The only phosphatase inhibitor that is approved for clinical use is 
Cyclosporin A, which targets the serine/threonine phosphatase PP2B/calcineurin and 
is used as an immunosuppressant for organ transplants (McConnell and Wadzinski, 
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2009). As we now know, specificity is achieved through temporal and spatial 
association with protein complexes and regulatory subunits that target phosphatases 
to specific substrates (Faux and Scott, 1996). Therefore identification and 
characterisation of these complexes and subunits will aid in the development of 
therapeutic compounds that can selectively target a broad phosphatase in a particular 
pathway or process. Small molecules are already being developed to target 
regulatory subunits in phosphatase complexes specific to a physiological process. 
Guanabenz binds to the PP1 regulatory subunit GADD34 to prevent 
dephosphorylation of the transcription initiation factor eIF2" in stress conditions 
(Tsaytler et al., 2011). Under stress conditions, dephosphorylation of eIF2" leads to 
the accumulation of misfolded proteins, which can be lethal, therefore the use of 
Guanabenz could be relevant for the treatment of conditions characterised by the 
accumulation of misfolded proteins (Tsaytler et al., 2011). 
 
PP2A is a well-established tumour suppressor showing reduced expression in various 
human cancers as well as other diseases such as Alzheimer’s and other 
neurodegenerative disorders. Pre-clinical studies are already underway to identify 
pharmacological compounds that can restore PP2A in such diseases and even 
inhibitors of PP2A that lead to cancer cell death (Lambrecht et al., 2013). 
 
1.7. Drosophila as a model organism 
Drosophila melanogaster has been used as a model organism for over a century due 
to its rapid generation time, easy manipulation, genetic tractability and the wealth of 
sophisticated genetic tools and resources available for functional genomic studies. It 
has become a predominant model for the study of numerous aspects of biology, 
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which has become more significant with the discovery that genes necessary for 
development in Drosophila also play a role in mammalian development (Jennings, 
2011). It is the origin of many significant discoveries in the history of science, 
including the finding by Thomas Hunt Morgan, who won the Nobel Prize in 
Physiology and Medicine in 1933, for his work in Drosophila showing chromosomes 
are the carriers of genetic traits (Rubin and Lewis, 2000; Pandey and Nichols, 2011). 
Morgan was also responsible for the isolation of the first Drosophila mutant as a way 
to characterise gene function, which was followed by Muller in 1927, who 
discovered gene mutations could be generated by exposure to x-rays (Muller, 1927). 
Since then a large collection of Drosophila mutations have been generated using 
ionising radiation and other classical chemical mutagenesis approaches such as the 
alkylating agent ethyl methanesulphonate (EMS) and are widely available to 
researchers. 
 
Muller was also responsible for the development of balancer chromosomes, to allow 
stocks of homozygous lethal mutations to be maintained as balanced heterozygotes 
(Muller, 1918; Hentges and Justice, 2004). Balancer chromosomes have multiple 
inversions to suppress recombination and a dominant phenotypic marker such as 
curly wings (CyO) to enable tracking of chromosomes across generations (Hentges 
and Justice, 2004). They are also recessive lethal so the balancer chromosome cannot 
exist in the homozygous state and the experimental chromosome cannot be lost 
(Hentges and Justice, 2004). Since the development of balancer chromosomes in 
Drosophila other model systems have adopted this tool in functional genomic studies 
including the mouse and Caenorhabditis elegans (C.elegans) (Boles et al., 2009; 
Kile et al., 2003).  
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The available resources for functional genomic studies was further increased after the 
Drosophila genome was successfully sequenced and annotated in March 2000, 
becoming the first major complex organism to have its genome sequenced (Adams et 
al., 2000; Jennings, 2011). This greatly enhanced already existing online tools such 
as FlyBase, a database of Drosophila genes and a resource for Drosophila related 
data and information (Pierre et al., 2014). The significance of sequencing the fly 
genome was highlighted a few years later after sequencing of the human genome was 
completed. It became apparent a significant degree of homology exists between the 
two genomes, which supports the use of Drosophila as a model organism to study 
various aspects of human biology and disease. A staggering 77% of disease causing 
genes in humans have a Drosophila orthologue and this data has been consolidated 
into an online database called Homophila, which links the two genomes to aid 
Drosophila studies addressing human disease (Reiter et al., 2001; Chien et al., 2002). 
This is further supported by FlyAtlas, a database of gene expression data from 9 
adult tissues (brain, head, testis, ovaries, crop, midgut, male accessory glands, 
hindgut and Malpighian tubules), based on micro-array data (Chintapalli et al., 
2007). This helps to identify the best tissues in which to study genes of interest and is 
particularly relevant as human disease genes often show a similar tissue expression 
pattern to their homologues in Drosophila (Chintapalli et al., 2007). 
 
1.7.1. Drosophila transposable elements 
Many of the tools used for studying gene function in Drosophila have been 
revolutionised by P-element mediated transgenesis (Ejsmont and Hassan, 2014). P-
elements are transposable (mobile) genetic DNA elements (transposons) that 
naturally occur in wild Drosophila strains. They are present in many organisms and 
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can integrate into genomes with the catalytic help of the enzyme transposase for 
germ line transmission when injected into G0 Drosophila embryos (Venken and 
Bellen, 2007). The source of transposase can either be genetically encoded in the P-
element (autonomous) or external, for example in an engineered construct (non-
autonomous) (Ryder and Russell, 2003). They are an efficient method for 
introducing foreign DNA into the Drosophila genome for various approaches to 
study gene function including genetic rescue (Rubin and Spradling, 1982), 
generating mutants by their insertion or excision (Cooley et al., 1990; Cooley et al., 
1988) and gene cloning (Searles et al., 1982).  
 
The use of non-directed P-elements for generating transgenic strains does have 
limitations. Integration into the genome is random and to identify the desired site 
specific transgenic insertion event requires extensive genetic screening. Random 
integration means position effects can complicate analysis as regulation of the 
transgene is influenced by the surrounding chromatin environment, with insertion 
into a heterochromatic region resulting in repression of the transgene (Venken and 
Bellen, 2007). For integration of genomic rescue constructs it is necessary to control 
the site in which it is integrated to avoid position effects. Furthermore large DNA 
fragments (>40kb) cannot be integrated as they are unstable in high copy number 
plasmids in bacteria, which hampers the study of large genes (Venken et al., 2006). 
These limitations have been overcome using the irreversible bacteriophage )C31 
(phiC31) integrase for site specific transgenesis (Groth et al., 2004). This allows site-
specific integration into the genome by catalysing recombination between two 
engineered docking sites in the Drosophila genome, the phage attachment (attP) and 
the bacterial attachment (attB) to create attL and attR sites (Venken et al., 2006). It 
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also enables integration of large DNA fragments (>100kb) into the Drosophila 
genome using low-copy number plasmids such as BAC (Bacterial Artificial 
Chromosome), which have been modified by including an inducible oriV origin of 
replication to amplify plasmid copy number (Venken et al., 2006; Venken and 
Bellen, 2007). 
 
1.7.2. The Drosophila Gene Disruption Project 
The Drosophila Gene Disruption Project (GDP) was established in 1991 and 
exploited the properties of transposons to disrupt gene function using insertional 
mutagenesis, to generate a genome wide collection of mutants for analysing gene 
function (Bellen, 2004; Spradling et al., 1999). This project generated a public 
collection of mutant strains, with genes disrupted through the insertion of a P- 
transposable element at the 5’ end of individual genes (Bellen et al., 2011). 
Annotation of the genome enabled more strains to be generated and by 2004 
approximately 40% of Drosophila genes had at least one strain carrying a P-element, 
which are available from the Bloomington Stock Centre (Bellen, 2004). To increase 
genome coverage and generate stronger loss-of-function alleles other transposable 
elements have been used including piggyBac (Thibault et al., 2004; Handler and 
Harrell, 1999), mariner (Garza et al., 1991) and minos (Metaxakis, 2005; Loukeris et 
al., 1995; Ryder and Russell, 2003; Venken and Bellen, 2007), which has likely 
increased gene coverage closer to 65% (Venken and Bellen, 2005). Transposable 
elements have different target site specificities with P-elements showing bias for the 
5’ end of genes, as well as distinctive ‘hotspots’ (sites that attract insertion of 
transposable elements at a high frequency) and ‘coldspots’, as well as different gene 
targets, with piggyBac targeting genes encoding transcription and chromatin factors 
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and genes involved in growth and behaviour (Bellen et al., 2011). In most strains 
gene function is directly affected but the transposable elements are also useful tools 
for generating additional mutations through imprecise excision (see Chapter 5) and 
for determining chromatin structure by utilising the position effects seen upon 
random integration (Bellen et al., 2011).     
 
1.7.3. The GAL4/UAS binary system in Drosophila 
P-element transgenesis has provided the Drosophila community with a range of 
other tools that can be used to study gene function. Probably the most revolutionary 
example described by Brand and Perrimon in 1993, is the use of the yeast 
GAL4/UAS binary expression system to ectopically express genes or transgenes in a 
cell or tissue specific manner and to fine-tune expression patterns both temporally 
and spatially in Drosophila (Brand and Perrimon, 1993). GAL4 is a transcription 
factor identified in the yeast Saccharomyces cerevisiae, which binds to the Upstream 
Activating Sequence (UAS) to activate transcription. A P-element carrying a UAS is 
inserted near the 5’ end of an experimental gene in one parental strain and is crossed 
to another parental strain carrying a GAL4 driver, which expresses GAL4 in a 
spatially specific pattern (Figure 1.2). In the progeny, the experimental gene is 
expressed in a pattern that reflects the driver used to mediate GAL4 expression. A 
range of GAL4 drivers are publicly available to target gene expression to various 
tissues including the ovaries, testis, imaginal discs and brain as well as specific cells 
such as the border cells in the ovary. Expression of GAL4 can be further refined 
using the GAL80 repressor, which binds to the carboxy-terminal of GAL4 and 
prevents it from activating transcription. This is the basis of the TARGET (temporal 
and regional gene expression targeting) system, which uses a temperature sensitive 
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variant of GAL80 (GAL80ts) under the control of the tubulin promoter (tubGAL80ts) 
to temporally control gene expression (McGuire et al., 2003). When raised at 
18/22°C, GAL80 remains bound to GAL4 and represses GAL4-mediated expression 
of UAS (Figure 1.2b). Upon shifting to 25/29°C, GAL80 repression is relieved to 
enable expression of UAS by GAL4 (Figure 1.2c). This approach is particularly 
useful when studying developmentally lethal gene mutations as it allows expression 
of these mutant transgenes to be induced after the lethal phase. 
 
The GAL4/UAS system can also be combined with heritable RNA interference 
(RNAi) technology to target knockdown of experimental genes to specific tissues or 
cells (Dietzl et al., 2007). Heritable RNAi is discussed in Chapter 6 but briefly gene 
knockdown can be achieved by expressing double stranded ‘hairpin’ RNA by 
cloning an experimental gene fragment as an inverted repeat (Kennerdell and 
Carthew, 2000). Expression of the gene specific inverted repeat can be under the 
control of the GAL4/UAS system to ectopically achieve gene knockdown in different 
tissues at any stage of development. Various resources are available that supply 
strains containing inverted repeat constructs downstream of UAS to allow users to 
cross to the desired GAL4 driver (Dietzl et al., 2007). The Transgenic RNAi Project 
(TRiP) is one of those resources, which used )C31 mediated integration to 

























































Figure 1.2 (previous page). The GAL4/UAS binary and TARGET systems in 
Drosophila. a) The yeast transcriptional activator GAL4 is expressed in a spatially 
restricted pattern specifically defined by an enhancer/driver. The GAL4 protein binds 
to UAS sites in the Drosophila genome and activates transcription of the 
experimental gene (gene X), which lies downstream of the UAS. b,c) GAL80ts is a 
temperature sensitive inhibitor of GAL4 mediated expression. At the restrictive 
temperature (18 or 22°C) GAL80 binds to the carboxy-terminal of GAL4 and 
represses its activity. At the permissive temperature (25 or 29°C) GAL80 repression 
is relieved, allowing GAL4 to activate transcription of the experimental gene. d) The 
GAL4/ UAS system can also be used to target knockdown of experimental genes to 
specific tissues/cells. An inverted repeat for the experimental Gene X is positioned 
downstream of UAS. Upon transcription activation by GAL4 under the control of a 
tissue/cell specific enhancer/driver a dsRNA hairpin structure is produced. 
 
1.7.4. The Flp/FRT system 
The Flp/FRT system is another tool that has benefited from P-element transgenesis 
(Golic and Lindquist, 1989). This system can be used to generate mosaic tissues 
composed of cells with different genotypes to study genes involved in developmental 
processes (Theodosiou and Xu, 1998). It utilises an enzyme derived from yeast 
called flippase (Flp) to induce mitotic recombination between Flippase Recognition 
Target (FRT) sites that have been inserted on homologous chromosomes at specific 
cytological locations close to the centromere (Golic and Lindquist, 1989). Flp and 
FRTs are usually integrated using site-specific P-element mediated transgenesis. In a 
heterozygous parent, one chromosome carries a wild type allele of the gene of 
interest and the other carries a mutant allele, on the same chromosome arm as the 
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FRT site. The wild type allele is usually marked by green fluorescent protein (GFP) 
under the control of a ubiquitous promoter and presence of the mutant allele is 
negatively marked by absence of GFP. Upon recombination between the FRT sites, 
tissues have a mix of GFP positive homozygous wild type cells (often referred to as a 
‘twin spot’) and GFP negative homozygous mutant cells allowing the behaviour of 
mutant cells to be directly compared to that of wild type in the same tissue (Figure 
1.3). Although FRT-mediated recombination has a much higher recombination rate 
compared to other methods used to induce recombination such as irradiation, it is not 
100% efficient and some cells will remain in the heterozygous state (Blair, 2003). 
Expression of Flp is usually under the control of an inducible promoter, most 
commonly a heat shock promoter, to allow temporal control over the induction of 
mitotic recombination. This is necessary when studying genes involved in cell 
growth and cell survival, allowing control over the size of the clonal patch, with 
clones induced early during development producing large patches and clones induced 
late producing smaller but more numerous clonal patches (Blair, 2003). Stocks are 
available with FRTs inserted at various locations on each of the chromosome arms as 
well as various strains that express Flp under the control of the heat shock inducible 
promoter.  
 
In some experiments it is an advantage to generate large patches of mutant cells. This 
can be achieved by giving them a growth advantage in developing tissues using 
dominant mutations at Minute (M) loci (Morata and Ripoll, 1975). Minutes are a 
class of mutants that carry mutations in genes encoding various ribosomal proteins 
(e.g. RpL27a) resulting in death in homozygous animals due to cell lethality 
(Amoyel and Bach, 2014). Heterozygous animals are viable but exhibit delayed 
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development due to a reduction in cell division rates (Amoyel and Bach, 2014; 
Marygold et al., 2007). In a homotypic environment heterozygous animals eventually 
produce a normal organism but when induced in a wild type background they are 
eliminated due to cell competition (Amoyel and Bach, 2014). In the context of the 
Flp/FRT system, M alleles can be recombined onto wild type chromosome arms 
bearing an FRT site so that wild type cells exhibit delayed growth in comparison to 
their mutant counterpart. This is particularly useful when studying genes involved in 






























Figure 1.3. The Flp/FRT system for generating mosaic tissues. Upon heat shock, 
expression of the enzyme flippase (FLP) induces recombination between FRT sites 
on homologous chromosome arms. A ubiquitous GFP marker is also present on the 
same chromosome arm as the experimental wild type allele. During mitosis 
recombinant chromosomes are segregated producing two daughter cells with one 
carrying two copies of the mutant allele (negatively marked by absence of GFP) and 
one carrying two copies of the wild type allele (positively marked by presence of 
GFP). An example of a Drosophila wing imaginal disc with mosaic clones is shown 





























positively marked homozygous wild type patches (white plus sign). Heterozygous 
cells are also GFP positive as they carry one copy of the wild type allele. 
 
1.8. Research Aims 
The aim of this research was to explore the in vivo role of the PP1 regulatory subunit 
PNUTS in Drosophila and to identify and characterise PNUTS interacting proteins to 
provide further insight into the complex regulation and targeting of PP1 and PNUTS 
in the nucleus. The identification of new substrates of the PNUTS-PP1 holoenzyme 
in the nucleus was also explored to understand its role in various nuclear processes. 
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2. Materials and methods 
2.1. Commonly used media and solutions 
LB (Luria-Bertani) Broth (BDH laboratory supplies)  
Required for growth of bacterial strains: 1.0% (w/v) Tryptone, 0.5% (w/v) Bacto-
yeast extract and 1.0% (w/v) NaCl dissolved in pure deionised water (pH 7.0) and 
autoclaved before use. 
 
LB Agar (BDH laboratory supplies)  
Required for growth of bacterial strains on solid plates: 1.0% (w/v) Tryptone, 0.5% 
(w/v) Bacto-yeast extract, 1.0% (w/v) NaCl and 1.6% (w/v) agar dissolved in pure 
deionised water (pH 7.0). Autoclaved and cooled to 55°C before adding the 
appropriate antibiotic, pouring into plates and allowing to set. Stored at 4°C. 
 
Apple juice agar 
For egg laying experiments: 15g agar powder dissolved in 335ml pure deionised 
water by gentle heating. 8g sucrose dissolved in 165ml Apple Juice plus 2ml 10% 
(v/v) Nipagen. Apple juice/sucrose/nipagen solution then added to agar once slightly 
cooled and poured into 35mm plates and allowed to set. Stored at 4°C. 
 
SOC (Super Optimal Broth) medium (Life Technologies) 
A nutrient-rich bacterial growth medium, which enables higher transformation 
efficiencies of plasmids: 2.0% (w/v) Tryptone, 0.5% (w/v) Yeast Extract, 10mM 




Complete Schneider’s Insect Medium  
Schneider’s Insect Medium (with L-glutamine and sodium bicarbonate, Sigma) 
substituted with 10% (v/v) heat inactivated Foetal Calf Serum (FCS, Gibco) and 
Penicillin-Streptomycin (Invitrogen) to a final concentration of 50 units Penicillin G 
and 50µg/ml Streptomycin sulphate. 
 
Tris-EDTA (TE) Buffer (Sigma)  
For resuspension of DNA: 10mM Tris-Cl pH 7.5 and 1mM EDTA 
(Ethylenediaminetetraacetic acid). 
 
ChromoTek lysis buffer  
Optimised by the manufacturer for GFP-trap immunoprecipitation and enables 
efficient cell lysis a protein solubilisation while avoiding protein degradation and 
interference with the proteins immunoreactivity and biological activity: 10mM Tris-
Cl pH 7.5, 150mM NaCl, 0.5mM EDTA and 0.5% (v/v) NP-40. 
 
2%  SDS sample buffer  
Laemmli sample buffer (Sigma) was used for protein extraction and loading of 
protein samples onto SDS-polyacrylamide gels for SDS-PAGE and Western 
Blotting: 4% SDS, 20% glycerol, 10% (v/v) 2-mercaptoethanol, 0.004% (w/v) 






1%  SDS-PAGE Running Buffer  
For protein separation during SDS-polyacrylamide gel electrophoresis: 25mM Tris 
(Anachem), 250mM Glycine (Anachem) pH8.3 and 0.1% (v/v) SDS dissolved in 
pure deionised water. 
 
Tris-glycine Transfer Buffer  
For protein transfer from SDS-PAGE gels to nitrocellulose membrane: 25mM Tris, 
193mM glycine and 20% (v/v) methanol in pure deionised water. 
 
Tris-buffered saline with Tween (TBST)  
For washing nitrocellulose membranes for during western blotting: 150mM NaCl, 
10mM Tris-HCl and either 0.1% or 0.05% (v/v) Tween-20 (SIGMA) diluted in pure 
deionised water. 
 
3.7%/ 10% (w/v) Paraformaldehyde (Sigma)  
3.7% for fixing Drosophila tissue and 10% for fixing S2R+ cells. An approximately 
37% stock was made by dissolving 0.185g in 500µL (+7µL 1M NaOH to aid 
solubilisation) 1 x PBS at 95°C for 5 minutes. Absolute concentration was 
determined after incubation and diluted accordingly for the each experiment. 
 
Blocking solution (Drosophila tissues)  




Blocking buffer (Western Blots) 
5% (w/v) Marvel skimmed milk powder or 5% (w/v) Bovine Serum Albumin (BSA, 
Sigma Aldrich) in 0.05% TBST 
 
PBS (Purchased as 10%  stock solution from Roche) 
1 * solution: 137mM NaCl, 2.7mM KCl, 8mM Na2HPO4, 2mM KH2PO4  
 
PBST (Drosophila tissues)  
1 * PBS, 0.1% (v/v) Triton X-100 
 
1 %  TAE buffer  
0.04M Tris-acetate, 1mM EDTA in pure deionised water. 
 
Testis buffer 
183mM KCl, 47mM NaCl, 10mM Tris-HCl, pH 6.8 in pure deionised water. 
 
2.2. Chromatin Immunoprecipitation (ChIP) buffers/reagents 
10 x buffer A stock (store at room temperature) 
600mM KCl, 150mM NaCl, 150mM Hepes-KOH, pH 7.6, 10mM EDTA, 1mM 
EGTA, 100mM Sodium Butyrate, autoclaved pure deionised water. 
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1 x complete buffer A stock (make on day of assay)  
10 x buffer A stock, 0.15mM spermine, 0.5mM spermidine, 0.5mM DTT, autoclaved 
pure deionised water. 
 
Buffer A+ (make on day of assay) 
1 x complete buffer A, 12mM EDTA, 0.5% (v/v) NP-40, 1 x Protease Inhibitor 
Cocktail (PIC, Roche cOmplete ULTRA mini EDTA-free tablets), 1mM 
Phenylmethylsulphonyl Fluoride (PMSF, SIGMA). 
 
Buffer AS (make on day of assay)  
1 x complete buffer A, 10% (w/v) sucrose. 
 
Buffer A+NP-40 (make on day of assay)  
10 x buffer A stock, 0.1% (v/v) NP-40, autoclaved pure deionised water. 
 
37% (w/v) Paraformaldehyde (Sigma), stock solution for crosslinking 
An approximately 37% stock was made by dissolving 0.185g in 500µL (+7µL 1M 
NaOH to aid solubilisation) 1 x PBS at 95°C for 5 minutes. Absolute concentration 
was determined after incubation and diluted accordingly for the each sample to a 




Nuclei Lysis Buffer (store stock at room temperature)  
1% (v/v) SDS, 50mM Tris-HCl pH 8.0, 10mM EDTA, 10mM Sodium Butyrate. 
 
TE Buffer (store stock at room temperature)  
10mM Tris-HCl pH 8.0, 1mM EDTA. 
 
Chromatin IP buffer  
25mM Tris-HCl pH 8.0, 137mM NaCl, 2.7mM KCl, 1% (v/v) Triton X-100, 1mM 
EDTA, 10mM Sodium Butyrate. 
 
RIPA Buffer  
140mM NaCl, 10mM Tris-HCl pH 8.0, 1mM EDTA, 1% Triton X-100, 0.1% (w/v) 
Sodium Deoxicolate, 0.1% (v/v) SDS. Add 1mM PMSF (SIGMA) immediately 
before use. 
 
Lithium Chloride (LiCl) Buffer  
250mM LiCl, 10mM Tris-HCl pH 8.0, 1mM EDTA, 1% Triton X-100, 0.1% (w/v) 





2.3. Bacterial lines and vectors used 
One Shot"  Top 10 chemically competent E.coli (Life Technologies)  
F- mcrA !( mrr-hsdRMS-mcrBC) #80lacZ!M15 ! lacX74 recA1 araD139 !( 
araleu)7697 galU galK rpsL (StrR) endA1 nupG 
 
dam!/dcm! Competent E.coli (New England Biolabs)  
ara-14 leuB6 fhuA31 lacY1 tsx78 glnV44 galK2 galT22 mcrA dcm-6 hisG4 rfbD1 




Table 2.1. Vector details 
Vector Type Source/stock # Main Features Resistance 












































Ampicillin, kanamycin and chloramphenicol were prepared as 100mg/ml, 50mg/ml 
and 35mg/ml filter-sterilised stock solutions respectively and stored at -20°C. 
Ampicillin was used at a concentration of 100µg/ml, kanamycin at 50µg/ml and 
chloramphenicol at 12.5µg/ml. 
 
2.4. Cell lines used 
Drosophila Schneider Receptor + (S2R+) cells 
A highly adherent cell line derived from Drosophila Schneider (S2) cells, originally 
isolated from early stage (20-24 hours old) Drosophila embryos, which possesses the 
wingless receptors Dfrizzled-1 and Dfrizzled-2 (Schneider, 1972; Yanagawa et al., 
1998). 
 
2.4.1. Initiating cultures from frozen stocks 
Cells were quickly thawed at room temperature and resuspended in 5ml complete 
Schneider’s medium (see section 2.1) in a 15ml centrifuge tube. The cells were 
centrifuged at 1500 x g for 5 minutes and the supernatant discarded to remove 
DMSO present in the storage medium. The cells were resuspended in 10ml fresh 
complete Schneider’s medium and split into two 25cm2 tissue culture flasks (5ml 
each). The cells were incubated at 28°C for 3-4 days until they reached a density of 
6-20 x106 cells/ml. 
 
2.4.2. Passaging S2R+ cells 
Upon reaching optimum confluency, the most adherent cells were selected for by 
gently tapping the flask to remove the least adhered cells. The excess medium was 
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discarded and adhered cells were resuspended in 10ml fresh complete medium by 
washing the surface of the flask. The cells were split 1:3 (5ml resuspended cells in 
10ml fresh complete Schneider’s medium) in 75cm2 flasks. 
 
2.5. Growth and maintenance of Drosophila 
Fly stocks were kept at 18°C, 22°C or 25°C on standard yeast/dextrose medium (1% 
(w/v) agar, 7.3% (w/v) dextrose, 5% (w/v) yeast, 6.7% (w/v) organic wholemeal 
flour, 0.25% (v/v) nipagin, 0.3% (v/v) propionic acid) in 30/50ml vials or 250ml 
bottles as appropriate. Flies were anaesthetised with CO2 and examined using Nikon 
SMZ-645 or Nikon SMZ-800 microscopes and Photonics 200 light sources using 
standard fly-pushing techniques (Greenspan, 2004). Fly stocks were ordered from the 
Vienna Drosophila RNAi Centre (VDRC, Austria), The National Institute of 
Genetics (NIG-FLY, Japan) and The Bloomington Stock Centre (Indiana, USA). 
Crosses were kept at 25°C and transferred to fresh vials every 2-3 days. 
 
2.6. Drosophila genotypes used  
2.6.1. For induction of PNUTS13B and wild type clones (For crossing schemes see 
Appendix 1) 
 
hsFLP122; Ubi-GFPnls, FRT40A/Cyo (made by Daimark Bennett in house) 
(Made using Bloomington stock 5629 and hsFLP122; en-GAL4, UAS-GFP/Cyo; 
TM2/TM6B as a source of Flippase. Expresses the enzyme Flippase under the 




w; dPNUTS13B, FRT40A/Cyo (made in house by Daimark Bennett) 
(dPNUTS null allele) 
 
w; M(2)24F, Ubi-GFPnls, FRT40A/Gla, Bc (gift from Daniela Grifoni) 
(M(2)24F is a dominant minute allele of ribosomal protein RpL27A, ubiquitously 
expresses GFP in the nucleus) 
 
hsFLP122; dPNUTS13B, FRT40A/Cyo (made in house by Daimark Bennett) 
(Expresses Flippase enzyme under control of Hsp70 promoter, dPNUTS null allele) 
 
hsFLP122/hsFLP122; en-GAL4, UAS-GFP/Cyo; TM2/TM6B (gift from Laura 
Johnston) 
(Source of hsFLP122 – expresses Flippase enzyme under control of Hsp70 promoter, 
ignore en-GAL4, UAS-GFP – this was not needed) 
 
w; P[w+]30C, FRT40A (Bloomington stock # 1646) 
(A strain carrying a P transposon that carries a wild type white gene to generate wild 
type clones in the wing disc. This strain was used to make genotype below) 
 
hsFLP122/hsFLP122; P[w+]30C, FRT40A/Cyo (made by author) 
(To generate wild type clones in the wing disc, expresses the enzyme Flippase under 





Final genotypes analysed: 
hsFLP122; dPNUTS13B, FRT40A/ Ubi-GFPnls, FRT40A 
hsFLP122; dPNUTS13B, FRT40A/ m(2)24F, Ubi-GFPnls, FRT40A 
hsFLP122; FRT40A, P[w+]30C/m(2)24F, Ubi-GFPnls, FRT40A 
 
2.6.2. For induction of PP1 mutant clones in salivary gland (For crossing 
scheme see Appendix 2) 
 
hsFLP122; +/Cyo; Ubi-GFPnls, FRT82B/TM6B (made in house by Daimark 
Bennett) 
(Expresses the enzyme Flippase under the control of the Hsp70 promoter, 
ubiquitously expresses GFP in the nucleus) 
 
w;;FRT82B, PP187BSu(var)3-6[1]/TM6B (gift from Luke Alphey) 
(Hypomorphic allele of PP187B – Flybase ID: FBal0013933) 
 
Final genotype analysed: 
hsFLP122; ;FRT82B, PP187BSu(var)3-6[1]/ Ubi-GFPnls, FRT82B 
 
2.6.3. For figure S6B – RNAPII phosphor marks in L1 larvae 
w1118; dPNUTSexKG/dPNUTSexKG (made in house by Daimark Bennett) 
(dPNUTS allele with P-element precisely excised) 
 
w1118; dPNUTS9B/dPNUTS9B (made in house by Daimark Bennett) 
(dPNUTS mutant allele) 
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2.6.4. For ChIP from L3 larvae 
w1118 (Bloomington # 6326) 
(isogenic for autosomes) 
 
da-GAL4, UAS-HM-dPNUTSW726A line1 (provided by Daimark Bennett) 




2.6.5. To make dTOX4null allele (For crossing scheme see Appendix 3) 
 
 
y1w67c23;;P{EPgy2}CG12104EY02201 (Bloomington # 15089) 
(P-element inserted in 5’UTR of CG12104) 
 
w*; Dr1/TMS, P{!2-3}99B (Transposase, Bloomington # 1610) 
(Source of transposase for remobilisation of P-elements) 
 
DrMio/TMS, P{!2-3}99B (Transposase, Bloomington # 406) 
(Source of transposase for remobilisation of P-elements) 
 
w; Tft/CyO; MKRS/TM6B (gift from Shengjiang Tan) 




2.6.6. For dTOX4 mutant analysis 
w1118 (Bloomington # 6326) 
(isogenic for autosomes) 
 
w; +/CyO; dTOX4null/ dTOX4null (homozygous dTOX4 mutant stock made in 
house by author, see 2.6.5) 
 
w; +/CyO; dTOX4null/ TM6B (heterozygous dTOX4 mutant stock made in house 
by author, see 2.6.5) 
 
 
2.6.7. To make GFP-dTOX4wt and GFP-dTOX4P216" overexpression rescue 
strains (For crossing schemes see Appendix 4) 
 
 
w; +/CyO; dTOX4 null/TM6B (made in house by author, see 2.6.5) 
(heterozygous dTOX4 mutant allele) 
 
w; Tft/Cyo; bam-GAL4-VP16  (gift from Helen White-Cooper) 
(GAL4-VP16 fusion protein expressed under the control of the bag of marbles gene 
promoter) 
 
w; maternal-"-tubulin-GAL4-VP16 (Bloomington # 7062) 
(GAL4-VP16 fusion protein expressed under the control of the maternal alpha 




w; Tft/CyO; MKRS/TM6B (gift from Shengjiang Tan) 
(source of balancer chromosomes) 
 
UAS-GFP-dTOX4wt and UAS-dTOX4P216! on second or third chromosomes (made 
by Cambridge fly facility over different balancers for author) 
(For overexpression of GFP tagged wild type and mutant dTOX4) 
 
w; da-GAL4/CyO (gift from Shengjiang Tan ) 




2.6.8. For PNUTS, PTEN complementation analysis in the eye  
(For crossing schemes see Appendix 5) 
 
w; P[w+]30C, FRT40A (Bloomington stock # 1646) 
(A strain carrying a P transposon that carries a wild type white gene to generate wild 
type clones in the wing disc) 
 
w*; GMR-hid, FRT40A, l(2)CL/Cyo; eyGAL4, UAS-FLP (Bloomington stock # 
5250) 
(Eye specific expression of cell lethal mutation on GMR-hid chromosome) 
 
w; P[w+]30C, PTEN[3], FRT40A/CyO (gift from Clive Wilson) 
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(PTEN mutant allele) 
 
w; PNUTS13B, FRT40A/Cyo; MKRS/TM6B (made in house by Daimark Bennett) 
(PNUTS mutant allele) 
 
w; PNUTS13B, P[w+]30C, PTEN[3], FRT40A/Cyo (made by author, see 
Appendix 5 for crossing scheme) 
(PNUTS13B allele recombined with PTEN mutant allele) 
 
Final genotypes of progeny screened (for crossing schemes see Appendix 5) 
 
GMR-hid, FRT40, l(2)/ P[w+]30c, FRT40A; ey-GAL4, UAS-FLP 
GMR-hid, FRT40A, l(2)/dPNUTS13B, FRT40A; ey-GAL4, UAS-FLP 
GMR-hid, FRT40A, l(2)/dPTEN[3], FRT40A; ey-GAL4, UAS-FLP 




2.6.9. Strains used for PcG phenotypic screen in chapter 6 
 
TRiP Lines for RNAi of PcG proteins 
y1 v1, P{TRiP.JF01392}attP2 (Bloomington stock # 31608) 
(Expresses dsRNA for RNAi of polyhomeotic proximal under UAS control) 
 
y1 v1, P{TRiP.JF01705}attP2 (Bloomington stock # 31190) 
(Expresses dsRNA for RNAi of polyhomeotic distal under UAS control) 
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y1 sc* v1, P{TRiP.HMS00082}attP2 (Bloomington stock # 33669) 
(Expresses dsRNA for RNAi of polyhomeotic proximal under UAS control) 
 
y1 v1, P{TRiP.HMS00016}attP2/TM3, Sb1 (Bloomington stock # 33622) 
(Expresses dsRNA for RNAi of polycomb under UAS control) 
 
y1 sc* v1, P{TRiP.HMS00921}attP2 (Bloomington stock # 33964) 
(Expresses dsRNA for RNAi of polycomb under UAS control) 
 
y1 v1, P{TRiP.JF01581}attP2 (Bloomington stock # 31110) 
(Expresses dsRNA for RNAi of polycomb under UAS control) 
 
y1 v1, P{TRiP.JF01396}attP2 (Bloomington stock # 31612) 
(Expresses dsRNA for RNAi of sex combs extra under UAS control) 
 
VDRC Stocks for RNAi of PcG proteins 
w1118; P{GD17399}v50028 (VDRC stock # 50028) 
(Expresses dsRNA for RNAi of polyhomeotic under UAS control) 
 
P{KK108787}VIE-260B (VDRC stock # 100811) 
(Expresses dsRNA for RNAi of polyhomeotic under UAS control) 
 
P{KK109179}VIE-260B (VDRC stock # 106328) 
(Expresses dsRNA for RNAi of sex combs extra under UAS control) 
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NIG-Fly Stocks for RNAi of PcG proteins 
18414R-1  
(Expresses dsRNA for RNAi of polyhomeotic under UAS control, inserted 
chromosome = 2) 
 
18414R-2 
(Expresses dsRNA for RNAi of polyhomeotic under UAS control, inserted 
chromosome = X) 
 
32443R-1 




(Expresses dsRNA for RNAi of sex combs extra under UAS control, inserted 
chromosome = 3) 
 
ey-GAL4 strains 
w*; P{GAL4-ey.H}4-8/Cyo (Bloomington stock # 5535) 
(Strongly expresses GAL4 in the pattern of the eyeless gene) 
 
w*; P{GAL4-ey.H}3-8 (Bloomington stock # 5534) 
(Moderately expresses GAL4 in the pattern of the eyeless gene) 
 
y1 w1118; P{ey3.5-GAL4.Exel}1 (Bloomington stock # 8221) 
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(Expresses GAL4 in the pattern of the eyeless gene)\ 
y1 w1118; P{ey3.5-GAL4.Exel}1 (Bloomington stock # 8220) 
(Expresses GAL4 in the pattern of the eyeless gene) 
 
Other strains used 
w*; P{tubP-GAL80ts}20; TM2/TM6B (Bloomington stock # 7019) 
(Temperature sensitive GAL80 expressed under the control of the alphaTub84B 
promoter) 
 
w; UAS-dicer-2/ UAS-dicer-2; pin/Cyo (gift from Neville Cobbe) 
(Expresses dicer-2 under UAS control) 
 
Final tester strain genotype 
w; ey-GAL4/CyO; tubulin-GAL80ts, SceIR5595R-2/TM6B (made by author) 
(Please see Appendix 6 for crossing scheme to make this strain) 
 
2.7. Generation of PNUTS13B clones by FLP/FRT mediated recombination in 
the wing disc  
Crosses (see section 2.6.1 for genotypes) were allowed to lay for 48 hours. Embryos 
were left to develop for a further 48 hours and then heat shocked in a 37°C water 
bath for 1 hour. Wing discs were dissected from third instar larvae at 48, 72 and 96 
hours post heat shock for clones induced late, early and very early respectively.  
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2.8. Generation of PNUTS13B and PP1 mutant clones by FLP/FRT mediated 
recombination in the salivary gland  
Crosses were allowed to lay for 48 hours after which the embryos were heat shocked 
in a 37°C water bath. Salivary glands were dissected from third instar larvae when 
they emerged. 
 
2.9. Immunostaining of wing imaginal discs and whole mount salivary glands 
Tissues were dissected in cold 1 x PBS, transferred to a watch glass and fixed in 
3.7% paraformaldehyde for 20 minutes at room temperature. Tissues were washed in 
1 x PBS for 15 minutes and then blocked in blocking solution (see section 2.1) for 30 
minutes at room temperature or a minimum of 2 hours at 4°C. Tissues were 
incubated with primary antibody (see Table 2.15) in blocking solution overnight at 
4°C and then washed three times (10 minutes per wash) in PBST. Tissues were 
incubated with the secondary antibody (see Table 2.15) diluted in blocking solution 
for 2 hours at room temperature in the dark. They were then washed two times (10 
minutes per wash) in PBST and incubated with TO-PRO®-3 Iodide (see Table 2.15) 
for ten minutes to visualise DNA. Tissues were mounted in 17.5µL of Vectashield 
mounting medium (Vector Laboratories) on a standard glass microscope slide and 
covered with a coverslip (22mm * 22mm). Wing discs were covered with a raised 
coverslip. The sides of the coverslip were sealed with clear nail polish and slides 
were stored in the dark at 4°C for no longer than a week. 
 
2.10. Chromatin Immunoprecipitation (ChIP)  
All equipment was autoclaved before use. Glass douncer was sterilised with 100% 
ethanol. Spatulas, pestles and mortars were stored at -80°C for at least 2 hours before 
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start of experiment. All steps were done on ice. A minimum of 3 biological replicates 
was done for each genotype. 1g of Drosophila third instar larvae were collected in 1 
x PBS, frozen in liquid nitrogen and stored at -80°C for at least 2 hours before the 
experiment. Frozen larvae were ground in a mortar and pestle to a fine powder in 
liquid nitrogen and resuspended in 5ml Buffer A+ in precooled beaker on ice. The 
suspension was homogenised in a dounce homogeniser with pestle B on ice for 10 
strokes then filtered through two layers of sterile Miracloth into a sterile beaker on 
ice. The remaining matter on the Miracloth was resuspended, homogenised in 2ml 
Buffer A+ in a dounce homogeniser for 10 strokes on ice and filtered through the 
same Miracloth with squeezing of the last liquid into a beaker using gloved hands. 
Homogenate was transferred over 2ml Buffer AS and nuclei were pelleted by 
centrifugation (3000rpm., 5 minutes, 4°C). The pellet was resuspended in 3ml Buffer 
A+ and homogenised in a dounce homogeniser with pestle A for 5 strokes on ice. 
The homogenate was transferred over 1ml Buffer AS and nuclei pelleted by 
centrifugation (3000rpm., 5 minutes, 4°C). The nuclear pellet was resuspended in 
3ml Buffer A+ 0.1% NP-40 and cross-linked by adding 37% paraformaldehyde to a 
final concentration of 1.8% for 15 minutes at room temperature with gentle shaking. 
Crosslinking was stopped by addition of glycine to a final concentration of 0.125M 
and incubated for 5 minutes at room temperature with shaking. Nuclei were pelleted 
by centrifugation (2000rpm., 5 minutes 4°C) and washed two times with 10ml Buffer 
A+ 0.1% NP-40 (+ PIC). The supernatant was discarded and the pellet frozen in 
liquid nitrogen and stored at -80°C until use. 
 
For sonication, nuclei were resuspended in 2-3 volumes of nuclei lysis buffer (+ 
PIC). Samples were split into 1.5ml tubes (300µL per tube) and sonicated for 35 x 30 
! 54 
seconds on and 30 seconds off using a high setting in a Diagenode Bioruptor. 
Samples were centrifuged (13000rpm, 1 minute, 4°C) and the supernatant transferred 
to a new tube. Concentration was measured as described in 2.15 and samples were 
stored at -80°C.  
 
For input preparation, the iPure Kit (Diagenode) was used to reverse crosslink 30µg 
of sonicated chromatin by adding 115.4µl of Buffer A and 4.6µl Buffer B to the 
sample and incubating overnight at 65°C in a hot block. The samples were kept at 
4°C until DNA purification was performed.  
 
For immunoprecipitations 30µg of chromatin was diluted 10* with RIPA buffer and 
incubated overnight at 4°C with antibody (5-10µg/IP) on a rotary mixer set at 25rpm. 
The following day, 20µl of Magna ChIP! protein A or G coated pre-blocked 
magnetic beads (Millipore) were added to each sample and incubated for a further 4 
hours at 4°C on a rotary mixer set at 25rpm. Samples were then centrifuged at 4°C 
(2000rpm, 1 minute), placed on a cold magnetic rack (DiaMag 1.5, Diagenode) and 
the supernatant discarded. The beads were then washed 5 times with 500µl cold 
RIPA buffer (+ PMSF) followed by one wash with 500µl LiCl buffer and two 
washes with 500µl TE buffer. Each wash was 10 minutes at 4°C on a rotary mixer 
set at 25 rpm. Samples were centrifuged at 2000rpm. for 1 minute and the 
supernatant removed in between each wash.  
 
For reverse cross-linking of immunoprecipitated chromatin, beads were resuspended 
in 115.4µl Buffer A and 4.6µl Buffer B from the iPure Kit (Diagenode) and 
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incubated overnight at 65°C. The following day samples were briefly centrifuged and 
placed on a magnetic rack. Supernatants were transferred to a fresh tube and kept on 
ice. 
 
For DNA purification of input and IP samples 2µl of carrier (iPure Kit) was added to 
each sample, vortexed briefly and centrifuged briefly. 100µl of 100% isopropanol 
was added to each sample, then vortexed and centrifuged briefly. 15µl of magnetic 
beads (iPure Kit) were added to each sample and incubated for one hour at room 
temperature on a rotary mixer set at 40rpm. Samples were then briefly centrifuged, 
placed on the magnetic rack and the supernatant discarded. The beads were then 
washed in 100µl wash buffer 1 (iPure Kit) for 5 minutes at room temperature on a 
rotary mixer set at 40rpm. This process was repeated with wash buffer 2 (iPure Kit). 
Samples were eluted in 100µl ultrapure water and stored at -20°C until further use. 
 
2.10.1. qPCR analysis of ChIP samples 
For qPCR analysis input samples were diluted 100$ in ultrapure water. Reactions 
were carried out in a total volume of 15µl made up of 7.5µl Power SYBR" Green 
PCR master mix (Life Technologies), 3µl DNA, 250nm primer 1, 250nm primer 2 
and ultrapure water to 15µl. Reactions were carried out using the StepOnePlus! 
Real Time PCR system (Applied Biosystems) using the conditions shown in Table 
2.2. Reactions were done in duplicate per biological repeat and the quantity of 




Oligonucleotides were designed using primer3, synthesised by MWG Biotech and 
diluted in TE buffer (Sigma, pH 8.0) according to the manufacturer’s 
recommendations to give 100.m stock solutions (stored at -80°C). A 10.m stock 
was made with ultrapure water for use in PCR and sequencing (stored at -20°C). A 





Table 2.2. Thermal cycling conditions used for qPCR 
Step Time Temperature (°C) Cycles 
AmpliTaq Gold" 
Enzyme Activation 
10 minutes 95 1 
Denature 15 seconds 95 
 
40 Anneal/Extend 60 seconds 60 
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Table 2.3. Primer list 
Primer name Sequence (5’ to 3’) Purpose 
TOX4 For CACCATGAATCAGTTCCACACTCC Pfx amplification of genes from cDNA 
vector clones to make tagged gene S2 or fly 
expression vector 
TOX4 Rev TGAGTTCATGGATATTACCCAGTGGTTG 
Wdr82 For CACCATGAAGATAAAACTAATAGATTCGG 
Wdr82 Rev CAAGCCCTCCTCGGATGTG 
ERR For CACCATGTCCGACGGCGTCA 
ERR Rev CCTGGCCAGCGGCTCGA 
MBD-R2 F CACCATGGATACCGCGGAGAT 
MBD-R2 R CTTGCTAGTGGCAGAATCTCTGAG 
M13-FP TGTAAAACGACGGCCAGT (at GATC) Sequencing TOX4, Wdr82 and ERR in 
pENTR M13-RP CAGGAAACAGCTATGACC (at GATC) 
ERR Forward GCGTTCTTTAAACGCACCATCC Sequencing ERR in pENTR 
ERR Reverse AGCTGGAGCGTCAGGATCTC 
MBD-R2 Forward 1 CAGCTTTCAGGCGTGGATGG Sequencing MBD-R2 in pENTR 
MBD-R2 Forward 2 CCATGGATGTGTCGATGAACTC 
MBD-R2 Forward 3 CTTTGGATGCTGGTCCAACTC 
TOX4 Primer 1 CGAGATGATGTTACTACCAGCAGAC 1,2 & 3 used to screen flies for deletion in 
dTOX4. 
2 & 3 used to sequence dTOX4null 
TOX4 Primer 2 CATTCGGCTGGGAGGAGGAG 
TOX4 Primer 3 CAAGCACTGGCTTGCTCCTC 
TOX4fw CACGGTGTCTCGAAAAGAACA PCR on cDNA to determine transcript 
levels in mutant TOX4rev ACGAGGTGTTTGAGCTGACC 
GAPDH2 Fw GGTGATCAACGACAACTTCG Control for above 
GAPDH2 Rev CCAGTGGAAGCTGGAATGAT 
Jil-1/36727/F TAATACGACTCACTATAGGGCCTCTCGGTTCTCGAACATTATG  dsRNA synthesis (first 19 bp = T7 
promoter sequence) Jil-1/36727/R TAATACGACTCACTATAGGGGTGGTGGACAGCTCTACGG 
Jil-1/40737/F TAATACGACTCACTATAGGGGAACGTCAACGGTTTTTCGTACG  
Jil-1/40737/R TAATACGACTCACTATAGGGTGAACCAGAAACGACCTTCCG  
PP187B/27290/F TAATACGACTCACTATAGGGCCTCCGAGAGCTGTACGTTTT 
PP187B/27290/R TAATACGACTCACTATAGGGCGCAACAGCATACGAAGAAATTTTCA  
PP187B/23299/F TAATACGACTCACTATAGGGCGGACTGCATTGTGGACGAA  
PP187B/23299/R TAATACGACTCACTATAGGGACCGACCAACCATTCACCCA  
Jil-1/Forward GAATCATTGGCTGCTCCTTC  Confirming gene knockdown in S2R+ cells 
















PP187B/Forward GAGGTCAAATCGGGACTGAG  Confirming gene knockdown in S2R+ cells 
PP187B/Reverse CGGAGAATTTCTTCCTGCTG  
H3S10,28A Forward ACTACTTCCGCTACCTGGCC  Sequencing the H3S10,28A mutant probe 
H3S10,28A Reverse CGTCCAGTTCGACCAGAATC  
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2.12. Transformation of TOP10 chemically competent cells 
For every two transformations, one vial (50µl) of One Shot! TOP10 Chemically 
Competent Cells (Life Technologies) was thawed on ice split between two fresh 
microcentrifuge tubes. 1µl of DNA was added and mixed gently. The cells were 
incubated on ice for 30 minutes to 1 hour and then heat shocked at 42°C for exactly 
30 seconds. Following heat shock, cells were placed on ice for two minutes and 
200µl of pre-warmed S.O.C Medium (Life Technologies) was added to each 
transformation reaction. Reactions were shaken horizontally at 225rpm for 1 hour at 
37°C and then spread on pre-warmed selective LB agar plates using sterile 
technique. The plates were inverted and incubated overnight at 37°C. The following 
day colonies were picked using sterile technique and propagated in 6ml LB broth 
plus selective antibiotic overnight at 37°C with shaking at 225rpm. Plasmid DNA 
was purified as in section 2.14. 
 
2.13. Transformation of dam-/dcm- competent E.coli 
For each transformation a tube of dam-/dcm- competent E.coli cells (New England 
Biolabs) was thawed on ice until the last ice crystals disappeared. Cells were mixed 
gently and 50µl transferred to a transformation tube on ice. 1µl (0.25ng) of plasmid 
DNA was added to the cells and the tube carefully flicked 4-5 times to mix. The 
sample was kept on ice for 30 minutes with no mixing and then heat shocked at 42°C 
for 30 seconds. The sample was kept on ice for a further 5 minutes followed by the 
addition of 950µl room temperature SOC medium. It was then incubated at 37°C for 
60 minutes with shaking at 250rpm. Cells were then mixed by flicking the tube and 
inverting the tube and diluted 10-fold in SOC medium. Diluted sample was spread on 
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pre-warmed selective plates and incubated at 37°C overnight. The following day 
colonies were picked using sterile technique and propagated in 3ml LB broth plus 
selective antibiotic overnight at 37°C. Plasmid DNA was purified as described in 
2.14. 
 
2.14. DNA extraction from culture 
Small-scale plasmid purification (<20µg) was carried out using the QIAprep Spin 
Miniprep Kit (Qiagen) and medium scale plasmid purification (! 100µg) was carried 
out using the QIAfilter Plasmid Midi Kit (Qiagen) according to the manufacturer’s 
instructions. Briefly E.coli cells amplified overnight in selective LB broth were 
pelleted at approximately 4500rpm for 5 minutes and the supernatant removed. Cells 
were lysed under alkaline conditions and debris removed by centrifugation (mini) or 
filtering (midi). Clear cell lysates were applied to columns containing a silica gel 
membrane capable of binding DNA and washed to remove contaminants. DNA was 
eluted with an appropriate volume of Qiagen Elution Buffer or TE buffer. DNA 
concentration was measured using a NanoDrop" (see section 2.15). DNA was 
stored at -20°C until use. 
 
2.15. DNA/RNA quantification 
DNA and RNA was quantified using the Thermo Scientific NanoDrop# 1000 
Spectrophotometer according to the manufacturers instructions. This measures the 
absorbance using a 1µl sample over a 220nm-750nm spectrum and gives an output of 
concentration and relative purity with 230/260 and 260/280ratio measurements.  
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2.16. DNA sequencing  
DNA sequencing was carried out by GATC Biotech (Germany). DNA was provided 
at a concentration of 30-100ng/µl (typically 50ng/µl) in a total volume of 20µl (DNA 
diluted in ultrapure ddH2O. Sequencing primers were designed with a theoretical 
melting temperature of 60°C and a G/C composition of approximately 50%. 
 
2.17. Vector storage  
Working purified DNA stocks were stored at -20°C. A frozen bacterial stock of each 
vector was prepared by adding glycerol to cultures to a final concentration of 15% 
and stored at -80°C.  
 
2.18.  PCR   
The Taq PCR Master Mix Kit (Qiagen) was used for all PCR reactions where not 
specified. Reactions were set up in a final volume of 20µl as shown in Table 2.4. 










Table 2.4. PCR reaction components 
Component Volume ("l) 
Mastermix 10 
Forward Primer (10"M) 1 
Reverse Primer (10"M) 1 
cDNA (~2"g) - 









2.19. Agarose Gel electrophoresis  
DNA was separated by size using agarose gel electrophoresis. High gelling 
temperature agarose (Bioline) was heated in 1×TAE buffer with Ethidium Bromide 
(0.2-0.5µg/ml). Samples were diluted with 1 x loading buffer (10x agarose loading 
buffer, 30% (v/v), 0.35% (v/v) bromophenol blue) and loaded onto the gel. The 
samples were electrophoresed at 100 volts for 45 minutes in 1!TAE buffer using 
Jencons Ltd gel electrophoresis equipment. 5µl of Smartladder (Eurogentec), 100bp 
DNA ladder (New England Biolabs, NEB) or Hyperladder I (bioline) was loaded as 
the molecular weight marker. DNA fragments were visualised using an ultraviolet 
light source (UVi-tech) and documented with a PULNiX TM-300 video camera 
system and Syngene UP-895MD video graphic printer. 
 
2.20. Gel extraction 
DNA fragments were cut from agarose gels using a scalpel blade under a UV light 
and purified using the QIAquick Gel Extraction Kit (Qiagen) according to the 
manufacturer’s instructions. Briefly, agarose is dissolved in an optimised buffer 
containing a pH indicator, to determine the optimal pH for DNA binding. DNA is 
Table 2.5. PCR Reaction conditions 
Temperature (°C) Time No of Cycles 
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purified by binding to an anion-exchange membrane, washed and eluted in an 
appropriate volume of TE buffer. 
 
2.21. Restriction digestion 
Restriction digests were performed using restriction endonuclease enzymes and their 
compatible buffers (New England Biolabs) according to the manufacturer’s 
guidelines. Reactions were carried out in a volume of 20µl using 1!enzyme buffer, 
0.4-1µl of each enzyme, 0.2µl BSA and 0.3/0.4µg DNA for diagnostic digests or 1µg 
DNA for gel purification. For double or triple digests, buffers compatible with all 
enzymes were used. Reactions were typically incubated at 37°C in a hot block or 
water bath for 2-3 hours or at 25°C (room temperature) overnight. 
 
2.22. Yeast two-hybrid assay 
Yeast two-hybrid screening was performed by Hybrigenics Services, Paris, France. 
An ULTImate Y2H screen was done using the full length coding sequence (amino 
acids 1-1135) of Drosophila PNUTS cloned into pB27 as a C-terminal fusion to 
LexA (N-LexA-dPNUTS-C) and checked by sequencing. This was used as a bait to 
screen a Drosophila third instar larvae cDNA library (Hybrigenics) constructed into 
pP6. For the cDNA library, RNA was extracted from third instar larvae in the 
Bennett lab by Dr Nick Lansdale and the library was prepared by Hybrigenics. Direct 
Y2H assays were also performed by Hybrigenics services. This is described in the 
results section of chapter 4 for each individual protein interaction. 
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2.23. Making the S2R+ cell expression constructs 
Vector cDNA clones for dTOX4 (CG12104), dMBD-R2, dERR and dWdr82 were 
purchased from the Drosophila Genomics Resource Centre (DGRC). The open 
reading frame for each gene was amplified from the vector clones using Pfx 
mediated amplification (see section 2.23.1). Primers were designed with CACC at 
the 5’ end of the forward primer to specify directional cloning. PCR products were 
separated on a 1% agarose gel (see section 2.19) to confirm amplification and then 
purified as in 2.23.2. Purified PCR products were cloned into the pENTR! entry 
vector as described in 2.23.3. Reactions were transformed into One Shot" TOP10 
Chemically Competent Cells and plated on kanamycin plates. 10 colonies were 
selected for each gene for colony PCR (see section 2.23.4) and PCR products 
separated on an agarose gel to check cloning was successful. The same colonies were 
amplified and three containing the gene were selected and purified as in section 2.14. 
A diagnostic digest was done on each gene in pENTR! as described in 2.21. dTOX4, 
dWdr82 and dMBD-R2 were digested with Not1 and EcoRV and dERR digested with 
Not1 and Nde1. Digests were separated on an agarose gel. Each gene specific 
pENTR! vector was sent for sequencing (see section 2.16). The dTOX4-pENTR 
vector was sent to BioPioneer (San Diego, USA) for site directed mutagenesis to 
generate a premature stop codon and thus remove the C-terminal PNUTS binding 
region. 
 
A dPNUTS ORF conjugated to a C-terminal Myc tag had already been made by the 
Bennett lab in the pDONR221 entry vector. This together with the other genes in 
pENTR were subcloned into the desired destination vectors pAGW and pAFMW as 
well as pAW for dPNUTS-Myc using Gateway" technology (see section 2.23.5). 1µl 
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of each reaction was transformed into One Shot! TOP10 Chemically Competent 
Cells and plated on ampicillin plates (see section 2.12). DNA was purified as in 
section 2.14. A diagnostic digest of each gene specific destination vector was done to 
confirm subcloning of the gene sequence into the destination vector. 
 
2.23.1. Pfx PCR 
Pfx amplification was done using the Platinum! Pfx DNA Polymerase Kit 
(Invitrogen). Reactions were set up in a 20µl volume. Reaction components (Table 
2.6) and reaction conditions (Table 2.7) are shown below. Extension time was 
















Table 2.6. Pfx amplification reaction components  
Component Amount 
10 " Pfx amplification buffer 2µl 
50mM MgSO4 0.4µl 
10mM dNTPs (Qiagen) 0.6µl 
10µM Forward Primer 1µl 
10µM Reverse Primer 1µl 
Pfx enzyme 0.25µl 
Vector clone DNA 50ng 
H2O to 20µl 
Table 2.7. Pfx Reaction conditions 
Temperature (°C) Time No of Cycles 
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2.23.2. PCR purification 
PCR products were purified using the QIAquick! PCR Purification Kit (Qiagen). 
All buffers described in this protocol are from the kit. All centrifugation steps are 
carried out at 13,000rpm for 1 minute. 5 volumes of buffer PB was added to 1 
volume of PCR reaction and mixed. If the colour of the mixture was orange or violet 
then 10µl 3M Sodium Acetate (pH 5.0) was added and mixed (colour should be 
yellow). The sample was applied to a QIAquick spin column in a 2ml collection tube 
and centrifuged. The flow through was discarded and 750µl buffer PE added to the 
column and centrifuged to wash. The flow through was discarded and the column 
centrifuged again to remove residual buffer. The column was placed in a clean 1.5ml 
tube and DNA eluted by adding 30µl buffer EB or TE directly onto the membrane 
and incubated for 5 minutes at room temperature followed by centrifugation. 
Samples were stored at -20°C until use. 
 
2.23.3. pENTR"  directional cloning 
The pENTR"/D-TOPO! Cloning Kit (Life Technologies) was used to clone gene 
products into the pENTR" entry vector for subcloning into a destination vector. A 
2:1 molar ratio of PCR product: TOPO Vector was used. To calculate the amount of 
PCR product to add the following equation was used: 
((ng vector #  kb PCR product/kb vector) #  (2/1) = ng PCR product 
The reaction was set up as shown in Table 2.8, mixed gently and incubated at room 
temperature for 15 minutes. The reaction was then put on ice and transformed into 
One Shot! competent E.coli as described in section 2.12.  








2.23.4. Colony PCR 
Colonies were picked from agar plates using a pipette tip and a scratch of each 
colony was made at the bottom of a PCR tube. The BioMix! Red PCR reaction mix 
(Bioline) was used to amplify DNA from bacterial plasmids using gene specific 
primers. Reaction components (Table 2.9) and reaction conditions (Table 2.10) for 













Table 2.8. TOPO® cloning reaction 
components 
Reagent Amount 
Fresh PCR Product 0.5-4!"l 
Salt Solution 1!"l 
Sterile water to 5!"l 
TOPO® vector 1!"l 
Table 2.9. Colony PCR reaction components  
Component Volume ("l) 
BioMix! Red 25 
Forward Primer (10"M) 2 
Reverse Primer (10"M) 2 
H2O 21 
Table 2.10. Colony PCR reaction conditions 
Temperature (°C) Time No of Cycles 
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2.23.5. Gateway!  LR Clonase"  II cloning 
The Gateway! LR Clonase" II Enzyme Mix (Life Technologies) was used to 
shuttle genes from the pDONR221 or pENTR" into the desired destination vectors 
(pAGW, pAFMW, pAW and pPGW purchased from DGRC). 50-150ng of the entry 
clone containing the gene of interest was mixed with 1µl (150ng/µl) of the 
destination vector and TE buffer pH 8.0 to a final volume of 8µl. The LR Clonase" 
II Enzyme Mix was thawed on ice for 2 minutes, vortexed briefly and 2µl added to 
the reaction. Reactions were incubated at 25°C for 1 hour and then 1µl of Proteinase 
K added to the reaction and incubated at 37°C for 10 minutes to stop the cloning 
reaction. 1µl was transformed into One Shot! TOP10 Chemically Competent Cells 
(see section 2.12). 
 
2.23.6. Transient transfection of S2R+ cells with Effectene!  
For transient transfection of S2R+ cells with gene expression vectors cells were 
plated at 2 # 106 cells in 4ml complete Schneider’s medium (approximately 60% 
confluency) in 6 well dishes and allowed to adhere for a minimum of 2 hours under 
normal conditions. Before transfection, the Schneider’s medium was removed and 
replaced with 1.6ml of fresh medium. Cells were either transfected or co-transfected 
with tagged expression constructs for each gene using the Effectene! Transfection 
Reagent (Qiagen) according to the manufacturer’s protocols. Reagent ratios for the 
constructs were optimised for efficient transfection. Briefly 0.8µg of plasmid DNA 
was diluted to a volume of 100µl with EC buffer and condensed by adding 6.4µl of 
Enhancer. This was vortexed for one 1s and incubated at room temperature for 5 
minutes followed by brief centrifugation. 20µl of Effectene transfection reagent was 
! 69 
added to the DNA-enhancer mixture, mixed by gently pipetting up and down five 
times and incubated for 15-20 minutes at room temperature to allow complex 
formation. 600µl of fresh complete Schneider’s medium was added to the 
transfection tube, mixed by pipetting up and down twice and immediately added 
drop-wise onto the cells in the 6-well plates. Plates were gently swirled to ensure the 
transfection solution was properly diffused. Reagent amounts were doubled for co-
transfections. Cells were left for 48-72 hours following transfection for suitable gene 
expression. Cells were then processed for western blot analysis as in section 2.24 or 
for fluorescence microscopy as in section 2.28. 
 
2.24. GFP-Trap immunoprecipitation of GFP tagged proteins 
Cells transfected with the same combination of plasmids were resuspended and 
pooled into a 15ml centrifuge tube. Cells were pelleted by centrifugation at 4000rpm 
for 3 minutes and the supernatant removed. The magnetic GFP-Trap!_M kit 
(Chromotek) was used to immunoprecipitate GFP tagged proteins. For each sample, 
cells were resuspended in 125µl of Chromotek lysis buffer (plus 1mM PMSF 
[SIGMA] and 1!Protease Inhibitor Cocktail [Roche]). Sample was kept on ice for 30 
minutes with extensive pipetting every 5 to 10 minutes. The lysate was centrifuged at 
13,000rpm for 10 minutes at 4°C and the supernatant transferred to a pre-cooled 
1.5ml tube on ice. The supernatant was diluted to 500µl with ice-cold Chromotek 
dilution buffer (plus 1mM PMSF and 1!Protease Inhibitor Cocktail). 50µl of sample 
was kept as a positive control. Next, 20µl of GFP-Trap magnetic beads were 
equilibrated by washing three times in 500µl ice-cold dilution buffer. Between each 
wash step the beads were precipitated using a DiaMag 1.5 magnetic separator 
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(Diagenode) and the buffer removed. Once equilibrated the cell lysate (450µl) was 
added to the beads and incubated for 2 hours at 4°C on a rotating mixer set at 25rpm. 
The magnetic beads were pelleted using the magnetic separator and the supernatant 
removed. The beads were washed two times with 500µl ice-cold Chromotek wash 
buffer. Samples were then boiled at 95°C for 20 minutes in 2 ! SDS sample buffer. 
Beads were pelleted using the magnetic separator and the remaining supernatant 
transferred to a 1.5ml tube and loaded onto a polyacrylamide gel for SDS-PAGE (see 
section 2.26) or stored at -20°C until use.  
 
2.25. Protein extraction from Drosophila L1 larvae and adult flies for western 
blotting 
For protein extraction from larvae 100-150 L1 larvae were collected in 1 ! PBS. 
Excess buffer was removed and larvae were immediately frozen in liquid nitrogen 
and stored at -80°C until use. For protein extraction from adult flies 3 males and 3 
females were transferred to a 1.5ml tube and frozen in liquid nitrogen. For protein 
extraction 100µl SDS buffer was added to the larvae/flies and homogenised in a 
1.5ml tube using a small pestle. Samples were incubated at 95°C for 5 minutes and 
then centrifuged at 13,000rpm for 5 minutes to pellet the debris. The supernatant was 
transferred to a clean 1.5ml tube and stored at -20°C until use for western blotting. 
 
2.26. SDS-PAGE  
Proteins were separated based on their molecular weight on SDS-polyacrylamide 
gels as described in (Sambrook and Russell, 2001). Briefly protein extracts were run 
on Tris-buffered SDS-polyacrylamide gels, made according to Table 2.11 or 
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purchased from Bio-Rad (7.5% or 12% Mini-PROTEAN! TGX" Precast Gels), in 
1 # Running Buffer, with the acrylamide concentration of the separating gel varying 
depending on the size of the proteins being separated. 5µl Precision Plus Protein" 
WesternC" prestained protein standards (Bio-Rad) was used on each gel to 
determine protein size. Mini-Protean II Vertical Electrophoresis Apparatus (Bio-
Rad) was used according to manufacturer’s instructions. Samples were run at 
approximately 90 volts with time varying depending on the size and level of 
separation required 
 
2.27. Western blotting 
After separation by SDS-PAGE proteins were transferred onto a nitrocellulose 
membrane (Amersham Hybond ECL, GE Healthcare) overnight at 25 volts and 4°C. 
Before setting up the transfer apparatus the membrane was pre-wetted with Tris-
Glycine transfer buffer. After blotting, membranes were stained for 5 minutes with 
Ponceau S solution (Sigma Aldrich) to check transfer was successful and to label the 
lanes with a pencil. Membranes were washed in 0.1% TBST to remove the Ponceau 
stain.  
Table 2.11. Components for SDS-PAGE gels 
Component Separating Gel (10ml) Stacking gel (5ml) 




1.5ml 2.0ml 2.5ml 3.0ml 3.5ml 0.625ml 
1.5M Tris-HCl 
pH 8.8 
2.5ml 2.5ml 2.5ml 2.5ml 2.5ml - 
1M Tris-HCl 
pH 6.8 
- - - - - 0.63ml 
10% SDS 0.1ml 0.1ml 0.1ml 0.1ml 0.1ml 0.1ml 
DdH2O 5.9ml 5.3ml 4.8ml 4.4ml 3.9ml 3.6ml 
10% APS 0.1ml 0.1ml 0.1ml 0.1ml 0.1ml 0.1ml 
TEMED 5µl 5µl 5µl 5µl 5µl 5µl 
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Membranes were incubated in blocking buffer (5% milk) for 60-90 minutes at room 
temperature to reduce non-specific binding of the antibody before incubation with a 
suitable primary antibody (Table 2.12) diluted in blocking buffer (BSA) overnight at 
4°C on a roller. Membranes were then washed four times, twice in 0.1% TBST 
followed by twice in 0.05% TBST for 10 minutes and incubated with an appropriate 
horseradish peroxidase (HRP) conjugated secondary antibody (Table 2.13) plus 
StrepTactin-HRP conjugate (1:10,000, Bio-Rad) for detection of the protein 
standards in blocking buffer (BSA) for 2 hours at room temperature on a roller. 
Membranes were then washed four times, twice in 0.1% TBST and twice in 0.05% 
TBST for 10 minutes. 
 
SuperSignal! West Pico chemiluminescent substrate (Pierce) was used to detect the 
HRP-conjugated secondary antibodies on the membrane. The chemiluminescent 
signal was detected and imaged using the ImageQuant" LAS 4000 Biomolecular 
Imager (GE Healthcare) or by exposure to Amersham Hyperfilm ELC (GE 
healthcare) for a length of time dependent on the signal intensity and then developed 










Table 2.12. Primary antibodies used in western blots 
Primary Antibody Supplier Species Concentration 
C-Myc (A14) Santa Cruz Rabbit 1µg/ml 
FLAG (M2) Sigma Mouse 5µg/ml 
GFP (JL-8) Clontech Mouse 1µg/ml 
RNAPII CTD S2-P (3E10) Chromotek Rat 1:10 
RNAPII CTD T4-P (6D7) Chromotek Rat 1:10 
RNAPII CTD S5-P (3E8) Chromotek Rat 1:20 
RNAPII S7-P (4E12) Chromotek Rat 1:10 
Actin (clone C4) Merck Millipore Mouse  1:5000 
 
Table 2.13. Secondary antibodies used in western blots 
Secondary Antibody Supplier Species Concentration 
Anti-mouse HRP Cell Signalling Goat 1:2000 (anti GFP);  
1:20,000 (anti-FLAG) 
1:25,000 (anti-Actin) 
Anti-rabbit HRP Cell Signalling Goat 1:20,000 
Anti-rat HRP Cell Signalling Goat 1:2000 
 
2.28. Fixing and staining transfected S2R+ cells 
For imaging cells transfected with GFP-dTOX4wt and GFP-dTOX4P216! +/- RFP-
dPNUTS-Myc. 48-72 hours after transfection with Effectene® in a 6 well dish, the 
medium was removed and cells resuspended in 2ml fresh complete Schneider’s 
medium. 1ml was transferred to a 6 well dish with a glass-bottomed micro-well 
(10mm diameter) and cells allowed to adhere for a minimum of 2 hours. The 
medium was then removed and 500µl 10% paraformaldehyde added and incubated 
for 10 minutes to fix the cells. Cells were washed three times 5 minutes with 1 ! PBS 
and blocked for 1 hour at room temperature or 2 hours at 4°C in blocking solution 
(5% FBS in 0.1% PBST). Cells were then incubated with Alexa Fluor® 633 
Phalloidin (diluted in 0.1% PBST, see Table 2.15 for details) and incubated for 1 
hour at room temperature in the dark. Cells were washed two times five minutes with 
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0.1% PBST and then final wash with DAPI (see Table 2.15) for ten minutes. 120µl 
Vectashield® mounting medium (Vector Labs) was added to the glass bottomed 
micro-well to preserve fluorescence. Dishes were stored at 4ºC in the dark for no 
longer than one week. 
 
2.29. Making the dTOX4null mutant strain 
The dTOX4null mutant strain was generated by imprecise excision of a P-element 
insertion (see section 2.6 for genotypes and Chapter 5 for details). A total of 82 
crosses were set up and progeny screened as follows. For each cross 15 male and 15 
female adult progeny were collected and snap frozen in liquid nitrogen. DNA was 
extracted as described in section 2.39. DNA from each cross was screened by PCR 
using primers mapped as shown in Figure 5.2 (see Table 2.2 for primer sequences). 
PCR was carried out using the Taq PCR Master mix kit with 4µl DNA (Table 2.4). 
Reaction conditions for these primers are shown in Table 2.14. Samples were 
separated on a 0.6% agarose gel for analysis. A band corresponding to an 
approximately 1200bp deletion (see Figure 5.2) was gel extracted as in section 2.20 
and sent for sequencing (see section 2.16) to determine the extent of the deletion.  
 
Table 2.14. PCR reaction conditions for screening the dTOX4null mutant 
Temperature (°C) Time No of Cycles 






60s (2&3), 100s (1 & 3) 
 
30 
72 5 min 1 
10 ! - 
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To check the dTOX4 transcript levels were also affected in the mutant 3 male and 3 
female adult flies were collected and RNA extracted as in section 2.40. cDNA was 
synthesised (see section 2.41) and PCR amplified (see section 2.18). Agarose gel 
electrophoresis (see section 2.19) was used to confirm absence of the transcript. 
 
2.30. Making the tools for rescue experiments 
For rescue by overexpressing GFP tagged dTOX4wt or dTOX4P216! genes were 
subcloned into a fly expression vector (pPGW) from pENTR as described in section 
2.23.5. The pPGW gene specific expression vectors were sent to The Fly Facility at 
the university of Cambridge for P-element mediated transformation into the 
Drosophila genome. Transformants were analysed by crossing to a daughterless 
(da)-GAL4 strain for ubiquitous ectopic overexpression of GFP-dTOX4wt/P216!. 
Protein was extracted and analysed using western blotting with an anti-GFP antibody 
as described in section 2.25. For overexpression in the testis, the UAS constructs (on 
the 2nd chromosome) were recombined with bam-GAL4 on the 3rd chromosome, For 
overexpression in the ovaries, the UAS constructs were combined with maternal-"-
tubulin-GAL4 on the second chromosome. 
 
For genomic rescue, gene fragments encoding genomic dTOX4wt and dTOX4P216! (a 
2714 bp fragment starting 459bp upstream of the transcription start site) with EGFP 
inserted immediately before the ATG start site, an attB site at the end of the fragment 
and restriction sites at either end of the fragment (5’ BamH1, 3’ Not1) was 
synthesised in pCaSpeR3 by GeneArt. This was amplified by transforming into One 
Shot! TOP10 Chemically Competent Cells as described in section 2.12 and sent to 
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The Fly Facility at the University of Cambridge for !C31 mediated P-element 
transformation into the Drosophila genome on the second chromosome. 
 
2.31. Drosophila survival assay  
Virgin males and females were collected over an 8 hour period for each genotype. 
Flies were then mated for 48 hours and then split into same sex vials of 10 flies on 
standard medium. Flies were kept at 25°C on standard yeast medium without dried 
yeast balls. Flies were transferred to fresh vials three times per week and the number 
of dead recorded.   
 
2.32. Egg laying and fertility assay 
10 female virgins were crossed to 6 males and allowed to mate for 48 hours at 25°C 
in 50ml vials on standard yeast medium with dried yeast balls. Flies were then 
transferred into 250ml bottles on apple juice agar plates with a small amount of yeast 
paste (dried yeast balls mixed with water) and kept at 25°C. After 24 hours the 
crosses were transferred onto new plates and the first collection of eggs was 
discarded. Recording of egg counts began with the second plate. Eggs were collected 
from the agar using a paintbrush and gently washed (to remove yeast paste) under a 
running tap over a nylon mesh to collect the eggs. They were then placed back onto 
the agar plates to be counted. The crosses were changed every 24 hours and the 
number of eggs counted. 48 hours after egg collection, the number of larvae emerged 
was counted and the percentage of eggs hatched calculated. 
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2.33. Dissection and staining of ovaries for fluorescence microscopy 
Newly eclosed (0-1 day old) w1118 and dTOX4null/ dTOX4null adult females were 
transferred to new vials with yeast paste and allowed to fatten for 1-2 days. Ovaries 
were dissected in cold 1 ! PBS and fixed for 30 minutes in 3.7% paraformaldehyde 
at room temperature. Ovaries were washed three times in 0.1% PBST for 10 minutes 
and blocked at 4°C in blocking solution for a minimum of 2 hours. Ovaries were 
washed two times 10 minutes in 0.1% PBST followed by another wash with TO-
PRO"-3 Iodide (Life Technologies, diluted 1:1000 in 1 ! PBS) for ten minutes. 
Tissues were mounted in 17.5µL of Vectashield mounting medium (Vector 
Laboratories) on a standard glass microscope slide and covered with a coverslip 
(22mm ! 22mm). Coverslip slides were sealed with clear nail polish and slides were  
stored in the dark at 4°C for no longer than a week. 
 
2.34. Dissection and staining of testes for fluorescence microscopy 
Testes were dissected from w1118 and dTOX4null/ dTOX4null newly eclosed males (0-1 
day old) in cold 1 ! PBS and fixed for 30 minutes in 3.7% paraformaldehyde at room 
temperature. Testes were washed three times in 0.1% PBST for 10 minutes and 
blocked at 4°C in blocking solution for a minimum of 2 hours. Samples were 
incubated with the primary antibody (phH2AX, see Table 2.15) and Alexa Fluor® 
555 Phalloidin (see section 2.14) diluted in blocking solution overnight at 4ºC in the 
dark. Testes were washed three times ten minutes in 0.1% PBST and then incubated 
with Alexa Fluor® 488 Goat Anti-Mouse antibody (anti-phH2AX, see Table 2.15 for 
details) for two hours at room temperature. Testes were washed two times 10 
minutes in 0.1% PBST followed by another wash with TO-PRO"-3 Iodide (Life 
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Technologies, diluted 1:1000 in 1 ! PBS) for ten minutes. Tissues were mounted in 
17.5µL of Vectashield mounting medium (Vector Laboratories) on a standard glass 
microscope slide and covered with a coverslip (22mm ! 22mm). Coverslip slides 
were sealed with clear nail polish and slides were stored in the dark at 4°C for no 
longer than a week. 
 
2.35. Dissection, squashing and phase contrast microscopy of live testes 
Testis of w1118 and dTOX4null/ dTOX4null adult flies were dissected as described in 
(White-Cooper, 2004), protocol: Phase Contrast Microscopy of Live Testes. Testes 
were dissected from newly eclosed (0-1day old) males in fresh testis buffer with 
2µg/ml of Hoechst 33342 (SIGMA, a vital dye for visualising DNA), on a 10cm 
petri dish.  Testes were transferred to a small drop of testis buffer on a clean standard 
microscope slide and cut open using sharp forceps. The testes were incubated like 
this for 5 minutes and then a clean coverslip was placed on top to gently squash the 
cells. For better imaging testis buffer was removed from under the coverslip using 
Kim wipes to further squash the sample. This was done whilst looking down the 
microscope to ensure the sample was not over-squashed. Experiments were carried 
out together with Dr Helen White-Cooper using her facilities at Cardiff University. 
Images were captured using an Olympus BX50 microscope using a Hamamatsu 





2.36. Confocal microscopy 
 Fixed tissues were imaged using an LSM 710 or LSM 780 Confocal microscope 
(Zeiss) and Zen 2011 confocal software (Zeiss) equipped with 405nm, 488nm, 
561nm and 633nm lasers. Tissues were imaged using a Plan Apochromat 40!/1.3NA 
oil immersion objective. Nurse cell nuclei were imaged using a Plan Apochromat 
63x/1.0NA air objective. GFP was excited at 488nm and RFP was excited at 561nm.  
 
 
2.37. Image analysis 
Images were prepared using Fiji (ImageJ). For co-localisation analysis of imaged 
S2R+ cells Fiji was used to plot a profile of intensity for GFP and RFP across a 
specified section of the cell. For whole cell co-localisation analysis the JACoP (Just 
Table 2.15. Antibodies and stains used for confocal microscopy 
Name Type Supplier Concentration Laser (nm) 
DAPI Fluorescent stain SIGMA 1:1000 405 
TO-PRO®-3 Fluorescent stain Life Technologies 1:1000 633 
Alexa Fluor® 555 
Phalloidin 
Fluorescent dye Life Technologies 1:500 561 
Alexa Fluor® 633 
Phalloidin 
Fluorescent dye Life Technologies 1:500 633 




Milliport 1:500 - 
H3 Phospho S10 Primary antibody 
(Rabbit) 
Abcam 1:100 - 
H3 Phospho S28 Primary antibody 
(Rabbit) 
Abcam 1:100 - 
H3 Acetyl K27 Primary antibody 
(Rabbit) 
Abcam 1:200 - 
H3 dimethyl K4 Primary antibody 
(Rabbit) 
Active motif 1:200 - 
H3 trimethyl K4 Primary antibody 
(Rabbit) 
Active motif 1:200 - 




Life Technologies 1:500 561 




Life Technologies 1:500 561 
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Another Colocalisation Plugin) Plugin was used to perform M1 and M2 coefficients 
(see results in Chapter 4 for details) and generate a cytofluorogram.  
 
2.38. Phylogenetic and alignment analysis 
BLAST (Basic Local Alignment Search Tool) analysis was performed on Drosophila 
protein CG12104 and human LCP1/TOX4 using the NCBI 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) database to identify homologues in a range 
of species. The protein sequences of the top hits were aligned using MSAProbs (Liu 
et al., 2012) and then a distance matrix generated using Tree-Puzzle (Strimmer and 
von Haeseler, 1996). The distance matrix was then used to generate a minimum 
evolution tree using FastME (Lefort and Gascuel, 2015), which was used as a 
starting point to generate a maximum likelihood tree using PHYML (Guindon and 
Gascuel, 2003). The tree was visualised using FigTree 1.4 
(http://tree.bio.ed.ac.uk/software/figtree/).   
 
For the alignment, the amino acid sequence for dTOX4 (CG12104) was taken from 
flybase and the amino acid sequence for LCP1 (KIAA0737) taken from GenBank. 
The T-Coffee Multiple Alignment tool was used in the ‘accurate’ mode to align both 
sequences. The alignment was put into BoxShade to identify the conserved residues 
and Ali2D to map secondary structures. 
 
2.39. DNA extraction from Drosophila 
The DNeasy Blood and Tissue Kit (Qiagen) was used to extract DNA from adult 
flies. All buffers mentioned in this protocol are from the kit. Frozen flies were 
homogenised in a 1.5ml tube using a small pestle. 180µl of buffer ATL was added 
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and the flies further homogenised. 20µl of Proteinase K was added, mixed 
thoroughly by vortex and incubated at 56°C until the tissue was completely lysed 
(approximately 1-2 hours with occasional vortexing). 200µl of buffer AL was added 
to the supernatant and mixed by vortex and then 200µl 100% ethanol added and 
mixed immediately by vortex. Samples were centrifuged at 13,000rpm for 
approximately 30 seconds and the supernatant transferred to a fresh 1.5ml tube. 
Samples were treated with 3µl RNase A for 2 minutes at room temperature and then 
transferred onto a DNeasy mini spin column in a 2ml collection tube and centrifuged 
at 8000rpm for 1 minute. The column was transferred to a fresh collection tube and 
500µl buffer AW1 added followed by centrifugation (8000rpm, 1 minute). This step 
was repeated with AW2 with centrifugation at 13,000rpm for 3 minutes. The column 
was placed in a clean 1.5ml tube and 100µl buffer AE added directly on to the 
column membrane. This was incubated at room temperature for 5 minutes before 
centrifugation at 8000rpm for 1 minute. The eluate was reloaded onto the column, 
incubated for another 1 minute at room temperature and centrifuged at 8000rpm for 1 
minute.  
 
2.40. RNA extraction from Drosophila adults and S2R+ cells 
The RNeasy Mini Kit (Qiagen) was used to extract RNA from adult flies and S2R+ 
cells. All buffers mentioned in this protocol are from the kit. Frozen flies were 
homogenised in a 1.5ml tube using a small pestle and then 350µl buffer RLT (plus !-
mercaptoethanol, 10µl/ml) added and homogenised further. S2R+ cells were pelleted 
by centrifugation for 5 minutes at 2500rpm after which the supernatant was removed 
and the cells lysed by adding 350µl buffer RLT (plus !-mercaptoethanol, 10µl/ml) 
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and mixing with the pipette. For complete homogenisation the sample was added 
directly on a Qiashredder spin column and centrifuged at maximum speed for 2 
minutes. For adult flies the lysate was then centrifuged for 3 minutes at maximum 
speed to pellet any debris and the supernatant transferred to a clean 1.5ml tube. 1 
volume of 70% ethanol was added and mixed immediately and the sample added to 
an RNeasy column and centrifuged for 15 seconds at 10,000rpm. The flow through 
was discarded and 700µl buffer RW1 added and the centrifugation step repeated. 
This was repeated again with 500µl buffer RPE and the flow through discarded. 
Another 500µl buffer RPE was added and centrifuged at 10,000rpm for 2 minutes. 
The column was transferred to a clean 1.5ml tube and 30µl RNase-free water added 
directly on to the membrane. This was then centrifuged at 10,000rpm for 1 minute to 
elute. 
 
2.41. cDNA synthesis  
The High Capacity RNA-to-cDNA (Applied Biosystems) kit was used according to 
the manufacturer’s protocol to synthesise cDNA. Reaction components (Table 2.16) 
and reaction conditions (Table 2.17) are shown below. RT buffer includes dNTP’s, 
random octamers and olido-dT-16. RT enzyme mix includes MuLV reverse 



















2.42. Making the H3wt and H3S10,28A phosphor FRET probes  
The DNA sequence of the wild type probe and a smaller fragment encoding a serine 
to alanine amino acid change at S10 and S28 were sent to GENEART for synthesis 
in an entry vector (pDONR221/pMA-T respectively). The vectors were diluted in TE 
buffer to give a stock concentration of 0.25µg/µl.  
 
2.42.1. H3wt probe  
1.25!10-3µg/µl of H3wt in pDONR221 was transformed into TOP10 competent E.coli 
(see 2.12) and DNA purified (see 2.14). A diagnostic digest with Age1 and Nco1 
followed by gel electrophoresis on a 1% agarose gel confirmed the presence of the 
construct.  
 
Table 2.16. cDNA synthesis reaction components  
Component Amount 
2 ! RT buffer 10µl 
20 ! RT enzyme mix 1µl 
RNA 1µg 
H2O to 20µl 
Table 2.17. cDNA synthesis reaction conditions  
Temp (°C) Time 
37 60 min 
95 5 min 
4 " 
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2.42.2 H3S10,28A probe  
0.25ng/µl of H3S10,28A fragment in pMA-T was transformed into dam-/dcm- 
competent E.coli (see 2.13) and DNA purified (see section 2.14). The H3wt probe in 
pDONR221 and H3S10,28A mutant fragment in pMA-T were digested with StuI and 
SacI (see section 2.21). Digests were chloroform extracted by adding 1 volume of 
chloroform, mixing vigorously and centrifuging at 13,000rpm for 3 minutes. The top 
phase was removed and separated on a 0.8% agarose gel. The bands corresponding 
to the H3S10,28A mutant fragment (insert) and H3wt backbone (vector) were gel 
extracted (see section 2.20). The formula below was used to calculate the amount of 
vector and insert to ligate together based on 40ng of vector and a 3 molar excess of 
insert: 
((ng vector ! kb insert)/kb vector) ! (moles insert/moles vector) = ng insert 
  








A reaction was also set up with double the amount of insert. All reactions were 
incubated at 16°C overnight followed by heat inactivation at 65°C for 25 minutes. 
2"l of each reaction was transformed into TOP10 competent E.coli (see section 
2.12). A diagnostic digest with AgeI (HF) and EcoRV (HF) (see 2.21) followed by 
Table 2.18. Ligation reaction components 
Component Amount 




10# Ligase buffer (NEB) 3"l 
DNA Ligase (NEB) 1"l 
H2O to 20"l 
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gel electrophoresis on a 1.2% agarose gel (see section 2.20) confirmed the presence 
of the mutant construct. 
 
2.42.3. Cloning of H3wt and H3S10,28A (in pDONR221) into destination vector 
(pAW)  
The Gateway® LR ClonaseTM II enzyme mix (Invitrogen) was used (see section 
2.23.5) to clone the wild type and mutant probes into the destination vector, pAW. 
This was transformed into TOP10 competent E.coli and processed as in section 2.12. 
Selective ampicillin (100µg/ml) plates were used. A diagnostic digest with NcoI (+ 
AgeI for mutant) followed by gel electrophoresis on a 1% agarose gel confirmed the 
presence of both constructs in pAW (see sections 2.21 and 2.20). 
 
2.43. dsRNA synthesis (PP187B & Jil-1)  
cDNA was synthesised from wild type Drosophila (L3 larvae or adult) RNA. The 
sequence of previously used amplicons for PP187B and Jil-1 were taken from 
www.flyrnai.org and used to design primers (see Table 2.2 for primer list) for the 
amplification of wild type cDNA. After choosing the primer sequence, the T7 
promoter sequence (TAATACGACTCACTATAGGG) was added to the 5’ end of all 
primers. cDNA fragments were amplified using the Taq PCR Master Mix Kit 

























 5"L of each sample was separated on a 1% agarose gel to check fragment size. PCR 
samples were cleaned up using the QIAquick PCR purification Kit (Qiagen) (see 
section 2.23.2). Ambion’s MEGAscript kit was used according to the manufacturer’s 
instructions to synthesise dsRNA fragments. Briefly a 20µl reaction was set up for 
each cDNA as shown in Table 2.20 using reagents from the MEGAscript kit. This 
was incubated at 37°C overnight (approximately 16 hours) and then briefly 
Table 2.19. PCR conditions for dsRNA synthesis 
Temp (°C) Time No of Cycles 














72 5 min 1 
Table 2.20. dsRNA synthesis reaction 
Component Amount 







10 ! Reaction Buffer 
RNA Polymerase Enzyme Mix 
2µl 
2µl 
Template DNA 0.1-1µg 
Nuclease-free water to 20µl 
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centrifuged. 1µl of TURBO DNase was added, mixed well and incubated at 37°C for 
15 minutes. A 20x dilution in DEPC-treated water of the dsRNA product was 
separated on a 1% agarose gel to check fragment size. dsRNA was purified using the 
RNAeasy Mini Kit (Qiagen) following the RNA clean-up protocol in the 
manufacturer’s manual. The same protocol was used as for RNA extraction from 
S2R+ cells (see section 2.40) but with two changes at the beginning: 1) sample 
volume was adjusted to 100µl with RNase free water before addition of RLT 2) 
250µl of 100% ethanol was added. 
 
2.43.1. Testing the dsRNA (in S2R+ cells)  
0.2-0.3µg of dsRNA was mixed with 30µl of Schneider’s medium (Lonza) 
supplemented with 10% FCS and 100"g/ml penicillin-streptomycin (Gibco) 
(complete Schneider’s medium). 3µl of Cellfectin II reagent (Invitrogen) was mixed 
with 30µl of complete medium. The two solutions were combined, gently mixed and 
incubated at room temperature (RT) for 15-30 minutes then 40µl of complete 
Schneider’s medium was added. Adhered S2R+ cells were re-suspended in complete 
Schneider’s medium. 3-8!104 cells in 100µl were aliquoted into wells of a 96-well 
plate. 100µl of the dsRNA/Cellfectin mix was added to the cells and incubated at 
26°C in a tissue culture chamber for 3-4 days. Cells were then re-suspended, 
transferred to a 1.5ml tube and pelleted by centrifugation at 2500rpm for 5 minutes. 
RNA was extracted (see section 2.40) and cDNA synthesised (see section 2.41) 
followed by PCR (see section 2.18) with primers for Jil-1 and PP187B (+GAPDH 
for control). Samples were separated on a 1.2% agarose gel to determine the extent 
of gene knockdown. 
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2.44. S2R+ transfections for FRET experiments 
Initial transfection experiments were performed using Cellfectin® II Transfection 
Reagent (Life Technologies) in a 96 well format. 4 !104 cells in 100µl was added to 
each well and allowed to adhere for at least 2 hours. 0.6µg of DNA +/- 0.6µg of 
dsRNA was mixed with 100µl Schneider’s insect medium (without serum or 
antibiotics). 6µl Cellfectin® II Reagent was mixed with 100µl Schneider’s insect 
medium (without serum or antibiotics) and added to the DNA/dsRNA mix and 
incubated at room temperature for 30 minutes then each reaction was split between 2 
wells of cells. Cells were incubated under normal conditions for 4 days before 
imaging. 
 
Due to problems with transfection efficiency using Cellfectin®, Effectene® was used. 
Each screen was performed by transfecting S2R+ cells with the H3wt and H3S10,28A 
probes 2 days prior to transfection with PP187B dsRNA. Qiagen’s Effectene® 
transfection reagent kit was used as described in section 2.23.6 but with 0.4µg DNA, 
3.2µl enhancer and 10µl Effectene reagent. 48 hours after transfection with the FRET 
probes cells were transfected with dsRNA for PP187B using the same protocol. Four 
days following transfection with dsRNA, the cells were imaged.  
 
2.45. Live imaging of S2R+ cells for FRET experiments 
The day before imaging, transfected S2R+ cells were re-suspended and 200µl 
transferred to an 8 chamber #1.0 Borosilicate cover glass system (Lab-Tek®) and 
incubated at 26°C in a tissue-culture chamber. Cells were imaged using a Zeiss 710 
confocal microscope with a 40!oil immersion objective. For sensitised emission, 
ECFP was excited at 458nm alone and in combination with YPet excitation at 
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514nm. YPet was excited at 514nm and in combination with ECFP excitation at 
458nm. The emission signal was measured for ECFP (479nm) and YPet (527nm). 
FRET was measured as a ratio of the mean ECFP/YPet intensity after excitation of 
ECFP at 458nm alone, using Image J software. For acceptor photobleaching 30 
images were taken with bleaching of YPet at 514nm between images 4 and 5 and the 
emission signal for ECFP (479nm) and YPet (527nm) measured. The average 
nuclear intensity of ECFP and YPet was calculated before and after bleaching using 
Cell Tracker software.   
 
2.46. Imaging of eyes  
Flies were collected in 1.5ml tubes and immediately frozen with liquid nitrogen. 




3. Characterisation of Drosophila PNUTS  
3.1 Introduction 
The PP1 Nuclear Targeting Subunit (PNUTS) is a highly conserved, ubiquitously 
expressed metazoan protein and is one of the two most abundant PP1-binding 
proteins in the mammalian nucleus (Landsverk et al., 2005; Kreivi et al., 1997; Allen 
et al., 1998). It was first described as a regulatory subunit of PP1 in 1998, when it 
was isolated in a yeast two-hybrid screen against a rat brain cDNA library, 
identifying PP1 binding proteins (Allen et al., 1998). The human homologue of 
PNUTS, p99, had been identified the previous year when it was purified with PP1 
from HeLa cell nuclear extracts (Kreivi et al., 1997).  p99 was found to be expressed 
in the nucleus and sequence analysis revealed it contained a nuclear localisation 
signal (NLS) (Kreivi et al., 1997). Further analysis showed PNUTS/p99 is an RNA 
binding protein, and binds to RNA through several closely spaced RGG boxes in its 
C-terminus (Kreivi et al., 1997; Allen et al., 1998). Given PP1 has been linked to 
RNA processing, it was believed PNUTS may be responsible for anchoring PP1 to 
RNA complexes in the nucleus (Mermoud et al., 1994; Allen et al., 1998; Kim et al., 
2003).  Other domains identified included a cysteine/histidine rich zinc (Zn2+) finger 
and a canonical PP1 binding motif (see Introduction, Section 1.3.2) (Kreivi et al., 
1997). 
 
Since then, the PNUTS-PP1 holoenzyme has been implicated in various nuclear 
processes including chromosome decondensation (Landsverk et al., 2005), cardiac 
aging (Boon et al., 2013) and the DNA damage response (Landsverk et al., 2010). 
As discussed in the introduction (see section 1.5) PP1 has been implicated in 
transcriptional regulation by targeting the CTD of RNAPII for dephosphorylation  
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(Washington et al., 2002). In 2011, Jerebtsova et al., suggested both NIPP1 and 
PNUTS may regulate this process by showing they co-immunoprecipitate with 
RNAPII (Jerebtsova et al., 2011). They hypothesised that NIPP1 functions to reduce 
the rate of elongation by targeting PP1 to the CTD for active dephosphorylation, to 
allow coupling of transcription with splicing and RNA processing (Jerebtsova et al., 
2011). Limited work has been done studying the physiological role of PNUTS and its 
role in RNAPII complexes. 
 
In a yeast two-hybrid screen looking for PP1 binding proteins in Drosophila the 
Bennett lab isolated a protein with significant similarity (approximately 24%) to 
PNUTS/p99 (Bennett et al., 2006). Sequence analysis revealed the amino and 
carboxy termini of PNUTS/p99, together with the zinc finger and PP1 binding region 
are conserved in dPNUTS. The RGG motifs are not found in dPNUTS indicating that 
RNA-binding through these motifs is not conserved in the Drosophila orthologue, 
although dPNUTS might still bind RNA through numerous histidine/glycine repeats 
found in the C-terminus.  
 
In the course of investigating phosphatases that might regulate gene expression 
through histone H3 phosphorylation, dPNUTS was selected as a candidate through 
its association with PP1, which is known to dephosphorylate serine 10 and serine 28 
of histone H3 (see Chapter 6). In the Bennett lab, work was already underway to 
characterise dPNUTS and, given preliminary experiments showing that it is essential 
for development in Drosophila, focus shifted to understanding the molecular 
mechanisms underlying this phenotype. The association of mammalian PNUTS with 
RNAPII complexes led to the possibility of a similar complex existing in 
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Drosophila, therefore the role of dPNUTS in RNAPII phosphorylation and, 
ultimately, in gene expression was investigated.  
 
The work performed in this chapter was recently published in PLoS Genetics. The 
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Introduction
Development must be tightly coupled with cellular metabolism
to ensure that necessary nutritional and energetic requirements are
met and the available resources are utilised effectively to sustain
appropriate levels of tissue growth. A particularly dramatic
example of how development is coupled to metabolism is during
the transition through the larval stages of Drosophila development,
during which animals accumulate a 200-fold increase in body
mass. The metabolic needs to sustain this rapid expansion are
underpinned by transcriptional programmes initiated in the
embryo; as maternal products become exhausted, large numbers
of zygotically expressed genes, responsible for converting raw
materials into cell mass, are induced to sustain developmental
growth [1]. Elucidating what factors are necessary to drive these
transcriptional programmes is not only critical for understanding
tissue and organism size regulation during normal development,
but is also important for understanding numerous disease
processes characterized by inappropriate gene expression.
Reversible phosphorylation plays important roles in the
regulation of transcriptional networks and in coordinating spatial
and temporal patterns of gene expression. Phosphorylation of RNA
polymerase II (RNAPII) at multiple sites on its C-terminal domain
(CTD) is critical for gene expression and its regulation [2]. Different
phospho-forms of the CTD appear at different stages of the
transcription cycle, and these are thought to facilitate initiation,
elongation and termination by recruiting specific histone and RNA
modifiers [3,4]. The consensus view from studies of RNAPII
occupancy in budding yeast is that there is a stereotypical pattern of
phosphorylation at most gene loci during the transcription cycle
[5,6]. However, numerous lines of evidence suggest that there is
active control of CTD phosphorylation in response to environmen-
tal cues [7–9] and during developmental transitions, e.g. in which
restriction of CTD phosphorylation to particular lineages [10] is
used to control cell fate [11]. Furthermore, studies of the enzymes
responsible for regulating CTD phosphorylation indicate that
phosphorylation may be modified at specific loci to determine
gene-specific patterns of expression [12,13].
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Serine/threonine protein phosphatase type 1 (PP1) is one of
four protein phosphatases known to contribute to the regulation of
CTD phosphorylation [14], the others being FCP1 [15], SCP1
[11] and Ssu72 [16]. In Drosophila, PP1 is found at multiple sites on
chromosomes where it has been postulated to play important roles
in regulating developmentally controlled gene expression [17,18].
However, analysing the role of PP1 in transcriptional regulation
has been complicated by its pleiotropic roles [19] and broad in vitro
substrate specificity. In vivo, PP1 has been shown to associate with
different targeting subunits that restrict its activity towards
particular substrates [20]. Therefore, a full understanding of PP1
function requires the identification and characterisation of these
regulatory proteins.
In mammalian cells, the PP1 Nuclear Targeting Subunit
(PNUTS) is one of the two most abundant PP1-interacting
proteins in the nucleus [21] and is known to be chromatin-
associated during interphase and not during mitosis [22,23]. Its
reassociation with chromatin during telophase and its ability to
augment chromosome decondensation in vitro [24] and in vivo
[25] have indicated a possible role in cell cycle progression.
Several lines of evidence also indicate that PNUTS is required
for cell survival [26–30] and contributes to cellular responses to
environmental stress, including hypoxia [31] and DNA damage
[32]. These roles may be especially important during ageing
since loss of PNUTS expression is associated with an age-
dependent increase in cardiomyocyte apoptosis and decline in
cardiac function [33]. Targeting of PNUTS to chromatin is
likely to be in part through association with the DNA-binding
factor Tox4/Lcp1 [25,34], which is capable of recognising
DNA adducts generated by platinum anticancer drugs [35].
PNUTS and Tox4 have also been reported to form a stable
multimeric complex with Wdr82 [25], which was previously
identified as an integral component of a distinct complex
containing Set histone H3-Lys4 methyltransferases. Although
the role of Wdr82 bound to PNUTS is not known, Wdr82 may
mediate interactions with initiating and early elongating
RNAPII by recognising Ser5-phosphorylated CTD, as it does
when it is associated with the Set1 complex [36]. A role for
PNUTS in transcription has been further suggested by recent
reports that it associates with RNAPII complexes [37]. Despite
these insights, an understanding of the physiological roles of
PNUTS remains incomplete.
Here we show that null mutants in the D. melanogaster orthologue
of PNUTS (dPNUTS), display a larval growth defect and are larval
lethal. Mutant clones show a cell autonomous growth defect and
are eliminated from wild type epithelia due to cell competition.
RNA-Sequencing (RNA-Seq) analysis indicates that dPNUTS
affects the expression of the majority of genes in 1st instar larvae,
including those that are highly expressed and are involved in
cellular metabolism and larval development. The function of
dPNUTS in tissue development is dependent on binding to the
catalytic subunit of Protein phosphatase 1 (PP1), which is targeted
by dPNUTS to RNA polymerase II in cell extracts and at many
active sites of transcription on polytene chromosomes. Loss of
dPNUTS function, or displacement of dPNUTS-PP1 using a non-
PP1 binding mutant of dPNUTS, results in hyperphosphorylation
of the C-terminal domain of RNA Polymerase II in whole animal
extracts and on chromosomes. Taken together, these data suggest
that dPNUTS-PP1 is a global regulator of gene expression via
effects on RNAPII phosphorylation and is required in larvae to
promote normal developmental growth.
Results
PNUTS is highly conserved across metazoa
Sequence homology searches have suggested that PNUTS is a
metazoan PP1-binding protein [38]. However, its absence from
species such as C. elegans indicates that it has not been retained in
all metazoa. D. melanogaster contains one gene encoding PNUTS:
CG33526/dPNUTS. Comparison of full-length PNUTS cDNA and
genomic sequences shows that all four of dPNUTS intron/exon
boundaries are shared with human PNUTS (hPNUTS; Figure S1),
indicating that hPNUTS and dPNUTS are derived from a single
ancestral gene. dPNUTS encodes two protein isoforms: dPNUTS
and dPNUTS-S, a truncated version containing only the N-
terminal region of dPNUTS. There is extensive homology
between dPNUTS and mammalian PNUTS in a number of
protein domains (Figure S1).
dPNUTS is expressed in developing tissues and localises
to transcriptionally active sites on interphase
chromosomes
PNUTS has been identified in all mammalian tissues so far
examined [22,23], but the highest level of expression is reported to
be in testis, brain, and intestine. In situ hybridisation revealed that
dPNUTS transcripts are maternally provided and are uniformly
distributed in most tissues during Drosophila embryogenesis.
However, strikingly, there was stronger staining in the developing
gut and in the nervous system during phases of rapid development
(Figure 1A). To determine the subcellular distribution of
dPNUTS, we generated transgenic fly lines capable of expressing
epitope-tagged dPNUTS under UAS-GAL4 control. Ectopic
dPNUTS shows a similar subcellular localisation to mammalian
PNUTS: dPNUTS is nuclear and associates with chromatin
during interphase when ectopically expressed in the wing disc, but
is excluded from condensed chromosomes at metaphase
(Figure 1B). In polytene nuclei, ectopic dPNUTS was visible in
both the nucleoplasm and on polytene chromosomes as revealed
by co-staining the DNA with Hoechst (Figure 1C,D). Strong
Hoechst staining is associated with condensed chromosomal
bands, which contain a high concentration of DNA, whilst weak,
or no Hoechst signal is detected in interband regions of less tightly
packed chromatin, which are thought to contain actively
transcribed genes. dPNUTS is predominantly associated with
regions of less condensed DNA corresponding to interbands that
stain weakly with Hoechst (Figure 1D).
Author Summary
During development, cells rely on appropriate patterns of
gene expression to regulate metabolism in order to meet
cellular demands and maintain rapid tissue growth.
Conversely, dysregulation of gene expression is critical in
various disease states, such as cancer, and during ageing.
A key mechanism that is ubiquitously employed to control
gene expression is reversible phosphorylation, a molecular
switch that is used to regulate the activity of the
transcriptional machinery. Here we identify an enzyme
that binds to and regulates the phosphorylation state of
RNA Polymerase II, a central component of the general
transcription machinery. We also show that an essential
role of this enzyme is to support normal patterns of gene
expression that facilitate organismal growth. These find-
ings are not only of relevance to the understanding of
normal enzyme function but may also assist in the
development of therapeutic strategies for the treatment
of aberrant patterns of gene expression that occur during
ageing and disease progression.
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To examine the chromosomal association of dPNUTS further,
we generated antibodies specific to dPNUTS and used them to
stain polytene chromosomes from 3rd instar larval salivary glands.
Although the dPNUTS antibodies worked well on polytene squash
preparations we were unable to obtain a reliable signal from whole
tissue mount preparations. We found that dPNUTS is localised at
a large number of discrete sites of varying strength along all the
chromosomes. To confirm the specificity of the dPNUTS
antiserum on polytene squashes, we knocked down dPNUTS levels
in salivary glands using heritable double-stranded RNA interfer-
ence (RNAi). Flies carrying an inverted repeat (IR) construct under
UAS control were crossed to a salivary gland GAL4 source to
induce expression of intron-spliced hairpin dsRNA for dPNUTS in
the progeny. In squash preparations from relatively normal
looking glands expressing UAS-dPNUTSIR we found greatly
reduced dPNUTS staining (Figure S2). To explore the possibility
that dPNUTS may be associated with transcriptionally active sites,
we performed double labelling experiments with antibodies against
Figure 1. dPNUTS is a nuclear protein that colocalises with transcriptionally active RNAPII on salivary gland polytene
chromosomes. A) Distribution of dPNUTS transcripts detected by RNA in situ hybridization; dPNUTS transcripts are maternally provided (top left)
and are ubiquitously distributed in embryos at cellularisation (top right). At gastrulation, dPNUTS mRNA levels are enriched in the germband and in
the fore- and hind-gut (fg and hg, respectively). Later, dPNUTS is highly expressed in the brain (br) and ventral nerve cord (vnc). Embryonic stage and
approximate age, hours post fertilization (hpf), are indicated. B) 3rd instar wing discs stained to reveal the distribution of ectopically expressed Myc-
tagged dPNUTS (green in merge), Histone H3S10ph (red in merge, marking mitotic nuclei) and DNA. C) Images of whole mount salivary gland and
magnified images of an individual nucleus (below), stained to show the localization of Myc-tagged dPNUTS (green in merge) and DNA (magenta in
merge). D) Line scans of images in C) reveal that Myc-tagged dPNUTS is localised to interbands that stain weakly for DNA. Fluorescence intensity of
anti-Myc antibody and TOPRO-3 staining was measured along a line through the indicated chromosomal region in the images shown. The profile plot
below shows that the peaks of Myc-PNUTS and DNA of staining do not overlap. E) Polytene chromosomes from salivary gland squashes showing that
dPNUTS localises to a number of discrete bands that are broadly distributed. F) Merging of the green signal representing dPNUTS with the red signal
representing RNAPII Ser2-P (H5) identifies sites where these two proteins co-localize (example indicated with arrow). The relative signals of dPNUTS
and RNAPII Ser2-P vary between sites, but the majority dPNUTS loci colocalize with RNAPII Ser2-P staining (star indicates example where only dPNUTS
staining is visible).
doi:10.1371/journal.pgen.1003885.g001
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the active form of RNA polymerase II (RNAPII). We found that
the relative levels of dPNUTS and RNAPII vary at many sites,
but, on close inspection, it is clear that the dPNUTS antibody
marks a large number of transcriptionally active sites containing
active RNAPII (H5 antibody, detecting RNAPII Ser2-P)
(Figure 1E, F), suggesting that dPNUTS might have a role in
transcriptional regulation.
dPNUTS loss of function results in larval growth arrest
and defective tissue development
To determine the in vivo role of Drosophila PNUTS, we generated
two deletion alleles, dPNUTS9B and dPNUTS13B, by imprecise
excision of a P element transposon (P[SUPor-P] dPNUTSKG00572,
referred to as dPNUTSKG572 hereafter). Molecular analysis revealed
that virtually all of the fourth coding exon of dPNUTS is deleted in
dPNUTS9B, and the entire coding region, including the translation
start site, is deleted in dPNUTS13B (Figure 2A). Consistent with
these findings, quantitative RT-PCR analyses revealed the absence
or almost complete loss of dPNUTS transcripts in dPNUTS9B and
dPNUTS13B homozygotes. dPNUTS levels were also greatly
reduced in dPNUTSKG572 homozygotes compared to revertant
controls (dPNUTSexKG) in which the P element had been precisely
excised (Figure 2B). dPNUTS9B and dPNUTS13B are recessive lethal
in combination with each other and over Df(2L)ast4, a deficiency
that removes the dPNUTS gene. The phenotype of dPNUTS9B and
dPNUTS13B homozygotes was indistinguishable from that of
dPNUTS9B or dPNUTS13B/Df(2L)ast4 hemizygotes, so we conclude
that the excision alleles have little or no residual dPNUTS function.
To confirm that disruption of the dPNUTS transcription unit is
responsible for the larval lethality, we generated transgenic flies
carrying a genomic fragment containing the entire PNUTS locus.
A single copy of the transgenic construct was capable of fully
rescuing the homozygous lethality of dPNUTS9B and dPNUTS13B
mutants (Table S1).
To examine the lethal phase of dPNUTS mutants we combined
the mutant alleles with a GFP-balancer chromosome and
examined the development of mutant (non-GFP) larvae alongside
their heterozygous (GFP marked) siblings. Homozygous
dPNUTS9B and dPNUTS13B animals developed to 1st instar larvae
but died in the ensuing 8 days without further growth and
development (Figure 2C, D). To further assess the requirement for
dPNUTS in tissue development we made use of the ey-FLP system
to produce genetically mosaic flies that are otherwise heterozygous
but in which the eye is composed exclusively of cells homozygous
mutant for dPNUTS. Cells that are not derived from the
homozygous mutant cells are eliminated by eye-specific expression
of the pro-apoptotic gene hid [39]. Eyes of heterozygous
dPNUTSKG572, dPNUTS9B and dPNUTS13B flies resembled wild
type. Flies with eyes homozygous for dPNUTSKG572 were modestly
reduced in size, with fewer and poorly organised ommatidia. Eyes
homozygous for either dPNUTS9B or dPNUTS13B showed a more
severe effect, indicating that cells lacking dPNUTS are incapable of
developing into adult eyes (Figure 2E).
dPNUTS mutant cells fail to compete with wild type cells
and are removed from developing epithelia
To understand more about the cellular role of dPNUTS, we
generated clones of homozygous null dPNUTS mutant cells in
otherwise dPNUTS heterozygous wing imaginal discs during early
or mid-larval development using Flp/FRT-mediated recombina-
tion [40] and analysed them at the wandering 3rd instar larval
stage. To do this we used a heat shock inducible Flipase (Flp)
enzyme to induce mitotic recombination between two FRT
chromatids, one of which carried a mutant dPNUTS allele and the
other which expressed a GFP marker. Mitotic recombination
events produce a GFP-negative cell clone that are homozygous for
the mutant allele, together with a ‘‘twin-spot’’ marked by the
presence of two copies of GFP. Surrounding heterozygous tissue is
labelled with one copy of GFP. We failed to recover homozygous
mutant cells when clones were induced in early 1st instar larvae,
whereas wild type cells induced at the same stage proliferated to
generate large clonal patches (Figure 3A, B). When we shortened
the time between clone induction and analysis by inducing clones
later on in 2nd instar larvae, we were able to observe very small
patches of dPNUTS mutant cells (Figure 3C, D). However, in
optical cross sections through the tissue it was apparent that
mutant cells accumulated at the basal face of the epithelium and
stained positive for cleaved caspase antibody (Figure 3E–J),
indicating that dPNUTS mutant cells were undergoing cell death.
This prompted us to examine whether clones were dying due to
cell competition, a process in which slow-growing cells are
eliminated by their faster-growing neighbours. To test this, we
gave the dPNUTS mutant cells a growth advantage by generating
them in tissues that were heterozygous for a dominant Minute (M)
allele of RpL27A. Notably, under conditions in which dPNUTS
mutant clones in a wild-type background are normally eliminated,
we recovered dPNUTS clones in M/+ discs (Figure 3K, L and
Figure S3) and mutant clones spanned the entire wing disc
epithelium indicating they were not being eliminated (Figure 3Q,
R and Figure S3). However, mutant clones colonised a signifi-
cantly smaller area of M/+ discs compared with wild-type clones,
indicating that they were still growth impaired (compare Figure 3K
and 3L).
dPNUTS mutants deregulate the expression of the
majority of genes in 1st instar larvae
To obtain an insight into the molecular basis for the growth
defects in dPNUTS mutants and assess the impact of dPNUTS loss
of function on gene expression, we analysed the transcriptomic
signature of dPNUTS9B and dPNUTS13B mutant larvae by RNA-
Seq. The control for these experiments was an isogenic strain that
carried the same background mutation (w1118) as the dPNUTS
mutant strains. Homozygous dPNUTS9B and dPNUTS13B mutant
1st instar larvae had widespread changes in gene expression
compared to control animals of the same stage (Figure 4A), with a
comparable pattern of genes being affected in both mutants
(Figure S4). In total, approximately 30% of genes (2819/9483)
previously reported to be expressed in 1st instar larvae [40] were
underexpressed, and a similar proportion (2850/9483) were
overexpressed .1.5-fold in both dPNUTS9B and dPNUTS13B
mutant animals relative to control larvae. Therefore, we conclude
that disruption of dPNUTS function affects the expression of the
majority of genes in developing 1st instar larvae.
To assess whether there was any enrichment of genes
belonging to functionally-related biological processes, we
analysed the distribution of Gene Ontology (GO) terms amongst
differentially expressed genes. When compared to the frequency
of GO terms amongst all genes encoded by the genome, we
observed significant (P#1024) enrichment of terms for cell death
and stress responses amongst genes overexpressed in dPNUTS
mutants (Figure S5, Table S2). Overexpression of these groups
of genes might indicate that the animals are under stress and is
consistent with their poor survival. The most significantly
enriched GO terms amongst the underexpressed genes in
dPNUTS mutants, were terms for cellular metabolic processes
that drive proliferative growth, including ribosome biogenesis,
rRNA processing, translation and metabolism of energy sources
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(Figure S5, Table S2). We observed a similar pattern of GO
enrichment when comparing differentially expressed genes in
the dPNUTS mutants to genes expressed in our developmentally
matched control (Table S3). These patterns of transcriptional
change are consistent with the larval growth defect exhibited by
the dPNUTS mutants. In addition, Ingenuity analysis identified a
number of different transcriptional networks involved in
organismal growth that are likely to be affected by loss of
dPNUTS (Table S4).
While these analyses provide biological insight into the likely
processes underpinning the dPNUTS mutant phenotype, it is
important to note that the enrichment of biologically-relevant GO
categories is correlated with the expression level of the represen-
tative genes in 1st instar larvae (Figure 4A). Indeed, GO categories
pertaining to cellular metabolism are also enriched amongst highly
expressed genes in the control (median expression level .(log2)2.9
FPKM; data not shown). Taken together with the widespread
effects on transcript abundance, these data indicate that dPNUTS
globally affects gene expression and in 1st instar larvae is required
to promote expression of highly expressed genes that support
developmental growth.
To confirm the RNA-Seq results, we selected genes represen-
tative of enriched GO categories for quantitative real-time qRT-
PCR analysis. Measurements of relative mRNA expression level
determined by qRT-PCR were consistent with our RNA-Seq data
(Figure 4B, Table S5).
Figure 2. dPNUTS loss of function results in larval growth arrest and defective tissue development. A) Genomic region showing dPNUTS
locus flanked by dribble and ninaA. Coding regions of the genes is represented by shading. dPNUTS produces two transcripts dPNUTS and dPNUTS-S.
ninaA is a non-essential gene that is expressed solely in the eye to regulate rhodopsin synthesis [75,76]. dPNUTSKG572 contains a P element insertion in
an untranslated region of dPNUTS. The extent of deletions in dPNUTS9B and dPNUTS13B resulting from imprecise excision of this element is indicated,
together with the genomic sequence of the breakpoints. The dPNUTS genomic rescue construct, which contains the coding region of ninaA, and the
59 end of dribble, is indicated. B) Levels of dPNUTS and dPNUTS-S transcripts produced in homozygous dPNUTSexKG, dPNUTSKG572, dPNUTS9B and
dPNUTS13B larvae, as determined by qRT-PCR. dPNUTSeexKG is a revertant strain in which the P element had precisely excised. C) Images of
homozygous mutant and control (heterozygous sibling) larvae at different time points after egg laying as indicated. D) Graph showing percentage of
surviving larvae over time for each genotype, as indicated. E) Images of adult female eyes. Homozygous dPNUTS mutant eyes are smaller than
controls (isogenic w1118 strain), but are able to form some facets, unlike eyes expressing the proapototic gene hid under GMR control.
doi:10.1371/journal.pgen.1003885.g002
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dPNUTS binds to and colocalises with PP1 on
chromosomes
dPNUTS was originally isolated from a two-hybrid screen for
putative PP1-binding proteins and contains a canonical PP1-
binding motif - K/R, (x), V/I/L, x, F/W that in PNUTS/p99 is
necessary for binding to, and inhibition of, PP1 [23,41]. This motif
(residues 722–726) is also contained within all the dPNUTS two-
hybrid clones, including the shortest interacting fragment encod-
ing residues 608 to 1135 [42], (Figure 5A). When we retested
binding in the two-hybrid system with full-length proteins,
dPNUTS, but not dPNUTS-S, interacted strongly with all four
D. melanogaster PP1 isoforms (Figure 5B), consistent with a role for
this motif in binding PP1. To determine the importance of the
putative PP1-binding motif for interaction with PP1, we compared
binding of endogenous PP1, to ectopically expressed wild type
dPNUTS (dPNUTSWT) and a mutant form in which Trp726 was
replaced with Ala (dPNUTSW726A). Immunoprecipitation with
antibodies against Myc-tagged dPNUTS, followed by immuno-
blotting with antibodies against PP1, showed that PP1 co-
precipitated very efficiently with dPNUTSWT but not
dPNUTSW726A (Figure 5C), indicating that Trp726 is crucial for
interaction with PP1.
To further explore the association between PP1 and dPNUTS in
vivo, we examined the distribution of dPNUTS and PP1 on
polytene chromosomes from 3rd instar larvae. We previously
reported that ectopic HA-tagged PP187B, the major PP1 isoform
in Drosophila [43], localised to many discrete chromosomal loci
[17,18]. Like the ectopic protein, we found a large number of
Figure 3. dPNUTS mutant clones reveal a cell autonomous growth defect in developing tissues. Clones (marked by absence of GFP) of
either wild-type or dPNUTS13B mutant cells are shown in wing imaginal discs obtained from 3rd instar larvae. Clones were induced in a wild type (A–J)
or Minute (M) mutant background (K–R) 48 hr, 72 hr or 96 hr prior to dissection, as indicated. The parental (p) genotypes are indicated, along with the
genotype of clones (c) generated by FLP-mediated mitotic recombination and are coded with grayscale to indicate the relative level of GFP
expression. A–J, wing discs were stained for activated caspase shown in blue, and in cross sections (E–J), apico-lateral junctions are marked by discs-
large staining in red; GFP is shown in green. In cross sections Q–R, DNA is shown in red. Arrowheads in panel L indicate the presence of dPNUTS13B
GFP-negative clones in a Minute (M) mutant background. +, M, GFP/+, M, GFP twinspot clones, indicated by arrowhead in panel R, were almost never
observed because of a severe growth defect.
doi:10.1371/journal.pgen.1003885.g003
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discrete sites widely dispersed along the chromosomes that
were stained with an anti-peptide antibody to Drosophila PP1
(Figure 5D). When we co-stained for dPNUTS, we found
that most sites staining for dPNUTS also stained strongly
for PP1 although the relative staining varied greatly
(Figure 5D).
Figure 4. dPNUTS mutants deregulate the expression of the majority of genes in 1st instar larvae, including highly expressed genes
involved in cellular metabolism and proliferative growth. A) MA plot of RNA-Seq data in which the log2 of the ratio of abundance of each
transcript between dPNUTS13B (13B) mutant and w1118 (WT) control (M) is plotted against the log2 geometric average of abundance (FPKM) in both
conditions (A). Transcripts with an FPKM of less than 0.25, which are a source of noise in these plots, are not shown for clarity. Transcripts that are
differentially expressed (DE) by,0.67 or.1.5 fold are shown in grey; unaffected transcripts are shown in white. Loci corresponding to enriched Gene
Ontology (GO) terms amongst the differentially expressed genes relative to the entire genome are highlighted in yellow (enriched amongst
overexpressed genes) or red (enriched amongst underexpressed genes). Log2 median expression for genes expressed in WT and 13B is indicated with
a dashed line. Log2 median expression for genes belonging to GO categories is given in the legend. A complete list of GO categories is provided in
the Supplementary information. B) Expression levels of the indicated genes in dPNUTS9B/dPNUTS9B and dPNUTS13B/dPNUTS13B mutant larvae, relative
to control (w1118) larvae, determined by qRT-PCR. Error bars represent the SE (n$3 biological replicates). The GO categories to which the genes
belong are shown at the top.
doi:10.1371/journal.pgen.1003885.g004
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dPNUTS recruits PP1 to chromosomes
Since salivary glands from 1st instar dPNUTS mutant larvae were
too small to analyse in squash preparations, we were unable to test
whether loss of dPNUTS function displaces PP1 from chromosomes.
Therefore, to examine whether PP1 is dependent on dPNUTS for
its localisation or vice versa, we utilised our transgenic overexpression
construct dPNUTSW726A, which exhibits reduced binding to PP1.
We reasoned that if PP1 is necessary for dPNUTS localisation we
would expect to observe loss of dPNUTSW726A from chromosomes;
conversely, if dPNUTS is responsible for recruiting PP1 then
overexpressed dPNUTSW726A should stoichiometrically compete
with endogenous PNUTS-PP1 complexes for binding to chromo-
somes resulting in the displacement of PP1. Chromosomal PP1
staining, but not total PP1 levels, was reduced in glands
overexpressing dPNUTSW726A compared to those expressing
dPNUTSWT (Figure 6A). To quantify the effect on PP1 localisation,
we performed line scans to measure fluorescence intensity at a
readily identifiable site on the X chromosome, where endogenous
PP1 and dPNUTS co-localise (Figure 5D). Intensity of PP1 staining
at this site on chromosomes from animals overexpressing
dPNUTSW726A was on average reduced 0.6 fold (Figure 6B). Taken
together, these data suggest that dPNUTS is responsible for targeting
PP1 to many distinct chromosomal loci. Anti-Myc staining of
ectopically expressed Myc-tagged dPNUTS was of relatively poor
quality but, in general there was a comparable distribution of
dPNUTSW726A and dPNUTSWT in squash preparations (Figure 6C).
Levels of dPNUTSW726A sometimes appeared weaker than
dPNUTSWT but this is accounted for by differences in the quality
of squash preparations and a lower expression level of
dPNUTSW726A relative to dPNUTSWT, as revealed by immunoblot-
Figure 5. dPNUTS binds to and co-localises with PP1 on chromosomes. A) Predicted domain structure of dPNUTS and dPNUTS-S proteins,
indicating the position of the putative PP1-binding motif (residues 722–726), which is located in the shortest yeast two-hybrid interacting clone (SIC)
of dPNUTS. B) Beta-galactosidase assays showing binding of dPNUTS but not dPNUTS-S to all four D. melanogaster PP1 isoforms in the yeast two-
hybrid system. C) dPNUTSWT, but not dPNUTSW726A, co-precipitates PP1 from nuclear extracts from adult flies. da-GAL4 UAS-HM-dPNUTSWT and da-
GAL4 UAS-HM-dPNUTSW726A fly extracts were subjected to immunoprecipitation (IP) with Myc antibodies followed by immunoblotting with PP1
antibodies. Blots of total lysates confirmed levels of HM-tagged dPNUTS and PP1. D) dPNUTS and PP1 colocalise at many sites on polytene
chromosomes. Inset is an enlarged view of the end of the X chromosome where this is clearly visible. Plot of fluorescence intensity of anti-PP1 and
dPNUTS antibody staining, measured along a line through the indicated chromosomal region, reveal the degree of colocalisation between PP1 and
dPNUTS.
doi:10.1371/journal.pgen.1003885.g005
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ting (Figure 6D). Taken together these data suggest that PP1
binding is not necessary for dPNUTS localization to polytene
chromosomes.
PP1-binding is important for dPNUTS function in tissue
development
To elucidate the functional significance of the interaction
between PP1 and dPNUTS in vivo, we examined whether
dPNUTSW726A was capable of rescuing the reduced eye phenotype
exhibited by our dPNUTS mutants. dPNUTSWT rescued the effect
of both dPNUTS9B and dPNUTS13B. However, ectopic overex-
pression of dPNUTSW726A failed to rescue either mutant
(Figure 6E), indicating that binding to PP1 is critical for dPNUTS
function in tissue development. We also took another approach to
examine the effect of reducing PP1 activity in dPNUTS mutant
eyes. For this, we generated flies that were homozygous for
dPNUTSKG572, which resulted in a modest reduction in eye size,
and also heterozygous for mutations in PP187B that reduce the
total PP1 activity by approximately 40% [44]. Reduced eye
phenotypes caused by dPNUTSKG572 mutants were dominantly
enhanced by PP187B, consistent with dPNUTS acting as a positive
regulator of PP1 function during imaginal disc development
(Figure 6F).
dPNUTS is complexed with and regulates the
phosphorylation state of RNA Polymerase II
RNAPII has recently been reported to co-precipitate PNUTS
from mammalian cell extracts [37]. Given the widespread effects
of dPNUTS mutations on transcription and its colocalisation with
active RNAPII at many transcriptionally active sites on chromo-
somes, we wondered whether dPNUTS also physically associates
with RNAPII complexes. To test this, we immunoprecipitated
endogenous dPNUTS from wild type embryo extracts and
examined precipitates for the presence of RNAPII. Two RNAPII
species, representing unphosphorylated (RNAPIIa) and phosphor-
ylated RNAPII (RNAPIIo), can be detected using an antibody
(ARNA-3) that recognises a peptide mapping to central region of
RNAPII. Both these forms precipitated with dPNUTS-S, but only
RNAPIIA co-precipitated efficiently with dPNUTS (Figure 7A).
Since PP1 was previously shown to be capable of dephosphory-
lating RNAPIIo in vitro [14], we wondered whether the pattern of
binding we observed was because dPNUTS is capable of binding
PP1 and dPNUTS-S is not. To test the role of PP1 in endogenous
dPNUTS complexes, we repeated our immunoprecipitations in
the presence of Inhibitor-2 (I-2), a specific inhibitor of PP1 [45].
There was no apparent difference in the abundance of RNAPIIa
or RNAPIIo in dPNUTS-S precipitates. However, when we
Figure 6. PP1 localisation is regulated by dPNUTS and binding to PP1 is important for dPNUTS function. A) Images of polytene
chromosome squashes from salivary glands expressing either dPNUTSWT or dPNUTSW726A stained with PP1 (in green). Inset are enlarged views of the
distal end of the X chromosome. Arrows indicate approximate lines along which quantitation of fluorescence (see B) was performed. B) Plots of line
scans through the chromosomal region indicated in A, showing levels of PP1 staining in salivary glands expressing either dPNUTSWT or dPNUTSW726A.
Bar graphs represent the average fluorescence in this region from 6 independent images/genotype. Genotypes are indicated by the colour key. C)
Levels and distribution of Myc-dPNUTS on polytene chromosome squashes from salivary glands expressing either dPNUTSWT or dPNUTSW726A, as
revealed by anti-Myc staining (green). D) Western blots showing levels of PP1 and Myc-dPNUTS, relative to Actin, in extracts from animals ectopically
expressing dPNUTSWT or dPNUTSW726A under the control of da-GAL4 (da.dPNUTSWT and da.dPNUTSW726A, respectively) compared to w1118 control
(2). E) Images of adult female eyes showing that the severely reduced eye phenotype of homozygous dPNUTSmutant eyes is fully rescued by ectopic
expression of dPNUTSWT but not dPNUTSW726A. F) Homozygous dPNUTSKG572 mutant eyes show a weaker phenotype than either dPNUTS9B or
dPNUTS13B, and this can be enhanced by loss of one copy of PP187B.
doi:10.1371/journal.pgen.1003885.g006
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precipitated dPNUTS in the presence of I-2, we found reduced
levels of RNAPIIa and elevated levels of RNAPIIo (Figure 7A). I-2
selectively targets PP1 over PP2A, which is the next most closely
related member of the PPP family of phosphatases [46].
Therefore, we conclude that PP1 is likely to be the major RNAPII
phosphatase in these complexes.
Mammalian PNUTS has been reported to bind to Wdr82,
which targets RNAPII phosphorylated on Ser5 of its CTD repeats
(RNAPII CTD Ser5-P). Although the degree of functional
conservation between mammalian and Drosophila Wdr82 (dWdr82)
has not yet been fully determined, we found that dWdr82 co-
precipitated with dPNUTS from Drosophila cell extracts indicating
that the ability of Wdr82 to bind PNUTS is shared between fly
and human orthologues (Figure S6A). This prompted us to assess
the effect of dPNUTS loss of function on the levels of RNAPII
CTD Ser5-P. Using an antibody (4H8) that recognizes the Ser5-
phosphorylated C-terminal domain [47], we observed elevated
levels of RNAPII CTD Ser5-P in total extracts from dPNUTS
mutant larval extracts by Western Blotting compared to wild type
(w1118) or revertant (dPNUTSexKG/dPNUTSexKG) controls
(Figure 7B). Using a panel of independent anti-phospho CTD
antibodies [48,49] we further confirmed the effect of dPNUTS loss
Figure 7. dPNUTS complexes with and regulates RNAPII phosphorylation. A) dPNUTS complexes contain RNAPII and PP1; inhibition of PP1
activity in dPNUTS complexes leads to hyperphosphorylation of RNAPII. dPNUTS-S and dPNUTS were immunoprecipitated (IP) from embryonic
nuclear extracts and precipitates were probed with ARNA-3 anti-RNAPII antibody. Lane 1, neither hypo- or hyper-phosphorylated RNAPII (RNAPIIa and
RNAPIIo respectively) precipitate with pre-immune serum; Lane 2, both RNAPIIa and RNAPIIo precipitate with dPNUTS-S; Lane 3, RNAPIIa, but almost
no RNAPIIo, is detected in dPNUTS precipitates. Lane 4, pre-immune serum does not precipitate RNAPII; Lane 5, Inhibitor 2 does not affect the ability
of RNAPIIa and RNAPIIo to associate with dPNUTS-S (compare Lane 2); Lane 6, inhibition of PP1 results in conversion of RNAPIIa to RNAPIIo in dPNUTS
precipitates (compare Lane 3). Ratios of RNAPIIa and RNAPIIo levels, as derived from densitometry measurements of the respective bands, are shown
above the blots. B) Western Blot showing levels of RNAPII CTD Ser5-P (4H8) in extracts from either 1st (L1) or 2nd (L2) instar larvae of the indicated
genotypes: homozygous revertant dPNUTSexKG/dPNUTSexKG (exKG/exKG); homozygous null mutant dPNUTS9B/dPNUTS9B (9B/9B) or dPNUTS13B/
dPNUTS13B (13B/13B); isogenic control strain w1118/w1118; homozygous hypomorphic mutant dPNUTSKG572/dPNUTSKG572 (KG/KG). 1st instar larval
samples from dPNUTS9B/9B and dPNUTS13B/13B were independent extracts run in parallel on the same gel. Blot with anti-Actin antibody shows relative
loading. C) Precipitation of RNAPII Ser5-P with dPNUTSW726A but not dPNUTSWT. dPNUTS complexes from Drosophila embryonic nuclear extracts
expressing Myc-tagged dPNUTSWT or dPNUTSW726A under the control of da-GAL4 were isolated by immunoprecipitation with anti-Myc antibody.
Control precipitations were performed on w1118 extracts (2). This was followed by immunoblotting with anti-RNAPII CTD Ser5-P (4H8) antibody to
test for co-immunoprecipitation. Lower panels show immunoblot analyses of total lysates, confirming the levels of total RNAPII and Myc-dPNUTS. D)
Levels of RNAPII CTD Ser5-P (H14) on polytene chromosome squashes from salivary glands expressing either histone-H2B YFP or Myc-dPNUTSW726A
prepared on the same slide to ensure identical staining conditions (H14 staining in green; DNA staining in magenta). Insets are enlarged views of the
distal end of the X chromosome. Arrows indicate approximate lines along which quantitation of fluorescence (in E) was performed. E) Representative
line scans through the regions illustrated in D, showing levels of RNAPII CTD Ser5-P staining in the two genotypes. Bar graphs represent the average
fluorescence in this region from 6 independent images/genotype. Genotypes are indicated by the colour key.
doi:10.1371/journal.pgen.1003885.g007
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of function on RNAPII CTD Ser5-P levels. We also observed a
modest increase in levels of RNAPII CTD Ser2-P but little or no
change in levels of RNAPII CTD Thr4-P or Ser7-P, in mutant
extracts (Figure S6B). To test whether dPNUTS regulates RNAPII
phosphorylation on chromosomes, we generated mutant clones in
the salivary gland and examined RNAPII phosphorylation on
polytene chromosomes in whole mount preparations. Levels of
RNAPII CTD Ser5-P, as detected with an antibody (H14), which
recognizes RNAPII Ser5-P in the context of Ser2 phosphorylation
[48], were also elevated in this context (data not shown).
Interestingly, on wild type polytene chromosome squashes, we
observed relatively little co-localisation between dPNUTS and
RNAPII Ser5-P (H14) (Figure S7), suggesting that the presence of
dPNUTS at chromosomal loci is associated with a reduction of
Ser5 phosphorylation at these sites. To confirm the role of
dPNUTS-bound PP1, we expressed Myc-tagged dPNUTSWT and
dPNUTSW726A in embryos, and tested their ability to bind to
RNAPII CTD Ser5-P. Immunoprecipitation with anti-Myc
antibodies, followed by immunoblotting with anti-RNAPII CTD
Ser5-P (4H8) antibody, revealed that RNAPII CTD Ser5-P was
only recovered in Myc-dPNUTSW726A and not Myc-dPNUTSWT
precipitates (Figure 7C), further indicating that dPNUTS-bound
PP1 dephosphorylates RNAPII Ser5-P.
Disruption of PP1-binding results in elevated RNAPII CTD
Ser5-P at chromosomal loci
To further test the role of PP1-bound dPNUTS, we examined
the effect of ectopic dPNUTSW726A on RNAPII phosphorylation on
polytene chromosome spreads. Since dPNUTSW726A shows re-
duced binding to PP1, we predicted that ectopic expression of this
mutant form would compete with endogenous PNUTS-PP1
complexes and thereby reduce RNAPII dephosphorylation by
PP1. Correspondingly, we found that levels of RNAPII CTD
Ser5-P appeared modestly elevated on chromosomes from glands
overexpressing dPNUTSW726A (Figure 7D). To quantitate this
effect, we compared the levels of RNAPII CTD Ser5-P staining on
chromosomes from larvae with or without ectopic dPNUTSW726A.
Since RNAPII CTD Ser5-P staining was variable from slide to
slide, chromosomes from animals over-expressing dPNUTSW726A
were prepared alongside control samples labelled with histone-
H2B YFP and stained on the same slides to ensure identical
staining conditions between the two samples. Line scans and
measurements of average signal intensity at a site at which
dPNUTSW726A displaces endogenous PP1 (Figure 6A,B), indicated
an average increase of 1.59 fold in RNAPII Ser5-P on
chromosomes from larvae ectopically expressing dPNUTSW726A
compared to wild type animals (Figure 7E). Ectopic dPNUTSWT on
average had no effect on RNAPII Ser5-P staining relative to
histone-H2B YFP labeled chromosomes (data not shown).
Together, these results indicate that the dPNUTS-PP1 holoen-
zyme associates with RNAPII and regulates the dephosphorylation
of its C-Terminal Domain.
Misregulation of gene expression, but not RNAPII
distribution, is a consequence of disrupting dPNUTS-PP1
binding
Relatively little is known about the effect of RNAPII Ser5
hyperphosphorylation on gene expression, but it has been
associated with decreased elongation rate or pausing of RNAPII
when it occurs on the body of genes [50,51]. To assess whether
effects on RNAPII occupancy might result from disrupting
dPNUTS binding to PP1, we examined the effect of ectopic
dPNUTSW726A on gene expression and the distribution of RNAPII
at specific gene loci. Overexpression of dPNUTSW726A in 3rd instar
larvae using da-GAL4 (da.dPNUTSW726A) had a similar, but
weaker, effect on gene expression to that of dPNUTS loss-of-
function in 1st instar larvae (Figure S8A). This might be because
the transgenic line of dPNUTSW726A that we used had only a weak
dominant-negative effect (animals expressing this construct were
viable with da-GAL4) and/or because the regulation of some target
loci is different at this later developmental stage. Amongst the
genes we examined, ImpL3, nop56 and ACC were underexpressed,
whereas the stress response gene Thor was overexpressed in
response to ectopic dPNUTSW726A. Next, we examined the
distribution of RNAPII at selected loci by Chromatin Immuno-
precipitation (ChIP). For these experiments, chromatin was
extracted from da.dPNUTSW726A or control larvae and precipi-
tated with either mouse IgG or anti-total RNAPII antibody
(8WG16). We determined the abundance of precipitated chroma-
tin by qPCR with gene specific primers. Control precipitations
with mouse IgG showed a low level of non-specific background in
all of these experiments (Figure S8B–E). When we analysed the
distribution of RNAPII at selected loci, we did not observe a
significant change in the occupancy of total RNAPII at the 59 ends
or coding regions of genes in da.dPNUTSW726A samples.
Together, these results provide evidence of the link between the
disruption of PP1 binding to dPNUTS and the misregulation of
RNAPII-mediated gene expression, but suggest that changes in
gene expression that we have observed may be linked to effects on
co-transcriptional processes, such as mRNA capping, rather than
transcription per se. Indeed, Ser5-P has been shown to bind and
stimulate the activity of mammalian capping enzyme (Mce1)
[52,53]. Furthermore, in yeast, lethality resulting from substitution
of all CTD Ser5 residues with Ala can be rescued by the tethering
of Mce1 to the CTD, suggesting that the essential function of CTD
Ser5 is in capping enzyme recruitment [54].
Discussion
dPNUTS is required for gene expression and for
developmental growth
Here we report the functional analysis of Drosophila PNUTS, a
regulatory subunit of PP1 that is highly conserved between flies
and humans. We find that dPNUTS is essential for organismal
growth, with mutant animals arresting early in larval development.
Survival of the null zygotic mutants until the early larval stage is
most likely due to perdurance of maternal dPNUTS gene products,
raising the possibility of additional roles for dPNUTS during
embryological development that we have not uncovered here.
Clonal analysis indicates that dPNUTS has a cell autonomous effect
on growth, with mutant clones failing to survive unless given a
growth advantage. Transcriptomics characterisation of dPNUTS
mutant animals indicates that the larval arrest phenotype is
associated with the underexpression of many RNAPII-dependent
genes, including those that normally support developmental
growth. Of particular interest in this regard is the significant
enrichment of genes involved in cellular metabolism. The
underexpression of these genes suggests that an important role
of dPNUTS during larval growth might be to ensure transcription
of highly expressed metabolic pathways responsible for fuelling
energy production and generating the macromolecular precursors
for RNA and protein synthesis. Metabolic state is monitored in
developing epithelia, ensuring that the fittest cells are selected as
organ precursors [55]. The failure to compete with wild type
neighbours is consistent with an altered metabolic state that is
recognised by cell competition, triggering cells to be outcompeted
by their neighbours and lost by caspase-dependent apoptosis.
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Is the effect on RNAPII-dependent transcription the cause of
growth defects? It is conceivable that roles that have been assigned
to hPNUTS, e.g. in the DNA damage response and chromatin
condensation, are conserved in dPNUTS and these might
contribute to the larval lethality exhibited by dPNUTS mutants.
Indeed the non-identical distribution of dPNUTS and RNAPII on
chromosomes suggests that dPNUTS is present in chromatin-
associated complexes lacking RNAPII. Notably we do not see any
detectable condensation defects in dPNUTS mutant clones but we
cannot exclude the possibility that dPNUTS may also contribute to
other processes that underlie tissue growth, such as transcription-
independent cell cycle control, as has been reported for other
enzymes that regulate CTD phosphorylation, such as FCP1 [56].
Nevertheless, loss of expression of any one of the cell metabolism
pathways affected by dPNUTS (Table S4) is sufficient to cause
larval growth arrest and is likely to explain the failure of dPNUTS
larvae to grow in size prior to their eventual demise.
dPNUTS associates with RNAPII at active sites of
transcription
Like its mammalian counterpart, we have shown that dPNUTS
is a nuclear protein that localises to chromatin during interphase.
By utilising larval polytene chromosomes, which are readily visible
by light microscopy, we have been able to extend this analysis by
determining the distribution of dPNUTS on interphase chromo-
somes in situ. These analyses show co-localisation of dPNUTS with
many transcriptionally active sites marked with RNAPII, suggest-
ing that the widespread changes in gene expression that we
observe upon loss of dPNUTS function are likely to be due to the
direct involvement of dPNUTS in RNAPII-mediated transcrip-
tional regulation. Correspondingly, we find that dPNUTS is
complexed to the large subunit of RNAPII in cell extracts.
However, it is important to note that not all RNAPII sites stain for
dPNUTS (and vice versa) and the relative amounts of the two
proteins vary widely amongst these sites. This suggests that the
association of dPNUTS with RNAPII, or with associated factors,
which may affect the availability of the dPNUTS epitope for
detection by our antibody, may be differentially regulated.
PNUTS contains a number of conserved macromolecular-
interaction domains, which have led to the suggestion it might
serve as a multivalent adapter protein. However, it has not yet
been established to what extent the known interactors, Tox4 and
Wdr82 aid in the recruitment of PNUTS to chromosomal loci.
These issues will require investigation of the genome-wide sites of
dPNUTS binding, as well as identification and comprehensive
characterisation of dPNUTS-interacting proteins and their role in
dPNUTS recruitment.
dPNUTS-PP1 regulates the phosphorylation state of
RNAPII
Since we found that PP1-binding is necessary for dPNUTS
function, we reasoned that dPNUTS affects transcription by
targeting PP1 to specific substrates on chromosomes. Several lines
of evidence indicate that one important target of dPNUTS-PP1 in
this context is the CTD of RNAPII: i) dPNUTS is complexed with
RNAPII in nuclear extracts and regulates RNAPII CTD
phosphorylation in a PP1-dependent manner; ii) RNAPII CTD
Ser5-P levels are elevated in dPNUTS mutant larval extracts and
tissues; iii) dPNUTS colocalises with PP1 and RNAPII on
chromosomes; iv) ectopic expression of a mutant version of
dPNUTS that displaces PP1 from polytene chromosomes results in
elevated RNAPII CTD Ser5-P levels on chromosomes. dPNUTS-
PP1 appears to preferentially target Ser5-P of the CTD as we
observed only a modest effect on Ser2-P levels and no effect on
phosphorylation of other RNAPII-CTD residues in dPNUTS
mutant larval extracts by Western blotting (Figure S6B). However,
PNUTS/PP1 is not the only PP1 holoenzyme that has been
implicated in regulation of RNAPII phosphorylation [37], raising
the possibility that different PP1 holoenzymes possess different
RNAPII CTD specificities.
Changes in the pattern of gene expression that we have
observed in dPNUTS mutant animals are correlated with the
normal expression level of the affected transcripts; these changes
may also reflect the spatial distribution of dPNUTS expression
during development. During embryogenesis we observed that the
levels of dPNUTS expression in the gut and the ventral nerve cord
correlates with stages in which these tissues are undergoing periods
of rapid expansion and development. In an analogous fashion to
SCP1, which restricts RNAPII dephosphorylation of neuronal
genes to non-neuronal cells by virtue of its expression pattern [11],
the enrichment of dPNUTS in proliferating tissues may function to
promote expression of highly expressed transcripts, such as those
involved in cellular metabolism, in these tissues, to support their
development. In mammals, the gradual decrease from a high level
of PNUTS during embryogenesis to a relatively low level in adults
has been taken to imply that PNUTS could play a role in cortical
development [22], but could equally reflect a requirement during
growth of developing tissues. Notably, PNUTS is not found in
some metazoans such as C.elegans, where strictly controlled cell
lineage determines tissue architecture. An evolved function of
PNUTS might therefore be to support proliferative states in
organisms where compensatory mechanisms such as cell compe-
tition are at play.
How do dPNUTS and RNAPII hyperphosphorylation regulate gene
expression? Studies of other enzymes that control CTD phosphor-
ylation state indicate that maintaining correct levels of CTD
phosphorylation is critical for normal levels of transcription and
that hyperphosphorylation of RNAPII can increase or reduce gene
expression depending on what stage of the transcriptional cycle
phosphorylation is affected. For instance, FCP1 targets Ser2-P in
vivo [57] and is thought to recycle RNAPII after the complex has
dissociated from the transcribed region [58]. Correspondingly,
conditional knockout of FCP1 in yeast results in a global defect in
transcription affecting 77% of genes [59]. SCP1 and Ssu72 both
target Ser5-P [16,60], but have contrasting roles in transcriptional
regulation: knockdown of SCP1 unmasks neuronal gene expres-
sion, indicating it normally acts as a transcriptional repressor [11],
whilst Ssu72 facilitates transcription by promoting the elongation
stage of the transcription cycle [61]. ChIP experiments from larvae
expressing dPNUTSW726A suggest that displacement of PP1 binding
to dPNUTS does not result in accumulation of RNAPII on the
coding region of affected loci. The precise mechanisms of how loss
of dPNUTS function and RNAPII hyperphosphorylation disrupt
gene expression require further investigation. However, we might
expect processes dependent on normal CTD phosphorylation,
including RNA processing, transcription-coupled chromatin
modification and transcription-associated homologous recombi-
nation [4], to be affected. In this regard, it is notable that
inhibition of TFIIH kinase activity, which phosphorylates
promoter-bound RNAPII at Ser5, predominantly affects mRNA
capping and stability rather than transcription per se [62–64].
In summary, the analysis of dPNUTS described here reveals an
important function for this evolutionarily conserved chromatin-
associated protein, via association with PP1, in the regulation of
RNAPII phosphorylation and the appropriate expression of genes
during larval development, which support organismal growth.
These findings provide insight into the role of PNUTS and
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RNAPII phosphorylation during normal development, and may
also be of relevance to the understanding of aberrant gene
expression patterns observed in disease processes and ageing.
Materials and Methods
Fly strains
Drosophila melanogaster stocks were kept at 18uC or 25uC on
standard agar-cornmeal-yeast medium. Genotypes are provided in
Text S1.
Isolation and characterisation of dPNUTS null alleles
Isolation of a null allele of dPNUTS by P element excision from
dPNUTSKG was carried out by crossing w; dPNUTSKG/CyO,
P(Delta2-3) males to y, w; Tft/CyO females. From each cross, a
single w revertant male in which the P element was excised, was
individually crossed back to w; Tft/CyO females. To determine the
molecular lesion in excisions, genomic DNA surrounding the
original dPNUTSKG insertion site was amplified from heterozygous
mutants by PCR using flanking primers (see Text S1) and
sequenced. For genetic complementation tests, a 9.1 kb BamHI
restriction fragment from P1 clone DS02684, which contains all of
the transcribed dPNUTS sequence, was subcloned into the BamHI
site in pW8 and injected into flies. Details of the growth arrest
experiment can be found in Text S1.
Ectopic expression of wild type dPNUTS and dPNUTSW726A
Full-length cDNAs for dPNUTS-S and PNUTS-L cloned into
pNB40 were isolated from a 3rd instar larval library (see Text S1).
dPNUTSW726A was generated by PCR-based site-directed muta-
genesis. For ectopic expression in flies, full-length dPNUTSWT and
dPNUTSW726A were subcloned into pUAS-HM, a modified of
pUAST that contains an N-terminal 36His 66Myc (HM) tag.
UAS-HM-PNUTS flies were made by P element-mediated germline
transformation into a w1118 stain by Genetic Services Inc.
(Cambridge, MA). Tagged dPNUTSWT and dPNUTSW726A were
ectopically expressed ubiquitously using da-GAL4 or in salivary
glands using AB1-GAL4.
RNA in situ hybridisation
pNB40-dPNUTS clones were used to generate Digoxigenin
(DIG)-labelled RNA probes. RNA in situ hybridisation was
essentially performed as previously described [45,65]. Following
hybridization, DIG-labelled probes were detected with an alkaline
phosphatase conjugated anti-digoxygenin antibody in the presence
of Nitro-blue tetrazolium salt (NBT) and X-phosphate/5-Bromo-
4-chloro-3-indolyl-phosphate (BCIP).
RNA extraction and qRT-PCR
RNA was extracted using the Qiagen RNeasy Mini kit and was
reverse transcribed using the High Capacity cDNA Reverse
Transcription kit (Applied Biosystems). Quantitative PCR was
performed following the incorporation of SYBRGreen (using the
Applied Biosystem StepOnePlus Real Time PCR System). Primers
are described in Text S1. All samples were normalized to 18S
RNA. The DDCT method was used for the calculation of the
relative abundances [66].
RNA-seq and bioinformatics
RNA from approximately 5000 1st instar larvae/genotype was
extracted using the Qiagen RNeasy Mini kit following the
manufacturer’s instructions. Total RNA quality and quantity
was verified on a NanoDrop1000 spectrophotometer (Thermo-
fisher) and Bioanalyzer 2100. mRNA was polyA selected using
Dynabeads mRNA Purification Kit for mRNA Purification from
Total RNA Preps (Invitrogen). The libraries were prepared
according to the SOLiD Total RNA-Seq Kit protocol (Part
Number 4452437 Rev. A, Applied Biosystems). RNA samples
were sequenced on an AB SOLiD sequencing platform with v4
chemistry, generating single-end 50 bp colour-space reads. More
than 93M reads were generated for each sample. Reads were
filtered for quality and mapped onto the dm3 D. melanogaster
reference genome [67,68] using TOPHAT [69]. Only uniquely
mapped reads were retained for analysis and reported as a BAM
[70] file. Cufflinks [71] software took the BAM files to calculate
expressions levels for annotated and predicted transcripts using
FPKM (fragments per kilobase of transcript per million fragments
mapped) values. Differentially expressed genes in the dPNUTS
mutants were defined as genes with ,0.67 or .1.5 fold change
relative to controls. A significance threshold of 1 FPKM [72] was
also applied. To analyse the enrichment of the genes belonging to
specific biological processes, genes differentially expressed in both
dPNUTS mutants were further analysed by Database for Anno-
tation, Visualization and Integrated Discovery (DAVID) (http://
david.abcc.ncifcrf.gov/) against the D. melanogaster database. To
increase the reproducibility, enrichment of gene function was
identified with EASE score #0.001, which is a conservative
adjustment to Fisher exact probability, and a fold change
enrichment (FE)$1.5 in all samples. The GO terms were
hierarchically classified using AMIGO. Human orthologues of
differentially expressed genes were identified by BioMart (www.
biomart.org) and used to reconstruct functional networks and
predict upstream regulators using Ingenuity IPA (Ingenuity
Systems Inc.), see Text S1 for details.
Immunoprecipitation from Drosophila extracts and
immunoblotting
Immunoprecipitation from 2–18 hr old Oregon R Drosophila
embryonic nuclear extracts was performed as in [73], with minor
modifications (see Text S1), using the following primary antibodies:
rabbit anti-Myc (A14, Santa Cruz Biotechnology, 1:100); mouse
anti-Myc (9E10, 1:50); guinea pig anti-dPNUTS and anti-
dPNUTS-S (1:10). The following primary antibodies were used
for Western Blotting: mouse anti-RNAPII (ARNA-3, Research
Diagnostics/Millipore, 1:500), which recognizes both phosphory-
lated and unphosphorylated forms of RNAPII; mouse anti-
RNAPII Ser5-P (4H8, Active Motif, 1:1000); purified rabbit
anti-PP1 (1:500); rabbit anti-Myc (A14, Santa Cruz Biotechnol-
ogy, 1:500); mouse anti-Actin (C4, Millipore, 1:5000). For
quantitation, X-ray film was digitized with an ImageQuant
biomolecular imager (GE Healthcare) and quantified using ImageJ
(http://rsbweb.nih.gov/ij/).
Immunostaining of wing discs and whole mount salivary
glands
Tissues were fixed and stained using standard approaches (see
Text S1) with the following primary antibodies: rabbit anti-Cleaved
Caspase-3 (Cell Signalling Technology, 1:100); mouse anti-Discs
large (Developmental Studies Hybridoma Bank, 1:100); rabbit
anti-Myc (A14, Santa Cruz Biotechnology, 1:100); mouse anti-
phospho-Histone H3 (Millipore, 1:500). TO-PRO-3 (Invitrogen,
1:1000) was used to visualise DNA.
Immunostaining of polytene chromosomes
Polytene chromosome squashes were prepared as reported
previously [74] (see also Text S1) and stained with the following
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primary antibodies: guinea pig anti-dPNUTS (1:30); rabbit anti-
PP1 (1:50); mouse anti-RNAPII Ser2-P (H5, Covance, 1:50);
mouse anti-RNAPII Ser5-P (H14, Covance, 1:50); rabbit anti-Myc
(A14, Santa Cruz Biotech, 1:100). For DNA staining, slides were
incubated with either DAPI or TO-PRO-3.
Image analysis and quantitation
Images were captured on Zeiss 510 and 710 Confocal
Microscopes equipped with 405 nm, 488 nm, 561 nm and
633 nm lasers using a Plan Apochromat 40x/1.3NA oil
immersion objective. Images were imported to Adobe Photo-
shop and adjusted for brightness and contrast uniformly across
entire fields. Projected images of wing discs in XY were
generated using ImageJ. XZ projections were generated using
the Cut function in Zen 2011 (Zeiss). Line scans of polytene
chromosomes were generated using ImageJ. For this analysis,
we imaged a region at end of the X chromosome that could be
reliably identified on chromosomes from multiple squashes.
Images were taken with identical microscope and laser settings,
with signal intensities below the level of saturation. The mean
intensity of RNAPII Ser5-P and PP1 fluorescence was deter-
mined for each genotype by calculating the average fluorescence
intensity through the center of unprocessed images of the same
chromosomal region from 6 samples, parallel to the long axis of
the structure.
GenBank accession numbers
The accession numbers for the dPNUTS and dPNUTS-S
nucleotide sequences reported in this paper are AJ580979 and
AJ580980, respectively.
Supporting Information
Figure S1 Sequence comparison of dPNUTS and related
proteins. A) Schematic representation of domains in human
PNUTS (hPNUTS) and dPNUTS: Region similar to Domain 1 of
TFIIS (and the corresponding domain in Elongin A); Ser-rich
region; Central region, highly conserved in hPNUTS and
dPNUTS containing a canonical PP1 binding motif; CCCH
zinc-finger typical of NUP/Tis11 proteins. The positions of
introns (arrowheads) in the coding regions are indicated. Identical
intron-exon boundaries are shown with connecting arrows. B)
Table of % identity and similarity of hPNUTS, Elongin A and
Tis11 in the different domains relative to dPNUTS. NA, not
applicable. Pairwise comparisons were performed using ALIGN
[77].
(TIF)
Figure S2 Specificity of the dPNUTS antibody for immunoflu-
orescent staining of polytene chromosomes. Chromosome squash-
es from salivary glands expressing either histone H2B-YFP (in green)
or dPNUTS RNAi stained on the same slide for dPNUTS (in red)
and DNA (in magenta). Levels of dPNUTS were greatly reduced
on chromosomes from dPNUTS RNAi glands.
(TIF)
Figure S3 A) Expanded images of clones in panels K–P of
Figure 3, showing DNA and GFP channels for each image. B)
Magnified image of panel L of Figure 3, with cross section through
a section of the epithelium containing a large dPNUTS mutant
clone, which shows normal distribution of nuclei compared to
neighbouring heterozygous (GFP positive) cells. In contrast, a rare
M, GFP/M, GFP twinspot is located at the basal face of the
epithelium and is being extruded.
(TIF)
Figure S4 Venn diagram showing overlap between differentially
expressed up- and down-regulated genes in dPNUTS mutants.
(TIF)
Figure S5 Gene ontology (GO) term enrichment of the genes
under-expressed (A) and over-expressed (B) in dPNUTS9B/
dPNUTS9B and dPNUTS13B/dPNUTS13B mutant larvae relative to
abundance of GO terms for all genes in the genome as determined
by DAVID. The top GO categories for each gene set are grouped
according to their hierarchical relationships along with the
number of genes affected in that category, the total number of
genes in that category (in parentheses), and the statistical
significance of the match.
(TIF)
Figure S6 A) dPNUTS binds dWdr82 in S2 cell extracts. Cells
were transfected with constructs expressing Flag-Myc-dWdr82 or
GFP-dPNUTS-Myc or both. Ectopic dPNUTS was precipitated
using GFP-Trap beads. Western Blotting with anti-Myc antibodies
revealed the presence of ectopic GFP-dPNUTS-Myc in precipi-
tates. Flag-Myc-dWdr82 co-precipitated with GFP-dPNUTS-
Myc, but not from cells lacking ectopic dPNUTS. IN= Input
(total lysate), NB=Non-bound, and IP= immuno-precipitated. B)
Western Blot showing levels of RNAPII CTD Ser2-P, Thr4-P,
Ser5-P, or Ser7-P in extracts from homozygous revertant
dPNUTSexKG/dPNUTSexKG (exKG/exKG) and homozygous null
mutant dPNUTS9B/dPNUTS9B (9B/9B) 1st instar larvae. mAb
identity is indicated in parenthesis. Relative levels in the two
conditions, as derived from densitometry measurements of the
respective bands, are shown below the blots. C) Published
conditions of recognition of phospho-CTD by mAbs, reproduced
from [48,49]. Phosphorylation of red amino acids results in full or
partial inhibition of mAb binding, whereas phosphorylation of
other Tyr, Ser or Thr residues does not.
(TIF)
Figure S7 Polytene chromosomes from salivary gland squashes
stained with dPNUTS and RNAPII Ser5-P (H14) antibodies.
Merging of the green signal representing RNAPII Ser5-P with the
red signal representing dPNUTS identifies sites where these two
proteins co-localize. Insets, boxes 1–4, show enlarged view of
chromosome regions. The relative signals of dPNUTS and
RNAPII Ser5-P vary between sites, but only a minority of
dPNUTS loci colocalize with RNAPII Ser5-P staining (indicated
with arrows).
(TIF)
Figure S8 A) Expression levels of the indicated genes in larvae
expressing dPNUTSW726A under the control of da-GAL4 relative to
control larvae, as determined by qRT-PCR. Error bars represent
the SE (n$3 biological replicates). B–E) Chromatin immunopre-
cipitation (ChIP) analyses of the indicated genes from 3rd instar
larval extracts using anti-total RNAPII (8WG16) antibody and
mouse IgG antibody. Immunoprecipitated DNA was amplified by
qPCR. The distribution at four loci (Thor, ImpL3, nop56 and ACC)
was evaluated using primers positioned at the start (S) and middle
(M), of the transcribed sequences. Percent input is the amount of
precipitated DNA relative to input DNA. Error bars represent the
SE of the mean (n$3 biological replicates).
(TIF)
Table S1 Rescue of dPNUTS mutant lethality by genomic
transgene. Expected and observed genotype frequencies of adult
progeny from complementation crosses with two independent
insertions of a dPNUTS wild type trangene (n$350 progeny/cross).
(DOCX)
PNUTS-PP1 Is Essential for Developmental Growth




Table S2 Gene Ontology (GO) classification determined by
DAVID. Biological process categories from GO analysis that are
significantly overrepresented among the genes for which the
expression was either decreased (downregulated worksheet) or
increased (upregulated worksheet) in the dPNUTS mutants. Only
the categories with a minimum of 4 genes per category and an
EASE score #0.001 were considered.
(XLSX)
Table S3 Comparison of Gene Ontology (GO) outputs from
DAVID and EASE. Shown are GO categories that were enriched
amongst genes that are differentially expressed (DE) in dPNUTS
mutants when compared against all genes in the genome (DAVID)
or against genes expressed in matched w1118 controls (EASE). GO
categories returned by the two approaches were not always identical
because the programs used different versions of the D. melanogaster
genome annotation for comparison (DAVID was updated Sept
2009; EASE used FlyBase annotation release 5.46 from July 2012).
(XLS)
Table S4 Ingenuity transcription factor analysis. The table
shows the IPA predicted ‘upstream regulators’ for up- and down-
regulated differentially expressed genes, ranked by an application
of a z-score algorithm. Genes from each predicted regulator ‘pool’
present in the analyzed dataset are listed in a ‘Target molecules’
column.
(XLSX)
Table S5 Comparison of RNA-Seq and qRT-PCR data,
showing log2 fold change in expression of the indicated loci in
dPNUTS mutants relative to control.
(DOCX)
Text S1 Additional information including detailed genotypes
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3.3. Supplementary Figures 
 
 
Figure S1. Sequence comparison of dPNUTS and related proteins. A) Schematic 
representation of domains in human PNUTS (hPNUTS) and dPNUTS: Region 
similar to Domain 1 of TFIIS (and the corresponding domain in Elongin A); Ser-rich 
region; Central region, highly conserved in hPNUTS and dPNUTS containing a 
canonical PP1 binding motif; CCCH zinc-finger typical of NUP/Tis11 proteins. The 
positions of introns (arrowheads) in the coding regions are indicated. Identical 
intron-exon boundaries are shown with connecting arrows. B) Table of % identity 
and similarity of hPNUTS, Elongin A and Tis11 in the different domains relative to 





 Figure S2. Specificity of the dPNUTS antibody for immunofluorescent staining of 
polytene chromosomes. Chromosome squashes from salivary glands expressing 
either histone H2B-YFP (in green) or dPNUTS RNAi stained on the same slide for 
dPNUTS (in red) and DNA (in magenta). Levels of dPNUTS were greatly reduced 



























Figure S3. A) Expanded images of clones in panels K–P of Figure 3, showing DNA 
and GFP channels for each image. B) Magnified image of panel L of Figure 3, with 
cross section through a section of the epithelium containing a large dPNUTS mutant 
clone, which shows normal distribution of nuclei compared to neighbouring 
heterozygous (GFP positive) cells. In contrast, a rare M, GFP/M, GFP twinspot is 

















Figure S4. Venn diagram showing overlap between differentially expressed up- and 






























Figure S4. Venn diagram showing overlap between differentially expressed up- and 
down-regulated genes in dPNUTS mutants. 
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Figure S5. Gene ontology (GO) term enrichment of the genes under-expressed 
(A) and over-expressed (B) in dPNUTS9B/dPNUTS9B and dPNUTS13B/dPNUTS13B 
mutant larvae relative to abundance of GO terms for all genes in the genome as 
determined by DAVID. The top GO categories for each gene set are grouped 
according to their hierarchical relationships along with the number of genes affected 
in that category, the total number of genes in that category (in parentheses), and the 




Figure S6. A) dPNUTS binds dWdr82 in S2 cell extracts. Cells were transfected 
with constructs expressing Flag-Myc-dWdr82 or GFP-dPNUTS-Myc or both. 
Ectopic dPNUTS was precipitated using GFP-Trap beads. Western Blotting with 
anti-Myc antibodies revealed the presence of ectopic GFP-dPNUTS-Myc in 
precipitates. Flag-Myc-dWdr82 co-precipitated with GFP-dPNUTS-Myc, but not 
from cells lacking ectopic dPNUTS. IN = Input (total lysate), NB = Non-bound, and 
IP = immunoprecipitated. B) Western Blot showing levels of RNAPII CTD Ser2-P, 
Thr4-P, Ser5-P, or Ser7-P in extracts from homozygous revertant 
dPNUTSexKG/dPNUTSexKG (exKG/exKG) and homozygous null mutant 
dPNUTS9B/dPNUTS9B (9B/9B) 1st instar larvae. mAb identity is indicated in 
parenthesis. Relative levels in the two conditions, as derived from densitometry 
measurements of the respective bands, are shown below the blots. C) Published 
conditions of recognition of phospho-CTD by mAbs, reproduced from [48], [49]. 
Phosphorylation of red amino acids results in full or partial inhibition of mAb 









Figure S7. Polytene chromosomes from salivary gland squashes stained with 
dPNUTS and RNAPII Ser5-P (H14) antibodies. Merging of the green signal 
representing RNAPII Ser5-P with the red signal representing dPNUTS identifies 
sites where these two proteins co-localise. Insets, boxes 1–4, show enlarged view of 
chromosome regions. The relative signals of dPNUTS and RNAPII Ser5-P vary 
between sites, but only a minority of dPNUTS loci co-localise with RNAPII Ser5-P 




















Figure S8. A) Expression levels of the indicated genes in larvae expressing 
dPNUTSW726A under the control of da-GAL4 relative to control larvae, as determined 
by qRT-PCR. Error bars represent the SE (n!3 biological replicates). B–E) 
Chromatin immunoprecipitation (ChIP) analyses of the indicated genes from 3rd 
instar larval extracts using anti-total RNAPII (8WG16) antibody and mouse IgG 
antibody. Immunoprecipitated DNA was amplified by qPCR. The distribution at four 
loci (Thor, ImpL3, nop56 and ACC) was evaluated using primers positioned at the 
start (S) and middle (M), of the transcribed sequences. Percent input is the amount of 
precipitated DNA relative to input DNA. Error bars represent the SE of the mean 











Table S1. Rescue of dPNUTS mutant lethality by genomic transgene. Expected and observed genotype frequencies of adult progeny from complementation 
crosses with two independent insertions of a dPNUTS wild type transgene (n! 350 progeny/cross) 
Cross 
No. 








1. PNUTS13B/Cyo; P[PNUTS+ genomic, Line09]/TM6B     X     
PNUTS13B /Cyo; P[PNUTS+ genomic, Line09]/TM6B      
 PNUTS13B /PNUTS13B; P[PNUTS+ genomic, Line09]/TM6B                                           0 22.2 18.6 
PNUTS13B /PNUTS13B; P[PNUTS+ genomic, Line09]/ P[PNUTS+ genomic, Line09]                         0 11.1 11.8 
PNUTS13B /Cyo; P[PNUTS+ genomic, Line09]/TM6B                                           66.6 44.4 37.05 
PNUTS13B /Cyo; P[PNUTS+ genomic, Line09]/ P[PNUTS+ genomic, Line09]                       33.3 22.2 32.4 
2.  PNUTS13B /Cyo; P[PNUTS+ genomic, Line03]/TM6B     X     
PNUTS13B /Cyo; P[PNUTS+ genomic, Line03]/TM6B      
 PNUTS13B / PNUTS13B; P[PNUTS+ genomic, Line03]/TM6B                                                  0 22.2 19.2 
PNUTS13B / PNUTS13B; P[PNUTS+ genomic, Line03]/ P[PNUTS+ genomic, Line03]            0 11.1 12.8 
PNUTS13B /Cyo; P[PNUTS+ genomic, Line03]/TM6B                               66.6 44.4 42.4 




Table S3. Comparison of Gene Ontology (GO) outputs from DAVID and EASE. Shown are GO categories that were enriched amongst genes that are differentially expressed (DE) in 
dPNUTS mutants when compared against all genes in the genome (DAVID) or against genes expressed in matched w1118 controls (EASE). GO categories returned by the two approaches 
were not always identical because the programs used different versions of the D.melanogaster genome annotation for comparison (DAVID was updated Sept 2009; EASE used FlyBase 
annotation release 5.46 from July 2012). 
Under-expressed genes in dPNUTS mutants 
 EASE (DE vs genes expressed in w1118) DAVID (DE vs all genes in the genome) 
Term List Hits List Size Pop. Hits Pop.Size EASE Score List Hits List Size EASE Score 
Ribonucleoprotein complex biogenesis      42 92 5.20E-08 
Ribonucleoprotein complex 12 1881 23 10256 1.18E-03    
Ribosome biogenesis 12 2189 22 11715 8.67E-04 34 60 6.58E-09 
ncRNA metabolic process      63 139 5.50E-13 
RNA processing 10 2189 38 11715 2.70E-01 107 396 3.02E-10 
rRNA processing 20 2189 26 11715 2.28E-09 24 35 9.40E-08 
Translation 87 2189 190 11715 2.55E-17 183 733 1.08E-18 
Amino acid activation      22 50 8.99E-05 
tRNA aminoacetylation for protein translation 14 2189 32 11715 3.23E-03    
DNA replication 29 2189 54 11715 3.94E-08 36 120 5.78E-05 
Oxidation reduction      177 517 7.48E-08 
Oxidation-reduction process 131 2189 459 11715 1.82E-07    




Phospholipid biosynthetic process 5 2189 14 11715 2.57E-01    
Monosaccharide metabolic process      36 80 7.39E-05 
Glucose metabolic process 5 2189 9 11715 6.91E-02 26 43 7.41E-05 
         
Over-expressed genes in dPNUTS mutants 
 EASE (DE vs genes expressed in w1118) DAVID (DE vs all genes in the genome) 
Term List Hits List Size Pop. Hits Pop.Size EASE Score List Hits List Size EASE Score 
Response to DNA damage stimulus 31 2242 95 11715 2.49E-03 42 259 1.16E-07 
Defense response 30 2242 98 11715 8.08E-03 59 247 4.04E-09 
Response to bacterium 8 2242 20 11715 7.09E-02 32 117 8.15E-09 
Immune response 18 2242 48 11715 5.82E-03 60 194 4.99E-10 
Programmed cell death 12 2242 16 11715 2.07E-05 49 167 8.43E-07 
Intracellular signalling cascade      86 286 7.42E-09 
Signal transduction 61 2242 208 11715 4.11E-04    
Small GTPase mediated signal transduction 34 2242 91 11715 9.05E-05 37 110 5.35E-06 
Regulation of cell cycle 13 2242 46 11715 1.55E-01 46 276 1.12E-04 
Key: List Hits = number of genes in differentially expressed (DE) group belonging to the respective GO category;  List Size = number of genes differentially expressed group; Pop. Hits 




Table S5. Comparison of RNA-Seq and qRT-PCR data, showing log2 fold change in 
expression of the indicated loci in dPNUTS mutants relative to control 
 
Gene name 
dPNUTS[9B]/ dPNUTS[9B] dPNUTS[13B]/ dPNUTS[13B] 




Thor 1.55 1.4 1.58 1.55 
Hid 1.53 2.58 1.96 2.96 






Hoip 1.64 2.65 2.117 2.07 
CG4038 0.73 1.53 1.434 2.02 
CG6388 2.608 2.55 3.49 2.57 
CG6712 1.39 1.51 1.68 1.47 
nop56 1.415 1.87 1.32 1.68 
CG18600 1.36 1.92 1.717 1.76 
CG3756 1.44 0.68 1.31 0.59 
RPI135 0.55 1.09 1.08 0.96 
RPII215 0.08 0.14 0.014 0.32 
CG3523 1.217 0.34 1.68 0.66 
CG11198 1.18 1.12 1.49 1.59 
Tpi 0.35 0.59 0.86 0.57 
GAPDH2 1 1.36 1.81 1.42 



























3.4.      Supplementary Text  
 
List of genotypes 
Fig.2B-D 
w1118; dPNUTSexKG/dPNUTSexKG 
w1118; dPNUTS9B/CyO, twi-GFP   
w1118; dPNUTS9B/dPNUTS9B 
w1118; dPNUTS13B/CyO, twi-GFP   
w1118; dPNUTS13B/dPNUTS13B 




w1118 (isogenic for autosomes) 
GMR-hid, FRT40A, l(2)/CyO; ey-GAL4, UAS-FLP1 
GMR-hid, FRT40A, l(2)/ dPNUTS9B, FRT40A; ey-GAL4, UAS-FLP1 
GMR-hid, FRT40A, l(2)/ dPNUTS13B, FRT40A; ey-GAL4, UAS-FLP1 
GMR-hid, FRT40A, l(2)/ dPNUTSKG, FRT40A; ey-GAL4, UAS-FLP1 
GMR-hid, FRT40A, l(2)/ dPNUTSexKG, FRT40A; ey-GAL4, UAS-FLP1 
 
Fig.3 and Fig.S3 
hsFLP122; dPNUTS13B, FRT40A/ Ubi-GFPnls, FRT40A 
hsFLP122; dPNUTS13B, FRT40A/ Ubi-GFPnls, FRT40A, M(RpL27A) 
 
Fig. 5C 
da-GAL4/+; UAS-HM-dPNUTSWT  line3/+ 
da-GAL4/+; UAS-HM-dPNUTSW726A  line1/+ 
 
Fig. 6A-C  
AB1-GAL4, UAS-HM-dPNUTSWT  line3 
AB1-GAL4, UAS-HM-dPNUTSW726A  line1 
 
Fig. 6D  
w1118 
da-GAL4, UAS-HM-dPNUTSWT  line3 
da-GAL4, UAS-HM-dPNUTSW726A  line1 
 
Fig. 6E 
GMR-hid, FRT40A, l(2)/ PNUTS9B, FRT40A; ey-GAL4, UAS-FLP1/+ 
GMR-hid, FRT40A, l(2)/ PNUTS9B, FRT40A; ey-GAL4, UAS-FLP1/ UAS-HM-
dPNUTSWT line3 
GMR-hid, FRT40A, l(2)/ PNUTS9B, FRT40A; ey-GAL4, UAS-FLP1/ UAS-HM-
dPNUTSW726A  line1 
 
GMR-hid, FRT40A, l(2)/ PNUTS13B, FRT40A; ey-GAL4, UAS-FLP1/+ 
GMR-hid, FRT40A, l(2)/ PNUTS13B, FRT40A; ey-GAL4, UAS-FLP1/ UAS-HM-
dPNUTSWT  line3 
GMR-hid, FRT40A, l(2)/ PNUTS13B, FRT40A; ey-GAL4, UAS-FLP1/ UAS-HM-
dPNUTSW726A  line1 
! 123 
Fig. 6F 
GMR-hid, FRT40A, l(2)/ PNUTS KG572, FRT40A; ey-GAL4, UAS-FLP1/+ 
GMR-hid, FRT40A, l(2)/ PNUTSKG572, FRT40A; ey-GAL4, UAS-FLP1/ PP187B1 
GMR-hid, FRT40A, l(2)/ PNUTSKG572, FRT40A; ey-GAL4, UAS-FLP1/ PP187Bhs46 
 
Fig. 7B 








da-GAL4, UAS-HM-dPNUTSWT  line3 
da-GAL4, UAS-HM-dPNUTSW726A  line1 
 
Fig. 7D,E  
AB1-GAL4, UAS-H2B-YFP 








da-GAL4, UAS-HM-dPNUTSW726A line1 
 
 
3.5. Supplementary Methods 
 
Growth arrest experiment 
PNUTS9B and PNUTS13B were balanced with Cyo, twi-GFP. For each genotype, 10 
females and 6 males were allowed to mate for 2 days and were then transferred to 
plates with laying apple juice medium at 25°C. The first-day egg collections were 
discarded, and, starting on the second day, a 4 hr egg collection regimen was 
established. After 24 hr, 30 homozygous (GFP negative) and 30 heterozygous (GFP 
positive) eggs from each genotype were transferred to separate fresh agar plates. 
After each 24 hr, the number of living larvae was counted and their size was 




Imaging of adult eyes 
Flies were collected in micro-centrifuge tubes and frozen and stored at -20°C until 
imaging. Flies were imaged using a Leica MZ10F stereomicroscope (Leica). 
 
dPNUTS cDNA isolation and sequence analysis  
5 x 106 Drosophila 3rd instar larval cDNAs were screened using PP1!9C as bait in 
the two-hybrid assay as [1, 2]. cDNAs containing the complete dPNUTS open 
reading frame were obtained by hybridisation using the screening procedure 
described in [3]. In brief, 1 x 106 clones from a 3rd instar larval library [4] were 
screened in pools by Southern Blotting and PCR, using the longest two-hybrid clone 
(DB388: nucleotides 1894-4831 of dPNUTS or a PCR product from the 3’ end of 
DB388 (nucleotides 3239-4096 of dPNUTS) as probes. These approaches identified 
full-length clones of dPNUTS-S and dPNUTS, respectively, representing the two 
alternative mRNA splice variants of the dPNUTS gene. Identification of the intron 
and exon structures of PNUTS and dPNUTS was done by comparison of the 
following sequences: dPNUTS cDNA reported in this study; AE003588, dPNUTS 
genomic; AJ544537, human PNUTS mRNA; AB088097, human PNUTS genomic. 
 
Yeast two-hybrid assays  
GAL4 activation domain-dPNUTS fusion constructs were made as follows: A 
BamHI site was introduced immediately 5’ of the translation start and a SalI site at 
the 3’ end of both dPNUTS and dPNUTS-S by PCR using the following primers: (+) 
5’-CTAAGGATCCAAATGCCTCGTATAGTTCC-3’,(-)5’-
GGGGTCGACAGACCGGAATTCGGCGG-3’. The whole open reading frames of 
dPNUTS and dPNUTS-S were then introduced as BamHI/SalI fragments into the 
BamHI/XhoI sites of pACT. For the 2-hybrid assays: GAL4 DNA-binding domain-
PP1c fusion constructs pAS2-PP1"87B, pAS2-PP1"13C, pAS2-PP1"96A and 
pAS2-PP1!9C have been previously described [2, 5]. Y190 yeast cells were 
transformed with pAS2 and pACT constructs and transformed cells were selected on 
drop-out base with agar plates (BIO 101) lacking leucine, tryptophan and histidine. 
Colonies appearing after 4-5 days of incubation at 30oC were tested for !-




dPNUTS and PP1 antisera  
Guinea pig anti-PNUTS and rabbit anti-PP1 antibodies were generated by Moravian-
Biotechnology and Eurogentec respectively using the following peptides as antigens: 
KLEVDNVPDHPNGNL (residues 789-792 of dPNUTS); KLFSILFHSPRTLVA 
(residues 581-594 of dPNUTS-S); RGARPGKNVQLSEGE and 
SDPDKDTMGWGENDR (residues 18-32 and 205-219, respectively of PP187B). 
 
Analysis of RNAPII CTD phosphorylation levels by Western Blotting  
The following monoclonal antibodies directed against phospho-CTD marks were 
obtained from Chromotek: 3E10 (Ser2-P); 6D7 (Thr4-P); 3E8 (Ser5-P); 4E12 (Ser7-
P). For relative quantitation, signals were captured using an ImageQuant 
biomolecular imager (GE Healthcare) and quantified using ImageJ 
(http://rsbweb.nih.gov/ij/). 
 
Co-immunoprecipitation from Drosophila extracts  
Nuclear extracts, prepared from approximately 200 !l of dechorionated embryos of 
each genotype, were incubated with primary antibodies overnight and then another 2-
4 hours the next day with either GammaBind Plus Sepharose (Amersham) or protein 
A-coated magnetic beads (Millipore). 
 
Co-immunoprecipitation from S2 cell extracts  
2 x 106 S2R+ cells in 2ml Schneider’s were seeded out 2-3 hours before transfection. 
Cells were either transfected or co-transfected with constructs containing Flag-Myc-
dWdr82 or GFP-dPNUTS-Myc using Effectene transfection reagent (Qiagen) 
according to the manufacturer’s protocol for the transient transfection of adherent 
cells. After 48-72 hours incubation, cells were harvested at 4000 rpm for 3 mins. 
Immunoprecipitation was carried out using magnetic GFP-Trap beads (Chromotek) 
according to the manufacturer’s protocol. Anti-Myc antibody (A14, 1:1000) was 
used for immunoblotting of S2 cell extracts. 
 
Chromatin Immunoprecipitation (ChIP) from larval extracts 
ChIP experiments were performed from wandering 3rd instar larvae, as described 
previously [7]. For the immunoprecipitations, 25 !g of chromatin was incubated 
overnight with antibody and another 4 hours the next day with protein A or G coated 
! 126 
magnetic beads (Diagenode or Millipore). The antibodies used in the IP were: mouse 
anti-total RNAPII (8WG16, Covance) and mouse IgG. A minimum of 3 biological 
replicates was done for each genotype. For the qPCR analysis, reactions were done 
in duplicates and the quantity of DNA bound by specific antibodies was calculated 
by % Input. Primers used for PCR are given in the table below. 
 
Immunostaining of wing discs and whole mount salivary glands  
Tissues were dissected from 3rd instar larvae were fixed in 3.7% paraformaldehyde in 
1x phosphate-buffered saline (PBS) for 20 minutes. Tissues were washed in 1x PBS 
for 15 minutes and then blocked in 1x PBS, 5% bovine serum albumin (BSA), 0.1% 
Triton X-100 (blocking solution) for 30 minutes at room temperature or a minimum 
of 2 hours at 4°C. Tissues were incubated with primary antibody in blocking solution 
overnight at 4°C. Tissues were washed in PBST (1x PBS, 0.1% Triton X-100) and 
incubated with secondary antibody conjugated to Alexa-Fluor 488, 555 or 633 
(1:500, Molecular Probes) for 2 hours at room temperature in the dark. Tissues were 
washed two times in PBST for 10 minutes each time followed by incubation with 
TO-PRO-3 (Invitrogen, 1:1000 in 1x PBS) for visualising DNA. Tissues were 
mounted in Vectashield mounting medium (Vector Laboratories). 
 
Immunostaining of polytene chromosomes  
Polytene chromosome squashes were done as described previously [8]. In brief, 
salivary glands of wandering larvae were fixed with 3.7% paraformaldehyde 
dissolved in phosphate-buffered saline (PBS) and then incubated in 45% acetic acid 
for 1 minute. Slides were blocked in PBST (PBS+ 0.1% Tween-20) + 5% BSA for 1 
hour at 25°C and incubated overnight at 4°C with primary antibodies. Slides were 
washed in PBST and incubated with secondary antibodies for 1 hour at 25°C: Alexa-
Fluor 488-conjugated goat anti-mouse IgG, Alexa-Fluor 488-conjugated goat anti-
guinea pig IgG and Alexa-Fluor 555-conjugated goat anti-rabbit IgG (Molecular 
Probes), were used at 1:500 dilutions. For DNA staining, slides were incubated with 






Expression Analysis Systematic Explorer (EASE) analysis 
Statistical measurement of GO term enrichment comparing genes differentially 
expressed to genes expressed in developmentally matched w1118 controls was 
determined using an EASE score (P< 0.05) [9]. 
 
Ingenuity IPA analysis 
Data sets containing identifiers for the human orthologues of differentially expressed 
(DE) Drosophila genes were uploaded into Ingenuity IPA. Each identifier was 
mapped to its corresponding object in the Ingenuity Knowledge Base. Network 
Eligible molecules, were overlaid onto a global molecular network developed from 
information contained in the Ingenuity Knowledge Base. Networks were 
algorithmically generated from Network Eligible Molecules based on their 
connectivity. All edges are supported by at least one reference from the literature, 
from a textbook, or from canonical information stored in the Ingenuity Knowledge 
Base. The generated networks were used by IPA to automatically predict ‘upstream 
regulators’ of DE genes. The term “upstream regulator” refers to any molecule that 
can affect the expression of another molecule.  Upstream regulators cover the gamut 
of molecule types founds in the literature, from transcription factors, to cytokines, 
microRNAs, receptors, kinases, chemicals and drugs. Upstream Regulator Analysis 
is based on expected causal effects between Upstream regulators and targets; the 
expected causal effects are derived from the literature compiled in the Ingenuity 
Knowledge Base. The analysis examines the known targets of each upstream 
regulator in the dataset, compares the targets’ actual direction of change to 
expectations derived from the literature, then issues a prediction for each upstream 
regulator. IPA uses a z-score algorithm to make predictions. The z-score algorithm is 













Oligonucleotide primer sequences 
 
Name Sequence (5’-3’) Purpose 
PNUTSATGex+ ACGCAGGAGTTTTCGGAGAG Mutant 
characterisation 
PNUTSATGex- ATTGTGGAGACCCTCGGTGA Mutant 
characterisation 
PNUTS3ex+ GCTGCCCGAGTGTGAGTCTA Mutant 
characterisation 
PNUTS3ex- GTTCGGTTTAATGGCAAACGTAATG Mutant 
characterisation 
PNUTS Fw GCCAAGATCGACATCAACAA qRT-PCR 
PNUTS Rev CTTGCGCTTCACCACCTT qRT-PCR 
dPNUTS-S Fw GGATCGAGTTTGAACTGCAAG qRT-PCR 
dPNUTS-S Rev AACATCAGGCAGCGACAAC qRT-PCR 
Thor Fw AACCCTCTACTCCACCACTCC qRT-PCR 
Thor Rev ACTTGCGGAAGGGAGTACG qRT-PCR 
Hid Fw GGCCGTAAAGTTGTCGTAGC qRT-PCR 
Hid Rev GACCTCCACGCCGTTATC qRT-PCR 
RPI135 Fw ACCGTGCGGACTGTTAAATC qRT-PCR 
RPI135 Rev GACCCAAGTGTTTGCCATCT qRT-PCR 
Nop56 Fw CAACTGATCCAGCAAAGCAA qRT-PCR 
Nop56 Rev TCCAGTGCAGTCACTTTGGA qRT-PCR 
Hoip Fw CCATCGAGATTCTGCTCCAT qRT-PCR 
Hoip Rev GTGATCTGCGACTTGAGCTG qRT-PCR 
CG6712 Fw CGACGACAAGAAGACACGAA qRT-PCR 
CG6712 Rev AGATTGGCCACCTCTGTTTG qRT-PCR 
CG4038 Fw GAGGAGGACGAGGATTTGGT qRT-PCR 
CG4038 Rev GGTCGTTTTGGCAGGAGTAA qRT-PCR 
CG6388 Fw ATCCGGATATTTGTGCGTGT qRT-PCR 
CG6388 Rev CTTCAGCTGCTGGGGATTAC qRT-PCR 
CG18600 Fw GGCCAAACATGACTTGAGGT qRT-PCR 
CG18600 Rev ACAAGGAGGCAACCAAAGTG qRT-PCR 
CG3756 Fw GAGGAGTATCGGGTGAAGCA qRT-PCR 
CG3756 Rev ATTTGCAATGGCGGGATAC qRT-PCR 
Tpi FW CTTGGAGATGTTGTCGCTCA qRT-PCR 
Tpi Rev CCTACGCCCAGAAGATCAAG qRT-PCR 
GAPDH2 Fw GGTGATCAACGACAACTTCG qRT-PCR 
GAPDH2 Rev CCAGTGGAAGCTGGAATGAT qRT-PCR 
ImpL3 Fw CTTGACCACGGATGTCACAC qRT-PCR 
ImpL3 Rev GATACACCTCCTGGGCCATT qRT-PCR 
CG3523 Fw CCACCATCGAGGAGTTCAAG qRT-PCR 
CG3523 Rev CACCGAAGAACTGTTGGTCA qRT-PCR 
CG11198 Fw TACGAGAGCCAGTCGAGGAT qRT-PCR 
CG11198 Rev GGCTATGCTGCGCTTAACA qRT-PCR 
18S Fw CGCAAGATCGTTATATTGGTTG qRT-PCR 
18S Rev GCTGCCTTCCTTAGATGTGG qRT-PCR 
RpII215 Fw ACCAGCTAGGCGACATTCC qRT-PCR 
RpII 215 Rev GATCGACACCGAGCATGAC qRT-PCR 
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p53 Fw GGACTTGCGCTTCTTGCTAT qRT-PCR 
p53 Rev TGTATCGGGCGAAAAGAAAC qRT-PCR 
Thor-S Fw CATAGCAGCCACACAAGCTC qPCR (from 
ChIP) 
Thor-S Rev   GGTGAAGCGGACATCTTAGC qPCR (from 
ChIP) 
Thor-M Fw   TTATCTACGAGCGGGCTTTC qPCR (from 
ChIP) 
Thor-M Rev   ACTTGCGGAAGGGAGTACG qPCR (from 
ChIP) 
ImpL3-S Fw   GGGCCAACAGACTGTCCTTA qPCR (from 
ChIP) 
ImpL3-S Rev   AATCATAGGCACGTGATAGCAA qPCR (from 
ChIP) 
ImpL3-M Fw   ATCACCTCGTAGGCGGAGT qPCR (from 
ChIP) 
ImpL3-M Rev   CGTTTGGTCTGGAGTGAACA qPCR (from 
ChIP) 
nop56-S Fw   TGCCGAATATATGCCGATTT qPCR (from 
ChIP) 
nop56-S Rev   GGCTTGCTATGGTCACACTTG qPCR (from 
ChIP) 
nop56-M Fw   CGTATTGGAGCGGGTCTTTA qPCR (from 
ChIP) 
nop56-M Rev   GCACCCAATCTGCAGTCTTT qPCR (from 
ChIP) 
CAA-S Fw AGCTCGCTTTACCACTCTGC qPCR (from 
ChIP) 
CAA-S Rev CATCTACAAATCGTGCGGAAC qPCR (from 
ChIP) 
CAA-M Fw CCACGCATTTGTCGTAGTGT qPCR (from 
ChIP) 
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3.7.     Further discussion 
The work in this chapter reports on the characterisation of dPNUTS function, 
showing it is essential for proper growth and development through regulation of 
genes involved in various metabolic pathways necessary for sustainable growth. 
RNAPII was identified as a dPNUTS-associated protein and a potential substrate of 
dPNUTS-PP1, specifically Serine 5 in the CTD of RNAPII. It was originally 
hypothesised that dPNUTS regulates gene expression through control of RNAPII 
CTD phosphorylation and occupancy. However, ChIP analysis did not provide any 
evidence of this, as the distribution of chromatin-bound RNAPII was not affected in 
regulated genes. It is possible the genes studied are not direct targets of dPNUTS. 
Mapping of chromatin sites bound by PNUTS would need to be done using either 
ChIP or DNA adenine methyltransferase Identification (DamID). Mathieu Bollen 
and his lab are currently taking the latter approach for mammalian PNUTS 
(communication from Daimark Bennett). DamID is a powerful tool for studying 
chromatin-protein interactions. It allows detection of binding sites using a 
methylation-based approach whereby a protein of interest is fused to a bacterial DNA 
adenine methyltransferase and expressed in cells or transgenic animals (Orian, 2006; 
Greil et al., 2006). Any sites bound by the protein of interest become methylated and 
subsequently identified using the Dpn1 restriction enzyme, which cleaves the 
sequence GATC when adenine is methylated (Orian, 2006; Greil et al., 2006). 
Microarray analysis can then be used to identify these fragments (Orian, 2006). 
 
The interaction of PNUTS with Wdr82 and TOX4 may offer more insight into the 
mechanisms underlying the observed effects on gene expression given that this 
complex has been implicated in transcriptional regulation (Lee et al., 2010; Lee et 
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al., 2009). Wdr82 is a highly conserved WD40 repeat protein with human Wdr82 
being 93% similar to Drosophila Wdr82 (Lee and Skalnik, 2008). It is involved in 
the regulation of H3K4 di- and tri-methylation by directly recruiting the Set1 
methyltransferase complex, COMPASS. H3K4 di- and tri-methylation is necessary 
for the recruitment of RNAPII to promoter regions (Chen, et al. 2011; Lee and 
Skalnik, 2008). It is possible that under normal conditions Wdr82 recruits PNUTS-
PP1 to actively dephosphorylate RNAPII Ser5 and allow progression through the 
transcription cycle. However, PP1 is not the only Ser5 phosphatase, for example the 
Ssu72 phosphatase also targets Ser5 for dephosphorylation and redundant 
mechanisms may be in place such that RNAPII occupancy is not affected in the 
dPNUTS mutant (Rosado-Lugo and Hampsey, 2014; Krishnamurthy et al., 2004). 
Interestingly, depletion of human Wdr82 in mammalian cells also does not affect 
RNAPII occupancy (Lee and Skalnik, 2008).  
 
It is possible other processes that determine gene expression are affected in the 
dPNUTS mutants especially considering RNAPII CTD phosphorylation is 
responsible for coupling transcription to RNA processing predominantly through 
recruitment of 5’ capping factors via phosphorylated Ser5 (Bentley, 2005). 
Determining the effect of PNUTS on capping using cap trapping approaches, 
whereby 5’ caps are tagged for subsequent purification and identification of capped 
mRNAs, may offer more insight into its role in RNAPII mediated gene expression 
(Efimov et al., 2001).   
 
The fact there is not complete co-localisation of RNAPII and dPNUTS on 
chromosomes suggests other chromatin bound dPNUTS-PP1 complexes may exist to 
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regulate gene expression. However, the factors responsible for recruiting dPNUTS to 
these sites, remains to be determined. In the case of the PNUTS-PP1/Wdr82/TOX4 
complex reported in mammals, both TOX4 and Wdr82 as well as PNUTS were 
shown to associate with chromatin, therefore Wdr82 or TOX4 could mediate the 
interaction with chromatin (Lee et al., 2010). If the relationship between PNUTS and 
TOX4/Wdr82 is conserved in Drosophila, this could provide a mechanistic insight 
into the role of dPNUTS in gene expression. Identification of dPNUTS interacting 
proteins is necessary to understand the mechanisms underlying its role in gene 





4. Identifying PNUTS interacting proteins in Drosophila 
4.1. Introduction 
Human PNUTS associates with chromatin during interphase and telophase 
(Landsverk et al., 2005). It has been reported to be capable of binding RNA and 
ssDNA through RGG motifs, histidine/glycine repeats and a Zinc-finger motif at its 
extreme C-terminus (Kim et al., 2003). However, it is unclear what role these 
domains of PNUTS play in chromatin binding. dPNUTS is also chromosome-
associated (Ciurciu et al., 2013). Notably, the short dPNUTS isoform, which lacks 
the C-terminal half of the protein, shows a similar distribution to the full-length 
dPNUTS isoform on chromosomes. Since this region does not possess DNA-binding 
ability, it has raised the possibility that the N-terminus of dPNUTS associates with 
other proteins that are responsible for directing the PP1 binding protein to particular 
substrates and chromatin-associated processes. The identification of dPNUTS-
interacting proteins may offer further insight into mechanisms behind its role in 
RNAPII-mediated gene expression and cell growth. 
 
In vitro studies using mammalian cell lines have identified a small number of 
proteins that interact with PNUTS and revealed complexes PNUTS-PP1 may be 
involved in that have implicated the protein in novel processes (Lee et al., 2010; 
Kavela et al., 2013). In a screen looking for PTEN-associated proteins, Kavela et al., 
found that PNUTS directly interacts with the lipid binding domain (C2 domain) of 
PTEN and sequesters it to the nucleus, away from its normal membrane-associated 
location (Kavela et al., 2013). PTEN is a well-described tumour suppressor gene that 
negatively regulates the ability of the PI3K/Akt pathway to promote cell growth and 
survival (Maehama and Dixon, 1998). PTEN is a dual specificity phosphatase that 
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has many protein and lipid targets, but its tumour suppressor activity is mediated 
through one of its lipid substrates, phosphatidylinositol-4,5-triphosphate (PIP3), 
which is required for the downstream activation of the Akt pathway (Maehama et al., 
2004; Myers et al., 1997). PTEN dephosphorylates PIP3 to phosphatidylinositol-4,5-
bisphosphate (PIP2) at the cellular membrane, thus preventing activation of the Akt 
pathway and cell growth. Due to its ability to negatively regulate PTEN by 
sequestration, PNUTS has been described as a proto-oncogene (Kavela et al., 2013). 
Currently it is not known if the interaction between PNUTS and PTEN is conserved 
in Drosophila, which might have relevance to the growth phenotype observed in 
animals mutant for dPNUTS. 
 
There is an increasing amount of evidence that PNUTS-PP1 exists in a complex with 
TOX4/Langerhans Cell Protein 1 (LCP1) and Wdr82. In 2006, Trinkle-Mulcahy et 
al., identified PNUTS, LCP1 and Wdr82 as PP1-associated proteins by mass 
spectrometry analysis (Trinkle-Mulcahy et al., 2006). Then in 2009, Lee et al., 
reported that the N-terminus of PNUTS binds to the C-terminus of LCP1 and 
suggested the complex has a role in mediating transcriptional activation (Lee et al., 
2009). Using a GAL4-based transcription assay they showed the N-terminus of 
LCP1 has a trans-activation domain that is inhibited by its interaction with PNUTS 
(Lee et al., 2009). It has since been shown that PNUTS-PP1 exists in a complex with 
TOX4 (LCP1) and Wdr82, with PNUTS acting as a molecular platform for complex 
formation (Lee et al., 2010). They suggested PNUTS predominantly associates with 
this complex therefore it may mediate the activity of PNUTS in different cellular 
processes such as chromosome decondensation and cell cycle progression as 
biochemical analysis showed all three proteins associate with chromatin (Lee et al., 
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2010). PNUTS, TOX4 and Wdr82 were also identified in a screen looking for 
proteins that associate with sites of damaged DNA, implicating the complex in the 
DNA damage response (Puch et al., 2011). LCP1 (TOX4) is a HMG-box protein, 
which physically binds to DNA (see Chapter 5 for more details) (O'Flaherty and 
Kaye, 2003; Lee et al., 2009). It is therefore conceivable that TOX4 recruits PNUTS 
to chromatin.  
 
In an attempt to understand more about dPNUTS-PP1 and the complexes it 
associates with, a yeast two-hybrid (Y2H) approach was used to identify proteins 
that interact with dPNUTS in Drosophila. Y2H assays (both an initial screen and 
subsequent experiments in this system) were carried out on a collaborative basis by 
Hybrigenics Services (Paris, France). Although PNUTS-binding proteins have been 
characterised to some extent in mammalian cells, Drosophila offers a more practical 
system in which to study interacting proteins due to its genetic tractability and the 
availability of various tools for cell biology experiments.  
 
4.1.1. Identifying protein interactions using the Y2H system 
Since its development by Fields and Song in 1989, the Y2H system has become a 
powerful and popular technique for identifying protein-protein interactions. It allows 
detection of binding partners using living yeast cells (Saccharomyces cerevisiae) and 
a transcriptional activation response that exploits the properties of the GAL4 
transcriptional activator (Brückner et al., 2009). GAL4 has an N-terminal DNA 
binding domain (DBD) and a C-terminal activation domain (AD), which are both 
required for transcriptional activation of target genes. The original Y2H assay 
involved fusing two proteins of interest, X and Y, to the DBD and AD of GAL4 
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respectively, creating a functional GAL4, which drives the expression of a reporter 
gene through RNAPII mediated transcription, if the two proteins bind (Fields and 
Song, 1989). The most common reporter genes used encode proteins that allow 
growth on minimal media (auxotrophic markers) and include genes such as HIS3, 
which encodes imidazole glycerol phosphate (IGP) dehydratase, and allows growth 
on media lacking histidine (Brückner et al., 2009). Since then, other DNA binding 
proteins have been exploited including the E.coli transcription factor LexA, the DBD 
of which can be fused to the AD of GAL4 to form a fully functional transcription 
activator in yeast (Van Criekinge and Beyaert, 1999).  
 
The main advantage of using the Y2H assay is it allows detection of proteins that 
bind directly, unlike other methods for studying protein-protein interactions, such as 
immunoprecipitation, which do not provide conclusive evidence of a direct 
interaction. Nevertheless it is important to recognise there are several limitations of 
this approach; the Y2H assay is based on overexpression of proteins of interest in 
yeast and may lead to false positives due to high concentrations of fusion proteins, 
which may under normal conditions not bind or be co-expressed. 
 
4.1.2. Aims 
The aim of this chapter was to validate and better characterise dPNUTS-interacting 
proteins, which were identified in the Y2H system, using biochemical techniques. In 
parallel, interactions between Drosophila orthologues of PTEN and PNUTS were 
examined to determine whether binding between these proteins is conserved in flies. 
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4.2. Identification of PNUTS interacting proteins by Y2H 
To identify proteins that bind to dPNUTS the Y2H method was used to screen a 
Drosophila 3rd instar larvae cDNA library using the full-length dPNUTS (amino 
acids 1-1135) protein as ‘bait’ fused to the LexA DBD of plasmid pB27. The screen, 
carried out by Hybrigenics Services (Paris, France), analysed 6.1x107 interactions 
and 351 positive clones were processed, and found to encode a total of 54 proteins. 
Each protein identified was assigned a Predicted Biological Score (PBS), which 
assesses the reliability of the interaction and is an e-value ranging from 0 to 1 
calculated by comparing the number of prey fragments identified for each interacting 
proteins to the probability of finding them at random (Rain et al., 2001; Formstecher, 
2005). For practicality, the e-values are arbitrarily defined into ranks from A to E 
with A being the highest confidence rank (closest to 0) and E most likely being 
artefacts from the assay (Rain et al., 2001). Hybrigenics also carried out domain 
analysis on each identified protein and provided information on the selected 
interaction domain, which corresponds to the minimal fragment capable of binding to 
dPNUTS. The majority of proteins (n=40) identified were assigned a predicted 
biological score of D, meaning they have a higher chance of being a false positive 
interaction as they were generally only identified through one unique prey fragment. 
All proteins assigned a score of A, B or C are shown in Table 4.1.  
 
61 of the 351 positive clones encoded the same unnamed protein, CG12104 (250 aa), 
which was the only protein given a confidence score of A. Domain analysis 
identified this as a High Mobility Group Box protein (Appendix 7) and fragment 
analysis revealed dPNUTS interacts with the C-terminus (amino acids 206-246) 
(Table 4.1). Phylogenetic analysis and sequence alignments indicate that CG12104 is 
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the Drosophila orthologue of LCP1/TOX4 (see Chapter 5). It is possible CG12104 is 
the only orthologue as other Drosophila proteins have not been identified that 
contain a HMG-box with similarity to the TOX family (O'Flaherty and Kaye, 2003). 
Therefore CG12104 will be referred to as dTOX4 hereafter. Another HMG-box 
containing protein, Sox14, was also identified (represented by 8 clones and given a 
confidence score of B). Other proteins given a confidence score of B included P32, a 
mitochondrial protein that may function in RNA splicing and apoptosis; MBD-R2, a 
component of the Non-specific Lethal (NSL) complex which binds DNA and is 
associated with active transcription; and Msr-110, which may be a target of 
microRNA miR-1-mediated post-transcriptional regulation (see Table 4.1 for 
references). Finally, two proteins identified were given a confidence score of C: 
Estrogen-Related Receptor (ERR, CG7404), a nuclear receptor involved in 







Table 4.1. The top hits from a Y2H screen using full length PNUTS as bait. The number of clones identified in the screen for each 















CG12104 250 61 A 206-246 Drosophila TOX4, HMG-box domain binds to 








1081 4 B 862-1081 Part of NSL complex involved in transcription 
regulation, DNA binding, associated with 
active chromatin states 
 
(Raja et al., 2010; 
Lam et al., 2012) 
Sox14 
(CG3090) 
669 8 B 161-282 Transcription factor, HMG-box domain, 







263 6 B 145-263 Mitochondrial protein, may function in RNA 
splicing, mitochondrial oxidative 
phosphorylation and apoptosis 
 
(Lutas et al., 2012) 
Msr-110 
(CG10596) 
608 3 B 147-244 Target of microRNA miR-1, post-
transcriptionally regulated by miR-1 
 





496 3 C 93-292 Nuclear receptor, transcription factor, regulates 
growth and metabolism 
 
 




396 3 C 371-396 Arginine kinase activity  
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4.3. Characterisation of the interaction between dPNUTS and dTOX4 
To verify the interaction between dPNUTS and the C-terminal region of dTOX4 a 
direct one-by-one Y2H assay was performed using full length dPNUTS (aa 1-1135) 
cloned in frame with the LexA DNA binding domain into plasmid pB27 and a 
dTOX4 fragment (aa 179-250) extracted from the original screen (see 4.2) cloned in 
frame with the Gal4 Activation Domain into plasmid pP7. Selective medium without 
tryptophan and leucine (DO-2) was used to select for the presence of the two 
plasmids and selective medium without tryptophan, leucine and histidine (DO-3) was 
used to select for an interaction. To increase stringency and reduce autoactivation by 
PNUTS an inhibitor (3-aminotriazol [3-AT]) of the reporter gene, HIS3, was used at 
increasing concentrations. Figure 4.1 shows that even at the highest concentration of 
3-AT (50mM) and on selective medium, an interaction between dPNUTS and the C-



































































































































Figure 4.1. dPNUTS binds to the C-terminus of dTOX4 in the Y2H assay. Yeast 
two hybrid analysis showing presence of interaction between dPNUTS (in pB27) and 
dTOX4 (in pP7). Interaction pairs were tested in duplicate (clone 1 and clone 2) on 
several dilutions (10-1, 10-2, 10-3, 10-4, normalised at 5x104 cells). Cells were grown 
on selective medium without tryptophan and leucine (DO-2) and selective medium 
without tryptophan, leucine and histidine (DO-3). 3-aminotriazol (3-AT) was used at 
various concentrations to increase stringency and test the affinity of binding. The 
highest concentration used (50mM) is shown. C+ = Hybrigenics interaction positive 
control, C- = negative controls. ! specifies empty vector. 
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Having confirmed the C-terminus of dTOX4 is essential for its interaction with 
dPNUTS, a dTOX4 mutant construct was made by site-directed mutagenesis to 
remove the dPNUTS-binding region for future characterisation of the interaction. To 
do this, a two base pair change was introduced that generated a premature stop codon 
in place of Proline 216, removing the last 34 residues of dTOX4 and the dPNUTS-
binding region (Figure 4.2). Mutagenesis was performed by BioPioneer (San Diego, 





Figure 4.2. Map of dTOX4. Map of wild type dTOX4 (dTOX4wt) protein with the 
PNUTS Binding Domain (BD) in red and the site-directed mutant (dTOX4P216!) with 




To provide further confirmation that dPNUTS binds dTOX4 and to test binding of 
dPNUTS to the dTOX4P216! construct, tagged expression constructs were made that 
could be used in co-immunoprecipitation (co-IP) experiments and co-localisation 
studies. The Bennett lab had already generated a construct for dPNUTS conjugated 
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to a C-terminal Myc tag in the Gateway® entry vector pDONR221, so this was 
subcloned into an appropriate S2 cell expression vector, pAW, for co-IP 
experiments. For the purposes of co-localisation studies in S2 cells, the dPNUTS-
Myc construct was also cloned into an N-terminal Red Fluorescent Protein (RFP) 
tagged S2 cell expression vector, pARW. The dTOX4 cDNA sequence was PCR 
amplified from the BDGP gold cDNA clone LP01188 and cloned into the pENTR 
entry vector, which was also used to generate the dTOX4P216!, as previously 
described and checked by sequencing. The dTOX4wt and dTOX4P216! were then 
subcloned into an N-terminal GFP tagged S2 cell expression vector, pAGW for the 
purposes of co-IP experiments and co-localisation studies.  
 
4.3.1. Co-immunoprecipitation of dPNUTS and dTOX4 in S2R+ cells 
For co-IP experiments, Drosophila S2R+ cells were transiently transfected with 
either GFP-dTOX4wt, dPNUTS-Myc (control in figure 4.3) or co-transfected with 
GFP-dTOX4wt and dPNUTS-Myc. Immunoprecipitation of GFP-dTOX4wt from 
transfected cells, using a magnetic GFP trap resulted in co-precipitation of dPNUTS-
Myc as detected by an anti-Myc antibody on a Western blot (Figure 4.3a). The same 
experiment was done using GFP-dTOX4P216!, which showed the site-directed mutant 
was unable to co-precipitate dPNUTS-Myc (Figure 4.3a), confirming it lacks the 
dPNUTS binding domain. The experiment was repeated to confirm the results and 
also to check expression of the GFP-dTOX4 constructs, having found a suitable anti-
GFP antibody (Figure 4.3b). Again dPNUTS-Myc was detected in 
immunoprecipitated GFP-dTOX4wt extracts when blotted with an anti-Myc antibody 
but not in GFP-dTOX4P216! extracts (Figure 4.3b). Blotting with an anti-GFP 
antibody (Clontech) confirmed expression of the GFP-dTOX4 constructs and also 
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revealed dTOX4P216! expresses a truncated protein with a lower molecular weight 












Figure 4.3. dPNUTS binds to dTOX4 in Drosophila S2R+ cells. a) Western blot 
showing Myc-tagged dPNUTS co-immunoprecipitates with GFP-tagged dTOX4wt 
but not GFP-dTOX4P216!. Immunoblot analysis of total protein extract (IN) and 
immunoprecipitated protein extract (IP) from S2R+ cells co- transfected with GFP-
dTOX4 (wt or P216!) and dPNUTS-Myc or with each expression vector alone and 
blotted with anti-Myc antibody. b) A repeat of experiment in (a) showing dPNUTS 
precipitates with dTOX4wt but not dTOX4P216! as shown by immunoblotting with 
anti-Myc. Immunoblotting with anti-GFP shows presence of GFP-dTOX4 constructs 
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4.3.2. Nuclear colocalisation of dPNUTS and dTOX4 in S2R+ cells 
dPNUTS is a nuclear protein that binds to chromosomes during interphase (Ciurciu 
et al., 2013). To confirm that dTOX4 binds to dPNUTS in the nucleus, S2R+ cells 
were transiently co-transfected with RFP-dPNUTS-Myc and GFP-dTOX4wt or with 
GFP-dTOX4wt alone and imaged using confocal microscopy. Single transfection of 
dTOX4wt revealed it is localised in the nucleus and the cytoplasm, with a higher level 
of localisation in the nucleus (Figure 4.4a, top row, GFP panel). Upon co-
transfection with RFP-dPNUTS, GFP-dTOX4wt became exclusively localised in the 
nucleus and co-localised with RFP-dPNUTS (Figure 4.4a top and second rows). To 
confirm this was due to the interaction between dPNUTS and dTOX4 and not a 
consequence of the GFP or RFP tags, GFP-dTOX4P216! was co-transfected with 
RFP-dPNUTS. Similar to GFP-dTOX4wt, GFP-dTOX4P216! was localised in the 
nucleus and cytoplasm (Figure 4.4a, third row, GFP panel). However, upon co-
transfection with RFP-dPNUTS, GFP-dTOX4P216! did not relocate to the nucleus 
(Figure 4.4a, fourth row, RFP and GFP panels), indicating that the ability of ectopic 
dPNUTS to sequester dTOX4 in the nucleus is dependent on the presence of the 
dPNUTS-binding region in dTOX4.  
 
To quantify the degree of co-localisation in co-transfected cells a line scan was 
performed to measure the fluorescent intensity of both GFP and RFP signals across 
the cell. In cells coexpressing GFP-dTOX4wt and RFP-dPNUTS, the signal from 
each fluorescent tag largely overlapped, showing a large peak of co-localisation in 
the nucleus (Figure 4.4b). In cells coexpressing GFP-dTOX4P216! and RFP-dPNUTS, 
the co-localisation plot showed a strong overlap in the nucleus followed by a drop in 
RFP-dPNUTS signal in the cytoplasm where the GFP-dTOX4P216! signal remained 
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relatively high (Figure 4.4c). To determine the degree of overlap in the whole cell, 
co-localisation analysis was carried out using the JaCOP plugin in Fiji and Manders' 
coefficient analysis performed (Manders et al., 1993). Figure 4.4c shows GFP-
dTOX4wt signal strongly correlates with RFP-dPNUTS signal in the whole cell 
(Manders’ coefficient M1=0.982, M2= 0.995). Figure 4.4e shows correlation is 
weaker in cells co-transfected with GFP-dTOX4P216! and RFP-dPNUTS (Manders’ 
coefficient M1= 0.488, M2=0.934). M1 is a ratio of the amount of GFP-dTOX4 
overlapping with RFP-dPNUTS and M2 is a ratio of the amount of RFP-dPNUTS 
that overlaps with GFP-dTOX4. A value of 1 represents complete co-localisation. 
 
Figure 4.4 (next page). dTOX4wt relocates to the nucleus when co-expressed 
with dPNUTS. a) S2R+ cells were transfected with GFP-dTOX4wt or GFP-
dTOX4P216! alone or in combination with RFP-dPNUTS. Staining with anti-actin 
was used to identify cell borders and staining with DAPI was used to identify the 
position of the nucleus. Cells were imaged using confocal microscopy. Scale bar = 
5µm. b) Plot of normalised fluorescence intensity for GFP-dTOX4wt and RFP-
dPNUTS co-transfected cell measured along a line through the indicated cell in the 
image to the left (white arrow). c) Cytofluorogram showing fluorescence intensity 
across whole cell transfected with GFP-dTOX4wt and RFP-dPNUTS. d) Plot of 
normalised fluorescence intensity for GFP-dTOX4P216! and RFP-dPNUTS co-
transfected cell measured along a line through the indicated cell in the image to the 
left (white arrow). e) Cytofluorogram showing fluorescence intensity across whole 
































































































































4.4. Characterisation of the interaction between dPNUTS and dMBD-R2 
Only four clones of dMBD-R2 were identified in the initial yeast two-hybrid screen 
but, given its role transcription, the interaction between dPNUTS and dMBD-R2 was 
investigated further. In the initial screen it was found that dPNUTS binds to the C-
terminus of dMBD-R2 (Table 4.1). To determine which part of dPNUTS interacts 
with dMBD-R2, a direct Y2H domain-mapping assay was done by Hybrigenics 
using fragments of dPNUTS and a fragment of dMBD-R2 (aa 950-1169) 
incorporating the minimal PNUTS-binding region, which was determined from the 
initial screen. The dMBD-R2 fragment was cloned in-frame with the Gal4 AD in 
plasmid pP7 and the dPNUTS fragments were cloned in-frame with the LexA DBD 
in plasmid pB27. Figure 4.5 gives a map of the dPNUTS fragments used in the assay 










Figure 4.5. Schematic representation of the dPNUTS fragments used to determine 
dMBD-R2 binding site. Fragments with a positive interaction are indicated with a 









1 1135 dPNUTS  


























Cells were grown on selective DO-2 and DO-3 medium with increasing 
concentrations of 3-AT. Figure 4.6 shows only full-length dPNUTS (fragment 1) and 
a fragment consisting of the first 147 amino acids of dPNUTS (fragment 2) binds to 
dMBD-R2 in the yeast two-hybrid assay. This interaction was only detectable when 
grown on plates with 1mM 3-AT suggesting the interaction is weak compared to 
binding between dPNUTS and dTOX4. Surprisingly fragment 7, which incorporates 
the N-terminus of dPNUTS, did not interact with dMBD-R2 (Figure 4.6). This is 
unexpected given fragment 1 and full-length dPNUTS do interact but might be 
because fragment 7 isn’t expressed, it’s unstable or it doesn’t fold correctly. 
Together, these results confirm that dMBD-R2 binds to dPNUTS in the Y2H assay, 




































































































































































































































































































































































































































































Figure 4.6 (previous page). dMBD-R2 binds to the N-terminus of dPNUTS in a 
Y2H assay. Yeast two-hybrid analysis showing full-length dPNUTS (frag 1) and a 
dPNUTS fragment consisting of amino acids 1-147 (frag 2) bind to dMBD-R2. 
Interaction pairs were tested in duplicate on several dilutions (10-1, 10-2, 10-3, 10-4, 
normalised at 5x104 cells). Cells were grown on selective medium without 
tryptophan and leucine (DO-2) and selective medium without tryptophan, leucine 
and histidine (DO-3). 3-aminotriazol (3-AT) was used at various concentrations to 
increase stringency and test the affinity of binding. Only the results for 1mM 3-AT 
are shown as no interaction was detected at higher concentrations. C+ = Hybrigenics 
interaction positive control, C- = negative controls. ! specifies empty vector. 
 
4.4.1. Co-immunoprecipitation of dPNUTS and dMBD-R2 in S2R+ cells 
To provide further confirmation that dPNUTS and dMBD-R2 bind to each other, a 
tagged expression construct was made for use in co-IP experiments.  The dMBD-R2 
cDNA sequence was PCR amplified from the BDGP gold cDNA clone SD10773, 
cloned into the pENTR Gateway® entry vector and checked by sequencing. This was 
then subcloned into an amino-terminal GFP tagged S2 cell expression vector, pAGW 
(DGRC) for co-IP experiments.  
 
Immunoprecipitation of GFP-dMBD-R2 from transfected cells, using a magnetic 
GFP trap (Chromotek) resulted in co-precipitation of dPNUTS-Myc as detected by 
an anti-Myc antibody on a Western blot (Figure 4.7). It is important to note that 
problems with transfection efficiencies and controls meant that this result could not 
be repeated. However, this does provide preliminary evidence that dPNUTS and 
dMBD-R2 bind in S2R+ cells. 
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Figure 4.7. dPNUTS binds to dMBD-R2 in S2R+ cells. Western blot showing Myc 
tagged dPNUTS co-immunoprecipitates with GFP tagged MBD-R2. Immunoblot 
analysis of total protein extract (IN) and immunoprecipitated protein extract (IP) 
from S2R+ cells co- transfected with GFP-dMBD-R2 and dPNUTS-Myc or with 
GFP-dMBD-R2 alone and blotted with anti-Myc antibody. Immunoblotting with 
anti-GFP shows presence of GFP-dMBD-R2 in transfected cell extracts.  
 
 
4.5. Characterisation of the interaction between dPNUTS and dERR 
The estrogen related receptor is a nuclear hormone receptor that plays an important 
role in regulating development, growth and metabolism (Chawla et al., 2001). Given 
that genes involved in metabolism and proliferative growth were found to be 
significantly underexpressed in dPNUTS mutants (see Chapter 1), the interaction 
between dERR and dPNUTS was further characterised. Only three clones were 
identified in the initial screen and the interaction was only given a confidence score 
of C (Table 4.1). Therefore to confirm the interaction, a direct one-by-one yeast two-
hybrid assay was done using full-length dPNUTS and fragments of dERR. dPNUTS 
was cloned in frame with the LexA DBD into plasmid pB27 and checked by 
sequencing. A prey fragment consisting of amino acids 93-309 of dERR 
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screen, cloned in frame with the Gal4 AD into plasmid pP7 and checked by 
sequencing. The coding sequences for different dERR fragments were also cloned in 
frame with the Gal4 AD into plasmid pP7. Figure 4.8 gives a map of the dERR 




Figure 4.8. Schematic representation of the dERR fragments used to determine the 
dPNUTS-binding site. Fragments with a positive interaction are indicated with a red  




Cells were grown on selective DO-2 and DO-3 medium. Figure 4.9 shows an 
interaction was detectable between the initial dERR prey fragment and dPNUTS, 
confirming the results from the original screen. Fragment 1, the selected interaction 
domain identified in the original screen, also bound to dPNUTS together with 
fragment 3, which incorporates amino acids 124-211. Fragments 2, 4 and 5 did not 
interact with dPNUTS suggesting amino acids 124-211 are sufficient for dPNUTS 
binding. 
! 155 
Figure 4.9 (next page). dERR binds to dPNUTS in a Y2H assay. Yeast two 
hybrid analysis showing full-length dPNUTS and the initial prey fragment from the 
original screen (aa 39-398) interact with dPNUTS as does fragment 1 (aa 93-292) 
and fragment 3 (aa 124-211). Interaction pairs were tested in duplicate using several 
dilutions (10-1, 10-2, 10-3, 10-4, normalised at 5x104 cells). Cells were grown on 
selective medium without tryptophan and leucine (DO-2) and selective medium 
without tryptophan, leucine and histidine (DO-3). C+ = Hybrigenics interaction 















































































































































































































































































































































































An attempt was made to identify the dERR-binding site in dPNUTS using a direct 
Y2H assay. Fragments of dPNUTS (Figure 4.10) were cloned in frame with the 
LexA DBD into plasmid pB27 and a fragment of dERR (aa 93-309) incorporating 
the PNUTS binding domain, which was extracted from the initial screen was cloned 
in frame with the Gal4 AD into plasmid pP7. Figure 4.10 gives a map of the 











Figure 4.10. Schematic representation of the dPNUTS fragments used to determine 
dERR-binding site. Fragments with a positive interaction are indicated with a red  + 
sign, fragments with a negative interaction are indicated with ! sign. 
 
Cells were grown on selective DO-2 and DO-3 medium with increasing 
concentrations of 3-AT. Figure 4.11 shows only full-length dPNUTS (fragment 1) 
binds to dERR in the Y2H assay. This interaction was detectable when grown on 
plates with up to 10mM 3-AT (only 1mM 3-AT shown) suggesting they bind with 
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Figure 4.11 (next page). dERR binds to dPNUTS in a Y2H assay. Yeast two 
hybrid analysis showing full-length dPNUTS binds to a dERR prey fragment (aa 93-
309). Interaction pairs were tested in duplicate using several dilutions (10-1, 10-2, 10-
3, 10-4, normalised at 5x104 cells). Cells were grown on selective medium without 
tryptophan and leucine (DO-2) and selective medium without tryptophan, leucine 
and histidine (DO-3). 3-aminotriazol (3-AT) was used at various concentrations to 
increase stringency and test the affinity of binding. Only the results for 1mM 3-AT 
are shown. C+ = Hybrigenics interaction positive control, C- = negative controls. ! 


















































































































































































































































































































































































4.5.1. Co-immunoprecipitation of dPNUTS and dERR in S2R+ cells 
To provide further confirmation that dPNUTS binds dERR, an epitope tagged 
expression construct of dERR was made that could be used in co-IP experiments.  
The dERR cDNA sequence was PCR amplified from the BDGP gold cDNA clone 
GH28308, cloned into the pENTR entry vector and checked by sequencing. This was 
then subcloned into an amino-terminal Flag-Myc tagged S2 cell expression vector, 
pAFMW. dPNUTS-Myc was subcloned into a GFP S2 cell expression vector, 
pAGW.  
 
Cells were transiently transfected with either Flag-Myc-dERR alone or in 
combination with GFP-dPNUTS-Myc. Immunoprecipitation of GFP-dPNUTS-Myc 
from transfected cells, using a magnetic GFP trap resulted in co-precipitation of 
Flag-Myc-dERR as detected by an anti-Flag antibody on a Western blot (Figure 
4.12). However, when the experiment was repeated using an anti-Myc antibody an 
interaction was not detected. Problems with transfection efficiencies in co-
transfected samples could be one possible explanation for the lack of 
immunoprecipitation in the repeat experiment. Due to time constraints more repeats 

















Figure 4.12. dPNUTS binds to dERR in S2R+ cells. Cells were transfected with 
S2 constructs expressing Flag-Myc-dERR or co-transfected with Flag-Myc-dERR 
and GFP-dPNUTS-Myc. Ectopic dPNUTS was precipitated using a magnetic GFP 
trap (Chromotek). Western blotting with an anti-Flag antibody shows dERR co-
immunoprecipitates with GFP-dPNUTS. A repeat experiment immunoblotted with 
anti-Myc antibody (bottom panels) did not detect an interaction. IN= input (total 
protein extract), NB = non-bound and IP = immunoprecipitated.  
 
 
4.6. Characterisation of the interaction between dPNUTS and dWdr82 
dWdr82 was not identified as a dPNUTS-interacting protein in the initial Y2H 
screen. However Lee et al., 2010 showed human PNUTS binds to human Wdr82 and 
they exist in a stable complex with TOX4 and PP1 (Lee et al., 2010). dWdr82 may 
not have been represented in the cDNA library used in the original screen therefore a 
direct one-by-one assay between full-length dPNUTS and full-length dWdr82 was 
done. Both genes were PCR amplified and cloned in frame with the LexA DBD into 
plasmid pB27 and the Gal4 AD into plasmid pP7 and checked by sequencing. Cells 











were grown on selective DO-2 and DO-3 medium. Figure 4.13 shows an interaction 
could not be detected in either reciprocal interaction assay.  
 
 
Figure 4.13 (next page). dPNUTS does not bind dWdr82 in the yeast two-hybrid 
system. Yeast two-hybrid analysis showing that an interaction between full-length 
dPNUTS and full-length dWdr82 was not detected. Interaction pairs were tested in 
triplicate in the form of streaks. Cells were grown on selective medium without 
tryptophan and leucine (DO-2) and selective medium without tryptophan, leucine 
and histidine (DO-3) to select for an interaction. C+ = Hybrigenics interaction 







































Hybrigenics Positive Control 
C- (pB27Ø + pP7Ø) 
C- (pB27-dPNUTS + pP7Ø) 
pB27-dPNUTS + pP7-dWdr82 
pB27-dWdr82 + pP7-dPNUTS 
Positive and negative controls
DO-2 DO-3
Hybrigenics’ positive control Negative control: pB27ø + pP7ø
DO-2 DO-3
1-by-1 Y2H Results of D. Bennett - 1999-2012 Hybrigenics Services SAS 2
Negative control: pB27ø + AD-Wdr82 Negative control: pB27ø + AD-PNUTS
DO-2 DO-3 DO-2 DO-3
C- (pB27Ø + pP7-dWdr82) 
Positive and negative controls
DO-2 DO-3
Hybrigenics’ positive control Negative control: pB27ø + pP7ø
DO-2 DO-3
1-by-1 Y2H Results of D. Bennett - 1999-2012 Hybrigenics Services SAS 2
Negative control: pB27ø + AD-Wdr82 Negative control: pB27ø + AD-PNUTS
DO-2 DO-3 DO-2 DO-3
C- (pB27Ø + pP7-dPNUTS) Negative controls and interactions
Negative control: LexA-PNUTS +pP7ø Negative control: LexA-Wdr82 + pP7ø 
DO-2 DO-3 DO-2 DO-3
1-by-1 Y2H Results of D. Bennett - 1999-2012 Hybrigenics Services SAS 3
LexA-PNUTS + AD-Wdr82 LexA-Wdr82 + AD-PNUTS
DO-2 DO-3 DO-2 DO-3
C- (pB27-dWdr82 + pP7Ø) 
DO-2 DO-3 
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4.6.1. Co-immunoprecipitation of dPNUTS and dWdr82 in S2R+ cells 
Despite not detecting an interaction in the Y2H assay, the evidence in the literature 
warranted biochemical analysis of this potential interaction in Drosophila. Therefore 
tagged expression constructs were made for co-IP experiments in Drosophila S2R+ 
cells. The dWdr82 cDNA sequence was PCR amplified from the BDGP gold cDNA 
clone GH09638, subcloned into the pENTR Gateway® entry vector and checked by 
sequencing. This was then subcloned into an amino-terminal FLAG-Myc tagged S2 
cell expression vector, pAFMW and an amino-terminal GFP tagged S2 cell 
expression vector, pAGW. Similarly dPNUTS-Myc was subcloned into an untagged 
vector (pAW) as previously described and also pAGW for biochemical analysis 
using reciprocal tags.  Drosophila S2R+ cells were transiently transfected with GFP-
dWdr82 with and without dPNUTS-Myc and FLAG-myc-dWdr82 with or without 
GFP-PNUTS-Myc. Immunoprecipitation of GFP-dWdr82 from co-transfected cells, 
using a magnetic GFP trap resulted in co-precipitation of dPNUTS-Myc as detected 
by an anti-Myc antibody on a Western blot (Figure 4.14). This was confirmed in the 
reciprocal experiment as immunoprecipitation of GFP-dPNUTS-Myc from co-
transfected cells, was able to pull down FLAG-myc-dWdr82 (see Figure S6 in 
section 3.2 of Chapter 3). This suggests that dPNUTS binds to dWdr82 despite the 
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Figure 4.14. dPNUTS binds to dWdr82 in S2R+ cells. Western blot showing Myc 
tagged dPNUTS co-immunoprecipitates with GFP tagged MBD-R2. Immunoblot 
analysis of total protein extract (IN) and immunoprecipitated protein extract (IP) 
from S2R+ cells co- transfected with GFP-dWdr82 and dPNUTS-Myc or with GFP-
dWdr82 alone and blotted with anti-Myc antibody. Immunoblotting with anti-GFP 
shows presence of GFP-dWdr82 in transfected cell extracts. 
 
 
4.7. Characterisation of the interaction between dPNUTS and dPTEN  
dPTEN was not identified as a dPNUTS binding protein in the original Y2H screen. 
However, recent evidence indicates that an interaction between the orthologous 
proteins occurs in human cells (Kavela et al., 2013). Binding between dPNUTS and 
dPTEN, if it could be demonstrated, could provide an alternative mechanism by 
which dPNUTS promotes developmental growth. Therefore in vitro and in vivo 
analysis was carried out to determine whether the interaction between PTEN and 
PNUTS is conserved in Drosophila.  
 
4.7.1. in vitro analysis of dPNUTS and dPTEN interaction 
Biochemical analysis in Drosophila S2R+ cells was done by subcloning dPNUTS-
Myc into an empty Drosophila expression vector (pAW) as previously described. 
! 166 
Drosophila expression vectors (pDEX) containing GFP tagged dPTEN splice 
variants (dPTEN1, dPTEN2 and dPTEN3) along with an empty pDEX-GFP vector 
were provided by T. Maehama (as reported in Maehama et al., 2004). The three 
splice variants were identified by (Smith et al., 1999) and differ at the C-terminus, 
with dPTEN2/3 having an extended C-terminus compared to dPTEN1, which lacks 
the majority of this region (Smith et al., 1999; Maehama et al., 2004). dPTEN1 
encodes a 418aa protein (predicted MW=48.1kDa), dPTEN2 encodes a 514aa protein 
(predicted MW=59.0kDa) and dPTEN3 encodes a 509aa protein (predicted 
MW=58.4kDa) (Smith et al., 1999; Maehama et al., 2004).  dPTEN3 is the 
predominant isoform involved in PIP3 mediated signalling in Drosophila (Maehama 
et al., 2004). S2R+ cells were transfected with pDEX, pDEX-GFP-dPTEN1 or 
pDEX-GFP-dPTEN2 alone or together with dPNUTS-Myc. Precipitation of GFP-
dPTEN1 or GFP-dPTEN2 using a magnetic GFP trap was unable to co-precipitate 
dPNUTS-Myc as shown by anti-Myc blotting on a Western blot (Figure 4.15). 
Unfortunately transfection with pDEX-GFP-dPTEN3 was unsuccessful as 
transfection efficiency varied between each experiment and it proved very difficult to 
achieve high transfection efficiencies suitable for biochemical analysis. This also 
made it difficult to repeat the biochemical analysis. It is also worth noting the band 
sizes seen in these experiments are different to the ones originally seen in (Maehama 
et al., 2004). For GFP-dPTEN2 and GFP-dPTEN1, band sizes of 78kDa and 68kDa 
were observed respectively, whereas Maehama et al reported band sizes of 
approximately 115kDa for GFP-dPTEN2 and 104kDa for GFP-dPTEN1 (Maehama 
et al., 2004). The band sizes reported here appear to be closer to the predicted 
molecular weight, if the molecular weight for the empty vector (pDEX-GFP, MW = 
approximately 25kDa, Figure 4.15) is accounted for. It is possible different 
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percentage gels were used, which could be one explanation for the differences in 
MW. However more analysis would need to be done to further characterise this 
interaction in Drosophila, in particular the relationship between PNUTS and 
dPTEN3, which may bind considering it is the predominant isoform involved in 
regulating the dAkt growth promoting pathway (Maehama et al., 2004). 
 













Figure 4.15. dPNUTS does not bind to dPTEN in Drosophila S2R+ cells.  
Western blot showing Myc tagged dPNUTS does not co-immunoprecipitate with 
GFP tagged dPTEN1 or dPTEN2 splice variants. Immunoblot analysis of total 
protein extract (IN) and immunoprecipitated protein extract (IP) from S2R+ cells co- 
transfected with dPTEN1/pDEX-GFP or dPTEN2/pDEX-GFP and dPNUTS-Myc or 
with each expression vector alone and blotted with anti-Myc antibody. pDEX-GFP is 
! 168 
an empty expression vector (negative control). Blotting with anti-GFP shows 
expression of GFP constructs in extracted samples. 
 
4.7.2. in vivo analysis of dPNUTS and dPTEN interaction 
To determine if a functional interaction exists in vivo the ey-FLP system was used to 
establish if a dPTEN mutant allele could suppress the dPNUTS mutant phenotype 
observed in developing adult eyes (see chapter 3). The ey-FLP system combines the 
UAS/GAL4 and FLP/FRT systems to generate eyes made up exclusively of 
homozygous mutant cells, in an otherwise heterozygous fly. Any cell that is not 
homozygous for the mutant allele is eliminated by apoptosis due to eye-specific 
expression of the gene hid (Stowers and Schwarz, 1999).  A dPTEN mutant allele 
(dPTEN3) was provided by Clive Wilson (Goberdhan et al., 1999). Eyes composed 
of homozygous dPTEN3 cells exhibit normal growth but with slightly enlarged and 
disorganised ommatidial facets whereas homozygous dPNUTS13B eyes are small 
with disorganised and aberrant ommatidial facets (Figure 4.16). Upon recombination 
of the two mutant alleles, eyes remained small and disorganised suggesting dPTEN3 
was unable to suppress the dPNUTS mutant eye phenotype (Figure 4.16). Together 
these results indicate that the dPNUTS loss-of-function phenotype in the developing 






















Figure 4.16. Loss of dPTEN does not suppress dPNUTS homozygous mutant eye 
phenotype. Images of adult female eyes showing eyes homozygous for dPTEN3 are 
able to develop into normal eyes, whereas eyes composed of homozygous 
dPNUTS13B cells are smaller and less organised than a wild type control. Co-
expression of both mutant alleles shows the effect of loss of dPNUTS cannot be 




A Y2H assay looking for dPNUTS interactors identified the Drosophila protein 
CG12104 (referred to as dTOX4) as the most abundant binding partner with 61 out 
of 351 clones and a predicted biological score of ‘A’. Domain analysis revealed 
dTOX4 contains a centrally located HMG-box, a highly conserved DNA binding 
domain that is characteristic of proteins belonging to the HMG group, the members 
of which are often implicated in transcriptional regulation (see Chapter 5, which 
reports on the functional characterisation of dTox4) (Ueda and Yoshida, 2010). A 
Y2H assay and biochemical analysis confirmed the interaction in Drosophila and 
revealed dTOX4 tightly associates with dPNUTS through its C-terminus (aa 216-
246). Immunofluorescence analysis showed dTOX4 is localised throughout the cell 
with a higher expression in the nucleus. Upon co-transfection with dPNUTS it is 
exclusively present in the nucleus and co-localises with dPNUTS protein, suggesting 
that ectopic dPNUTS sequesters dTOX4 in the nucleus. These data support the 
biochemical evidence that the two proteins physically interact. Interestingly in 
humans the HMG-box protein LCP1 (human TOX4) also binds to PNUTS in a Y2H 
assay using a human brain cDNA library and using biochemical analysis (Lee et al., 
2009). Mapping of the dTOX4 binding region in dPNUTS was not done however 
two studies show human TOX4 binds to the N-terminus of PNUTS (Lee et al., 2010; 
Lee et al., 2009), which is separate from its PP1 binding domain. Together these 
results reveal a novel PNUTS binding partner in Drosophila and suggest the human 
PNUTS-LCP1 interaction is conserved in flies. This highlights the likely biological 
significance of the relationship between TOX4 and PNUTS and techniques available 
in Drosophila will aid in further characterisation of this interaction.  
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TOX4 and PNUTS-PP1 have been shown to exist in a complex with Wdr82, which 
is more well known for its role in regulating histone H3 lysine 4 methylation through 
association with the histone methyltransferase containing complex, COMPASS (Lee 
et al., 2010). Two-hybrid screening did not identify dWdr82 as a dPNUTS binding 
protein however biochemical analysis did confirm an association in Drosophila, 
suggesting this complex is conserved in flies. Interestingly Wdr82 was not identified 
in a Y2H screen looking for PNUTS-binding partners in humans, despite 
biochemical analysis showing they directly interact (Lee et al., 2010; Lee et al., 
2009). This suggests Wdr82 may not be detectable using a Y2H approach, possibly 
because it is toxic to yeast or because of other limitations of the Y2H method. Yeast 
has a different post-translational modification system, which often means proteins of 
higher eukaryotes aren’t modified correctly and cannot be detected (Brückner et al., 
2009; Osborne et al., 1996). Furthermore Wdr82 is known to associate with multiple 
complexes but whether its association in these complexes is mutually exclusive is 
unknown (Lee et al., 2010). Therefore it is plausible its interaction with dPNUTS is 
transient and transient interactions can go undetected in Y2H assays (Brückner et al., 
2009). 
 
Other proteins identified in the screen include dMBD-R2. A direct Y2H assay 
confirmed binding and revealed dMBD-R2 associates with the N-terminus of 
PNUTS. Initial biochemical analysis confirmed binding, however the results have to 
be taken with caution due to the lack of repeats. Problems with transfection 
efficiencies with the dMBD-R2 tagged expression vector alone and together with the 
dPNUTS expression vector made it difficult to obtain repeatable results therefore 
further biochemical and functional analysis is necessary. As a commercial antibody 
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against dMBD-R2 is available, one way to address this would be to test the 
interaction between dPNUTS and dMBD-R2 in immunoprecipitated fly extracts. 
 
dMBD-R2 is part of the non-specific lethal (NSL) complex that plays a major role in 
active transcription in Drosophila through recruitment of RNAPII and the histone H4 
lysine 16 methyltransferase, Males absent On First (MOF) (Raja et al., 2010). 
Interestingly disruption of dMBD-R2 and other NSL genes by P-element insertion 
causes early larval lethality in Drosophila. If the interaction with dMBD-R2 could be 
confirmed, it would be interesting to determine whether dMBD-R2 mutant larvae 
display a similar growth arrest phenotype to dPNUTS (see Chapter 3) (Mendjan et 
al., 2006; Raja et al., 2010). Functional analysis of dMBD-R2 and its interaction 
with dPNUTS may offer insights into the mechanisms by which dPNUTS is 
recruited to chromatin.  
 
The Drosophila Estrogen Related Receptor (dERR) was also identified in the Y2H 
screen as a dPNUTS-binding partner. Only 3 out of 351 clones were recovered, 
however fragment analysis confirmed binding and showed dPNUTS interacts with a 
region near the N-terminus of dERR that contains a Zinc-finger DNA binding 
domain (Appendix 7). In Drosophila, ERR directs a metabolic switch to ensure 
proper carbohydrate metabolism during embryogenesis and support rapid growth 
during larval development (Tennessen et al., 2011). dERR mutants die as second 
instar larvae due to metabolic defects caused by the absence of a dERR-dependent 
transcriptional programme (Tennessen et al., 2011). Notably, transcriptomic analysis 
revealed that genes involved in glucose metabolism, which are regulated by dERR, 
are also underexpressed in dPNUTS mutants (see Figure S5, Chapter 3). Not all 
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genes controlled by dERR are similarly affected by dPNUTS, but this might reflect 
the difference in the developmental stage at which the transcriptomes were 
determined (1st instar larvae for dPNUTS, 2nd instar for dERR mutants). It is 
interesting to speculate that an association with sequence-specific DNA-binding 
proteins such as dERR may direct PNUTS-PP1 to specific transcriptional targets e.g. 
to control the metabolic status of the organism. 
 
PTEN was studied as a potential dPNUTS interactor based on evidence from studies 
of the mammalian counterparts (Kavela et al., 2013). PTEN was not identified in the 
initial Y2H screen but this could be because PTEN is predominantly associated with 
the cell membrane and membrane proteins often go undetected in Y2H assays 
because of poor recruitment to the nucleus where interactions must take place to be 
observed (Brückner et al., 2009). Co-IP experiments also failed to detect an 
interaction between dPNUTS and dPTEN1 and dPTEN2, however problems with 
transfection efficiencies made these analyses difficult to interpret. Furthermore, 
transfection with dPTEN3, which may be the predominant PTEN isoform in 
Drosophila, was unsuccessful, therefore an interaction between dPNUTS and 
dPTEN3 can’t be ruled out. Due to the problems with biochemical approaches, in 
vivo functional analysis using the ey-FLP system was used to study the interaction 
between dPNUTS and dPTEN. Loss of dPTEN function in the developing eye failed 
to rescue the reduced eye phenotype caused by dPNUTS loss-of-function. Taken at 
face value, these results appear to indicate that PNUTS and PTEN do not functionally 
interact in Drosophila. However, dPNUTS is likely to have pleiotropic roles and the 
dPNUTS alleles used in these experiments were null mutations. Consequently, it 
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would be worth repeating these experiments with a weaker (hypomorphic) dPNUTS 
mutant allele that might allow suppression of the growth phenotype to be revealed.   
 
Surprisingly PP1 was not identified as a dPNUTS-binding protein in the Y2H screen. 
A possible reason is that PP1 may be toxic to yeast when the PNUTS-PP1 
holoenzyme is reconstituted and in combination with the plasmids used for 
expression. For example, overexpression of PP1 in the vector pAS2 has previously 
been reported to be toxic in the Y2H system (Bennett and Alphey, 2007).  
 
Analysis of overlapping cDNA clones isolated from the Y2H screen highlighted the 
selected interaction domain (SID) for each identified protein. Interestingly the SID in 
dERR and dMBD-R2, as well as other identified proteins, contain a Zinc-finger 
domain (Appendix 7). Zinc-fingers are well known for facilitating DNA binding but 
some, such as the PHD Zinc-finger found in dMBD-R2 (Appendix 7) facilitate 
protein-protein interactions. The PHD Zinc-finger is known to bind both modified 
and unmodified histone tails allowing proteins to associate with chromatin (Ali et al., 
2012). This might suggest that dPNUTS regulates the activity of these proteins by 
modifying the DNA/histone binding affinity or utilises the properties of interacting 
partners to associate (indirectly) with DNA/chromatin. Although dTOX4 has not 
been reported to possess a Zinc-finger motif, analysis of the C-terminus, which is 
necessary for dPNUTS binding, reveals a series of separated cysteine residues (C 
(X4), C (X14), C (X3), C (X4), C), and has similarity to atypical zinc-finger motifs. 
The C-terminus is highly conserved in humans (see Chapter 5) so it would be 
interesting to determine if this region is capable of binding metal ions and if metal 
ions are required for the interaction with dPNUTS. 
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aa: 1 1135 KxVxW 
 Zinc finger  MBD-R2 & TOX4 BD   Wdr82 BD 
dPNUTS 
 PP1  BD  
 
In conclusion this work has identified a number of dPNUTS-binding proteins, some 
confirming interactions already reported for mammalian PNUTS (TOX4 and Wdr82) 
and others representing novel relationships (MBD-R2 and ERR). Figure 4.17 shows 
where these proteins are predicted to bind to dPNUTS based on evidence from Y2H 




Figure 4.17. Domain map of dPNUTS showing binding sites for known and novel 
dPNUTS interactors. BD = binding domain. 
 
Both dMBD-R2 and dTOX4 are predicted to interact with the N-terminus of 
dPNUTS, which raises the question of whether their binding is mutually exclusive or 
if they compete for dPNUTS binding. Results from the Y2H assay suggest dMBD-
R2 and dPNUTS bind with low affinity whereas dTOX4 and dPNUTS bind with 
high affinity. This might suggest their association with dPNUTS is competitive but 
that dPNUTS predominantly associates with dTOX4. It is also possible they bind 
exclusively at different stages of development and therefore never have the 
opportunity to compete for binding.  It is important to note these protein interactions 
were identified using a Y2H approach followed by ectopic protein expression in 
S2R+ cells. Therefore it will be important to confirm whether they bind in vivo under 
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normal biological conditions. Future experiments should focus on studying the 
endogenous proteins to establish their pattern of expression spatially and temporally 
and to look for functional interactions in vivo using the various genetic techniques 
available in Drosophila.  
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5. Investigating the function of dTOX4 
5.1. Introduction 
High Mobility Group (HMG) proteins are a superfamily of proteins that bind to 
DNA and facilitate various DNA-dependent nuclear activities including 
transcription, replication and DNA repair by inducing structural changes in the target 
DNA/chromatin (O'Flaherty and Kaye, 2003; Stros et al., 2007; Bianchi and Agresti, 
2005). In mammals there are three families of HMG proteins: the HMG-nucleosome 
binding family (HMGN), the HMG-AT-hook family (HMGA) and the HMG-box 
family (HMGB) (Reeves, 2010). Each family is unique in the functional motif that 
binds DNA but a highly acidic C-terminal Domain is common among all families, 
which is thought to modulate the affinity for various DNA structures, mediate 
chromatin unfolding or contribute to protein-protein interactions (Hock et al., 2007). 
HMGB proteins are the most abundant family and recognise DNA through a 
structurally conserved 70-80 amino acid sequence, which defines the HMG-box and 
is composed of three !-helices that form an L-shaped configuration (Malarkey and 
Churchill, 2012; Bustin, 1999). This structural motif binds to the minor groove of B-
form DNA, creating a severe bend and altering the local the chromatin structure to 
allow access of chromatin remodelling complexes and transcription factors (Reeves, 
2010; Bianchi and Agresti, 2005; Malarkey and Churchill, 2012; Wilkinson et al., 
2002). Consequently, HMGB proteins are often described as ‘architectural factors’ 
having an important role in modulating chromatin structure, replication, DNA repair, 
transcription regulation and proper development (Reeves, 2010).  
 
LCP1/TOX4 belongs to the HMG-box family, which is usually divided into two 
groups of proteins; those that bind DNA in a sequence dependent manner and those 
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that bind independently of the underlying sequence. However, there are members of 
both groups that bind to distorted DNA structures such as four-way junctions and 
adducts generated by platinating agents (Ueda and Yoshida, 2010; Puch et al., 2011; 
Stros et al., 2007; P-ohler et al., 1998). TOX4 is a sequence-independent DNA-
binding protein and binds to DNA adducts generated by Cisplatin, a platinum-based 
anticancer drug, implicating this HMGB protein in the DNA damage response (Puch 
et al., 2011).  
 
Apart from binding to damaged DNA and being implicated in transcriptional 
regulation through binding in a complex with PNUTS, PP1 and Wdr82 (as discussed 
in Chapter 4), very little is known about TOX4. The work in this chapter aimed to 
characterise the TOX4 gene in Drosophila and provide further insight into its role in 
the PNUTS/PP1 complex and gene expression.  
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5.2. Drosophila gene CG12104 is an orthologue of mammalian LCP1 (TOX4) 
CG12104 was identified as the most abundant dPNUTS-interacting protein in the 
yeast two-hybrid screen reported in Chapter 4. Previous sequence analysis of the 
TOX subfamily of HMGB proteins suggested that CG12104 encodes a protein with a 
partial HMG-box and has weak similarity to other proteins in the TOX family, 
though its C-terminus is similar to mammalian LCP1 (TOX4) (O'Flaherty and Kaye, 
2003).  Initial BLAST analysis using CG12104 (isoform A) revealed TOX proteins 
as the top hits in human, mouse, zebrafish and xenopus with TOX3 showing the 
highest level of similarity in humans. However further phylogenetic analysis reveals 
TOX4 is the closest related homologue to CG12104, to which it is also demonstrably 
orthologous (Figure 5.1a). Interestingly a reciprocal BLAST search using human 
TOX3 only identifies CG12104 in Drosophila whereas human TOX4, TOX2 and 
TOX1 identify CG12104 as the top hit as well as other less similar proteins including 
Dorsal Switch Protein 1 (DSP1). DSP1 is also a HMG-box protein (Lehming et al., 
1994) and BLAST and phylogenetic analysis suggest it is related to other HMG-box 
proteins in humans that are not members of the TOX family including HMG-B3, 
HMG-B2 and HMG-B1. It is likely DSP1 was identified in the initial BLAST 
searches because of the highly conserved HMG-Box. This work supports the analysis 
of the TOX subfamily by O’Flaherty and Kaye in 2003 and given LCP1/TOX4 has 
been shown to bind PNUTS (Lee et al., 2009), a sequence alignment of CG12104 
and LCP1/TOX4 was performed to determine the degree of conservation. Figure 
5.1b shows there is a significant level of conservation in the C-terminus of the 
protein as recognised by O’Flaherty and Kaye, 2003  and 63% of the residues that 
make up the HMG-box in LCP1/TOX4 (red text in Figure 5.1b) are either sequence 
conserved (black shading, Figure 5.1b) or similar in amino acid type (grey shading, 
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Figure 5.1b) in CG12104. More importantly, mapping of secondary structures in 
both proteins revealed all three !-helices that are defining features and are essential 
for the function of HMG-box proteins are found in CG12104, confirming it is likely 
to have a functional HMG-box and may have similar roles to other HMGB proteins 
as discussed above. Given this analysis, CG12104 will be referred to as dTOX4 
hereafter.  
 
Figure 5.1 (next two pages). CG12104 is the Drosophila orthologue of human 
TOX4. a) Phylogenetic tree showing the relationship between Drosophila CG12104 
and the TOX subfamily of HMG-box proteins in human, mouse, xenopus and 
zebrafish. TOX proteins were identified as the top hits in a BLAST search using 
CG12104. Other proteins identified included DSP1, which is also included in the 
phylogenetic analysis and is more likely related to other HMG-box proteins that are 
not part of the TOX subfamily. b) Multiple sequence alignment of full-length 
mammalian LCP1 and full-length Drosophila CG12104. The T-Coffee alignment 
tool was used in ‘accurate’ mode to generate the alignment. BoxShade was used to 
identify conserved residues. Identical residues are shaded in black and similar 
residues are shaded in grey. Ali2D was used to map secondary structural features. 



































































LCP1         1 MEFPGGNDNYLTITGPSHPFLSGAETFHTPSLGDEEFEIPPISLDSDPSLAVSDVVGHFD 
CG12104      1 M-----------------------NQFHTPSFGDEVFELTDTPAESQSPSQ--------- 
consensus    1 *.......................  ***** *** **.     .*     ......... 
 
 
LCP1        61 DLADPSSSQDGSFSAQYGVQTLDMPVGMTHGLMEQGGGLLSGGLTMDLDHSIGTQYSANP 
CG12104     29 ------------------------------------------------------------ 
consensus   61 ............................................................ 
 
 
LCP1       121 PVTIDVPMTDMTSGLMGHSQLTTIDQSELSSQLGLSLGGGTILPPAQSPEDRLSTTPSPT 
CG12104     29 --------------------------------------------------ASRRMLSLDQ 
consensus  121 ..................................................           
 
 
LCP1       181 SSLHEDGVEDFRRQLPSQKTVVVEAGKKQKAPKKRKKKDPNEPQKPVSAYALFFRDTQAA 
CG12104     39 SMLNDDDEENCDTYASGGGQNLL-----VQPEQQQNQAMAQAPPKPLAPFALFFRDTVTA 
consensus  181 * * .*  *            .......            . * **.  .*******  * 
 
 
LCP1       241 IKGQNPNATFGEVSKIVASMWDSLGEEQKQVYKRKTEAAKKEYLKALAAYKDNQEC-QAT 
CG12104     94 IKQQNPTCSLEQMQVIVQTMWESLDETQKNVYALRHEQEKREYVRLMRGYRHQLSESEGT 
consensus  241 ** ***  .   .  ** .**.** * **.**  . *  *.**.. . .*. .   . .* 
 
 
LCP1       300 V---ETVELDPAPPSQTPSPPPMATVDPASPAPASIEPPALSPSIVVNSTLSSYVANQAS 
CG12104    154 SEAEAPPAVATNQPPPLVTTKLESVEDLQ------------------------------- 
consensus  301  ...    .    *    .       *  ............................... 
 
 
LCP1       357 SGAGGQPNITKLIITKQMLPSSITMSQGGMVTVIPATVVTSRGLQLGQTSTATIQPSQQA 
CG12104    183 ------------------------------------------------------------ 
consensus  361 ............................................................ 
 
 
LCP1       417 QIVTRSVLQAAAAAAAAASMQLPPPRLQPPPLQQMPQPPTQQQVTILQQPPPLQAMQQPP 
CG12104    183 ------------------------------------------------------------ 
consensus  421 ............................................................ 
 
 
LCP1       477 PQKVRINLQQQPPPLQIKSVPLPTLKMQTTLVPPTVESSPERPMNNSPEAHTVEAPSPET 
CG12104    183 ---QSVDAQQEPPPDQIQLLTE-------------------------------------- 
consensus  481 ...  .  ** *** **  .  ...................................... 
 
 
LCP1       537 ICEMITDVVPEVESPSQMDVELVSGSPVALSPQPRCVRSGCENPPIVSKDWDNEYCSNEC 
CG12104    202 -----------------------------AARVQKCTREQCNKPAIINPDWEDEYCSNEC 
consensus  541 .............................     .* *  *  * *.  **. ******* 
 
 
LCP1       597 VVKHCRDVFLAWVASRNSNTVVFVK 
CG12104    233 VVIHCRNVFNHWVI-------SMNS 







5.3. Isolation of a null dTOX4 mutant 
To determine the in vivo role of dTOX4 and understand more about its functional 
relationship with dPNUTS, a null mutant in the dTOX4 gene was generated through 
imprecise P-element excision. Mutational analysis still remains an important 
approach in which to study gene function and many tools exist in the Drosophila 
community to allow the easy generation of mutant alleles. One such tool is through 
insertion of a P-transposable element, which often disrupts gene function, but can 
also be used to generate deletions of flanking DNA upon remobilisation (Bellen et 
al., 2011). The Drosophila Gene Disruption Project was created by the Berkeley 
Drosophila Genome Project (BDGP) in collaboration with a number of Drosophila 
laboratory groups and is a publicly available collection of strains containing single 
transposable element insertions in a single gene spanning over 40% of Drosophila 
genes (Bellen, 2004; Bellen et al., 2011). A strain containing a transposable P-
element inserted in the 5’ untranslated region (UTR) of dTOX4 
(P{EPgy2}CG12104EY02201) was used to generate the mutant allele through 
imprecise excision of the P-element (Figure 5.3a). It was crossed to two strains, each 
containing a stable insertion of P{!2-3}, a genomic source of P-transposase that 
mobilises other P-elements (Robertson et al. ,1988). Individual males carrying the P-
element and transposase were collected and crossed to a balancer strain. White eyed 
male progeny from this cross (P-element has been excised) were collected and 
crossed again against a balancer strain. Progeny carrying the excision and the 
balancer TM6B were inbred to generate stocks of individual excision events that 
were screened by PCR to look for deletions in the dTOX4 gene using the primer 
strategy shown in Figure 5.2a (see Appendix 3 for crossing scheme). From this, one 
strain was identified (#16, Figure 5.2b, called dTOX4null hereafter) as having an 
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approximately 1200bp deletion when screened with primer sets 2+3 and 1+3 (Figure 
5.2a). RT- PCR confirmed the loss of dTOX4 transcripts in dTOX4null flies compared 
to w1118 and a strain where the P-element had been precisely excised (12, Figure 
5.2c). DNA sequencing analysis revealed a 1180bp portion of the dTOX4 gene, 
including the translation start site and the majority of the coding sequence (CDS), is 
deleted in dTOX4null flies (Figure 5.2a). 
 
 
Figure 5.2 (next page). Generating a dTOX4 null allele. a) Genomic region of 
CG12104 (Drosophila TOX4) showing all three transcripts and flanking genes. Grey 
shading represents coding regions. CG12104EY02201 contains a P-element insertion in 
the 5’ untranslated region of dTOX4. dTOX4null is the mutant allele generated through 
excision of the P-element. The map shows the extent of the deletion spanning the 
coding region; the genomic sequence either side of the deletion is indicated. The 
primer map shows the position of the primers used to detect the deletion. dTOX4P216! 
is a mutant in vitro construct of dTOX4 lacking the dPNUTS binding domain as a 
result of site-directed mutagenesis to generate a premature stop codon. The base pair 
changes in the dTOX4P216! allele are shown. b) Standard PCR on DNA samples 
extracted from flies containing a potential deletion in the dTOX4. Primer sets used 
(as shown in (a)) are shown at the side. Numbers indicate the cross number. c) RT-
PCR on the selected deletion strain (#16), a revertant strain where the P-element was 



































































5.4. Characterising the dTOX4null strain 
As discussed in Chapter 1, homozygous dPNUTS13B animals die during the L1 phase 
of larval development. However, unlike dPNUTS13B homozygotes, animals with two 
copies of the dTOX4null allele survived to adulthood and displayed an expected 2:1 
ratio of heterozygotes:homozygotes suggesting viability was not affected. Despite 
this, it was very clear the strain did not thrive and this led to a number of 
investigations to further characterise the gene function. 
 
5.4.1 Deletion of dTOX4 causes sterility in male and female Drosophila 
The first avenue of investigation was to look at the effect of dTOX4null mutation on 
fertility. If mutant animals are partially sterile, this could explain why the strain does 
not thrive and could provide a good system in which to study the role of dTOX4 
further.  
 
Two approaches were taken; firstly, fecundity was measured by monitoring egg 
production in homozygous dTOX4null female flies compared to w1118. Egg production 
can be affected by various factors including the male and the seminal fluid proteins 
they transfer (Chapman and Davies, 2004) therefore male and female homozygous 
dTOX4null animals were crossed to female and male w1118 animals respectively to 
determine if there was a sex related phenotype. The second approach, measured 
fertility by counting the number of eggs that hatched from those laid in the fecundity 
assay.   
 
Egg production was significantly reduced in inbred homozygous dTOX4null mutant 
animals compared to the w1118 control (p=<0.0001, Figure 5.3a) laying an average of 
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80% less during the monitored period. It was evident this was not due to factors 
contributed by the homozygous dTOX4null male mutant as w1118 females showed no 
significant reduction in egg production when crossed to homozygous mutant males 
compared to the inbred w1118 control (p=0.2827, Figure 5.3a). Furthermore when 
crossed to w1118 males, homozygous mutant females still exhibited the same reduced 
level of egg production as when inbred (Figure 5.3a). Not only was egg production 
reduced in mutant animals but the embryos also failed to hatch (Figure 5.3b). No 
larvae emerged from eggs laid by inbred homozygous mutants, and when crossed to 
w1118 males only a few eggs hatched (approximately 90% less than the w1118 inbred 
control; p=<0.0001, Figure 5.3b). Interestingly, eggs laid by w1118 females mated to 
homozygous dTOX4null males also fail to hatch despite egg production not being 
affected. A few larvae emerged and developed to adulthood, but the number of 
larvae was significantly lower than the inbred w1118 control (p=<0.0001, Figure 
5.3b), suggesting that both female and male fertility is affected in dTOX4null mutant 
flies. 
 
It is clear that in both male and female mutants the chances of generating viable 
offspring are rare when mated to a control strain. To test whether this was a 
consequence of all flies being partially sterile or due to a rare adult that was semi-
fertile, 20 individual homozygous dTOX4null males were mated with virgin w1118 
females. None of the males were able to produce viable progeny suggesting that the 
observed escapers are likely to be the product of an occasional semi-fertile male. 
Together, these results suggest dTOX4 is essential for both male and female fertility, 
but the exact mechanism remains unclear. The results described could be due to a 
defect in germline development leading to failed fertilisation or it could be a 
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consequence of a defect in embryonic development whereby fertilisation does occur 
but progeny subsequently die.  
 
 
Figure 5.3 (next page). Homozygous dTOX4null mutants are sterile. a) The 
number of eggs laid per female normalised to w1118 to account for unavoidable 
changes in conditions between experimental repeats (3 repeats with 3 to 5 counts 
taken every 24 hours). b) The number of eggs hatched represented as a percentage of 
the total number of eggs laid and normalised to w1118. Hatched eggs were counted 48 


































































































































































5.4.2 dTOX4 mutants display defects in nurse cell chromosome dispersion and 
dorsoventral patterning  
 
To understand the molecular and cellular basis for the apparent fertility defects 
observed in homozygous dTOX4null female mutants, ovaries of w1118 and 
homozygous mutant females were dissected, stained for DNA and visualised by 
confocal microscopy to look for defects in germline development. Drosophila 
ovaries consist of 16-20 ovarioles, each ovariole being a string of egg chambers at 
different developmental stages starting from the germarium (a mass of cells 
containing a source of germ-line and somatic stem cells) up to stage 14 when a 
mature egg is produced (Bate and Arias, 2009; Bastock and St Johnston, 2008; 
Klusza and Deng, 2010). Egg chambers consist of three cell types; 1 oocyte and 15 
nurse cells (derived from germ-line stem cells) surrounded by a monolayer of follicle 
cells (derived from somatic stem cells) (Bate and Arias, 2009; Bastock and St 
Johnston, 2008).  Comparing the two genotypes, there was a noticeable difference in 
the appearance of the nurse cell nuclei, with mutant egg chambers displaying a ‘blob-
like’ appearance in chromosome organisation compared to controls, indicative of a 
defect in chromosome (de)condensation.  
 
The role of nurse cells is to provide the developing oocyte with the majority of its 
nutrients and cytoplasmic content, so they have to synthesise vast amounts of 
mRNAs and protein to support the development of the oocyte and also provide a 
store of maternal products, which will be utilised during the growth and 
differentiation of the embryo (Bate and Arias, 2009; Klusza and Deng, 2010; Dej and 
Spradling, 1999; Bastock and St Johnston, 2008). This content has to be synthesised 
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at a very high rate to support rapid growth and is possible due to the polytene state of 
nurse cell chromosomes, which undergo 10-12 cycles of endoreplication to increase 
DNA content and support development (Dej and Spradling, 1999; Bate and Arias, 
2009; Klusza and Deng, 2010). During the first five endocycles, nurse cell 
chromosomes are somatically paired and are visible as a ‘five blob’ structure up to 
stage 4 of oogenesis, with each blob representing one of the major polytenic 
chromosomal arms (X, 2L, 2R, 3L and 3R) (Klusza and Deng, 2010). At the end of 
the fifth cycle there is evidence to suggest a mitosis-like phase occurs as the 
association between somatically paired homologous chromosomes weakens and 
chromosome dispersal takes place resulting in a loss of the five-blob structure by 
stage six of oogenesis (Klusza and Deng, 2010; Dej and Spradling, 1999; Reed and 
Orr-Weaver, 1997).  
 
Looking at all stages of egg chamber development in w1118 and homozygous 
dTOX4null egg chambers, it was clear mutant chromosomes remained in the polytene 
state past stage 4 of egg chamber development (Figure 5.4). Figure 5.4a shows a wild 
type ovariole with images of nuclei at different stages of egg chamber development 
taken at a higher magnification below. A "blob-like" phenotype is present up to stage 
4, after which the chromosomes disperse and continue to spread further as the egg 
chamber progresses through oogenesis, causing the nuclei to increase in volume 
(Figure 5.4a). Figure 5.4b shows a homozygous mutant ovariole with nurse cell 
nuclei remaining in a polytene state throughout the progressive stages of egg 
chamber development, even up to stage 10. It is important to note that this phenotype 
is not fully penetrant as 37.5% of observed nuclei remained in the polytene state 
from stage 6 onwards with 56.9% undergoing normal dispersion (Table 5.1). 
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Interestingly there seemed to be a variety of dispersal phenotypes suggesting that in 
some nuclei chromosome dissociation does start but does so at a later stage or is not 
completed as shown in the bottom panel of Figure 5.4b. Nuclei like this adopted 
more of a ring structure and were recorded as such in Table 5.1.  
 
Figure 5.4 (next page). dTOX4null/dTOX4null nurse cell chromosomes fail to 
disperse. a) w1118 ovariole with magnified images of nurse cell nuclei below showing 
chromosomes disperse after stage 4. b) Homozygous dTOX4null ovariole with 
magnified images of nurse cell nuclei below showing chromosomes fail to disperse 
after stage 4. Numbers indicate the stage of egg chamber development. Ovariole 
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Table 5.1. The percentage of polytene nuclei (from stage 6) and appendage phenotypes observed from w1118 and females homozygous for dTOX4null including the 
appendage phenotypes observed when crossed to w1118 
  % nurse cell phenotype   % appendage phenotype 
Genotype Wild type Polytene Ring n   Wild type Fused/Crown Short/wide Expanded operculum n 
w1118 99.9 0.1 0.0 1343 
 
100.0 0.0 0.0 0.0 1326 
dTOX4null/dTOX4null 56.9 37.5 5.6 1436 
 
12.6 21.6 22.1 43.7 412 
(f) w1118  x (m) dTOX4null/dTOX4null - - - - 
 
99.9 0.0 0.1 0.0 1564 
(m) w1118 x (f) dTOX4null/dTOX4null - - -     -   11.7 20.6 19.0 48.7 394 
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The dTOX4null nurse cell nuclei phenotype has also been described in flies mutant for 
squid (sqd), glorund (glo) and hrb27c (also known as hrp48) (Goodrich et al., 2004; 
Kalifa et al., 2006; Kalifa et al., 2009), all of which encode heterogeneous nuclear 
ribonucleoproteins (hnRNPs). Mass spectrometry analysis carried out in a study of 
protein complex networks in Drosophila, showed dTOX4 is capable of binding to 
Hrp48, Squid and other hnRNPs, with the top hit being Glorund (a Drosophila 
hnRNP F/H homologue) (Guruharsha et al., 2011). Although hnRNP proteins were 
identified as binding many of the bait proteins in this study, the remarkable similarity 
in phenotype between dTOX4 and sqd, glo and hrp48 mutants suggest that the 
reported physical association is not simply an artefact. Drosophila mutant for these 
genes also display abnormal dorsal appendages therefore the appendages of eggs laid 
by homozygous dTOX4 mutants was studied. A range of phenotypes were observed 
in the mutant with 21.6% of appendages exhibiting a fused/crown phenotype, 22.1% 
displaying short/wide appendages and the majority (43.7%) having an expanded 
operculum (Table 5.1). Only 12.6% of homozygous mutant eggs had narrow, well-
separated appendages characteristic of wild type eggs (Table 5.1). Reassuringly, 
similar results were also found in homozygous mutant females that had mated with 
w1118 males, verifying the abnormal dorsal appendage phenotype is due to a maternal 
requirement for dTOX4 (Table 5.1). Eggs also appeared to be much smaller than the 
w1118 control (data not shown).    
 
5.4.3 dTOX4 mutants display defects during spermatogenesis 
To elucidate the cause of infertility in male dTOX4 mutants, testis from w1118 and 
homozygous dTOX4null males were dissected. An initial observation of the whole 
tissue revealed dTOX4 mutant testes were, in most cases, significantly smaller than 
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the w1118 control and lacked the bundles of sperm tails that could be seen in the 
control. Testis were then stained for DNA, actin and phosphorylated H2AX at Serine 
(Ser) 139 and imaged by confocal microscopy (Figure 5.5a). Phosphorylation of 
histone H2A variant H2AX at Ser 139 occurs when double-stranded breaks (DSBs) 
are produced in DNA and is therefore a marker for DNA damage (Sharma et al., 
2012). The rationale for looking at this was because TOX4 together with PNUTS and 
Wdr82 have been shown to bind DNA damaged by platinating agents (Puch et al., 
2011) therefore could have a role in the DNA damage response.  
 
During sperm individualisation each nuclei in a 64 spermatid cyst becomes 
surrounded by an actin cone, often referred to as an ‘investment cone’ as each 
spermatid is invested in its own membrane at the end of the process (Fabian and 
Brill, 2012). The array of investment cones make up the individualisation complex 
(IC), which translocates the length of the cyst, starting from the nuclear end of the 
developing sperm, removing excess cytoplasm and organelles from between the tails 
as it proceeds to the tail end (Fabrizio et al., 1998; Fabian and Brill, 2012). Once the 
individualisation process is complete the IC detaches and is known as a ‘waste bag’ 
(Fabrizio et al., 1998). In wild type testis the IC can be seen in the whole tissue as 
actin foci (Figure 5.5a, green arrow, top panel), however these were not present in 
dTOX4 mutant testes (Figure 5.5a, bottom panel), suggesting individualisation does 
not take place and an earlier stage of spermatogenesis is affected. This was also 
apparent when examining squashed preparations of testicular tissue where waste 
bags and elongation could be seen in the control but not the dTOX4 mutant (Figure 
5.5b). Furthermore, the 64 needle shaped nuclei bundles could be visualised in the 
wild type tissue using confocal microscopy (Figure 5.5a, red arrow, top row) and 
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also in squashed preparations using phase microscopy (Figure 5.5c) but not in the 
dTOX4 mutant (Figure 5.5a and 5.5c) suggesting nuclear shaping does not take 
place. Staining with H2AXph did not show any sites of DNA damage but in the 
absence of a positive control it cannot be determined whether dTOX4 plays a role in 
the DNA damage response. However, the image does show the difference in the 
whole tissue in relation to the bundles of tails, which can easily be seen in w1118 but 
are absent in the mutant (Figure 5.5a, H2AXph). 
 
Figure 5.5 (next page). dTOX4null/dTOX4null testes display defects in sperm 
development. a) Confocal microscopy images of w1118 (top panel) and 
dTOX4null/dTOX4null (bottom panel) testes stained for actin (green in merge), 
phosphorylated histone H2AX (magenta in merge) and DNA (TOPRO-3, Red in 
merge). Individualisation complexes are visible in w1118 testes as actin foci (green 
arrow). Bundles of sperm heads visible as DNA foci (red arrow) Scale bar = 40µm. 
b) Phase contrast micrographs of apical regions of w1118 (left panel) and 
dTOX4null/dTOX4null (right panel) testes. In w1118, elongating spermatid tails visible 
as bundles of lines along the lumen of the testis (arrow). Waste bags containing 
excess cytoplasm and organelles removed during individualisation are found at the 
apical end (black arrow head). In some cases elongation can be seen in the mutant 
but it always starts further along the lumen (white arrow head). c) Phase contrast 
micrographs of squashed w1118 (top panel) and dTOX4null/dTOX4null (bottom panel) 
testes stained for DNA (red, Hoechst). Needle shaped sperm heads are visible in 
w1118 but not in the mutant. Phase contrast images were captured together with Helen 
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Drosophila spermatogenesis has been well described and identification of the 
different stages is relatively easy as cells are large and easily visualised when 
squashed (White-Cooper, 2009). To gain more insight into the defects observed in 
dTOX4 mutants and identify which stage of spermatogenesis is affected, squash 
preparations were made and examined by phase contrast microscopy (Figure 5.6). 
Interestingly a range of defects was observed at multiple stages of spermatogenesis. 
In some cases the testes were very difficult to find because they were smaller and 
lacked the spiral shape characteristic of wild type testes (Figure 5.6a and a’); when 
squashed they were found to consist only of primary spermatocytes (Figure 5.6b’). 
Visualisation of the DNA with Hoechst 33342 revealed a difference in chromatin 
occupancy when compared to w1118 (Figure 5.6c and c’). Immediately before the first 
meiotic division, the nucleus of primary spermatocytes exhibits three distinct 
chromatin masses, which correspond to the three major bivalents (Cenci et al., 1994; 
McKee et al., 2012). Once the spermatocytes have reached maturity the nucleus is 
fully expanded and the bivalents are far apart (Figure 5.6c) (McKee et al., 2012). 
However, the nuclei of primary spermatocytes from small mutant testes lacked the 
tri-lobular chromatin phenotype and instead the chromatin appeared as a ‘cloudy’ 
ring.  
 
The most common phenotype observed is shown in Figure 5.6d’ and is often referred 
to as the ‘two wheel drive’ or ‘four wheel drive’ phenotype due to its resemblance to 
mutants in the Drosophila gene four wheel drive (fwd), which display defects in 
cytokinesis (Brill et al., 2000). During telophase II of meiosis the mitochondria 
migrate to one side of the nucleus and then fuse to form two large mitochondria 
which become arranged as a sphere and establish a mitochondrial derivative known 
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as the nebenkern (Fabian and Brill, 2012; Bate and Arias, 2009). This is often 
referred to as the onion stage as the nebenkern contains multiple layers of wrapped 
mitochondrial membranes that resemble an onion (Cenci et al., 1994; Bate and Arias, 
2009). This stage can easily be visualised using phase contrast microscopy on squash 
preparations as the nebenkern appears as a phase-dark circle next to the phase-light 
haploid nucleus (Bate and Arias, 2009) as shown in phase contrast images taken of 
onion stage spermatids in w1118 males (Figure 5.6d). In wild-type onion stage, each 
spermatid in a cyst has the same sized nebenkern and nucleus as represented in 
Figure 5.6d. In homozygous dTOX4 mutants, the nebenkern appears abnormally 
large and is surrounded by two, three or four nuclei (Figure 5.6d’). 
 
Figure 5.6 (next page). Phase contrast microscopy reveals various defects in 
dTOX4 mutant testes. a) Wild type testes showing characteristic spiral shape and 
sperm development. a’) Some dTOX4 mutant testes are small and lack spiral shape 
and consist only of primary spermatocytes. b) Wild type primary spermatocytes with 
large nucleus in the centre. b’) Primary spermatocytes from dTOX4 mutant with 
small testes, some lacking an obvious nucleolus. c) Hoechst staining showing DNA 
in (b) illustrating tri-lobular configuration of chromatin. c’) Hoechst staining 
showing DNA in (b’) illustrating lack of tri-lobular chromatin and a ‘cloudy’ ring 
arrangement of chromatin. d) w1118 spermatids at the onion stage containing a single 
white nucleus (white arrowhead) associated with a single dark nebenkern (white 
arrow, 1Nk) d’) dTOX4 mutant spermatids at the onion stage showing a single large 
nebenkern associated with two (white arrow 2Nk) or four (white arrow 4Nk) nuclei. 
Images a and a’ were taken using a 10X objective, images b to d’ were taken using a 
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Other phenotypes were seen in the dTOX4 mutant at a lower frequency (Figure 5.7). 
These included primary spermatocytes with smaller nuclei (Figure 5.7a, white arrow 
head, phase panel) and decondensed chromatin (Figure 5.7a, white arrow head, 
Hoechst panel) in a seemingly normal cyst and the appearance of needle shaped 
stellate crystals in otherwise normal looking dTOX4 mutant primary spermatocytes. 
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Figure 5.7. (previous page). Other phenotypes observed in squashed testes of 
dTOX4 mutants. a) Some primary spermatocytes displayed smaller nuclei (Phase, 
white arrow head) and decondensed chromatin (Hoechst, white arrow head) in a cyst 
primarily consisting of normal spermatocytes. b) In some testes the appearance of 
stellate crystal like formations could be observed (white arrows). Images were 
captured together with Helen White-Cooper (Cardiff University). 
 
5.5. dTOX4 plays a role in Drosophila longevity 
As mentioned in Chapter 3, loss of PNUTS expression during cardiac aging is 
associated with cardiomyocyte cell death and loss of cardiac function (Boon et al., 
2013). The identity and role of PNUTS-interacting proteins that might mediate its 
function in healthy aging are not fully understood. Given the interaction between 
dPNUTS and dTOX4 and the inability of the dTOX4 mutant to thrive, the impact of 
the dTOX4null allele on Drosophila longevity was assessed. Survival of 
dTOX4null/dTOX4null flies was significantly reduced compared to the w1118 control 
(p=<0.0001) and even loss of one copy of dTOX4 had a significant impact on 








Figure 5.8. dTOX4 has a role in Drosophila survival. Survival curves of dTOX4 
homozygous and heterozygous mutants and a wild type control (w1118).  
 
5.6. Generating transgenic flies overexpressing dTOX4wt and dTOX4P216! 
The results discussed in Section 5.4 onwards assume that disruption of the dTOX4 
coding region is responsible for the phenotypes observed. Indeed, Section 5.3 
provides evidence that the dTOX4 transcript is absent in the mutant. Although 
generating null alleles through imprecise excision of a P-element is common and has 
proved to be very efficient, caution has to be taken as this method does have a 
potential caveat that could affect the validity of the results. Upon immobilisation of 
the P-element, there is the potential for it to re-insert itself in another part of the 
genome where it could disrupt another gene, before eventually being lost.  
 
Therefore, to confirm that the disruption of dTOX4 is responsible for the phenotypes 
described, the wild type dTOX4 gene was subcloned from the DGRC cDNA clone 
LP0118 into the Drosophila Gateway® vector pPGW (pUASP-GW) for GAL4-
driven, N-terminal GFP tagged somatic and female germline ectopic overexpression 
of dTOX4. UASP-GFP-dTOX4wt flies were made using P-element mediated germline 




















transformation into a w1118 strain. In parallel with this, a dTOX4 transgene with a 
site-directed mutation that removes the dPNUTS binding region of dTOX4 (Chapter 
4) was also subcloned into pPGW and UASP-GFP-dTOX4P216! flies were generated. 
These could be used to determine whether the dTOX4 mutant phenotypes are 
dependent on the interaction between dPNUTS and dTOX4, or if they represent 
dPNUTS-independent functions of dTOX4. 
 
Various transgenic lines were generated with insertion of UASP-GFP-dTOX4wt/P216! 
on different chromosomes. To determine which lines to use for the complementation 
experiments, the GAL4-UAS system was used to ectopically overexpress each 
transgene in the fly using daughterless (da)-GAL4 for ubiquitous expression. Protein 
extracts were then analysed by Western blot analysis (Figure 5.9). Although not 
evident in Figure 5.9, the transgenic lines overexpressing dTOX4wt expressed at a 
similar level to each other, and had an extremely low level of expression compared 
to the dTOX4P216! lines. Transgenic lines overexpressing dTOX4P216! varied in 
expression levels therefore a range of lines were selected for functional analysis 
(Figure 5.9.). Notably, dTOX4wt and dTOX4P216! overexpression under the control of 
daughterless had no discernable biological effect. 
 
The selected lines were then combined with different GAL4 drivers for tissue 
specific expression. GAL4 driven by the maternal-!-tubulin promoter was combined 
with each transgenic line to drive overexpression in the female germline in an 
attempt to rescue the nurse cell nuclei and appendage phenotypes described in 5.4.2. 



















































































overexpression in the male germline in an attempt to rescue the testicular phenotypes 
described in 5.4.3. This work is currently ongoing in the Bennett lab. 
 
 
Figure 5.9. Immunoblots of UASP-dTOX4wt/P216!-GFP transgenic flies. Protein 
extracts from each line were analysed by Western blot anti-GFP antibody to detect 
the overexpressed protein. Anti-actin antibody was used as a control to determine the 
relative levels of protein in each extraction. 
 
 
5.7.  Generating transgenic dTOX4wt and dTOX4P216! genomic rescue flies 
Rescuing mutant phenotypes by overexpressing wild type transgenes does have a 
number of limitations - in particular, efficient rescue is reliant on using a suitable 
GAL4 driver that drives expression in the correct spatial and temporal pattern and at 
the appropriate level. Rescue of mutant phenotypes using a genomic construct is 
often preferred since the wild type gene is under the control of its own promoter and 
the pattern of expression can better match that of the endogenous alleles. To do this a 
DNA fragment incorporating the genomic dTOX4 sequence was chemically 
synthesised with a few modifications to improve its utility. Firstly, the sequence for 
EGFP was inserted before the transcription start site to allow visualisation of the 
expressed protein and determine the stage of expression in the ovaries and testes to 
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further understand the phenotypic changes seen in the dTOX4 mutant. An attB site 
was also added at the end of the sequence for !C31 site specific recombination 
(Groth et al., 2004) along with a BamH1 and Not1 enzyme restriction site at the 
beginning and end of the sequence respectively for sub-cloning into a suitable fly 
transformation vector. In parallel an identical construct was generated that carried the 
site-directed mutant that removes the dPNUTS-binding site through incorporation of 
a premature stop codon. The fragments were synthesised by GeneArt/Invitrogen, 
subcloned into the pCaSpeR3 fly transformation vector (pCaSpeR3 was purchased 
from DGRC and sent to GeneArt) and sent to the Fly Facility (University of 
Cambridge, Department of Genetics) for site-specific integration into the Drosophila 




The work described in this chapter reports the functional analysis of CG12104, 
which is the Drosophila homologue of the human gene LCP1 (TOX4). In the 
literature LCP1 has been shown to bind PNUTS and may have a role in recruiting 
transcriptional complexes to chromosomes at the sites were it is bound (Lee et al., 
2009). This study was interested in identifying the in vivo role of dTOX4 and 
exploring its potential involvement in regulating dPNUTS and dPNUTS-mediated 
gene expression (described in Chapter 3). 
 
5.8.1. The role of dTOX4 during oogenesis 
dTOX4 is essential for female fertility as mutant animals fail to produce viable 
progeny. Tissue analysis revealed sterility in females is likely a consequence of 
defects in two processes during oogenesis: abnormal dorsal-ventral patterning of 
dorsal appendages of the eggshell and chromosome dispersal in nurse cell nuclei.  
 
In Drosophila, proper establishment of the major body axes of the egg is essential for 
normal development of the future embryo (Clouse et al., 2008). Axis formation relies 
on the strict localisation of certain maternal mRNAs for localised protein translation 
(Norvell et al., 2005). Gurken (Grk), a TGF!-like ligand, is essential for establishing 
both the anterior-posterior axis during early oogenesis and the dorsal-ventral axis 
during mid to late oogenesis, where it activates the Epidermal Growth Factor 
Receptor (EGFR) in the overlying follicle cells to specify cell differentiation for 
proper axis formation (Johnstone and Lasko, 2001; Norvell et al., 2005; Neuman-
Silberberg and Schüpbach, 1993; Kalifa et al., 2009). Spatio-temporal expression of 
Gurken relies on proper grk mRNA localisation and regulation of its translation for 
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localised activation of EGFR and induction of dorsal cell fates (Johnstone and Lasko, 
2001; Goodrich et al., 2004).  
 
Genetic and biochemical studies have identified various proteins responsible for the 
localisation and translational regulation of grk mRNA and these include the 
heterogeneous nuclear ribonucleoproteins (hnRNPs) Squid (Sqd), Hrp48 and 
Glorund (Glo) (Kalifa et al., 2009; Kalifa et al., 2006). hnRNPs are RNA binding 
proteins and function in a wide variety of processes including mRNA 
localisation/transport/stability/splicing, transcription, translation and protein stability 
(Dreyfuss et al., 2002; Goodrich et al., 2004). In sqd, glo and hrp48 mutants grk 
mRNA is ectopically translated across the entire anterior region of the oocyte and the 
resulting phenotype is an expansion of the dorsal appendages at the anterior region of 
the egg (Kelley, 1993; Goodrich et al., 2004), as seen in dTOX4 homozygous 
mutants. 
 
Like dTOX4 mutants, a failure in nurse cell chromosome dispersion from stage 6 is 
also a common phenotype in hrp48, sqd and glo mutants (Goodrich et al., 2004; 
Kalifa et al., 2009) . The role of chromosome dispersal in Drosophila oogenesis is 
still unknown but it has been suggested to be necessary for rapid ribosomal synthesis 
of proteins required for the remainder of oogenesis (Dej and Spradling, 1999; Klusza 
and Deng, 2010), which could explain why the eggs laid by mutants are often 
smaller. This phenotype has also been described for ovarian tumour (otu), half-pint 
(hfp) and poly mutants (Dej and Spradling, 1999; Van Buskirk and Schüpbach, 2002; 
King et al., 1981; King and Storto, 1988; Klusza and Deng, 2010). It has been shown 
that Hrp48 binds to Hfp and Glorund and it is believed, together, they participate in a 
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splicing complex that regulates the alternative splicing of otu to contribute to grk 
mRNA regulation and nurse cell chromosome dispersion (Kalifa et al., 2009). 
Moreover, the defects exhibited by hrp48, glo and hfp mutants can be rescued by the 
Otu-104 isoform (Van Buskirk and Schüpbach, 2002; Kalifa et al., 2009; Goodrich 
et al., 2004). This suggests the defects are a consequence of disrupting otu 
regulation. Given dTOX4 may bind Hrp48 and Glorund in Drosophila (Guruharsha 
et al., 2011), dTOX4 could function in this RNP complex; the defects observed in 
the dTOX4 mutant may therefore be a consequence of disruption of otu splicing. 
Interestingly, Hrp48 also binds to Sqd, another hnRNP shown to bind dTOX4 
(Guruharsha et al., 2011). Goodrich et al., 2004, proposed Hrp48, Sqd and Otu may 
also participate in a complex to regulate grk mRNA localisation and nurse cell 
chromosome dispersion through an unknown mRNA but as Sqd and Otu do not bind 
to Hfp and Glo respectively, it is likely Hrp48/Hfp/Glo and Hrp48/Sqd/Otu represent 
two distinct complexes (Goodrich et al., 2004; Kalifa et al., 2009). It is possible 
dTOX4 functions in both of these complexes or may act to bring both complexes 
together to regulate grk mRNA localisation and nurse cell chromosome dispersion. It 
would be interesting to see if grk mRNA localisation is affected in dTOX4 mutants 
and if a wild type copy of otu can rescue one or both phenotypes.  
 
One caveat to the mass spectrometry analysis showing dTOX4 binds to these hnRNP 
proteins is the author deemed hnRNP proteins non-specific as they were common 
interactors throughout their analysis (Guruharsha et al., 2011). However the 
phenotypic resemblance between hnRNP mutants and the dTOX4 mutant suggests in 
this case the interaction is specific and they are likely to be real interactors. This 
needs to be confirmed by independent co-immunoprecipitation experiments; the 
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molecular function of dTOX4 in these complexes would then need to be determined. 
As discussed in the introduction, dTOX4 is a HMGB protein; therefore it seems 
plausible for dTOX4 to play a structural role in these complexes by opening up 
secondary nucleic acid structures to allow recruitment of hnRNP complexes. 
 
5.8.2. The role of dTOX4 during spermatogenesis 
dTOX4 is essential for male fertility as mutant animals fail to produce fertilised eggs 
when mated to females from a wild type strain. Whole tissue analysis revealed 
mutant males lack the characteristic sperm head/tail bundles and investment cones of 
wild type Drosophila suggesting spermatogenesis is impaired. Squash preparations 
uncovered multiple defects at the cellular level. Firstly, a number of testes appeared 
smaller, misshapen and consisted only of primary spermatocytes. Moreover, the 
chromatin of these spermatocytes appeared abnormal and lacked the tri-lobular 
appearance of normal spermatocytes. This phenotype is often associated with meiotic 
arrest mutants as primary spermatocytes fail to enter the meiotic stages (White-
Cooper, 2010). However the meiotic arrest phenotype in the dTOX4 mutant occurs 
less frequently than in meiotic arrest mutants reported in the literature but when it 
does occur, it appears more severe as testes are smaller and misshapen.  
 
dTOX4null males also displayed defects typical of mutants in genes involved in 
cytokinesis as spermatids had abnormally large nebenkerns surrounded by two or 
four nuclei. This phenotype has also previously been observed in Drosophila mutant 
for the gene eIF4E-3, an initiation factor which binds to the 5’ cap of mRNAs and 
regulates their recruitment to the ribosome (Hernández et al., 2012). Furthermore a 
similar cytokinetic defect has been described in mutants for the gene Larp, which 
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associates with poly(A) binding protein (PABP) (Blagden et al., 2009). PABP was 
also identified as a dTOX4 binding protein in the same screen as the hnRNP proteins 
(Guruharsha et al., 2011). Interestingly PABP attaches to the 3’ poly(A) tail of 
mRNAs and another initiation factor, eIF4G, which in turn binds to eIF4E. This 
brings the 3’ and 5’ ends of the mRNA together, forming a closed circular structure 
to initiate translation and maintain mRNA stability (Blagden et al., 2009). Given the 
evidence linking dTOX4 to mRNA regulation during oogenesis through its 
association with hnRNPs, it is conceivable that dTOX4 plays a similar role during 
spermatogenesis through association with PABP. eIF4E also binds to an ovarian 
protein called Cup, which has been shown to function together with Squid and 
PABP55B to regulate gurken translation in Drosophila ovaries (Clouse et al., 2008; 
Nakamura et al., 2004). Furthermore, work done in Dr Helen White-Cooper’s lab has 
showed that sqd displays a two-wheel drive phenotype in the testes, the data for 
which can be found on the online resource, Flannotator (http://www.flyprot.org/) 
(Lowe et al., 2014). This suggests the cytokinetic defects observed in the testes could 
be due to an interaction with Squid. 
 
Other defects included the appearance of Stellate crystalline structures, which have 
been associated with mutations in piRNA pathway genes (Bozzetti et al., 2012). 
Stellate (ste) is a male meiotic gene located on the X chromosome and its expression 
is controlled by another male meiotic gene, Suppressor of Stellate (Su(ste)), located 
on the Y chromosome (Stapleton et al., 2001). In Su(ste) mutants Ste mRNA and 
protein are present in abundance in primary spermatocytes, which leads to male 
sterility and the formation of needle-shaped crystals, as seen in the dTOX4 mutant, 
and other meiotic defects including chromosome fragmentation (Stapleton et al., 
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2001). Moreover, mutants of homeless, a RNA helicase, which functions in 
collaboration with Su(ste) to repress ste in primary spermatocytes, have the same 
meiotic defects as Sus(ste) mutants (Stapleton et al., 2001). homeless is also required 
for the localisation of mRNAs for anteroposterior and dorsoventral axis formation 
during oogenesis, including grk and osk, and mutants of homeless cause female 
sterility, as well as male sterility (Gillespie and Berg, 1995; Stapleton et al., 2001). It 
is therefore conceivable that the sterility defects observed in males are a consequence 
of a role for dTOX4 in ste mRNA regulation. 
 
It is very clear dTOX4 is essential for both proper oogenesis and spermatogenesis but 
its role at the molecular level is still unknown. It is possible dTOX4 functions in 
various RNP complexes and the defects observed are a consequence of misregulation 
of mRNA processing and defective protein translation. This is further supported by 
the fact that dTOX4 has also been shown to bind to various ribosomal proteins in 
mass spectrometry analysis as well as the hnRNPs already discussed (Guruharsha et 
al., 2011). The importance of dTOX4s identity as a HMGB protein in this remains 
unclear. HMGB proteins are better known for interacting with DNA, but given all 
that has been discussed, the results could represent an RNA binding function of 
dTOX4 that has not been reported elsewhere. It will also be interesting to see if 
dTOX4 operates in similar pathways/complexes during oogenesis and 




5.8.3. dTOX4 promotes longevity in Drosophila 
dTOX4 mutant flies exhibit reduced survival compared to a wild type control 
suggesting it contributes to Drosophila longevity. Although the data is preliminary 
there is a rationale supporting further investigation of this function. It has already 
been suggested that TOX4 plays a role in DNA damage as it binds to sites of DNA 
damage induced by platinating agents together with PNUTS and Wdr82 (Puch et al., 
2011). It is well known that increased levels of DNA damage are associated with 
aging. PNUTS has also been directly linked to cardiac aging where a decrease in 
PNUTS is associated with an increase in microRNA-34a as cardiac aging progresses 
(Boon et al., 2013; Garinis et al., 2008). MicroRNA-34a is transcriptionally 
regulated by p53, a tumour suppressor gene induced during DNA damage involved 
in DNA repair and apoptosis (Dorn, 2013). It is possible aging is affected by dTOX4 
through association with a PNUTS/PP1/Wdr82 complex and effects on gene 
expression or DNA damage.  
 
5.8.4. dTOX4 and PNUTS 
Unfortunately it was not possible to verify rescue of the mutant phenotypes with 
either overexpressed or genomic wild type dTOX4 due to time constraints. Likewise 
the relevance of the interaction between dPNUTS and dTOX4 in the results 
described could not be determined. However, the necessary tools to test this were 
generated and the Bennett lab is continuing work to confirm these limitations. It is 
possible the phenotypes represent dPNUTS-independent roles of dTOX4, in which 
case investigating the association of dTOX4 and hnRNPs is a plausible avenue to 
follow up. If these phenotypes are dependent on dPNUTS then is PP1 also involved 
and what are the substrates? Given these proteins exist in a complex with Wdr82 in 
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mammals and humans; does this have a role in the phenotypes observed? The 
PNUTS-PP1/Wdr82/TOX4 complex has been shown to function in the regulation of 
chromatin decondensation at late telophase (Lee et al., 2010) so is Wdr82 also 
involved. It is possible the different phenotypes represent two distinct roles of 
dTOX4, one in mRNA regulation possibly through binding to hnRNPs and the other 










One aspect that has emerged through studies on PP1 is the importance of 
phosphorylation in maintaining cell identity through epigenetic regulation of 
transcription (Rudenko et al., 2003). Gene expression patterns are established early 
during animal development to specify cell identity and are maintained throughout the 
multiple cell divisions necessary for proper development by epigenetic modifications 
such as phosphorylation, methylation and acetylation. These modifications exist on 
DNA and the N-terminal tail of histones and different modifications/combinations of 
modifications have different effects on gene expression that mainly act to modulate 
chromatin structure via recruitment of chromatin remodelling complexes (Farkas et 
al., 2000). 
 
One of the major findings from studies looking at transcriptional memory in 
Drosophila is the discovery of the Polycomb group (PcG) of repressive protein 
complexes, which repress gene expression via association with post-translational 
epigenetic modifications (Martinez et al., 2009). They localise to many chromosomal 
sites and hundreds of target genes have been identified in Drosophila and mammals, 
with most functioning in major developmental pathways, suggesting PcG proteins 
are major regulators of transcription during development (Di Croce and Helin, 2013; 
Simon and Kingston, 2009; Schwartz et al., 2006; Nègre et al., 2006; Tolhuis et al., 
2006; Boyer et al., 2006; Lee et al., 2006). PcG proteins exist as subunits in two 
major complexes; Polycomb Repressive Complex 1 (PRC1) and PRC2 (Chen et al., 
2010). PRC2 has histone methyltransferase activity in its enhancer of zeste 2 (EZH2) 
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(E(z) in Drosophila) subunit, which mediates the mono- di- and tri-methylation of 
histone H3 on lysine 27 (H3K27me1/2/3) allowing recruitment and binding of PRC1 
to target genes via its chromobox-domain subunits (Cao et al., 2002; Enderle et al., 
2011). PRC1 is thought to promote gene silencing through regulation of chromatin 
condensation (Simon and Kingston, 2009; Margueron and Reinberg, 2011). The 
H3K27me3 epigenetic mark is predominantly associated with the repression of 
homeotic and developmental genes to maintain cell identity and prevent uncontrolled 
proliferation during development (Gehani et al., 2010). 
 
In 2003 it was hypothesised that recruitment of regulatory proteins to methylated 
histone tails could be modified by phosphorylation of neighbouring residues (Fischle 
et al., 2003). In 2005 it was reported that tri-methylation of histone H3 lysine 9 
(H3K9) associates with Heterochromatin Protein 1 (HP1, isoforms -!, -", -#), 
triggering a change in chromatin structure to a repressive state (heterochromatin 
formation), a mechanism analogous to the H3 lysine 27 (H3K27)/PcG situation 
(Fischle et al., 2005; Hirota et al., 2005). They showed that upon phosphorylation of 
the adjacent Serine 10 (S10) residue, HP1 dissociated from methylated K9 to allow 
expression of target genes. If phosphorylation of S10 was inhibited, the interaction 
between HP1 and methylated K9 was maintained (Hirota et al., 2005; Fischle et al., 
2005). This led to the proposal that phosphorylation of histone H3 at serine 28 
(H3S28) may inhibit the interaction between methylated K27 and PcG proteins, 
suggesting H3S28 is a key site for gene regulation. In 2011, Lau and Cheung 
described the reactivation of the PcG-silenced gene, !-globin, by inducing 
phosphorylation of H3S28 at its promoter using mitogen-and-stress-activated kinase 
1 (MSK1). They also reported a decrease in H3K27 methylation and PcG elements 
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when MSK1 was present; suggesting phosphorylation of H3S28 displaced the 
repressive PcG complex (Lau and Cheung, 2011b; Lau and Cheung, 2011a). Other 
recent work has also shown that a phospho-methyl mark does exist at S28-K27 and 
S28 phosphorylation modifies recruitment of PcG to K27 (Gehani et al., 2010).  
However the kinases and phosphatases that control the phosphorylation state of this 
important regulatory site remain poorly understood.  
Since the discovery of this field, many epigenetic modifications have been linked to 
cancer adding further complexity to cancer biology (Rodríguez-Paredes and Esteller, 
2011). In 2010 a report linked drug resistant cancer cells to changes in the epigenetic 
landscape of those cells (Sharma et al., 2010). Many cancers have aberrant 
epigenetic states and more studies are discovering mutations that cause cancer stem 
from epigenetic changes (Rodríguez-Paredes and Esteller, 2011; Brower, 2011). 
From these studies it has become increasingly evident that epigenetic modifications 
could act as biomarkers for cancer detection (Rodríguez-Paredes and Esteller, 2011; 
Brower, 2011). Furthermore these modifications are reversible, suggesting they are 
good drug targets as has been shown by Squamocin, which modulates H3S10/H3S28 
phosphorylation and can inhibit the proliferation of cancer cells (Lee et al., 2011). 
A number of studies have used Drosophila to demonstrate the link between PcG 
proteins and cancer. They have revealed that mutations in core PcG proteins cause 
hyperproliferation of the eye imaginal disc in Drosophila (Classen et al., 2009). This 
was accompanied by the activation of the JAK-STAT mitogenic pathway suggesting 
PcG proteins act as tumour suppressors by repressing JAK-STAT signalling (Classen 
et al., 2009). The Drosophila eye has also been used as a model to show cells 
harbouring a mutation in the PcG protein, Polyhomeotic, over proliferate and fail to 
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differentiate (Martinez et al., 2009). These studies propose PcG proteins have tumour 
suppressor activity and highlight the need to further understand H3S28 regulation 
and its effect on PcG recruitment. 
6.1.1. Aims 
The aim of the work of this chapter was to develop assays that would permit the 
Drosophila genome to be interrogated for kinases and phosphatases that regulate 
H3S28 phosphorylation, PcG-chromatin interactions and transcriptional memory. 
Two complementary experimental approaches were attempted. The first approach 
was to develop probes capable of Fluorescence Resonance Energy Transfer (FRET) 
that could be used in an RNA interference (RNAi) based in vitro substrate screen to 
identify kinases and phosphatases that regulate H3S28 phosphorylation. In parallel 
with this a functional in vivo screen was planned to complement the substrate screen 
with the aim of identifying kinases/phosphatases that enhance or suppress the eye 
overgrowth phenotype observed upon polyhomeotic loss-of-function using heritable 
RNAi in adult Drosophila. Work was also done to study the role of PNUTS-PP1 in 
histone phosphorylation and other histone marks associated with active transcription 
to further understand the role of this holoenzyme in gene expression in Drosophila. 
 
6.1.2. Detecting protein interactions using FRET 
FRET is a method capable of detecting protein-protein interactions in living and 
fixed cells by fluorescently labelling proteins of interest (Snapp and Hegde, 2001; 
Karpova et al., 2003). An interaction is identified through the non-radioactive 
transfer of energy from one fluorescent molecule (known as the donor) to another 
fluorescent molecule (known as the acceptor), upon donor excitation, when the 
adjoining proteins interact and bring the fluorophores into close proximity (Figure 
! 221 
6.1) (Snapp and Hegde, 2001). Many parameters influence the probability and 
efficiency of FRET, but the most important to consider when designing a FRET 
probe is the distance separating the fluorescent pairs (this needs to be less than 
approximately 10nm) and the spectral overlap between donor and acceptor 
fluorescent proteins (Snapp and Hegde, 2001; Broussard et al., 2013; Ishikawa-
Ankerhold et al., 2012). The donor should be excited at a wavelength lower than the 
acceptor, the emission spectrum of the donor should overlap significantly with the 
excitation spectrum of the acceptor and the emission spectrum of the acceptor should 
be reasonably separate from the donor emission spectrum to allow selective 
measurement of the acceptor emission (Snapp and Hegde, 2001; Ma et al., 2014). 
Other factors to consider when choosing fluorescent proteins include the ‘brightness’ 
(a protein should emit enough signal above autofluorescence to be detected and 
imaged), its expression in the chosen system (expression levels need to be similar) 
and its photostability (Shaner et al., 2005). Differences in expression levels often 
arise when using intermolecular probes (detecting an interaction between two 
separate proteins) and this can be circumvented by using an intramolecular FRET 
biosensor were the two proteins and their fluorescent proteins are expressed as part 
of the same molecule (Broussard et al., 2013). A wide variety of fluorescent proteins 
are available and the literature reports many optimized FRET pairs but one of the 
most efficient and commonly used is ECFP and EYFP (Ma et al., 2014; Broussard et 














Figure 6.1. Structure and design of FRET probes. In the absence of binding, 
FRET cannot occur and energy from excitation of the donor (CFP) is lost. Upon 
interaction of the peptide substrate with the peptide-binding domain, the 
fluorophores are brought into close proximity and energy is transferred from CFP to 
YFP and an increase in acceptor (YFP) fluorescence is observed. 
 
 
Numerous methods for detecting FRET in microscopy are available (Van Munster et 
al., 2005). Techniques include sensitized emission (see 6.2.4), acceptor 
photobleaching (see 6.2.5), spectral imaging and Fluorescence lifetime imaging 
microscopy (FLIM) (Broussard et al., 2013). FLIM-FRET measures the lifetime 
decay of the donor fluorophore over time, after excitation (Ma et al., 2014; 
Broussard et al., 2013). The time it takes to decay back to the ground state is 
shortened when in close proximity to an acceptor fluorophore as energy is transferred 
from the donor to the acceptor (quenching) (Ishikawa-Ankerhold et al., 2012). 
However measurements are sensitive to the local environment therefore pH, 
temperature, oxygen, ion concentration, polarity and refractive index of the medium 
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have to be strictly controlled (Ma et al., 2014). Furthermore, FLIM requires 
expensive and custom designed instruments, which means it is not always readily 
available. Spectral imaging is usually used in combination with sensitized emission 
and collects images spanning the entire fluorescence emission spectrum to determine 
what proportion of the signal is from ECFP and EYFP (FRET) and what is from 
autofluorescence (Broussard et al., 2013). This improves sensitivity and allows a 
more accurate calculation of true FRET signal to be made (Broussard et al., 2013). 
Sensitized emission and acceptor bleaching are more commonly used approaches in 
FRET experiments and require more commercially available instruments. These are 
discussed further in sections 6.2.4 and 6.2.5. 
 
6.1.3. RNA interference (in vitro vs. heritable) 
RNAi is a high throughput method for analysing gene function, which acts to silence 
target genes by using short (!19 nucleotides) double-stranded RNA (dsRNA) 
fragments. These bind to the target mRNA resulting in cleavage and degradation of 
the mRNA, thereby abrogating gene function. There are many different methods for 
introducing dsRNA fragments into a system. The FRET-based substrate screen in 
Drosophila S2R+ cells would make use of in vitro transcribed dsRNA, which would 
be introduced into cells by transfection. The phenotypic screen in Drosophila adults 
would make use of the UAS-GAL4 system to drive expression of an inverted repeat 
construct stably inserted into the genome. Upon expression of the inverted repeat a 
dsRNA hairpin structure is produced, which has homology to the target mRNA 
(Dietzl et al., 2007). Gene knock down can be specifically targeted to the eye using 
the eyeless promoter.   
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6.2. FRET substrate screen 
6.2.1.  Design of the H3S28 Phospho-FRET probe 
To identify kinases and phosphatases that regulate H3S28 phosphorylation a 
H3S28Phospho-FRET probe was made based on a previously designed probe for 
detecting H3S10 and H3S28 phosphorylation consisting of ECFP, the first 30 
residues of Histone H3, the phospho-binding protein 14-3-3! and YFP (Lin et al., 
2004). Although Lin and Ting had observed FRET, the low dynamic range of the 
FRET change suggested there was potential to improve the probe. In 2005, Nguyen 
and Daugherty described the evolutionary optimization of ECFP/YFP to CyPet/YPet, 
improving the dynamic range and sensitivity of FRET (Nguyen and Daugherty, 
2005). However CyPet is known to fold poorly (Ouyang et al., 2008) therefore to 
avoid any complications with CyPet dynamics, the ECFP component was kept and 
the YFP component was altered to YPet. Moreover, there was no evidence in the 
literature to suggest any of the other isoforms of 14-3-3 had a higher affinity for 
phosphorylated H3S28 than 14-3-3! and so this along with the linker sequence 
(amino acid sequence: AGGTGGSL) and first 30 amino acid residues of Histone H3 
were used to construct the H3S28Ph-FRET probe (referred to as H3wt). To further 
improve the construct, a KOZAK sequence was inserted before ECFP, specifying the 
translation start site and a nuclear localisation signal (NLS) and stop codon (TAA) 
were inserted after YPet. Various restriction sites were removed and created (Figure 
6.2) for future manipulation of the construct and to enable making of a mutant H3 
FRET probe. The probe was synthesised by GeneArt and cloned into the entry vector 
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6.2.2. Making a S10,28A mutant Histone H3 FRET probe 
In all FRET experiments it is important to have good controls that define the limits 
of experimental FRET values to avoid false positive/negative results. Previous 
reports demonstrating FRET have often used a mutant version of the probe; therefore 
S10 and S28 were mutated to alanine (S10,28A) in the redesigned H3wt-FRET probe 
so that it could not be phosphorylated. The Age1 restriction site was also removed for 
diagnostic identification of the mutant probe (Figure 6.2). The H3S10,28A mutant 
FRET probe (referred to as H3S10,28A) was synthesised by GeneArt in the pMA-T 
vector and then ligated into the backbone of the H3wt probe in pAW after restriction 
enzyme digestion of H3S10,28A in pMA-T. It was then checked by sequencing and 














Figure 6.2. (previous page) Making the mutant H3S10,28A FRET probe. a) 
Structure of H3S28Ph probe highlighting the changes made to the original probe 
(black). The changes made to make the mutant FRET probe are shown in red. Both 
serine 10 and serine 28 are changed to alanine in the mutant. Removal of the Age1 
restriction site in the mutant is a diagnostic change to confirm insertion of the mutant 
fragment. KOZAK sequence: TCAAC. Nuclear Localisation signal: 
CCCAAGAAGAAGCGCAAG. Stop codon: TAA. +Nde1: ATGCAC!ATGCAT. 
+Age1: ACCGGC!ACCGGT. +Sac1: GAGCTG!GAGCTC. "Nde1: 
CATATG!CACATG. "Age1: ACCGGT!ACCGGC. S10A: AGC!GCC. S28A: 
TCC!GCC. b) The mutant probe was sequenced across the inserted mutant 
fragment to check the correct fragment had been inserted. 
 
6.2.3. RNA interference in S2R+ cells 
To validate the Histone H3wt and H3S10,28A FRET probes, dsRNA fragments were 
synthesised for RNAi-mediated knockdown of Jil-1 and PP187B in S2R+ cells, 
which would act as negative and positive controls respectively in the FRET substrate 
screen. Jil-1 is a kinase known to regulate H3S10 phosphorylation (Regnard et al., 
2011) and is a good candidate to be a H3S28 kinase. PP1 has been shown, in the 
context of mitosis, to dephosphorylate H3S10 and H3S28 and is also likely to be an 
interphase H3S28 phosphatase (Qian et al., 2011) (Rudenko, 2004). To test the 
effectiveness of the synthesised dsRNAs, the level of gene knockdown in S2R+ cells 
was determined by RT-PCR before co-transfection with the H3wt and H3S10,28A FRET 
probes (Figure 6.3). Several attempts were made at generating dsRNA fragments that 
significantly reduced the level of Jil-1 and PP187B. Originally four dsRNAs were 






































    





































    





cDNA and primers designed to amplify sequences from previously screened 
amplicons for these genes. Amplicon sequences were taken from www.flyrnai.org. 
However only one (PP187B 27290) produced a noticeable reduction in gene 
expression (Figure 6.3). This dsRNA was selected to validate the FRET probes for 


















Figure 6.3. Expression levels of Jil-1 and PP187B in S2R+ cells transfected with 
dsRNA fragments targeting each gene. GAPDH levels were used as an internal 
control. 
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6.2.4. Sensitised emission 
One of the most widely used and simplest approaches in FRET-based experiments 
requires excitation of the donor molecule (CFP) and detection of the acceptor (YPet) 
emission (em) (Karpova et al., 2003). Any fluorescence from YPet should be as a 
result of FRET, as it cannot be excited at 458nm and the energy from ECFP is 
transferred to YPet, causing it to enter an excited state due to spectral overlap of 
ECFP and YPet (Ishikawa-Ankerhold et al., 2012). This allows a FRET ratio to be 
calculated of the mean YPetemission(em) (FRET):ECFPem intensity in cells expressing a 
FRET probe after excitation of ECFP (458nm) alone (Figure 6.4a). However 
emission cross-talk due to emission spectra overlap can occur meaning some of the 
signal in the FRET (YPetem) channel upon excitation of ECFP at 458nm, will be 
from ECFP fluorescence bleed-through. It is therefore necessary to have controls to 
correct for this to give a reliable FRET measurement. Ideally controls would include 
cells expressing ECFP alone, YPet alone, unlinked ECFP and YPet, ECFP and YPet 
linked with a positive biological control and a negative biological control (Broussard 
et al., 2013). For preliminary validation of the FRET probes, the H3S10,28A probe was 
the only control available so initial experiments looked for a difference in the FRET 
ratio between H3wt and H3S10,28A. S2R+ cells were transfected with either probe and 
imaged using confocal microscopy. FRET was measured by exciting ECFP at 458nm 
and detecting YPet emission at 527nm. The experiments were carried out in the 
presence or absence of PP187B dsRNA. In two individual experiments (Figure 6.4b) 
H3S10,28A (-dsRNA) gave a lower FRET ratio than H3wt (-dsRNA) as expected. 
However the dynamic range was very small and ideally for a screen, a greater 
reduction in the FRET ratio for the mutant would be needed. Importantly the 
difference between H3wt (-dsRNA) and H3S10,28A (-dsRNA) in the first experiment 
! 229 
was not significant (p=0.31) whereas it was in the second experiment (p<0.0001, 
Figure 6.4b). This highlights the differences between FRET experiments and the 
need to use controls in every repeat. It is also important to note that different 
transfection reagents were used for these experiments. Cellfectin II (Invitrogen) was 
used for experiment one but due to its poor transfection efficiency (<1%), Effectene® 
(Qiagen) was used for the second experiment, giving a better transfection efficiency 
of !30%. This could explain the variation between experiments and highlights the 
need for consistent experimental conditions in each repeat. 
 
When dsRNA for PP187B (phosphatase) was added, a significant reduction in FRET 
was observed in the second experiment (Figure 6.4b), although an increase in FRET 
signal would have been expected due to an increase in Histone H3 phosphorylation. 
One possible explanation for this is PP187B was not reduced to a significant level, 
which is likely given the results in Figure 6.3, or that transfection of S2R+ cells with 













Figure 6.4. Simultaneous imaging of ECFP and YPet in S2R+ cells transfected 
with H3wt or H3S10,28A FRET probes. a) Representative images of cells expressing 
H3wt and H3S10,28A FRET probes. The excitation wavelength used for each image is 
shown above. Scale bars = 15µm b) average FRET:ECFP ratios upon excitation of 
ECFP in two individual experiments. Experiment 1: n= 27, 26, 22 and 20 (left to 
right). Experiment 2: n= 30 25, 19, 21 (left to right). Error bars represent the standard 
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6.2.5. Acceptor Photobleaching 
Acceptor photobleaching is a simple and quick assay for verifying FRET and 
detecting protein interactions and is therefore an appealing choice when designing 
FRET experiments (Broussard et al., 2013; Snapp and Hegde, 2001). The leading 
principle behind acceptor photobleaching is FRET should not occur in the absence of 
an acceptor therefore by photobleaching the acceptor an increase in donor intensity 
should be seen if the two fluorophores are in close proximity (Karpova et al., 2003; 
Broussard et al., 2013; Snapp and Hegde, 2001). If an increase in donor fluorescence 
is observed after bleaching, this is a reliable diagnostic readout as bleaching usually 
causes a decrease in fluorescence intensity (Karpova et al., 2003). The advantage of 
this approach is it is not affected by bleed-through and successful photobleaching is 
easily observed by a sudden decrease in acceptor fluorescence (Snapp and Hegde 
,2001). Furthermore bleaching is straightforward on a confocal laser scanning 
microscope (CLSM) and can allow bleaching of a region of interest (ROI) 
(Broussard et al., 2013). The main disadvantage is that it destroys the biosensor so 
only one measurement can be taken for a particular cell (Snapp and Hegde, 2001). 
 
Thirty images of ROIs in S2R+ cells transfected with the H3wt or H3S10,28A FRET 
probes were taken, with photobleaching of YPet between images 4 and 5. The 
nuclear intensity was measured for ECFP (channel 479nm, figure 6.5a) and YPet 
(channel 527, figure 6.5a) before and after bleaching and the percentage 
increase/decrease in intensity calculated (respectively).  In all cases YPet was 
successfully bleached (Figure 6.5); a comparable level of bleaching was observed for 
cells transfected with H3wt and H3S10,28A (average % decrease = 73.9 ± 4.5 and 74.4 
± 2.4 respectively). An increase in ECFP was observed in all cells, including those 
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transfected with the H3S10,28A probe despite it lacking the phosphorylatable S10 and 
S28 residues (Figure 6.5a). The percentage increase in ECFP fluorescence for cells 
transfected with H3wt was greater than that observed in cells transfected with 
H3S10,28A (average % increase = 28.0 ± 7.8 and 24.0 ± 11.1) however statistical 
analysis (student’s t-test) suggests the difference is not significant (p=0.19, figure 










Figure 6.5. Acceptor photobleaching of S2R+ cells transfected with H3wt and 
H3S10,28A FRET probes. a) Nuclear intensity of representative examples of cells 
transfected with either H3wt or H3S10,28A FRET probes immediately before and after 






























































bleaching of the acceptor fluorophore (YPet). Quantification shows an increase in 
ECFP emission (479nm) and a dramatic decrease in YPet emission (527nm). b) The 
average percentage increase of ECFP emission and decrease of YPet emission for 
cells transfected with H3wt (n=21) or H3S10,28A (n=20) FRET probes. p value shows 
there is no significant difference in ECFP emission change between the two probes. 
Error bars represent the standard error for each dataset. 
 
6.3. Phenotypic screen 
In 2009, Martinez et al. showed that loss of the PcG component polyhomeotic in the 
eye causes cells to over proliferate and in 2011, Feng et al. provided more evidence 
suggesting that mis-regulation of PcG promotes proliferation. To further understand 
the molecular mechanisms underlying this phenomenon and to complement the 
substrate screen, a phenotypic screen was designed to identify kinases and 
phosphatases that enhance/suppress the overgrowth phenotype observed in eyes upon 
polyhomeotic loss of function. To generate the strains needed for this screen an initial 
set of experiments were performed to determine which PcG element gives the 
strongest overgrowth phenotype when knocked down by RNAi in the eye. The three 
PcG elements targeted for knockdown were polyhomeotic, polycomb and sex combs 
extra, which have all been shown to cause hyperproliferation in loss of function 
mutants (Classen et al., 2009). 11 available RNAi lines (flies carrying an inverted 
repeat construct under UAS control) for these genes were crossed to flies with either 
a moderate (5534, see section 2.6.9) or strong (5535, see section 2.6.9) eyeless-
GAL4 (ey-GAL4) promoter, to induce expression of the gene-specific inverted 
repeats exclusively in the eye. The number of flies in the progeny with either normal 
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or overgrown eyes was recorded (Table 6.1). Representative images of selected 








Table 6.1. The number of eye phenotypes observed upon gene knockdown in the eye 










TRiP 31608 3 75 6 - 62 1 - Viable 
TRiP 31190 3 55 5 - 83 7 - Viable 
TRiP 33669 3 73 - - 72 - - Viable 
VDRC 50028 3 - - -  - - DBE-V 
VDRC 100811 2 64 - - 42 - - Viable 
NF 18414R-1 2 56 - -  - - Viable* 




NF 32443R-1 3 - - - - - - DBE-PL 
TRiP 33622 3 75 - - 52 - - Viable 
TRiP 33964  1 - - - - - DE 




VDRC 106328 2 - - - - - - DBE-V 
NF 5595R-1 3 - - 1 - - - DE 
NF 5595R-2 3 - - 4 - - - DE 
TRiP 31612 3 37 10 6 24 4 2 Viable 
wt=wild type eyes, MOG=mild overgrowth, SOG=strong overgrowth, - = no flies with this phenotype. 
Moderate and strong = moderate (Bloomington stock number 5534) and strong (Bloomington stock 
number 5535) ey-GAL4 promoters. DBE-V=die before eclosion but should be viable, Viable*=viable 











Figure 6.6. Representative images of eye phenotypes for selected RNAi lines. RNAi 
lines indicated were crossed to a source of either moderate (M) or strong (S) eyeless-
GAL4.  
 
To identify enhancers of PcG-mediated overgrowth it was necessary to select RNAi 
lines where the majority of flies had wild type eyes and a small number displayed 
over growth. On this basis the TRiP line 31612 (targets sex combs extra) and Nig-Fly 
line 1814R-2 (targets polyhomeotic) were selected with the moderate ey-GAL4 
promoter (Table 6.1). The rationale behind this decision was to select RNAi lines 
that would identify both weak and strong enhancers of overgrowth. TRiP 31612 
produced a number of flies with different eye phenotypes (Table 6.1) therefore it 
would be difficult to identify weak enhancers as the number of flies displaying an 
over growth phenotype may be similar to the results in Table 6.1. However it would 
be simple to identify strong enhancers, where an increase in the number of flies 
displaying a strong overgrowth phenotype in the eye would be expected. Nig-Fly 
18414R-2 should identify weak enhancers as all flies displayed a wild type eye 
TRiP 31612 (M) TRiP 31612 (M) Nig-Fly 5595R-2 (M) 
Nig-Fly 18414R-2 (M) Nig-Fly 18414R-2 (S) 
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phenotype with the moderate ey-GAL4 promoter. Any over growth would identify an 
enhancer and it is clear from the results with the strong ey-GAL4 promoter that Nig-
Fly 18414R-2 can produce an overgrowth phenotype (Figure 6.6).  
 
To identify suppressors of PcG-mediated overgrowth the Nig-Fly RNAi line 5595R-
2 (targets polyhomeotic) was selected on the basis that only a small number of flies 
emerged and all had a strong over growth eye phenotype (Table 6.1 and Figure 6.6), 
suggesting that knockdown of polyhomeotic is semi-lethal. A suppressor would be 
easily identified by rescue of the overgrowth phenotype and an increase in the 
number of flies emerging. 
 
6.3.1. Making a tester strain for the in vivo phenotypic screen 
The inverted repeat for the selected genes was recombined with ey-GAL4 (moderate) 
and a temperature sensitive tubulin-GAL80 (tub-GAL80ts) element (McGuire et al., 
2003) to make a permanent strain that could be crossed to RNAi lines targeting 
kinases and phosphatases in the Drosophila genome. The tub-GAL80ts is necessary 
due to the semi-lethality exhibited upon knockdown of sex combs extra using the 
RNAi line 5595R-2. GAL80 suppresses GAL4-mediated gene expression allowing a 
stock to be maintained at a permissive temperature and experiments to be carried out 
at a restrictive temperature that will relieve GAL80 suppression of GAL4. The only 
RNAi line that was recombined successfully with ey-GAL4 and tub-GAL80ts was 
Nig-Fly 5595R-2 (targets sex combs extra); this will be referred to as the tester strain 
from hereafter.  
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A series of experiments to validate the tester strain were carried out to ensure it 
would be suitable for use in the screen. Firstly, the strain was kept at a permissive 
temperature of 22°C and restrictive temperature of 29°C to check it behaved as 
originally observed. At the permissive temperature the strain survived and no flies 
displayed an overgrown eye phenotype therefore it was concluded the tub-GAL80ts 
element was working. However, when stored at the restrictive temperature, which 
should relieve repression of the Sex combs extra inverted repeat (SceIR5595R-2) and 
induce knockdown of Sce, all flies survived and none displayed an overgrowth 
phenotype. This was unexpected considering only a small number of flies survived in 
the original experiment with Nig-Fly 5595R-2 and those that did emerge displayed 
severely overgrown eyes. It was thought the inverted repeat might not be strong 
enough when in combination with the GAL80 element so the tester strain was 
crossed to a strain carrying UAS-Dicer2, a component of the RNAi machinery in an 
attempt to enhance knockdown of Sce. However the progeny of this cross still 
survived.  
 
Another mini screen was done using a variety of ey-GAL4 strains of differing 
strengths to determine if any enhanced the overgrowth phenotype originally 
observed, and could consequently be used to make a new tester strain. Three ey-
GAL4 strains (Bloomington stock numbers 8221, 8220 and 5534) caused pupal 
lethality when crossed to SceIR5595R-2. An advantage of this lethal phenotype is it 
would make the screen more stringent and easier to perform. Lethality is difficult to 
rescue so if knockdown of a particular kinase/phosphatase suppressed lethality it is 
likely to be involved in PcG regulation and the assay would simply be looking for 
emerging flies. The three ey-GAL4 elements were combined with SceIR5595R-2 and 
! 239 
tub-GAL80ts and the same validation tests were performed. The new tester strains 
survived at the permissive temperature and were pupal lethal at the restrictive 
temperature as expected. To further test the strains they were crossed to a wild type 
strain (w1118) to ensure that only those without the SceIR5595R-2 emerged at the 
restrictive temperature. Unfortunately flies with both ey-GAL4 and SceIR5595R-2 
elements emerged although some did have an overgrowth phenotype. A final attempt 
to validate the tester strain involved crossing it to a line expressing GFP tagged 
STAT. A report in 2009 showed the JAK-STAT signalling pathway is upregulated 
when PcG components are knocked down (Classen et al., 2009). Knockdown of 
SceIR5595R-2 could be detected by looking for an increase in GFP in affected flies. 
Unfortunately no difference was seen suggesting the inverted repeat was not 
effective in combination with other elements tested. 
 
6.4. The PP1/PNUTS phosphatase regulates active marks of transcription 
Validation of the tools to do an unbiased screen to identify histone phosphatases that 
regulate H3 serine 10 and serine 28 phosphorylation and the recruitment of PcG 
complexes was unsuccessful. Therefore focus shifted to PP1, which has been shown 
to dephosphorylate histones in vitro during mitosis (Qian et al., 2011). Chapter 3 
described the co-localisation of PP1-PNUTS with sites bound by RNAPII on 
polytene chromosomes and showed RNAPII is a substrate of PP1-PNUTS. However 
not all sites bound by PP1-PNUTS co-localised with RNAPII suggesting other 
chromatin associated substrates may be targeted by PP1-PNUTS. Given histones are 
targets of PP1 mediated dephosphorylation during mitosis, the histone 
phosphorylation status of the underlying chromatin was studied in cells lacking PP1 
and PNUTS. To do this, negatively marked dPNUTS13B or PP187B (the major PP1 
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isoform in Drosophila) mutant clones were generated in the salivary gland using 
Flp/FRT mediated recombination. Salivary glands were dissected from 3rd instar 
larvae, fixed, stained for histone H3S10 and H3S28 phosphorylation and imaged 
using confocal microscopy. The salivary glands of third instar Drosophila larvae 
offer a good system in which to study various aspects of transcription as the 
chromosomes in this tissue undergo many rounds of replication without cell division. 
This gives rise to large polytene chromosomes that contain thousands of copies of 
each gene and enable better visualisation of histone modification status in antibody 
labelling experiments. Figure 6.7 shows both H3S10 and H3S28 phosphorylation 
were increased in PP187B mutant clones. PNUTS13B clones also displayed an 
increase in H3S10 phosphorylation.  
 
As previously discussed, serine 28 phosphorylation disrupts recruitment of PcG 
proteins to methylated H3K27 via epitope masking and also induces a methyl-
acetylation switch on K27 to activate transcription (Lau and Cheung, 2011b). Given 
H3S28 phosphorylation was increased in PP187B mutants, the H3K27 acetylation 
status of PP187B and dPNUTS mutant clones was studied. Interestingly an increase 
in H3K27 acetylation was observed in negatively marked PP187B and dPNUTS 
mutant clones (Figure 6.7) suggesting PP1-PNUTS may indirectly regulate H3K27 













Figure 6.7. PP1-PNUTS regulates histone phosphorylation and acetylation. 
Negatively marked (non-GFP) PP1 mutant (top panels) and PNUTS13B clones 
(bottom panel) generated by Flp/FRT mediated recombination in the salivary glands 
of 3rd instar larvae. Salivary glands stained for Histone H3 S10 phosphorylation and 
H3 K27 acetylation. Scale bars = 55 µM. For control see Figure 6.8. 
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Given PNUTS/PP1 binds to Wdr82, which associates with the COMPASS complex, 
responsible for the di- and tri- methylation of histone H3 lysine 4 (H3K4me2/3) 
(Hallson et al., 2012), the histone methylation status of mutant PP187B and 
dPNUTS13B clones was examined using antibodies specific for each methylated form 
of H3K4. Interestingly levels of Histone H3K4me2 and H3K4me3 were markedly 
increased in negatively marked dPNUTS13B nuclei and to a lesser extent in PP187B 
mutant nuclei (Figure 6.8). This suggests PP1-PNUTS regulates the di- and tri-
methylation of H3K4, marks that are both associated with active transcription 
(Heintzman et al., 2007; Hallson et al., 2012). 
 
Figure 6.8 (next page). H3K4me2/3 is increased in PNUTS13B and PP1 mutant 
clones. Negatively marked (non-GFP) PP1 mutant (top panels) and PNUTS13B 
clones (middle panels) generated by Flp/FRT mediated recombination in the salivary 
glands of 3rd instar larvae. Salivary glands stained for indicated histone methylation 
marks.  Control = PNUTS13B clones stained with anti-rabbit Alexa-555 secondary 





































Epigenetic post-translational modifications on histones and DNA are essential for 
maintaining appropriate patterns of gene expression during development by 
modulating chromatin structure (Rossetto et al., 2014). Different modifications exist 
on specific histone residues that can directly or indirectly affect chromatin structure 
through the recruitment of chromatin-associated factors; modifications include 
methylation, acetylation, phosphorylation and ubiquitination. Histone 
phosphorylation is a key regulator of active gene expression and the outcome of 
many signal transduction pathways to allow changes in gene expression patterns to 
be made in response to external stimuli. H3S28 phosphorylation has been reported to 
activate transcription by preventing recruitment of repressive polycomb group 
proteins to neighbouring methylated lysine 27, however little is known about the 
kinases and phosphatases that regulate this key residue. 
 
This chapter describes the development of tools to identify Drosophila kinases and 
phosphatases that regulate H3 serine 28 phosphorylation, recruitment of PcG to 
chromatin and gene expression using a FRET based in vitro substrate screen in S2R+ 
cells and an in vivo phenotypic screen in adult flies. An intramolecular FRET probe 
capable of detecting H3S28 phosphorylation was developed, consisting of the first 30 
residues of histone H3 conjugated to YPet and the phosphor binding protein 14-3-3! 
conjugated to ECFP linked together via a short linker sequence. A non-
phosphorylatable variant was also made through substitution of S10 and S28 for 
alanine in the H3 component. Initial validation of these probes using acceptor 
photobleaching and sensitized emission to measure a FRET ratio proved 
unsuccessful, as measurements displayed a small dynamic range and no difference 
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between H3wt and H3S10,28A was observed, making them unsuitable for a large scale 
screen. There are many reasons why the H3S10,28A negative control behaves like the 
H3wt probe. Firstly high concentrations of the probe may have been present leading 
to the potential for intermolecular FRET to occur between fluorophores in adjacent 
molecules rather than within the same probe, giving a false positive signal. The small 
intensity changes observed with the H3wt probe also presented a major problem and 
suggested that the probe may not be efficient. This could be due to the design of the 
reporter, as YPet is better paired with CyPet rather than ECFP. Furthermore the 
linker sequence may not have been flexible enough to allow binding between the two 
reporter proteins, although the reporter design was taken from the original probe 
used in the literature.  
 
It is important to note that the results described were preliminary and the view was to 
validate the FRET probe to see if any evidence of an interaction could be detected 
using sensitised emission and acceptor photobleaching. The view was to use the 
H3S10,28A probe as a negative control to determine the background level of 
fluorescence. Of course other negative controls would have been necessary to further 
validate the probes and undertake the in vitro screen. Further validation of the FRET 
probes using synthesised dsRNA, as a way of mimicking the conditions that would 
be used in the screen, also proved unsuccessful, as the dsRNA fragments did not 
significantly reduce the level of target gene expression.  
 
A tester fly strain was made that could be used in an RNAi-based in vivo screen to 
identify kinases and phosphatases that enhance/suppress the eye overgrowth 
phenotype observed upon loss of PcG proteins. Eyeless-GAL4 was recombined with 
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an inverted repeat element targeting knockdown of sex combs extra, a subunit of 
PRC1, and a temperature sensitive tub-GAL80 element for controlled gene silencing. 
The strain was optimised and initial tests showed the strain survived at the 
permissive temperature and was semi-lethal at the experimental temperature with 
flies that emerged displaying an overgrowth phenotype in the eye. However further 
validation by crossing to a wild type strain suggested the tester strain would not be 
suitable for a screen as flies expressing the inverted repeat emerged in the progeny 
and displayed no overgrowth phenotype in the eye. This is unexpected given a wild 
type strain should not be able to suppress the semi-lethal phenotype of the tester 
strain.  
 
Focus shifted to PP1 and its role in epigenetic regulation of gene expression via 
H3S28 phosphorylation. Work in Chapter 3 showed the association of PP1 and 
dPNUTS at many sites on Drosophila polytene chromosomes with some sites 
marked by RNAPII. Further work showed RNAPII is a target of dPNUTS-PP1 
mediated dephosphorylation but what other substrates could be targeted by PP1 at 
sites not bound by RNAPII, and is dPNUTS necessary for dephosphorylation of 
these unknown substrates? Negatively marked mutant PP187B clones in the 
Drosophila salivary gland confirmed H3S28 and H3S10 are likely to be targets of 
PP1-mediated dephosphorylation as both marks were increased in mutant clones. 
Furthermore clonal analysis revealed dPNUTS is also essential for regulation of H3 
phosphorylation as dPNUTS13B clones exhibited an increase in H3S10 
phosphorylation. Unfortunately problems with the H3S28 phospho-specific antibody 
meant results could not be obtained for the effect of dPNUTS at this site. However, 
phosphorylation of H3S28 has also been reported to induce a methyl-acetylation 
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switch on the neighbouring lysine 27 residue (Lau and Cheung, 2011b) and staining 
revealed H3K27 acetylation is increased in both PP187B and dPNUTS mutant 
clones. This is consistent with there being a role for dPNUTS in regulating H3S28 
phosphorylation. To provide evidence of the role of dPNUTS-PP1 in a phosphor-
methyl switch one could look at the H3K27 methylation status in PNUTS and PP1 
mutants clones and determine if PNUTS associates with PcG-regulated promoters 
using a ChIP based approach.  
 
The histone H3K4 methylation status of PP187B and dPNUTS mutant clones was 
studied due to the association of PNUTS-PP1 with Wdr82, a component of the 
methyltransferase complex, COMPASS (Hallson et al., 2012). Mutant clones 
exhibited an increase in H3K4 di- and tri-methylation, the main target of COMPASS 
mediated methylation (Hallson et al., 2012). One interpretation of these results is that 
Wdr82 binds competitively to COMPASS and dPNUTS and in the absence of 
dPNUTS there is more COMPASS-bound Wdr82, which promotes COMPASS 
function. Consequently, it would be interesting to test whether dPNUTS 
overexpression abrogates Wdr82-dependent COMPASS function, leading to a loss of 
H3K4 methylation.  
 
It appears various changes in histone modification status occur in PP187B and 
dPNUTS mutant clones suggesting the dPNUTS-PP1 holoenzyme is essential for 
epigenetic control of gene expression. However, active marks of transcription are 
increased in mutant clones suggesting PP1 and dPNUTS negatively regulate 
epigenetic control of active transcription. This is contradictory to its role in active 
transcription (Chapter 3) but may be necessary for temporal and spatial control of 
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target genes in response to certain stimuli. Interestingly, genes targeted by PcG 
proteins are not always repressed, with reports suggesting PcG proteins associate 
with actively transcribed genes and with different phosphorylated forms of RNAPII 
(Brookes et al., 2012). In repressed PcG target genes, PcG proteins associate with 
stalled RNAPII phosphorylated at Ser5 and in expressed targets, PcG associates with 
elongating RNAPII marked by phosphorylated Ser5, Ser2 and Ser7 (Brookes et al., 
2012). It is thought in actively transcribed genes, PcG acts to regulate the level of 
mRNA, therefore PcG may not only function to completely repress target genes but 
also regulate their expression through mRNA abundance (Enderle et al., 2011; 
Brookes et al., 2012).  
 
It will be interesting to see if PcG proteins are also localised at sites marked by 
PNUTS and RNAPII on polytene chromosomes and if genes affected in dPNUTS 




7. Final Discussion and summary 
This work describes the characterisation of the PP1 nuclear regulatory subunit, 
PNUTS, in Drosophila and of PNUTS-interacting proteins that are conserved in 
humans and mammals. Mutational analysis showed dPNUTS is essential for cell 
survival and development in Drosophila as null mutants die as L1 larvae and mutant 
cells are unable to proliferate in developing tissues. Many RNAPII-dependent genes 
are misregulated in loss-of-function animals. Most notably, genes involved in 
metabolic processes such as carbohydrate metabolism are downregulated, whereas 
genes involved in apoptosis are upregulated. These changes are consistent with the 
growth defect and lethality exhibited by dPNUTS mutant animals. The RNAPII CTD 
was found to be hyperphosphorylated at Ser5 in mutant larval extracts and on 
polytene chromosomes in flies overexpressing a non-PP1 binding variant of 
dPNUTS. These data suggest that dPNUTS may play a direct role in transcription, or 
in co-transcriptional events such as RNA processing, through regulating RNAPII 
CTD phosphorylation status (Hsin and Manley, 2012). The latter explanation is 
favoured because RNAPII occupancy across selected loci was not affected and 
because CTD Ser5 phosphorylation is thought to primarily regulate mRNA capping. 
Future work should be directed at identifying genomic loci where dPNUTS is bound, 
e.g. by ChIP or DamID approaches. This information could then be used to 
determine which genes are direct targets of dPNUTS and to reassess the effects of 
altered RNAPII phosphorylation on mRNA levels and processing. 
 
Analysis of modification status at specific gene loci using native chromatin 
immunoprecipitation approaches (Brand et al., 2008) will help determine if the 
effects on gene expression are due to changes in histone modification status. 
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Alternatively, looking at the effect of loss of function of dPNUTS on RNA 
processing events such as 5’ capping using cap-trapping techniques (see Chapter 6) 
will determine if the gene expression changes observed are a result of defects in 
transcription-coupled processes. 
 
Identification of dPNUTS-binding proteins using a yeast two-hybrid approach and 
biochemical analyses to confirm these interactions, identified dTOX4, dWdr82, 
dMBD-R2 and the Drosophila estrogen related receptor (dERR) as dPNUTS 
interactors. Binding to dERR could offer some insight into the effects on metabolic 
genes observed as it is necessary for co-ordinating metabolic gene expression 
patterns during Drosophila development (Tennessen et al., 2011). There are three 
ERR isoforms in mammals (ERR!, " and #) that also have roles in metabolic 
processes (Eichner et al., 2010; Charest-Marcotte et al., 2010; Alaynick et al., 2007) 
and have been linked to cancer progression, predominantly breast cancer, but little is 
known about the molecular basis of this association (Ariazi et al., 2002; Stein et al., 
2008; Eichner et al., 2010). It is well known cancer cells exhibit the Warburg effect 
whereby they take on an altered metabolic programme and become dependent on 
aerobic glycolysis rather than mitochondrial oxidative phosphorylation to efficiently 
create biomass (Zhao et al., 2013). It has also been suggested the primary function of 
dERR is biomass production during larval development, which is reminiscent of the 
Warburg effect (Tennessen et al., 2011). Further characterisation of the interaction 
between ERR and PNUTS in Drosophila may have implications in cancer 
therapeutics as cancer drug resistance has been linked to altered metabolic pathways 
in cancer cells (Zhao et al., 2013). Targeting of proteins involved in these pathways 
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may therefore offer a way to overcome drug resistance for better treatment of the 
disease. 
 
The identification and confirmation of dTOX4 and dWdr82 as dPNUTS-binding 
proteins was consistent with reports in humans and mammals that show these 
proteins are part of a complex with PP1. Although this work has not confirmed the 
Drosophila orthologues exist as a complex, it is likely that these interactions are 
conserved. This is further supported by work in yeast, which shows Swd2, a 
homologue of mammalian Wdr82, is part of the stable APT complex which includes 
Glc7, the yeast homologue of PP1 (Nedea et al., 2003). The exact role of the 
TOX4/Wdr82/PNUTS/PP1 complex and its substrates remains to be determined but 
it is likely it functions in transcription or related RNA processing events as all 
members are known to be chromatin associated (Lee et al., 2010). dTOX4 is a 
member of the high mobility group of proteins that facilitate various DNA-dependent 
nuclear activities including transcription and DNA repair by binding to DNA and 
inducing changes in local chromatin structure. LCP1, the human homologue of 
dTOX4, binds to PNUTS and exhibits transcriptional activity, suggesting it may 
have a direct role in transcription (Lee et al., 2009). Furthermore, Wdr82 associates 
with RNAPII phosphorylated at Ser5 in its CTD (Mohan et al., 2011). Confirmation 
that these proteins exist as a complex in Drosophila and characterisation using 
various genetic and biochemical approaches available in this model system will 
provide further insight into its chromatin-associated functions. 
 
Mutational analysis of dTOX4 in Drosophila revealed unexpected phenotypes with 
homozygous adults displaying defects in oogenesis and spermatogenesis resulting in 
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sterility. Females had defects in dorsal ventral patterning in the egg and chromosome 
dispersal/decondensation in nurse cell nuclei. Males displayed multiple defects in 
spermatogenesis, predominantly cytokinesis, and were unable to produce mature 
sperm. How such processes are regulated by dTOX4 and the importance of dPNUTS 
binding to dTOX4 remains to be determined. If dPNUTS is necessary for these 
functions then identifying substrates and the role of phosphorylation in these 
processes will be important. PNUTS is known to be necessary for proper 
chromosome decondensation in human cells (Landsverk et al., 2005); it is possible 
that dTOX4 mediates a similar role for dPNUTS in the Drosophila germline. 
However, it is possible these phenotypes represent PNUTS-independent roles of 
dTOX4. Notably, the phenotypes observed in the ovary are the same as in mutants in 
various hnRNP proteins that regulate mRNA localisation and reports in the literature 
suggest dTOX4 may bind to these proteins (Guruharsha et al., 2011). One of these 
hnRNP proteins, Squid, also displays defects in cytokinesis in the testes (Lowe et al., 
2014). Confirmation of these interactions may be important in understanding the 
dTOX4 mutant phenotypes observed. Expression data in FlyAtlas shows dTOX4 
(CG12104) is most highly expressed in the testes and ovaries (data not shown). 
LCP1 is also most highly expressed in the testes in humans (O'Flaherty and Kaye, 
2003). Therefore characterisation of the defects in dTOX4 mutants could have 
important implications in understanding male infertility. Male factor infertility is a 
growing concern with an increasing number of patients exhibiting reduced sperm 
concentration, decreased motility and a high percentage of abnormal sperm 
morphology (Fardilha et al., 2011). An understanding of the molecular basis for male 
factor infertility will be important in identifying targets for therapeutic intervention. 
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Preliminary evidence suggests dTOX4 null mutants have a reduced lifespan and 
therefore may have a role in the ageing process, possibly by affecting gene 
expression patterns or through involvement in DNA damage pathways. TOX4 is 
known to bind sites of DNA damage induced by platinating agents and interestingly 
PNUTS and Wdr82 were also found at these sites (Puch et al., 2011). PNUTS has 
also been implicated in cardiac aging where a decrease in PNUTS expression is 
linked to an increase in microRNA-34a as aging progresses (Boon et al., 2013). 
Further analysis of the dTOX4 mutant may help in our understanding of processes 
that promote aging.  
 
Analysis of histone modifications in dPNUTS and PP187B mutant cells suggest that 
some effects on gene expression observed in dPNUTS mutant animals may be related 
to changes in epigenetic histone modifications. Various marks of active transcription 
were upregulated in both dPNUTS and PP187B mutants. Post-translational 
modifications on histones regulate transcription by recruiting chromatin-modifying 
complexes that affect the local chromatin structure and determine access of proteins 
such as transcription factors. Whether the epigenetic status of genes misregulated in 
dPNUTS mutants is altered remains to be determined. Aberrant epigenetic regulation 
has been strongly linked to various cancers in the literature, with many cancers 
exhibiting altered epigenetic landscapes (Rodríguez-Paredes and Esteller, 2011). 
 
7.1. Future work 
Due to time constraints it was not possible to determine if the phenotypes observed 
in the dTOX4 mutant were a result of disruption of the dTOX4 gene. However, the 
tools to investigate this were developed and are currently under investigation. 
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Overexpression of wild type dTOX4 using GAL4-UAS mediated overexpression 
under the control of the bam and mat-!-tubulin promoters should provide some 
insight into this but it is not known what stage of spermatogenesis and oogenesis 
dTOX4 is expressed so these may be unsuitable promoters for rescue experiments. 
Expression of GFP tagged genomic dTOX4 is likely to provide better insight not only 
in terms of rescue but also to determine where dTOX4 is expressed in both tissues. 
One caveat is the GFP tag may affect the behaviour of the genomic construct, 
therefore an untagged version should also be used. Another possible approach is to 
use the GAL4-UAS system to overexpress short hairpin RNAs for RNAi mediated 
knockdown of dTOX4 to see if loss of expression produces the same phenotypic 
consequence as the dTOX4null allele. One potential problem with this approach is the 
publicly available RNAi lines are not always efficient and complete knockdown of 
the protein encoding mRNA is very rarely achieved. Furthermore off-target effects 
can be observed which complicate analysis.  
 
In parallel with this, it will be important to determine whether binding to dPNUTS is 
necessary for dTOX4 function. Complementation experiments, using either UAS or 
genomic constructs for dTOX4P216! in the testes and ovaries should provide further 
insight into this. To further understand the relationship between dPNUTS and 
dTOX4, it will be interesting to examine the ability of these proteins to co-localise 
with each other and RNAPII on chromosomes.  
 
If dPNUTS binding is not required for the function of dTOX4 in male and female 
fertility or aging, then determining the relationship between dTOX4 and the various 
hnRNP proteins discussed in Chapter 5 may explain the phenotypes observed. Using 
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similar techniques described in this thesis, such as biochemical analysis of tagged 
expression constructs and genetic complementation experiments to see if the mutant 
phenotype can be rescued by expressing a wild type copy of Otu, will determine if 
dTOX4 associates with hnRNP complexes. Analysis of gurken mRNA distribution in 
dTOX4 mutant egg chambers will provide an immediate answer as to whether gurken 
misregulation is responsible for the observed defects in dorsal-ventral patterning.  
 
Confirming dTOX4, dWdr82 and dPNUTS exist in a complex with PP1, as in 
humans and mammals, is the first step towards characterising these interactions in 
Drosophila. Transfection of S2 cells with tagged dTOX4 and dWdr82 with or 
without tagged dPNUTS will determine if they bind as a complex. The exact role of 
this complex in transcription or chromatin-related processes in Drosophila will 
provide further insight into this conserved complex. 
 
dERR and dMBD-R2 represent novel PNUTS-binding proteins and further 
characterisation of these interactions may provide insight into the role of dPNUTS in 
determining gene expression patterns that control metabolic state, as well as other 
cellular processes. In this respect, identifying sites of interaction in dPNUTS may 
facilitate the development of targeted mutations in dPNUTS that disrupt specific 
protein-protein interactions. Looking at the levels of circulating sugars in dPNUTS 
mutant larvae will determine if processes regulated by dERR are affected, suggesting 
a functional interaction may exist. Examining the distribution of dMBD-R2 and 
dPNUTS on polytene chromosomes in wild type flies and flies expressing an RNAi 
construct against dMBD-R2, will help to establish a possible function of dMBD-R2 
in the recruitment of dPNUTS to chromatin. Mutational analysis of dMBD-R2 will 
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determine if loss-of-function of dMBD-R2 has the same phenotypic effect as the 
dPNUTS mutant. 
 
Finally, repeating the dPTEN complementation experiments with a weaker 
(hypomorphic) dPNUTS mutant allele together with further biochemical analysis 
using tagged expression constructs in S2R+ cells will confirm if they do interact in 
Drosophila. Further analysis using a reporter for visualising PIP3 levels at the cell 
membrane (a GFP-PH domain fusion protein whereby the PH domain binds to PIP3) 
in flies overexpressing PNUTS will determine if a functional interaction does exist in 
Drosophila. 
 
7.2. Implications for the future 
As PP1 is involved in numerous cellular processes both in the cytoplasm and 
nucleus, inhibiting its catalytic subunit using therapeutic compounds will probably 
produce unwanted side effects. It may be more desirable to target PP1 holoenzymes 
such as the PP1/PNUTS/Wdr82/TOX4 multiprotein complex to manipulate 
phosphorylation in specific disease states, including cancer. Drug specificity could 
be achieved through disrupting the interaction between PP1c and its regulatory 
subunits or by disrupting the interaction between all subunits and the substrate. 
Therefore further characterisation of PNUTS-associated proteins and the substrates 
of PNUTS-PP1 is necessary to identify possible sites for drug targeting. (McConnell 
and Wadzinski ,2009). As proof of concept, small molecules have been identified 
that can disrupt PP1 complexes (McConnell and Wadzinski, 2009). One example is 
the use of trichostatin A (TSA), a histone deacetylase (HDAC) inhibitor, to disrupt 
PP1-HDAC complexes for the potential treatment of prostate cancer and 
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glioblastoma (Chen et al., 2005). Disrupting PP1-HDAC allows PP1 to become more 
highly associated with Akt, leading to its dephosphorylation and inactivation of the 
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 FRT40A 
(dissect GFP positive L3 larvae)  
hsFLP
122
; P[w+]30C, FRT40A     
hsFLP
122
  Cyo 
! 289 
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;   +  ; ubi-GFP
nls
, FRT82B     
       
            Cyo             TM6B 
w;   +  ; PP187B
Su(var)3-6[1]
, FRT82B        
  +                     TM6B 
hsFLP
122
;   +  ;      ubi-GFP
nls
, FRT82B        (dissect GFP positive L3 larvae)         
       







  (15089) 






;        Dr            (406 or 1610)        
   TMS, "2-3 
w; ; CG12104
EY02201 




; MKRS        
Cyo  TM6B 
w; ; CG12104
excision 
              
MKRS / TM6B 
w; Tft
 
; MKRS        
Cyo  TM6B 
(100 individual males)  
! 
(100 individual males, 
white eyes, screen by 
PCR once progeny 
thrive)  
! 
w;   +   ; CG12104
excision 
           
Cyo         TM6B  
(Final strain with excision referred to 
as this in thesis)  
w;   +   ; dTOX4
null 
           
Cyo     TM6B 
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To recombine UAS-GFP-dTOX4wt and UAS-GFP-dTOX4P216! with maternal-
!-tubulin-GAL4: (note UAS-GFP-dTOX4wt or P216! have been shortened to UAS- 

































           
             SM6A 
w;      mat-!-tubGAL4     ‘     
 
   










; MKRS        








                                Tft 
w; Tft
 
; MKRS        








































w; Tft ; bam-GAL4
 
  
     Cyo  bam-GAL4          
  
w;   +   ; dTOX4
null 
           
Cyo     TM6B 
w; Tft ; bam-GAL4
 
  
     Cyo  dTOX4
null




; MKRS        
Cyo  TM6B 
w; Tft ; bam-GAL4, dTOX4
null 
  
     Cyo      MKRS or TM6B         
  (individual males, select for 
bam-GAL4 by eye colour)  
w; Tft
 
; MKRS        
Cyo  TM6B 
(screen by PCR for 
dTOX4 excision once 




w; Tft ; bam-GAL4, dTOX4
null 
  






, P[w+]30C, PTEN[3] FRT40A 
      
Cyo 




; GMR-hid, FRT40A, l(2)CL ; ey-GAL4, UAS-FLP  




;         GMR-hid, FRT40A, l(2)CL           ; ey-GAL4, UAS-FLP  
       PNUTS
13B
































         
              Cyo 
w; FRT40A, P[w+]30C, PTEN[3]
 
  
       
                       Cyo 




           
       




       
Cyo   
w; PNUTS
13B
, P[w+]30C, PTEN[3] FRT40A       





       
    Cyo 
To test presence of PTEN[3]. 
PTEN[3]/PTEN[1] is lethal so all 
progeny should have Tft or Cyo 
w; PNUTS
13B
, P[w+]30C, PTEN[3] FRT40A 
      
Cyo 





(20 crosses using individual males) 
Single fly PCR to validate presence of 
PNUTS
13B
 once crosses started to 






    





; GMR-hid, FRT40A, l(2)CL ; ey-GAL4, UAS-FLP  




;GMR-hid, FRT40A, l(2)CL ; ey-GAL4, UAS-FLP  
             PNUTS
13B
, FRT40A                       +  
! 
w; P[w+]30C, PTEN[3], FRT40A 
    
                             
    Cyo 





; GMR-hid, FRT40A, l(2)CL ; ey-GAL4, UAS-FLP  




;   GMR-hid, FRT40A, l(2)CL    ; ey-GAL4, UAS-FLP  
       P[w+]30C, PTEN[3], FRT40A                       +  
! 











































w; P[w+]30C, FRT40A 
    
                                





; GMR-hid, FRT40A, l(2)CL ; ey-GAL4, UAS-FLP  




; GMR-hid, FRT40A, l(2)CL ; ey-GAL4, UAS-FLP  





 ;   TM2      (7019) 
        
tubGAL80
ts
   TM6B 
w; ey-GAL4
 
; +    (5534) 
       
ey-GAL4   + 
! 
w;   ey-GAL4  
 
;     +         
       
tubGAL80
ts




       
Cyo  TM6B 
w; ey-GAL4, tubGAL80
ts 
;     +                 




       
Cyo  TM6B 
w; ; sce
IR 
   (5595R-2) 
 
      sce
IR
 
w;     +    
 
;   sce
IR  
           
Cyo     TM6B 
w; ey-GAL4, tubGAL80
ts 
;   sce
IR   
  
        
























DomSight: DLTS_RP1_hgx3052v1 vs. Drosophila 3rd instar larvae_RP1 (30 Apr 2012)








SID: Selected Interact ion Domain
It  is the amino acid sequence shared
by all prey fragments matching the
same reference protein.
SIDs have been found in numerous cases
to correspond to an ident if ied structural







1 25 Signal pept ide domain
1106 1131 Zinc f inger, CCCH- type- INTERPRO
5 848 PTHR12506- PANTHER
5 848 PTHR12506:SF8- PANTHER
1106 1131 zf- CCCH- PFAM
1107 1131 ZnF_C3H1- SMART






41 396 ATP:guanido phosphotransferase- INTERPRO
138 394 Glutamine synthetase/ guanido kinase, cat- INTERPRO
41 135 ATP- gua_Ptrans- GENE3D
42 135 ATP- gua_Ptrans- SSF
58 135 ATP- gua_PtransN- PFAM
104 396 PTHR11547:SF13- PANTHER
104 396 ATP- gua_Ptrans- PANTHER
136 396 SSF55931- SSF
138 394 ATP- gua_Ptrans- GENE3D
146 396 ATP- gua_Ptrans- PFAM
311 317 GUANIDO_KINASE- PROSITE





1010 1031 Coiled domain
125 184 Tudor- INTERPRO
198 254 Tudor- INTERPRO
334 431 DNA- binding, integrase- type- INTERPRO
357 433 Methyl- CpG DNA binding- INTERPRO
552 577 Zinc f inger, C2H2- type- INTERPRO
814 884 Zinc f inger, RING/ FYVE/ PHD- type- INTERPRO
823 883 Zinc f inger, FYVE/ PHD- type- INTERPRO
831 878 Zinc f inger, PHD- type- INTERPRO
125 184 TUDOR- SMART
135 739 PTHR15856:SF5- PANTHER
135 739 PTHR15856- PANTHER
198 254 TUDOR- SMART
202 251 SSF63748- SSF
334 431 DNA- binding_integrase- type- SSF
357 431 MBD- PFAM
357 426 MBD- PROFILE
361 432 Methyl_CpG_DNA- bd- GENE3D
362 433 MBD- SMART
550 578 SSF57667- SSF
552 577 ZINC_FINGER_C2H2_2- PROFILE
552 577 zf- C2H2- PFAM
554 577 ZINC_FINGER_C2H2_1- PROSITE
756 1010 PTHR15856- PANTHER
756 1010 PTHR15856:SF5- PANTHER
814 884 Znf_RING/ FYVE/ PHD- GENE3D
823 883 FYVE_PHD_ZnF- SSF
831 878 PHD- PFAM






1 21 Signal pept ide domain
68 203 Polysaccharide deacetylase- INTERPRO
72 340 Glycoside hydrolase/ deacetylase, beta/ al- INTERPRO
68 203 Polysacc_deac_1- PFAM






161 189 Coiled domain
90 150 Tudor- INTERPRO
1 241 PTHR12664- PANTHER
89 146 SSF63748- SSF
89 146 G3DSA:2.30.30.140- GENE3D
90 148 TUDOR- SMART






3 127 BTB/ POZ fold- INTERPRO
22 128 BTB/ POZ- INTERPRO
32 128 BTB/ POZ- like- INTERPRO
171 186 Phosphopantetheine attachment site- INTERPRO
517 540 Zinc f inger, C2H2- like- INTERPRO
517 573 Zinc f inger, C2H2- type- INTERPRO
545 568 Zinc f inger, C2H2- like- INTERPRO
3 118 BTB/ POZ_fold- GENE3D
6 572 PTHR23110- PANTHER
6 572 PTHR23110:SF13- PANTHER
7 127 BTB/ POZ_fold- SSF
22 128 BTB- PFAM
32 98 BTB- PROFILE
32 128 BTB- SMART
171 186 PHOSPHOPANTETHEINE- PROSITE
517 545 ZINC_FINGER_C2H2_2- PROFILE
517 540 zf- C2H2- PFAM
517 540 ZnF_C2H2- SMART
519 540 ZINC_FINGER_C2H2_1- PROSITE
527 571 SSF57667- SSF
545 568 zf- C2H2- PFAM
545 573 ZINC_FINGER_C2H2_2- PROFILE
545 568 ZnF_C2H2- SMART






4 37 Coiled domain
1 622 WD40 repeat- like- INTERPRO
288 631 WD40 repeat- INTERPRO
303 623 WD40/ YVTN repeat- like- INTERPRO
1 622 WD40_like- SSF
288 341 WD40- SMART
299 651 PTHR12442:SF22- PANTHER
299 651 PTHR12442- PANTHER
303 623 WD40/ YVTN_repeat- like- GENE3D
334 631 WD_REPEATS_REGION- PROFILE
346 385 WD40- SMART
347 385 WD40- PFAM
392 435 WD40- SMART
489 534 WD40- SMART
490 534 WD40- PFAM
513 543 WD_REPEATS_2- PROFILE
537 577 WD40- SMART
538 577 WD40- PFAM






138 222 High mobility group box, HMG- INTERPRO
140 225 High mobility group box, HMG1/ HMG2- INTERPRO
138 222 HMG- box- SSF
139 376 PTHR10270:SF43- PANTHER
139 376 PTHR10270- PANTHER
140 225 HMG- box- GENE3D
141 211 HMG- SMART
142 210 HMG_BOX_2- PROFILE
142 210 HMG_box- PFAM
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138 394 ATP- gua_Ptrans- GENE3D
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125 184 Tudor- INTERPRO
198 254 Tudor- INTERPRO
334 431 DNA- binding, integrase- type- INTERPRO
357 433 Methyl- CpG DNA binding- INTERPRO
552 577 Zinc f inger, C2H2- type- INTERPRO
814 884 Zinc f inger, RING/ FYVE/ PHD- type- INTERPRO
823 883 Zinc f inger, FYVE/ PHD- type- INTERPRO
831 878 Zinc f inger, PHD- type- INTERPRO
125 184 TUDOR- SMART
135 739 PTHR15856:SF5- PANTHER
135 739 PTHR15856- PANTHER
198 254 TUDOR- SMART
202 251 SSF63748- SSF
334 431 DNA- binding_integrase- type- SSF
357 431 MBD- PFAM
357 426 MBD- PROFILE
361 432 Methyl_CpG_DNA- bd- GENE3D
362 433 MBD- SMART
550 578 SSF57667- SSF
552 577 ZINC_FINGER_C2H2_2- PROFILE
552 577 zf- C2H2- PFAM
554 577 ZINC_FINGER_C2H2_1- PROSITE
756 1010 PTHR15856- PANTHER
756 1010 PTHR15856:SF5- PANTHER
814 884 Znf_RING/ FYVE/ PHD- GENE3D
823 883 FYVE_PHD_ZnF- SSF
831 878 PHD- PFAM






1 21 Signal pept ide domain
68 203 Polysaccharide deacetylase- INTERPRO
72 340 Glycoside hydrolase/ deacetylase, beta/ al- INTERPRO
68 203 Polysacc_deac_1- PFAM






161 189 Coiled domain
90 150 Tudor- INTERPRO
1 241 PTHR12664- PANTHER
89 146 SSF63748- SSF
89 146 G3DSA:2.30.30.140- GENE3D
90 148 TUDOR- SMART






3 127 BTB/ POZ fold- INTERPRO
22 128 BTB/ POZ- INTERPRO
32 128 BTB/ POZ- like- INTERPRO
171 186 Phosphopantetheine attachment site- INTERPRO
517 540 Zinc f inger, C2H2- like- INTERPRO
517 573 Zinc f inger, C2H2- type- INTERPRO
545 568 Zinc f inger, C2H2- like- INTERPRO
3 118 BTB/ POZ_fold- GENE3D
6 572 PTHR23110- PANTHER
6 572 PTHR23110:SF13- PANTHER
7 127 BTB/ POZ_fold- SSF
22 128 BTB- PFAM
32 98 BTB- PROFILE
32 128 BTB- SMART
171 186 PHOSPHOPANTETHEINE- PROSITE
517 545 ZINC_FINGER_C2H2_2- PROFILE
517 540 zf- C2H2- PFAM
517 540 ZnF_C2H2- SMART
519 540 ZINC_FINGER_C2H2_1- PROSITE
527 571 SSF57667- SSF
545 568 zf- C2H2- PFAM
545 573 ZINC_FINGER_C2H2_2- PROFILE
545 568 ZnF_C2H2- SMART






4 37 Coiled domain
1 622 WD40 repeat- like- INTERPRO
288 631 WD40 repeat- INTERPRO
303 623 WD40/ YVTN repeat- like- INTERPRO
1 622 WD40_like- SSF
288 341 WD40- SMART
299 651 PTHR12442:SF22- PANTHER
299 651 PTHR12442- PANTHER
303 623 WD40/ YVTN_repeat- like- GENE3D
334 631 WD_REPEATS_REGION- PROFILE
346 385 WD40- SMART
347 385 WD40- PFAM
392 435 WD40- SMART
489 534 WD40- SMART
490 534 WD40- PFAM
513 543 WD_REPEATS_2- PROFILE
537 577 WD40- SMART
538 577 WD40- PFAM






138 222 High mobility group box, HMG- INTERPRO
140 225 High mobility group box, HMG1/ HMG2- INTERPRO
138 222 HMG- box- SSF
139 376 PTHR10270:SF43- PANTHER
139 376 PTHR10270- PANTHER
140 225 HMG- box- GENE3D
141 211 HMG- SMART
142 210 HMG_BOX_2- PROFILE
142 210 HMG_box- PFAM
services@hybrigenics.com www.hybrigenics- services.com page 1 /  5
Appendix 7  
 
Yeast two-hybrid screen results. Identified proteins together with domain analysis 
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SID: Selected Interact ion Domain
It  is the amino acid sequence shared
by all prey fragments matching the
same reference protein.
SIDs have been found in numerous cases
to correspond to an ident if ied structural







119 228 Zinc f inger, NHR/ GATA- type- INTERPRO
124 200 Zinc f inger, nuclear hormone receptor- ty- INTERPRO
127 143 Vitamin D receptor- INTERPRO
188 198 Steroid hormone receptor- INTERPRO
197 493 Nuclear hormone receptor, ligand- binding- INTERPRO
307 490 Nuclear hormone receptor, ligand- binding- INTERPRO
308 345 Steroid hormone receptor- INTERPRO
396 411 Steroid hormone receptor- INTERPRO
453 470 Steroid hormone receptor- INTERPRO
486 496 Vitamin D receptor- INTERPRO
119 228 Znf_NHR/ GATA- GENE3D
124 195 ZnF_C4- SMART
124 199 NUCLEAR_REC_DBD_2- PROFILE
125 214 PTHR11865- PANTHER
125 214 PTHR11865:SF151- PANTHER
125 213 SSF57716- SSF
125 200 zf- C4- PFAM
126 192 Znf_C4steroid- PRODOM
127 143 VITAMINDR- PRINTS
127 153 NUCLEAR_REC_DBD_1- PROSITE
127 143 STROIDFINGER- PRINTS
143 158 STROIDFINGER- PRINTS
144 163 VITAMINDR- PRINTS
176 184 STROIDFINGER- PRINTS
184 192 STROIDFINGER- PRINTS
188 198 STRDHORMONER- PRINTS
197 492 Str_ncl_receptor- SSF
254 493 PTHR11865:SF151- PANTHER
254 493 PTHR11865- PANTHER
281 493 Nucl_hrmn_rcpt_lig_bd- GENE3D
307 465 HOLI- SMART
308 329 STRDHORMONER- PRINTS
310 490 Hormone_recep- PFAM
329 345 STRDHORMONER- PRINTS
396 411 STRDHORMONER- PRINTS
453 470 STRDHORMONER- PRINTS






1 446 Translat ion elongat ion factor EF1A, euka- INTERPRO
5 240 Protein synthesis factor, GTP- binding- INTERPRO
238 335 Translat ion elongat ion and init iat ion fa- INTERPRO
260 327 Translat ion elongat ion factor EFTu/ EF1A,- INTERPRO
334 442 Translat ion elongat ion factor EFTu/ EF1A,- INTERPRO
337 443 Translat ion elongat ion factor EF1A/ init i- INTERPRO
1 361 PTHR23115:SF37- PANTHER
1 361 PTHR23115- PANTHER
1 446 EF- 1_alpha- TIGRFAMs
2 261 SSF52540- SSF
4 217 G3DSA:3.40.50.300- GENE3D
5 240 GTP_EFTU- PFAM
9 22 ELONGATNFCT- PRINTS
61 76 EFACTOR_GTP- PROSITE
68 76 ELONGATNFCT- PRINTS
88 98 ELONGATNFCT- PRINTS
104 115 ELONGATNFCT- PRINTS
148 157 ELONGATNFCT- PRINTS
238 335 Translat_factor- SSF
241 329 G3DSA:2.40.30.10- GENE3D
260 327 GTP_EFTU_D2- PFAM
334 442 GTP_EFTU_D3- PFAM
335 442 G3DSA:2.40.30.10- GENE3D






207 285 Zinc f inger, AD- type- INTERPRO
686 739 Zinc f inger, GATA- type- INTERPRO
686 745 Zinc f inger, NHR/ GATA- type- INTERPRO
1 435 PTHR10071- PANTHER
1 435 PTHR10071:SF1- PANTHER
207 285 zf- AD- PFAM
228 286 SSF57716- SSF
681 746 SSF57716- SSF
686 736 ZnF_GATA- SMART
686 739 GATA_ZN_FINGER_2- PROFILE
686 745 Znf_NHR/ GATA- GENE3D
692 716 GATA_ZN_FINGER_1- PROSITE






1 102 Histone H4- INTERPRO
1 103 Histone- fold- INTERPRO
25 94 Histone core- INTERPRO
28 93 TATA box binding protein associated fact- INTERPRO
1 102 Histone_H4- PANTHER
1 101 Histone- fold- SSF
1 103 Histone- fold- GENE3D
5 16 HISTONEH4- PRINTS
15 19 HISTONE_H4- PROSITE
16 90 H4- SMART
20 39 HISTONEH4- PRINTS
25 94 Histone- PFAM
28 101 Histone_H4- PRODOM
28 93 TAF- SMART
40 60 HISTONEH4- PRINTS
62 76 HISTONEH4- PRINTS
77 89 HISTONEH4- PRINTS






956 981 Coiled domain
124 316 DEAD- like helicase, N- terminal- INTERPRO
131 411 SNF2- related- INTERPRO
140 305 Helicase, superfamily 1 and 2, ATP- bindi- INTERPRO
435 586 DNA/ RNA helicase, C- terminal- INTERPRO
697 798 Nucleosome remodelling ATPase ISWI, HAND- INTERPRO
796 845 SANT, DNA- binding- INTERPRO
799 850 Homeodomain- like- INTERPRO
852 968 SLIDE- INTERPRO
898 962 SANT, DNA- binding- INTERPRO
42 304 SSF52540- SSF
52 1010 PTHR10799- PANTHER
52 1010 PTHR10799:SF73- PANTHER
124 316 DEXDc- SMART
131 411 SNF2_N- PFAM
140 305 HELICASE_ATP_BIND_1- PROFILE
416 896 SSF52540- SSF
432 585 G3DSA:3.40.50.300- GENE3D
435 586 HELICASE_CTER- PROFILE
461 545 HELICc- SMART
466 545 Helicase_C- PFAM
697 798 Nucl_remodel_ATPase_ISWI_HAND- SSF
697 796 HAND- PFAM
796 845 SANT- SMART
799 850 Homeodomain_like- SSF
851 978 Homeodomain_like- SSF
852 968 SLIDE- PFAM






1 16 Signal pept ide domain
30 158 Hemocyanin, N- terminal- INTERPRO
159 530 Di- copper centre- containing- INTERPRO
159 525 Hemocyanin, copper- containing- INTERPRO
310 796 Arthropod hemocyanin/ insect LSP- INTERPRO
310 796 Hemocyanin related larval storage protei- INTERPRO
530 784 Hemocyanin, C- terminal- INTERPRO
531 784 Immunoglobulin E- set- INTERPRO
30 158 Hemocyanin_N- SSF
31 157 Hemocyanin_N- PFAM
50 158 hemocyanin_N- GENE3D
159 525 Hemocyanin_M- PFAM
159 529 Di- copper_centre- GENE3D
271 530 Di- copper_centre- SSF
310 796 Hemocyanin- PANTHER
310 796 Arylphorin- PANTHER
505 513 HEMOCYANIN_2- PROSITE
530 784 hemocyanin_C- GENE3D
531 783 Hemocyanin_C- PFAM






46 68 Transmembrane domain
232 258 Coiled domain
378 406 Coiled domain
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6 176 Ribosomal protein L18ae- INTERPRO
6 176 Ribosomal_L18ae- PFAM
26 176 PTHR10052- PANTHER






183 299 Ribosomal protein L22e- INTERPRO
183 299 Ribosomal_L22e- PANTHER
184 297 Ribosomal_L22e- PFAM






2 131 Ribosomal protein S17e- INTERPRO
1 62 G3DSA:1.10.60.20- GENE3D
2 131 Ribosomal_S17E- PANTHER
2 122 Ribosomal_S17e- PFAM






1 152 Ribosomal protein S19e- INTERPRO
1 152 Ribosomal_S19E- PANTHER
3 108 Ribosomal_S19E- PRODOM
4 143 Ribosomal_S19e- PFAM
48 136 SSF46785- SSF






211 239 Coiled domain
1 247 Ribosomal protein S6, eukaryot ic- INTERPRO
1 248 Ribosomal protein S6e- INTERPRO
1 127 Ribosomal_S6e- PFAM
1 247 Ribosom_S6_euk- PIRSF
7 248 Ribosomal_S6E- PANTHER
52 63 RIBOSOMAL_S6E- PROSITE
73 145 Ribosomal_S6E- PRODOM
D Sox102F
Drosophila melanogaster
GadFly V3: CG11153- RA
1 580
225 580 SID
365 457 High mobility group box, HMG- INTERPRO
383 461 High mobility group box, HMG1/ HMG2- INTERPRO
365 457 HMG- box- SSF
377 519 PTHR10270:SF29- PANTHER
377 519 PTHR10270- PANTHER
383 461 HMG- box- GENE3D
384 454 HMG- SMART
385 453 HMG_BOX_2- PROFILE






167 259 High mobility group box, HMG- INTERPRO
185 270 High mobility group box, HMG1/ HMG2- INTERPRO
167 259 HMG- box- SSF
181 276 PTHR10270:SF27- PANTHER
181 276 PTHR10270- PANTHER
185 270 HMG- box- GENE3D
186 256 HMG- SMART
187 255 HMG_BOX_2- PROFILE






159 251 High mobility group box, HMG- INTERPRO
177 262 High mobility group box, HMG1/ HMG2- INTERPRO
159 251 HMG- box- SSF
176 273 PTHR10270:SF47- PANTHER
176 273 PTHR10270- PANTHER
177 262 HMG- box- GENE3D
178 248 HMG- SMART
179 247 HMG_BOX_2- PROFILE
179 247 HMG_box- PFAM
547 552 PTHR10270:SF47- PANTHER






188 209 Coiled domain
1 124 Mov34/ MPN/ PAD- 1- INTERPRO
1 75 Mov34- 1- INTERPRO
1 309 PTHR10410- PANTHER
1 309 PTHR10410:SF3- PANTHER
1 98 Mov34- PFAM
1 124 JAB_MPN- SMART






253 409 Armadillo- type fold- INTERPRO
253 417 eIF4- gamma/ eIF5/ eIF2- epsilon- INTERPRO
2 420 PTHR14208- PANTHER
253 417 eIF5C- GENE3D
253 409 ARM- type_fold- SSF
326 411 eIF5C- SMART






333 400 Homeobox- INTERPRO
334 411 Homeodomain- like- INTERPRO
335 407 Homeodomain- related- INTERPRO
23 241 PTHR11850:SF10- PANTHER
23 241 PTHR11850- PANTHER
333 396 HOMEOBOX_2- PROFILE
334 411 Homeodomain_like- SSF
335 400 HOX- SMART
335 407 Homeodomain- rel- GENE3D
336 395 Homeobox- PFAM






148 169 Coiled domain
29 155 Paired box protein, N- terminal- INTERPRO
30 152 Homeodomain- like- INTERPRO
32 97 Winged helix  repressor DNA- binding- INTERPRO
218 314 Homeodomain- related- INTERPRO
238 310 Homeodomain- like- INTERPRO
249 313 Homeobox- INTERPRO
29 153 PAX- SMART
29 155 PAIRED_2- PROFILE
29 153 PAX- PFAM
30 152 Homeodomain_like- SSF
32 97 Wing_hlx_DNA_bd- GENE3D
38 125 PTHR19418- PANTHER
38 125 PTHR19418:SF73- PANTHER
63 79 PAIRED_1- PROSITE
98 162 Wing_hlx_DNA_bd- GENE3D
218 314 Homeodomain- rel- GENE3D
238 310 Homeodomain_like- SSF
243 322 PTHR19418- PANTHER
243 322 PTHR19418:SF73- PANTHER
249 309 HOMEOBOX_2- PROFILE
251 313 HOX- SMART
252 308 Homeobox- PFAM
253 308 Homeobox- PRODOM
284 307 HOMEOBOX_1- PROSITE
403 427 PTHR19418:SF73- PANTHER
403 427 PTHR19418- PANTHER
455 509 PTHR19418:SF73- PANTHER





24 43 Transmembrane domain
76 98 Transmembrane domain
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7 29 Transmembrane domain
44 66 Transmembrane domain









12 34 Transmembrane domain
44 66 Transmembrane domain
79 101 Transmembrane domain
121 143 Transmembrane domain
156 178 Transmembrane domain
1 221 Cytochrome c ox idase, subunit  I- INTERPRO
1 220 COX1- PANTHER
1 221 COX1- SSF
1 219 COX1- PROFILE





24 46 Transmembrane domain
51 73 Transmembrane domain














29 51 Transmembrane domain
55 77 Transmembrane domain













21 43 Transmembrane domain
68 85 Transmembrane domain





82 104 Transmembrane domain
111 133 Transmembrane domain
183 205 Transmembrane domain
226 248 Transmembrane domain
41 44 Coiled domain
45 48 Coiled domain
49 58 Coiled domain





20 39 Transmembrane domain






155 316 C2 calcium/ lipid- binding region, CaLB- INTERPRO
161 294 C2 calcium- dependent membrane target ing- INTERPRO
495 578 Protein of unknown funct ion DUF1041- INTERPRO
616 734 Munc13 homology 1- INTERPRO
827 933 Munc13 homology 2- INTERPRO
1 330 PTHR15015- PANTHER
1 330 PTHR15015:SF9- PANTHER
155 316 C2_CaLB- SSF
161 279 C2- PROFILE
175 302 G3DSA:2.60.40.150- GENE3D
175 294 C2- SMART
176 279 C2- PFAM
495 578 DUF1041- PFAM
616 734 MHD1- PROFILE






56 148 High mobility group box, HMG1/ HMG2- INTERPRO
74 151 High mobility group box, HMG- INTERPRO
56 148 HMG- box- GENE3D
74 151 HMG- box- SSF
75 149 PTHR13711- PANTHER
75 145 HMG- SMART
76 144 HMG_BOX_2- PROFILE






1 23 Signal pept ide domain
65 262 Mitochondrial glycoprotein- INTERPRO
1 263 PTHR10826- PANTHER
1 263 PTHR10826:SF2- PANTHER
65 262 MAM33- GENE3D
65 260 MAM33- SSF






2 163 PTHR10411- PANTHER
2 163 PTHR10411:SF1- PANTHER






248 269 Coiled domain
1 360 Uncharacterised conserved protein UCP030- INTERPRO
1 358 Protein of unknown funct ion DUF89- INTERPRO
1 337 PTHR12280- PANTHER
1 358 DUF89- SSF
1 360 UCP030210- PIRSF
53 310 DUF89- PFAM
D CG10475
Drosophila melanogaster
GadFly V3: CG10475- RA
1 262
5 262 SID
1 17 Signal pept ide domain
27 262 Peptidase, trypsin- like serine and cyste- INTERPRO
37 259 Peptidase S1 and S6, chymotrypsin/ Hap- INTERPRO
67 82 Peptidase S1A, chymotrypsin- INTERPRO
205 217 Peptidase S1A, chymotrypsin- INTERPRO
1 256 PTHR19355- PANTHER
1 256 PTHR19355:SF72- PANTHER
27 262 Pept_Ser_Cys- SSF
37 254 Tryp_SPc- SMART
38 254 Trypsin- PFAM
38 259 TRYPSIN_DOM- PROFILE
66 256 G3DSA:2.40.10.10- GENE3D
67 82 CHYMOTRYPSIN- PRINTS
205 217 CHYMOTRYPSIN- PRINTS
206 217 TRYPSIN_SER- PROSITE
D CG17266
Drosophila melanogaster
GadFly V3: CG17266- RA
1 183
21 91 SID
11 183 Cyclophilin- like- INTERPRO
15 183 Peptidyl- prolyl cis- trans isomerase, cyc- INTERPRO
11 183 CSA_PPIase- SSF
15 183 PTHR11071:SF58- PANTHER
15 183 PPIase_cyclophilin- GENE3D
15 183 PPIase_cyclophilin- PANTHER
18 183 Pro_isomerase- PFAM
20 182 CSA_PPIASE_2- PROFILE
66 83 CSA_PPIASE_1- PROSITE






DomSight: DLTS_RP1_hgx3052v1 vs. Drosophila 3rd instar larvae_RP1 (30 Apr 2012)








SID: Selected Interact ion Domain
It  is the amino acid sequence shared
by all prey fragments matching the
same reference protein.
SIDs have been found in numerous cases
to correspond to an ident if ied structural




GadFly V3: CG14711- RA
1 377
199 371 SID
6 84 Zinc f inger, AD- type- INTERPRO
226 248 Zinc f inger, C2H2- like- INTERPRO
226 253 Zinc f inger, C2H2- type- INTERPRO
251 278 Zinc f inger, C2H2- type/ integrase, DNA- bi- INTERPRO
254 276 Zinc f inger, C2H2- like- INTERPRO
256 276 Zinc f inger, C2H2- type- INTERPRO
282 304 Zinc f inger, C2H2- like- INTERPRO
282 309 Zinc f inger, C2H2- type- INTERPRO
307 334 Zinc f inger, C2H2- type/ integrase, DNA- bi- INTERPRO
310 332 Zinc f inger, C2H2- like- INTERPRO
312 332 Zinc f inger, C2H2- type- INTERPRO
338 362 Zinc f inger, C2H2- like- INTERPRO
338 365 Zinc f inger, C2H2- type- INTERPRO
5 85 SSF57716- SSF
6 84 zf- AD- PFAM
223 368 PTHR11389- PANTHER
226 248 zf- C2H2- PFAM
226 253 ZINC_FINGER_C2H2_2- PROFILE
226 248 ZnF_C2H2- SMART
228 248 ZINC_FINGER_C2H2_1- PROSITE
236 280 SSF57667- SSF
251 278 Znf_C2H2/ integrase_DNA- bd- GENE3D
254 281 ZINC_FINGER_C2H2_2- PROFILE
254 276 zf- C2H2- PFAM
254 276 ZnF_C2H2- SMART
256 276 ZINC_FINGER_C2H2_1- PROSITE
278 339 SSF57667- SSF
282 304 zf- C2H2- PFAM
282 309 ZINC_FINGER_C2H2_2- PROFILE
282 304 ZnF_C2H2- SMART
284 304 ZINC_FINGER_C2H2_1- PROSITE
307 334 Znf_C2H2/ integrase_DNA- bd- GENE3D
310 337 ZINC_FINGER_C2H2_2- PROFILE
310 332 zf- C2H2- PFAM
310 332 ZnF_C2H2- SMART
312 332 ZINC_FINGER_C2H2_1- PROSITE
335 362 SSF57667- SSF
338 362 zf- C2H2- PFAM
338 365 ZINC_FINGER_C2H2_2- PROFILE
338 362 ZnF_C2H2- SMART






5 533 T- complex protein 1, delta subunit- INTERPRO
5 533 Chaperonin Cpn60/ TCP- 1- INTERPRO
17 533 GroEL- like chaperone, ATPase- INTERPRO
42 54 Chaperonin TCP- 1, conserved site- INTERPRO
63 79 Chaperonin TCP- 1, conserved site- INTERPRO
91 99 Chaperonin TCP- 1, conserved site- INTERPRO
5 533 Cpn60/ TCP- 1- PANTHER
5 533 Chap_CCT_delta- PANTHER
17 533 GroEL- ATPase- SSF
17 532 chap_CCT_delta- TIGRFAMs
20 529 G3DSA:1.10.560.10- GENE3D
37 533 Cpn60_TCP1- PFAM
42 54 TCP1_1- PROSITE
63 79 TCP1_2- PROSITE
91 99 TCP1_3- PROSITE
151 413 SSF54849- SSF












226 247 Coiled domain
6 144 ENTH/ VHS- INTERPRO
6 136 Regulat ion of nuclear pre- mRNA protein- INTERPRO
190 203 Carbohydrate/ puine kinase, PfkB, conserv- INTERPRO
329 487 Nucleot ide- binding, alpha- beta plait - INTERPRO
401 473 RNA recognit ion motif , RNP- 1- INTERPRO
1 1215 PTHR14124- PANTHER
6 136 RPR- SMART
6 144 ENTH_VHS- SSF
22 131 ENTH_VHS- GENE3D
190 203 PFKB_KINASES_2- PROSITE
329 487 a_b_plait_nuc_bd- GENE3D
366 474 SSF54928- SSF
401 473 RRM- PROFILE
402 469 RRM- SMART






1111 1132 Coiled domain
933 1017 Cyclin- like- INTERPRO
933 1017 Cyclin_like- SSF
1124 1464 PTHR23246- PANTHER
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